US11793881B2 - Polyethylene glycol conjugate medicament, preparation method therefor and use thereof - Google Patents

Polyethylene glycol conjugate medicament, preparation method therefor and use thereof Download PDF

Info

Publication number
US11793881B2
US11793881B2 US17/779,649 US202017779649A US11793881B2 US 11793881 B2 US11793881 B2 US 11793881B2 US 202017779649 A US202017779649 A US 202017779649A US 11793881 B2 US11793881 B2 US 11793881B2
Authority
US
United States
Prior art keywords
mmol
added
polyethylene glycol
independently
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US17/779,649
Other versions
US20230088403A1 (en
Inventor
Gaoquan Li
Dajun Li
Qian Zhang
Yusong Wei
Yongchen PENG
Xiangwei YANG
Xiafan ZENG
Gang MEI
Diedie LI
Chengzhi GAO
Xiaoling Ding
Yue Liu
Jia Gao
Yuyang YI
Yanxia HENG
Xi Liu
Tao Tu
Kai Wang
Liwei Liu
Mei Liu
Qiang Luo
Xiao Tang
Jie Lou
Huiyu CHEN
Yue Yang
Yuanqiang WANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Upgra Biotechnology Co Ltd
Original Assignee
Chongqing Upgra Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Upgra Biotechnology Co Ltd filed Critical Chongqing Upgra Biotechnology Co Ltd
Assigned to Chongqing Upgra Biotechnology Co., Ltd. reassignment Chongqing Upgra Biotechnology Co., Ltd. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, Huiyu, DING, XIAOLING, GAO, Chengzhi, GAO, Jia, HENG, Yanxia, LI, Dajun, LI, Diedie, LI, GAOQUAN, LIU, LIWEI, LIU, MEI, LIU, XI, LIU, YUE, LOU, Jie, LUO, QIANG, MEI, GANG, PENG, Yongchen, TANG, XIAO, TU, TAO, WANG, KAI, WANG, Yuanqiang, WEI, Yusong, YANG, Xiangwei, YANG, YUE, YI, Yuyang, ZENG, Xiafan, ZHANG, QIAN
Publication of US20230088403A1 publication Critical patent/US20230088403A1/en
Application granted granted Critical
Publication of US11793881B2 publication Critical patent/US11793881B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33396Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595Polyamides, e.g. nylon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C08G81/024Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
    • C08G81/025Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G containing polyether sequences
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002Dendritic macromolecules
    • C08G83/003Dendrimers
    • C08G83/004After treatment of dendrimers

Definitions

  • the present invention belongs to the technical field of medicine, and relates to a polyethylene glycol conjugated drug, preparation method thereof and use thereof.
  • Pegylated drug has great advantages over the original drug, which can increase water solubility of drug molecules (which is very important for drugs with extremely low solubility such as paclitaxel, camptothecin or platinum); and can prevent or reduce drug agglomeration, immunogenicity and antigenicity.
  • Most small-molecule anticancer drugs can only stay in the blood circulation for a few minutes, while polymer-(anticancer drug) conjugates may stay for tens or hundreds of hours or even longer, which is beneficial from the “enhanced permeability and retention” effect, i.e., the EPR effect, caused by leakage of tumor capillaries.
  • the renal elimination of the drugs is weakened, the drugs are protected from enzymatic degradation, the half-life of the drugs in plasma is extended, and the bioavailability of the drugs is increased.
  • the anticancer drugs can be highly enriched in diseased organs, tissues or cells through the EPR passive targeting or active targeting, thereby greatly reducing the toxic side effects caused by small molecule anticancer drugs spreading all over the body.
  • the polymer-(anticancer drug) conjugates can limit the cell absorption of drugs to the endocytic pathway, which is conducive to drug delivery to the lysosome, thereby avoiding drug resistance caused by p-glycoprotein pumping out; the polymer-(anticancer drug) conjugates can also stimulate or restore immune function, and this is conducive to killing cancer cells.
  • the NEKTAR company and the ENZON company in the United States have successfully developed polyethylene glycol conjugated drugs.
  • polyethylene glycol conjugated drugs which have been approved by the FDA to enter the market, and in addition, 36 new clinical drugs are in the first-phase, second-phase, third-phase clinical trials or in the NDA phase.
  • all the above pegylated drugs are pegylated single drugs.
  • Chinese patent ZL201510996205.4 discloses that gemcitabine, a chemotherapeutic drug, and AZD7762, a Chk1 inhibitor, are grafted onto a four-arm polyethylene glycol carrier simultaneously.
  • the Chk1 inhibitor has no anticancer effect in itself, but, when combined with gemcitabine, it can enhance the effect of the chemotherapeutic drug.
  • Chinese patents ZL201710761441.7 and ZL201710761572.5 disclose that two anticancer drugs are grafted onto one graft site of polyethylene glycol simultaneously, to thereby realize the inhibition of different cancer cell biological signal channels and targets, and the free combination between different treatment methods.
  • the present invention is directed to solving, at least to a certain extent, one of the technical problems in the related art. Therefore, the present invention provides a polyethylene glycol conjugated drug which has excellent tumor inhibition activity. Through the preparation method of the present invention, the polyethylene glycol conjugated drug of the present invention can be prepared efficiently and conveniently.
  • the present invention provides a polyethylene glycol conjugated drug of formula (I) or a pharmaceutically acceptable salt thereof.
  • polyethylene glycol conjugated drug of the present invention multiple identical or different drug molecules are conjugated together by using an amino acid or a polypeptide as a linking chain, and a dicarboxylic acid with an amino group (for example, a natural amino acid with two carboxyl groups) as a linking bridge.
  • the type, ratio and drug loading of the drug can be adjusted.
  • PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight may be from 2 k to 40 k, such as from 5 k to 10 k or from 10 k to 40 k, such as about 2 k, about 5 k, about 10 k, about 20 k, about 30 k or about 40 k.
  • PEG reacts with a carboxyl group on the main chain through a terminal amino group to form an amide bond.
  • PEG reacts with an amino group on the main chain through a terminal carboxyl group to form an amide bond.
  • the molecular weight of the PEG comprises the terminal amino group thereof (i.e., the PEG derivative bearing reactive group), and in some embodiments, the molecular weight of the PEG is the molecular weight of polyethylene glycol and X or X′ as a whole, which may be from 2 k to 40 k, such as 2 k to 3 k, 3 k to 5 k, 5 k to 10 k, or 10 k to 40 k, such as about 2 k, about 3 k, about 5 k, about 10 k, about 40 k.
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—, —C( ⁇ O)—, —NH—C 1-6 alkylene-NH—, —C( ⁇ O)—C 1-6 alkylene-NH—,
  • PEG m is a single-arm or multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k or 10 k;
  • A1, A1′ each independently are
  • A2 independently is a direct bond or
  • L1 independently is a direct bond or —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—;
  • W1, W1′, W2 each independently are Q1,
  • Q is —N-AC
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N, N1, N2 each independently are GFLG, G,
  • AC, AC1, AC2 each independently are drug molecules (for example, drug molecules with anti-tumor activity), preferably PCB, DOX, LPT, SB7, PKA, SN38, PTX or NPB;
  • n1, n2 each independently are 0, 1, 2, 3, 4, 5 or 6;
  • Y, Y′ each independently are a direct bond, GLFG, —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—,
  • X, X′ each independently are
  • PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight independently is 5 k-40 k;
  • j1 is 1, 2, 3, 4, 5 or 6;
  • j2, j3 each independently are 0 or 1.
  • PEG m is linked to the residual structure of the compound of the formula (I) through carbonyl.
  • polyethylene glycol conjugated drug of the present invention multiple identical or different drug molecules are conjugated together by using an amino acid or a polypeptide as a linking chain, and a dicarboxylic acid with an amino group (for example, a natural amino acid with two carboxyl groups) as a linking bridge.
  • the type, ratio and drug loading of the drug can be adjusted.
  • PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight may be from 2 k to 40 k, such as from 5 k to 10 k or from 10 k to 40 k, such as about 2 k, about 5 k, about 10 k, about 20 k, about 30 k or about 40 k.
  • PEG reacts with a carboxyl group on the main chain through a terminal amino group to form an amide bond.
  • PEG reacts with an amino group on the main chain through a terminal carboxyl group to form an amide bond.
  • the molecular weight of the PEG comprises the terminal amino group thereof (i.e., the PEG derivative bearing reactive group), and in some embodiments, the molecular weight of the PEG is the molecular weight of polyethylene glycol and X or X′ as a whole, which may be from 2 k to 40 k, such as 2 k to 3 k, 3 k to 5 k, 5 k to 10 k, or 10 k to 40 k, such as about 2 k, about 3 k, about 5 k, about 10 k, about 40 k.
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—, —C( ⁇ O)—, —NH—C 1-6 alkylene-NH—, —C( ⁇ O)—C 1-6 alkylene-NH—,
  • A1, A1′ each independently are
  • A2 independently is a direct bond or
  • L1 independently is a direct bond or —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—;
  • W1, W1′, W2 each independently are Q1,
  • Q is —N-AC
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N, N1, N2 each independently are GFLG, G,
  • AC, AC1, AC2 each independently are drug molecules (for example, drug molecules with anti-tumor activity), preferably PCB, DOX, LPT, SB7, PKA, SN38 or PTX;
  • n1, n2 each independently are 0, 1, 2, 3, 4, 5 or 6;
  • Y, Y′ each independently are a direct bond, GLFG, —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—,
  • X, X′ each independently are
  • PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight independently is 5 k-40 k;
  • j1 is 1, 2, 3, 4, 5 or 6;
  • j2, j3 each independently are 0 or 1.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (II), the formula (III), the formula (IV) or the formula (V):
  • the polyethylene glycol conjugated drug has the structure represented by the formula (II), wherein:
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—
  • PEG m is a single-arm or multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k or 10 k,
  • A1 independently is
  • Y independently is a direct bond
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N, N1, N2 each independently are G, GFLG,
  • AC, AC1, AC2 each independently are SN38, PKA, PCB, LPT, SB7, PTX or NPB, the number-average molecular weight of PEG independently is 5 k-40 k.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (II), wherein:
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—
  • A1 independently is
  • Y independently is a direct bond, GLFG, —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—,
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N, N1, N2 each independently are G, GFLG,
  • AC, AC1, AC2 each independently are SN38, PKA, PCB, LPT or SB7, the number-average molecular weight of PEG independently is 5 k-40 k.
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—, A1 is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is PCB
  • AC2 is PKA.
  • M is —NH—C 1-6 alkylene-NH—
  • A1 is
  • Y is GLFG
  • X is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is GLFG
  • X is
  • Q is —N-AC, N is G, AC is SN38.
  • M is N
  • Y is a direct bond or —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—, X is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • X is
  • Q is —N-AC
  • N is GFLG
  • AC is LPT.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q is —N-AC
  • N is GFLG
  • AC is PCB.
  • M is N
  • Y is a direct bond
  • X is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • X is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 are GFLG
  • AC1 is NPB
  • AC2 is PCB.
  • M is PEG m
  • PEG m is a single-arm polyethylene glycol segment
  • its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k
  • Y is a direct bond
  • X is
  • M is PEGm
  • PEG m is a single-arm polyethylene glycol segment
  • its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k
  • A1 is
  • Y is a direct bond
  • X is
  • Q is —N-AC, N is G, AC is SN38.
  • M is PEGm
  • PEG m is a multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 10 k
  • A1 is
  • Y is a direct bond
  • X is
  • M is PEGm
  • PEG m is a multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 10 k
  • A1 is
  • Y is a direct bond
  • X is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 are GFLG
  • AC1 is LPT
  • AC2 is PCB.
  • M is N
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 are GFLG
  • AC1 is LPT
  • AC2 is PCB.
  • M is N
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 are GFLG
  • AC1 is LPT
  • AC2 is PCB.
  • M is N
  • Y is a direct bond
  • X is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • X is
  • AC is PTX.
  • M is N
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q is —N-AC, N is G, AC is SN38.
  • Y is a direct bond, GLFG, —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)— or
  • Y is a direct bond, GLFG, —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)— or
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is GLFG
  • X is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is GLFG
  • X is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is LPT.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • X is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1, AC2 each independently are PCB, SB7 or LPT.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q is —N-AC
  • N is GFLG
  • AC is PCB.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • X is
  • Q is —N-AC
  • N is GFLG
  • AC is NPB.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (III), wherein: M is
  • A1, A1′ each independently are
  • Y, Y′ each independently are a direct bond or
  • W1, W1′ each independently are
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N, N1, N2 each independently are GFLG, G,
  • AC, AC1, AC2 each independently are SN38, PKA, PCB, PTX, LPT, SB7 or DOX,
  • the number-average molecular weight of PEG independently is 5 k-40 k.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (III), wherein:
  • Y, Y’ each independently are a direct bond or
  • W1, W1′ each independently are Q1
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1, N2 each independently are GFLG, G,
  • AC1, AC2 each independently are SN38, PKA, PCB, PTX, LPT, SB7 or DOX,
  • the number-average molecular weight of PEG independently is 5 k-40 k.
  • Y is a direct bond
  • Y′ is
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • Y′ is
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 is G
  • N2 is GFLG
  • AC1 is SN38
  • AC2 is PKA.
  • M is —C( ⁇ O)—C 1-6 alkylene-NH—
  • A1 is
  • Y is a direct bond
  • Y′ is
  • W1′ is Q1, Z2 and Z0 are
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y is a direct bond
  • Y′ is
  • W1′ is Q1
  • Z2 is Q1
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 is G or
  • N2 is GFLG
  • AC1 is PTX or DOX
  • AC2 is PCB or LPT.
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—
  • A1 and A1′ are
  • W1′ is —Z0-(Q1) 2 , Z3 and Z1 are
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • A1 and A1′ are identical to A1 and A1′.
  • W1′ is —Z0-(Q1) 2 , Z3 and Z1 are
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is SB7
  • AC2 is PCB.
  • M is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—
  • A1 and A1′ are
  • W1′ is Q1, Z1 and Z0 are
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • A1 and A1′ are identical to A1 and A1′.
  • W1′ is Q1, Z1 and Z0 are
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is PCB
  • AC2 is LPT.
  • M is —C( ⁇ O)—C 1-6 alkylene-NH—
  • A1 is
  • Y and Y′ are a direct bond
  • W1 and W1′ are
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Y and Y′ are a direct bond
  • W1 and W1′ are
  • Q is —N-AC
  • N is GFLG
  • AC is SB7.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (IV), wherein:
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1, AC2 each independently are PCB, SB7, LPT, PKA,
  • the number-average molecular weight of PEG independently is 5 k-40 k.
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is LPT
  • AC2 is SB7.
  • M is N
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is PCB
  • AC2 is PKA.
  • M is N
  • M is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-phenyl
  • Q is —N-AC
  • N is GFLG
  • AC is LPT or PCB.
  • the polyethylene glycol conjugated drug has the structure represented by the formula (V), wherein:
  • L1 is —C( ⁇ O)—C 1-6 alkylene-C( ⁇ O)—, preferably
  • W1, W2 each independently are
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1, AC2 each independently are PCB or SB7,
  • the number-average molecular weight of PEG is 5 k-40 k.
  • W1 and W2 are identical to W1 and W2 in some specific embodiments.
  • Q1 is —N1-AC1
  • Q2 is —N2-AC2
  • N1 and N2 are GFLG
  • AC1 is PCB
  • AC2 is SB7.
  • the present invention provides a polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, the polyethylene glycol conjugated drug being selected from:
  • the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (II) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
  • the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (II) or a pharmaceutically acceptable salt thereof, comprising the following steps:
  • —Y—OH has a terminal carboxyl group, when Y is a direct bond
  • —Y—H has a terminal amino group, when Y is a direct bond
  • the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (III) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
  • the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (III) or a pharmaceutically acceptable salt thereof, comprising the following steps:
  • the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (IV) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
  • the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (IV) or a pharmaceutically acceptable salt thereof, comprising the following steps:
  • the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (V) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
  • the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (V) or a pharmaceutically acceptable salt thereof, comprising the following steps:
  • the present application provides a pharmaceutical composition, comprising a therapeutically and/or prophylactically effective amount of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to the present invention; the composition further comprises one or more pharmaceutically acceptable excipients, such as carriers and/or vehicles.
  • the carriers and/or vehicles include, but are not limited to: ion exchangers, alumina, aluminum stearate, lecithin, serum proteins such as human serum protein, buffer substances such as phosphate, glycerin, sorbic acid, potassium sorbate, a mixture of partial glycerides of saturated plant fatty acids, water, salt or electrolyte, such as protamine sulfate, disodium hydrogen phosphate, potassium hydrogen phosphate, sodium chloride, zinc salt, colloidal silica, magnesium trisilicate, polyvinylpyrrolidone, cellulose material, polyethylene glycol, sodium carboxymethyl cellulose, polyacrylate, beeswax, polyethylene-polyoxypropylene block polymer, and lanolin.
  • ion exchangers alumina, aluminum stearate, lecithin
  • serum proteins such as human serum protein
  • buffer substances such as phosphate, glycerin, sorbic acid, potassium sorbate, a mixture of
  • the pharmaceutical composition may be prepared into any pharmaceutically acceptable dosage form.
  • the pharmaceutical composition may also be applied to individuals in need of such treatment in any suitable way of administration, such as oral, parenteral, rectal or pulmonary administration.
  • oral administration the pharmaceutical composition may be made into conventional solid preparations, such as tablets, capsules, pills, granules, etc.; it may also be made into oral liquid preparations, such as oral solutions and oral suspensions, and syrup.
  • suitable fillers, binders, disintegrants, lubricants, etc. may be added.
  • parenteral administration the pharmaceutical composition may be made into injection preparations, including injection solutions, sterile powders for injection, and concentrated solutions for injection.
  • the pharmaceutical composition When the pharmaceutical composition is made into injection preparations, they may be produced by a conventional method in the current pharmaceutical field. In the case of preparation of injection preparations, it is not required to add additives, or appropriate additives may be added according to the nature of the drug. In the case of rectal administration, the pharmaceutical composition may be made into suppositories and the like. In the case of pulmonary administration, the pharmaceutical composition may be made into an inhalant or a spray. Preferably, the pharmaceutical composition of the present invention may be made into an injection preparation, such as an injection solution. Alternatively, normal saline is used as the carrier of the injection solutions.
  • the present application provides use of the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating and/or preventing a disease (such as a cancer).
  • a disease such as a cancer.
  • the disease refers to a disease treated by the active ingredient in the polyethylene glycol conjugated drug.
  • the present application provides the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof for use in treating and/or preventing a disease (such as a cancer).
  • a disease such as a cancer.
  • the disease refers to a disease treated by the active ingredient in the polyethylene glycol conjugated drug.
  • cancer refers to a disease state characterized by cell proliferative, including but not limited to: colon cancer, leukemia, lymphoma, bladder cancer, bone cancer, brain tumor, medulloblastoma, glioma, breast cancer, adenoma/carcinoid, adrenal cortical cancer, pancreatic islet cell cancer, cervical cancer, endometrial cancer, ovarian cancer, colorectal cancer, skin cancer, esophageal cancer, eye cancer, gallbladder cancer, stomach cancer, head and neck cancer, liver cancer, melanoma, Kaposi's sarcoma, kidney cancer, oral cancer, lung cancer, nasopharyngeal cancer, neuroblastoma, ovarian cancer, pancreatic cancer, thyroid cancer, parathyroid penile cancer, prostate cancer, urethral cancer, vaginal cancer, vulvar cancer, anal cancer, sarcoma, etc., including metastasis of the aforementioned cancers.
  • the present application provides a method for treating and/or preventing a disease (such as a cancer), comprising administering an effective amount of the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof to an individual in need thereof.
  • the dosage regimen may be adjusted to provide the optimum desired response. For example, a single amount of drug may be administered, several divided doses may be administered over time, or the dose may be proportionally reduced or increased as indicated by the urgent need for the treatment. It should be noted that the dose value may vary with the type and severity of the condition to be alleviated, and may include single or multiple doses. It should be further understood that for any particular individual, the specific dosage regimen should be adjusted over time according to the individual's needs and the professional judgment of the person administering the composition or supervising the administration of the composition.
  • “individual” includes a human or a non-human animal.
  • Exemplary human individuals include human individuals suffering from diseases such as those described herein (referred to as patients) or normal individuals.
  • “non-human animals” include all vertebrates, such as non-mammals (such as birds, amphibians, and reptiles) and mammals, such as non-human primates, livestock and/or domesticated animals (such as sheep, dogs, cats, cows, pigs, and etc.).
  • the active ingredient suitable for being conjugated with polyethylene glycol may be a drug molecule with at least one amino group, hydroxyl group, carboxyl group or acyl group, for example, a drug molecule having anti-tumor activity with at least one amino group, hydroxyl group, carboxyl group or acyl group, such as MK2, LPT, PCB, SB7, PKA, NPB and the like, which represent the following meanings:
  • PEG is an abbreviation for polyethylene glycol, which refers to a homopolymer with a repeating unit of —CH 2 CH 2 O—, including single-arm polyethylene glycol, multi-arm polyethylene glycol and their derivatives, such as a derivative with a reactive functional group such as amino or carboxyl group at the terminal.
  • the arms of the multi-arm polyethylene glycol preferably have the same degree of polymerization.
  • the molecular weight means the total molecular weight of each arm.
  • the letter “m” or “n” in the subscript of the repeating unit of polyethylene glycol represents the degree of polymerization of polyethylene glycol.
  • the letter “m” or “n” represents the degree of polymerization of each arm.
  • substituents for the disclosed compounds of the present invention are disclosed in terms of group species or ranges. It is specifically pointed out that the present invention includes every independent subcombination of each member of these group species and ranges.
  • C 1 -C 6 alkyl specifically refers to independently disclosed methyl, ethyl, C 3 alkyl, C 4 alkyl, C 5 alkyl and C 6 alkyl.
  • alkyl refers to a saturated, straight-chain or branched-chain, monovalent hydrocarbon group with 1 to 6 carbon atoms (C 1 -C 6 alkyl group), or 1 to 4 carbon atoms (C 1 -C 4 alkyl group), or 1 to 3 carbon atoms (C 1 -C 3 alkyl group), wherein the alkyl group may be independently and optionally substituted by one or more substituents described herein, including but not limited to deuterium, amino, hydroxyl, cyano, F, Cl, Br, I, mercapto, nitro, oxo ( ⁇ O) and the like.
  • alkyl group examples include, but not limited to, methyl (Me, —CH 3 ), ethyl (Et, —CH 2 CH 3 ), n-propyl (n-Pr, —CH 2 CH 2 CH 3 ), iso-propyl (i-Pr, —CH(CH 3 ) 2 ), n-butyl (n-Bu, —CH 2 CH 2 CH 2 CH 3 ), iso-butyl (i-Bu, —CH 2 CH(CH 3 ) 2 ), sec-butyl (s-Bu, —CH(CH 3 )CH 2 CH 3 ), tert-butyl (t-Bu, —C(CH 3 ) 3 ), n-pentyl (—CH 2 CH 2 CH 2 CH 2 CH 3 ), 2-pentyl (—CH(CH 3 )CH 2 CH 2 CH 3 ), 3-pentyl (—CH(CH 2 CH 3 ) 2 ), 2-methyl-2-butyl (—C(CH 3
  • alkylene refers to a saturated divalent hydrocarbon group obtained by removing two hydrogen atoms from a linear or branched saturated alkyl group, such as “C 1 -C 6 alkylene” derived from C 1 -C 6 alkyl, “C 1 -C 4 alkylene” derived from C 1 -C 4 alkyl, “C 1 -C 3 alkylene” derived from C 1 -C 3 alkyl.
  • alkylene group may be substituted or unsubstituted, wherein the substituent may be, but not limited to, deuterium, hydroxyl, amino, halogen, cyano, aryl, heteroaryl, alkoxy, alkyl, alkenyl, alkynyl, heterocyclyl, mercapto, nitro or aryloxy.
  • alkylene group examples include, but not limited to, methylene (—CH 2 —), ethylene (—CH 2 —CH 2 —), isopropylidene (—CH 2 —CH(CH 3 )—), ethane-1,1-diyl, 2-methoxypropane-1,1-diyl, 2-hydroxypropane-1,1-diyl, 2-methyl-2-hydroxypropane-1,1-diyl and the like.
  • the meaning of the alkyl group is as described above.
  • a certain variable being “a direct bond” refers to that the linker group does not exist, and at the same time, the substituent on the linker group correspondingly does not exist. For example, regarding —X—Y—Z, if Y is a direct bond, then it is expressed as —X—Z, and at the same time, the substituent on Y correspondingly does not exist.
  • the “pharmaceutically acceptable salt” of the compound of the present invention includes an acid addition salt and base addition salt of the compound, such as hydrochloride, hexafluorophosphate, and meglumine salt.
  • the wavy line “ ” in the structural formula means the position where another group is bonded to the structure represented by the structural formula.
  • the term “effective amount” refers to the amount of a compound that will relieve one or more symptoms of the disease being treated to a certain extent after being administered.
  • treating means reversing, alleviating, or inhibiting the disease or condition to which such term is applied or the progression of one or more symptoms of such a disease or condition, or preventing such a disease or condition or one or more symptoms of such a disease or condition.
  • the polyethylene glycol conjugated drug of the present invention has excellent anti-tumor activity. Through the preparation method of the present invention, the polyethylene glycol conjugated drug of the present invention can be prepared efficiently and conveniently.
  • FIG. 1 shows the preparation of drugs 44-2 and 27-134
  • FIG. 2 shows the measured absorbance values of drugs 44-2 and 27-134
  • FIG. 3 shows the inhibitory effect of drug 44-2 on MDA-MB-231 cancer cells
  • FIG. 4 shows the inhibitory effect of drug 27-134 on Colo205 cancer cells
  • FIG. 5 shows the IC 50 calculation results of drugs 44-2 and 27-134
  • FIG. 6 , FIG. 7 and FIG. 8 show the tumor growth trend of each group in Example 3;
  • FIG. 9 , FIG. 10 and FIG. 11 are schematic diagrams of the tumor weight inhibition rate of each group in Example 3.
  • FIG. 12 shows the photos of euthanized animals of each group in Example 3.
  • FIG. 13 shows the photos of tumors of each group in Example 3.
  • FIG. 14 shows the tumor growth trend of each group in Example 4.
  • FIG. 15 is a schematic diagram of the tumor weight inhibition rate of each group in Example 4.
  • Boc-Glu-OH purchased from Ark Pharm, 15.0 g, 60.6673 mmol
  • HBTU purchased from Aladdin, 69.0225 g, 182.0022 mmol
  • HOBT purchased from Innochem, 24.5921 g, 182.0022 mmol
  • H-Glu (OBn) 2 ⁇ TosOH purchased from Ark Pharm, 63.6473 g, 127.4014 mmol
  • the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • saturated sodium bicarbonate solution 300 mL was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • deionized water 300 mL was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated and evaporated to dryness.
  • the obtained dry product was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, 150 mL of silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (60%-100% ethyl acetate: 40%-0% petroleum ether and 1%-4% methanol: 99%-96% ethyl acetate) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-73: 44.4 g, yield: 95.56%.
  • reaction solution was evaporated to dryness, then sodium bicarbonate powder was added, the obtained mixture was diluted with dichloromethane, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with 50% ethyl acetate/petroleum ether were carried out, thus obtaining the product 27.3 g, yield 70%.
  • the aqueous phase was extracted with ethyl acetate until there was no product in the aqueous phase, and the obtained organic phases were combined.
  • the organic phase was dried with anhydrous sodium sulfate powder, suction filtering was carried out, and the operations of dry sample loading, column chromatography and gradient elution with 30%-100% ethyl acetate/petroleum ether were carried out, thus obtaining the product 20 g, yield 52%.
  • the operations of dry sample loading, column chromatography and elution with 40%400% ethyl acetate/petroleum ether were carried out, thus obtaining the product 10.1 g, yield 62%.
  • Boc-LC-OH (synthesized according to the method of synthesizing 24-36, 15.0236 g, 57.0608 mmol), HBTU (32.4596 g, 85.5912 mmol), HOBT (11.5651 g, 85.5912 mmol) and 25-73 (43.7 g, 57.0608 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (150 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (61.5 mL, 342.3648 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at ⁇ 5° C.
  • reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • saturated sodium chloride solution 300 mL was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • saturated sodium chloride solution 300 mL was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • deionized water 300 mL was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • the organic phase was concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 22-181: 20.3 g, yield: 84.2%.
  • Fmoc-L-Lys (Boc)-OH purchased from Accela, 1.39 g, 2.967 mmol), 22-181 (2.70 g, 2.967 mmol), HBTU (1.69 g, 4.4505 mmol), HOBT (0.6 g, 4.4505 mmol) were added in a 100 mL flask, and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (2.21 mL, 13.3515 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at ⁇ 5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight.
  • reaction solution was transferred to a 1 L separatory funnel and extracted with saturated saline solution (200 mL) and ethyl acetate (250 mL), and the organic phase was separated.
  • the aqueous phase was washed with ethyl acetate (200 mL ⁇ 1), and the obtained organic phases were combined.
  • the organic phase was washed with saturated saline solution (200 mL ⁇ 1), concentrated and evaporated to dryness, thus obtaining the product 35-3: 4.0 g.
  • 35-3 (4.04 g, 2.967 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (3.31 mL, 44.505 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was first concentrated to a small amount. The operation of washing with stirring was carried out with the addition of n-hexane (120 mL) to remove the trifluoroacetic acid, the supernatant was discarded, and n-hexane (120 mL) was added to the lower oily solution. Such operations were repeated three times. Finally, a viscous oily product was obtained. The oily product was dried to give 35-4: 3.74 g.
  • Boc-GFLG-OBn (as synthesized in accordance with literature, 6.8282 g, 11.7184 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL).
  • the hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out.
  • the diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
  • 35-4 (3.74 g, 32.967 mmol), 25-102 (1.75 g, 3.560 mmol), HBTU (1.69 g, 4.451 mmol), HOBT (0.6 g, 4.451 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (4.4 mL, 26.703 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight.
  • DIEA 4.4 mL, 26.703 mmol
  • reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated.
  • the aqueous phase was washed with ethyl acetate (200 mL ⁇ 2), and the obtained organic phases were combined.
  • the organic phase was washed with saturated saline solution (200 mL ⁇ 2), evaporated to dryness, and dried in an oven, thus obtaining the product 35-6: 5.1 g.
  • 35-6 (5.1 g, 2.967 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), morpholine (3.9 mL, 44.505 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour.
  • the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated saline solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL ⁇ 2), and the obtained organic phases were combined.
  • reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated sodium bicarbonate solution (200 mL) and ethyl acetate (250 mL), and the organic phase was separated.
  • the aqueous phase was washed with ethyl acetate (200 mL ⁇ 3), and the obtained organic phases were combined.
  • the organic phase was washed with saturated saline solution (200 mL ⁇ 2), and concentrated.
  • Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • Boc-GFLG-OH (synthesized according to the method of synthesizing 25-102, 13.97 mmol), PCB (5 g, 11.17 mmol), HBTU (6.35 g, 16.76 mmol) and HOBT (2.26 g, 16.76 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (8.31 mL, 50.28 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the filter cake was washed with deionized water (1000 mL), and a yellow solid was separated out by precipitation, and dried, thus obtaining the product 10.3 g.
  • Fmoc-Glu-OtBu (3.223 g, 7.5915 mmol, purchased from Ark pharm), 30-33 (synthesized according to the method of synthesizing 30-33) (5.2 g, 6.3263 mmol), HBTU (3.5988 g, 9.4895 mmol), HOBT (1.282 g, 9.4895 mmol) were added in a 500 mL flask, and stirred for 10 minutes. Then DIEA (4.7 mL, 28.4684 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight.
  • n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated five times, to obtain a viscous oily product.
  • the oily product was then dried, thus obtaining the product 28-258: 7.78 g.
  • Boc-GFLG-OH (synthesized according to the method of synthesizing 25-102, 4.9738 g, 10.0977 mmol), HBTU (4.4186 g, 11.6513 mmol), HOBT (1.5743 g, 11.6513 mmol) and SB-743291 (4.0162 g, 7.7675 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (5.8 mL, 34.9538 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at ⁇ 5° C.
  • reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • saturated sodium chloride solution 300 mL was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase.
  • n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the obtained solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation.
  • Such operations were repeated three times, to obtain an oily solid.
  • the oily solid was dissolved with dichloromethane (10 mL), methyl tert-butyl ether (150 mL) was added to the obtained solution for precipitation to separate out a powdery solid, and then a solid product was obtained by filtering.
  • the solid product was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (80 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-4% methanol: 96%-95% dichloromethane) were carried out.
  • the elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 25-132: 5.4 g, yield: 77.98%.
  • n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated six times to obtain a viscous oily product.
  • the oily product was dissolved with methanol (10 mL) and dichloromethane (40 mL), methyl tert-butyl ether (450 mL) was added to the obtained solution to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL ⁇ 3), and dried, thus obtaining the product 28-264: 12.9 g.
  • n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated five times, to obtain a viscous oily product.
  • the oily product was dissolved with dichloromethane (20 mL) and methanol (80 mL), methyl tert-butyl ether (350 mL) was added to the obtained solution to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (120 mL ⁇ 2), and dried, thus obtaining the product 28-265: 11.5 g.
  • n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated four times, to obtain a viscous oily product.
  • dichloromethane (70 mL) and methyl tert-butyl ether (350 mL) were added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 3), and dried in a vacuum oven, thus obtaining the product 37-1: 12.5 g.
  • the filter cake was washed with methyl tert-butyl ether (100 mL ⁇ 3), and dissolved with a mixed solvent of methanol (60 mL) and dichloromethane (240 mL), silica gel powder (25 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 15% ammonia water and 7%-8% methanol were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-2: 9.7 g, yield 82%.
  • n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution, the obtained solution was shaken to be layered, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were further added to the lower liquid, and such operations were repeated six times, to obtain a viscous oily product.
  • dichloromethane (30 mL) and methyl tert-butyl ether (250 mL) were added to the oily product to separate out a solid, and suction filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (100 mL ⁇ 3), and dissolved with a mixed solvent of methanol (30 mL)/dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-7% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, thus obtaining the product 35-14: 1.2 g, yield 56%.
  • 35-14 (1.2 g, 0.0695 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (15 mL), TFA (1.0322 mL, 13.6 mmol) was added, and the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was concentrated to a small amount, methyl tert-butyl ether (100 mL) was added to the concentrated solution to separate out a powdery solid, and suction filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water: 6%-7% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 35-16: 0.74 g, yield 67%.
  • 35-16 (0.3011 g, 0.01754 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), M-SCM-40K (1.5227 g, 0.0369 mmol, purchased from JenKem) was added, and ultrasonic treatment was carried out to dissolve the reactants, the mixed solution reacted in the dark for 7 days at a low speed of stirring at room temperature.
  • n-hexane (120 mL) and methyl tert-butyl ether (40 mL) were added to the reaction solution, the supernatant was discarded, and n-hexane (120 mL) and methyl tert-butyl ether (40 mL) were added to the lower liquid.
  • Such operations were repeated three times, to obtain a viscous oily product.
  • Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (25 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-7% methanol were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (5 mL) and dichloromethane (20 mL).
  • Boc-Glu-(OH) —OBn purchased from Accela, 10 g, 29.64 mmol
  • Glu-(OBn) 2 ⁇ TosOH (16.3 g, 32.61 mmol)
  • HBTU (16.9 g, 44.46 mmol
  • HOBT 6.1 g, 44.46 mmol
  • the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight.
  • saturated sodium bicarbonate solution 200 mL was added to the reaction solution, and then extraction with ethyl acetate (200 mL ⁇ 3) was carried out three times, and the obtained organic phases were combined.
  • Saturated sodium chloride solution 200 mL ⁇ 2 was added to the organic phase, and then extraction with ethyl acetate (100 mL ⁇ 2) was carried out twice. Finally, the organic phase was dried with anhydrous sodium sulfate, concentrated and evaporated to dryness, thus obtaining the product 31.4 g (weighed).
  • Boc-GFLG-OBn (as synthesized in accordance with literature, 19.0 g, 32.6 mmol), 10% Pd/C catalyst (300 mg) were added in a hydrogenation reactor, and dissolved with DMF (50 mL) where the level of the solvent was above a stirrer.
  • the hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation (i.e., pumping the air from the reaction system with a vacuum water pump for about 3 minutes—charging hydrogen—pumping hydrogen—charging hydrogen-pumping hydrogen—charging hydrogen) so that the pressure on the hydrogenation reactor was read as 18 Psi, and then the obtained solution reacted at room temperature overnight.
  • reaction solution was taken out and evenly added dropwise to a suction funnel filled with compacted diatomaceous earth.
  • the reactor was washed with DMF (90 mL) until the reactor did not contain any product, thus obtaining the reaction product.
  • the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded.
  • the above operations were repeated three times.
  • Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded.
  • the above operations were repeated three times.
  • a powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-86: 8.2 g, yield 100%.
  • the filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (40 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • a mixed solvent 100 mL
  • silica gel powder 40 g
  • the elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 18-87: 5.56 g, yield 70%.
  • the filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1%-5% methanol were carried out.
  • the elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-92: 2.4 g, yield 92.3%.
  • the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded.
  • the above operations were repeated three times.
  • Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded.
  • the above operations were repeated three times.
  • a powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-89: 5.34 g, yield 100%.
  • a powdery solid was separated out of the reaction solution, and suction filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4).
  • Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-7% methanol were carried out.
  • the elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-90: 2.65 g, yield 51%.
  • the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded.
  • the above operations were repeated three times.
  • Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded.
  • the above operations were repeated three times.
  • a powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-71: 5.42 g, yield 100%.
  • the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded.
  • the above operations were repeated three times.
  • Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded.
  • the above operations were repeated three times.
  • a powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and the washed filter cakes were collected, and dired in a vacuum oven, thus obtaining the product 10-97: 2.8 g, yield 100%.
  • the filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • a mixed solvent 100 mL
  • silica gel powder 10 g was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-12% methanol were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 10-109: 0.7 g, yield 51%.
  • Boc-Glu-OH (1.2 g, 4.8 mmol), GFLF-PCB (synthesized according to the method of synthesizing 30-33, 8.2 g, 9.7 mmol), HBTU (5.5 g, 14.4 mmol) and HOBT (1.9 g, 14.4 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (7.1 mL, 43.2 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, a light yellow solid was separated out by precipitation, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 22 g (weighed).
  • the filter cake was dissolved with dichloromethane (80 mL), methanol (20 mL), silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and gradient elution with 1% ammonia water/3% methanol/dichloromethane-1% ammonia water/5% methanol/dichloromethane were carried out.
  • the elution product was then collected, concentrated, thus obtaining the product 5.9 g, yield 70.2%.
  • n-hexane (100 mL) and methyl tert-butyl ether (300 mL) were added to the obtained solution for precipitation to separate out a solid, and suction filtering was carried out. The filter cake was dried in vacuum.
  • Reactants 15-91 (synthesized according to the method of synthesizing 35-3, 0.33 g, 0.1503 mmol) and 10% Pd/C (30 mg) were added in a micro-reactor, and dissolved with DMF (30 mL), H 2 (20 psi) was introduced, and then the mixed solution was stirred to react.
  • the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed 4 times with DMF to obtain the DMF solution of 24-205 used for the next reaction.
  • reaction solution was precipitated with n-hexane (100 mL) and methyl tert-butyl ether (300 mL) to separate out a solid, and suction filtering was carried out.
  • the filter cake was dried in vacuum.
  • Reactant 41-7 (0.7 g, 0.082 mmol) was dissolved with DMF (30 mL), morpholine (0.214 mL, 2.46 mmol) was added, and then the mixed solution was stirred to react until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product, and suction filtering was carried out.
  • Boc-Asp-OH purchased from damas-beta, 0.18 g, 0.8 mmol
  • GFLG-SB7 synthesized according to the method of synthesizing 25-132, 1.5 g, 1.68 mmol
  • HBTU 0.9 g, 2.4 mmol
  • HOBT HOBT (0.32 g, 2.4 mmol
  • DIEA (1.19 mL, 7.2 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react.
  • deionized water 200 mL was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL ⁇ 3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness.
  • reaction solution was extracted with deionized water (200 mL), ethyl acetate (100 mL), and the organic phase was separated.
  • the aqueous phase was extracted three times with ethyl acetate (100 mL ⁇ 3), and the obtained organic phases were combined.
  • the organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness, thus obtaining the product 1.3 g.
  • Reactants 41-9 (0.5 g, 0.06 mmoL), 39-10 (0.134 g, 0.060 mmoL), HBUT (0.034 g, 0.09 mmoL), HOBT (0.012 g, 0.09 mmoL) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (0.044 mL, 0.27 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react.
  • methyl tert-butyl ether 100 mL
  • n-hexane 200 mL
  • the operations of column chromatography, dry sample loading and elution with 1% ammonia water: 4% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out.
  • the elution product was evaporated to dryness, thus obtaining the product 0.5 g, yield 80%.
  • Reactant 39-15 (1 g) was dissolved with DMF solution (20 mL), M-SCM-20K (0.4 g) was added, and the obtained solution reacted at a low speed of stirring in the dark. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (50 mL) and n-hexane (100 mL) to separate out a solid, and suction filtering was carried out.
  • the filter cake was dissolved with dichloromethane (50 mL), silica gel powder was added to the obtained solution, and the operations of evaporation, column chromatography, dry sample loading and gradient elution with dichloromethane—1% ammonia water: 6% methanol/dichloromethane were carried out.
  • the elution product was collected, evaporated to dryness, and then dissolved with anhydrous ethanol (10 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, and then n-hexane (50 mL) was added for precipitation. Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 0.15 g.
  • Boc-L-Lys (Fmoc)-OH purchased from Aladdin, 2.78 g, 5.927 mmol), 22-181 (5.4 g, 5.927 mmol), HBTU (3.38 g, 8.891 mmol), HOBT (1.2 g, 8.891 mmol) were added in a 100 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react at ⁇ 5° C. for about 30 minutes. Then DIEA (5.878 mL, 35.565 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at ⁇ 5° C. with stirring for 3 hours.
  • reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (200 mL) were added, and the obtained solution was shaken for extraction.
  • the aqueous phase was washed with ethyl acetate (150 mL ⁇ 2), and the obtained organic phases were combined.
  • the organic phase was washed with saturated saline solution (200 mL ⁇ 1), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 34-15: 8.07 g.
  • 34-17 (7.5 g, 5.92 mmol), 34-18 (synthesized according to the method of synthesizing 25-102, 3.5 g, 7.11 mmol), HBTU (3.36 g, 8.88 mmol), HOBT (1.2 g, 8.88 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react at ⁇ 5° C. for about 30 minutes. Then DIEA (8.8 mL, 53.28 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at ⁇ 5° C. with stirring for 3 hours.
  • reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (200 mL) were added, and the obtained solution was shaken for extraction.
  • the aqueous phase was washed with ethyl acetate (150 mL ⁇ 2), and the obtained organic phases were combined.
  • the organic phase was washed with saturated saline solution (200 mL ⁇ 1), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 34-19: 10.3 g.
  • the reaction solution was precipitated three times with n-hexane (120 mL) and methyl tert-butyl ether (30 mL), and a viscous oily product was obtained. Then, methyl tert-butyl ether (250 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 3), and dissolved with dichloromethane (150 mL) and methanol (30 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 3), and dissolved with a mixed solvent of methanol (30 mL) dichloromethane (120 mL), silica gel powder (20 g) was added, the obtained solution was evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-8% methanol were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 43-24: 1.11 g, yield 73%.
  • the elution product was then collected, concentrated, and evaporated to dryness to obtain a solid.
  • the solid was dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (5 mL) and dichloromethane (20 mL). Then, methyl tert-butyl ether (80 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL ⁇ 2), and dried in a vacuum oven, thus obtaining the product 43-27: 0.9 g, yield: 38%.
  • the organic phase was evaporated to dryness and concentrated to about 50 mL, and then washed with saturated sodium chloride solution (100 mL*3). The obtained organic phases were combined. The organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 27-120 (1.4317 g, 100%)
  • Succinic acid (0.039 g, 0.3339 mmol), HBTU (0.3798 g, 1.0017 mmol), HOBT (0.1354 g, 1.0017 mmol) were added in a flask loaded with 27-120 (0.8368 g, 0.7345 mmol), and dissolved with a proper amount of DMF, then the obtained solution was placed at ⁇ 5° C., and DIEA (0.50 mL, 3.0051 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight.
  • the organic phase was evaporated to dryness, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (50 mL) was added, and the operations of evaporation to dryness, dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6% methanol were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 27-121 (0.5811 g, 73.72%)
  • 35-12 (synthesized according to the method of synthesizing 37-2, 1.8 g, 0.9566 mmol), HBTU (0.54 g, 1.4348 mmol), HOBT (0.19 g, 1.4348 mmol) were added in a flask loaded with 27-123 (0.1782 g, 0.1087 mmol), and dissolved with a proper amount of DMF, then the obtained solution was placed at ⁇ 5° C., and DIEA (0.23 mL, 4.3045 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight.
  • Dichloromethane was added in a flask loaded with 27-128 (0.8 g, 0.0483 mmol), ultrasonic vibration was carried out to completely dissolve the compound, then TFA (0.107 mL, 1.4503 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the dichloromethane in the reaction solution was evaporated, methyl tert-butyl ether (100 mL) was added, and the obtained solution was shakn to separate out a solid, and suction filtering was carried out.
  • the filter cake was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (40 mL) was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 7-10% methanol were carried out.
  • the elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 27-132 (0.5633 g, 71.34%).
  • the filter cake was washed with methyl tert-butyl ether (40 mL ⁇ 3), and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (50 mL) was added, the obtained solution was evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 7% methanol were carried out.
  • the elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 27-134 (0.5876 g, 61.85%).
  • 7-ethyl-10-hydroxycamptothecin also referred to as SN38, 20 g, 50.9684 mmol
  • tert-butyl diphenylchlorosilane purchased from Innochem, TBDPSC1, 79.5 mL, 305.8104 mmol
  • dichloromethane 250 mL
  • triethylamine Et 3 N, 42.5 mL, 305.8104 mmol
  • the reaction solution was concentrated and evaporated to dryness under reduced pressure to remove the dichloromethane, the obtained solid was dissolved with dichloromethane (20 mL), the obtained solution was precipitated with n-hexane (200 mL) to separate out a solid product, and filtering was carried out.
  • the filter cake was washed with n-hexane (100 mL), the filtrate was kept in a refrigerator at 2° C.-8° C. for 30 minutes, taken out and filtered, and the filter cake was washed with n-hexane (100 mL).
  • Such operations were repeated five times, to obtain a solid product.
  • the solid product was dried in an oven, thus obtaining the product 25-189: 23.9 g, yield: 74.34%.
  • Boc-glycine (Boc-Gly-OH, 7.9647 g, 45.4661 mmol), 25-189 (23.9 g, 37.8884 mmol) and DMAP (0.9258 g, 7.5777 mmol) were added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (100 mL), the mixed solution was stirred at 0° C. for about 30 minutes, then dicyclohexylcarbodiimide (DCC, 15.6350 g, 75.7767 mmol) was added, and the obtained solution was stirred to react at 0° C. for 3 hours.
  • DCC dicyclohexylcarbodiimide
  • reaction solution was first filtered to remove the DCC, the filter cake was washed with dichloromethane (60 mL), and the filtrate was collected, evaporated to dryness, and dried, thus obtaining the product 25-199: 29.8549 g.
  • Boc-Gly-OH purchased from Aladdin, 3.0 g, 17.1252 mmol
  • HBTU 9.7418 g, 25.6878 mmol
  • HOBT 3.4709 g, 25.6878 mmol
  • H-Glu (OBzl)-OBzl ⁇ TosOH 8.5554 g, 17.1252 mmol
  • DMF 50 mL
  • reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, saturated sodium chloride solution (300 mL) was further added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase.
  • the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-2% methanol: 99%-98% ethyl acetate) were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-211: 6.9213 g, yield: 83.41%.
  • reaction product solution 25-211 (2.6890 g, 5.5382 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL).
  • the hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out.
  • the diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
  • 25-220 (1.6853 g, 5.5382 mmol), HBTU (6.3009 g, 16.6146 mmol), HOBT (2.2450 g, 16.6146 mmol) and 25-200 (8.3810 g, 12.1841 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and the mixed solution was stirred at ⁇ 5° C. for 30 minutes. Then DIEA (8.2 mL, 49.8438 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at ⁇ 5° C. for 1 hour, and then moved to room temperature and stirred to react for 2 hours.
  • the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-222: 9.0 g, yield: 98.85%.
  • 25-222 (9.0 g, 5.4745 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (6.1 mL, 82.1178 mmol) was added with stirring, and the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, then the reaction solution was transferred to a 2 L separatory funnel, saturated sodium chloride solution (400 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase.
  • Fmoc-Glu (OtBu)-OH purchased from Ark Pharm, 4.0646 g, 9.5134 mmol
  • HBTU 5.4118 g, 14.2701 mmol
  • HOBT 2.482 g, 14.2701 mmol
  • 25-201 sinthesized according to the method of synthesizing 22-181, 9.1 g, 9.9890 mmol
  • DMF 60 mL
  • the obtained solution continued to react with stirring at ⁇ 5° C. for 2 hours, and then moved to room temperature and stirred to react overnight.
  • the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-203: 12.5430 g.
  • reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-221: 8.8211 g.
  • 25-221 (8.8211 g, 3.4609 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), morpholine (4.5 mL, 51.9135 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours.
  • the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated.
  • 25-226 (3.2368 g, 1.5382 mmol), HBTU (1.7500 g, 4.6146 mmol), HOBT (0.6235 g, 4.6146 mmol) and 25-207 (synthesized according to the method of synthesizing 25-102) (1.7426 g, 3.5379 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at ⁇ 5° C. for 30 minutes. Then DIEA (2.3 mL, 13.8438 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at ⁇ 5° C.
  • reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated.
  • reaction product solution 25-227 (0.6519 g, 0.2135 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL).
  • the hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight.
  • the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out.
  • the diatomaceous earth was washed with DMF (50 mL) until it did not contain any product, thus obtaining a reaction product solution.
  • reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated.
  • the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (3%-10% methanol: 97%-90% dichloromethane) were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-238: 1.9233 g, yield: 61.96%.
  • n-hexane (100 mL) and methyl tert-butyl ether (10 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation.
  • Such operations were repeated three times, to finally obtain a viscous oily product.
  • dichloromethane (5 mL) was added to the viscous oily product, the obtained solution was precipitated with methyl tert-butyl ether (60 mL) to obtain a powdery solid, and filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (60 mL), to obtain a solid product.
  • the solid product was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (40 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (4%-12% methanol: 96%-88% dichloromethane) were carried out.
  • the elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-260: 1.6 g, yield: 50.17%.
  • 25-260 (0.8233 g, 0.0085 mmol) was dissolved with THF (20 mL); TBAF ⁇ 3H 2 O (0.0860 g, 0.2726 mmol) was dissolved with THF (10 mL); the THF solution of TBAF was added to the THF solution of 25-260, a certain amount of diluted hydrochloric acid solution (30 mL, 0.05 mol/L) was added, and then the mixed solution was stirred to react at room temperature in the dark overnight. At the end of the reaction, the reaction solution was first evaporated to dryness, anhydrous ethanol (20 mL) was added, the obtained solution was concentrated under reduced pressure and evaporated to dryness. Such operations were repeated three times.
  • the obtained solid was dissolved with DMF (1.0 mL), isopropanol (50 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out.
  • the filter cake was further dissolved with DMF (3.0 mL), isopropanol (50 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out.
  • the filter cake was washed with isopropanol (30 mL).
  • the solid obtained in the second step was dissolved with dichloromethane (2.0 mL), methyl tert-butyl ether (50 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out.
  • the filter cake was then dissolved with dichloromethane (2.0 mL), methyl tert-butyl ether (50 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out.
  • the filter cake was washed with methyl tert-butyl ether (30 mL), and dried, thus obtaining the product 44-2: 0.5519 g, yield: 69.79%.
  • Fmoc-Glu-OtBu purchased from Accela, 3.2226 g, 7.5741 mmol
  • HBTU 4.3086 g, 11.3612 mmol
  • HOBT (1.5351 g, 11.3612 mmol)
  • 44-19 synthesized according to the method of synthesizing 22-181, 6.9 g, 7.5741 mmol
  • DMF 60 mL
  • DIEA 7.5 mL, 45.4460 mmol
  • the obtained solution was stirred to react at ⁇ 5° C. for 2 hours.
  • the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated.
  • 1,2-bis (2-aminoethoxy) ethane (purchased from TCl, 50 mL, 340.7327 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (150 mL), triethylamine (94.8928 mL, 681.4654 mmol) was added, and then di-tert-butyl dicarbonate (purchased from Innochem, 74.3751 g, 340.7321 mmol) was slowly added dropwise with stirring at room temperature. At the end of the addition, the obtained solution was stirred to react at room temperature overnight.
  • silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid.
  • the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 2%-3% methanol were carried out.
  • the elution product was then collected, concentrated, and dried, thus obtaining the product 33-143, yield 10%.
  • the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 42-27: 5.4 g, yield: 95.40%.
  • reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated.
  • the obtained solution continued to react with stirring at ⁇ 5° C. for 1 hour, and then moved to room temperature and stirred to react overnight.
  • n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded.
  • Such operations were repeated three times, to obtain a viscous product.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyamides (AREA)

Abstract

The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.

Description

TECHNICAL FIELD
The present invention belongs to the technical field of medicine, and relates to a polyethylene glycol conjugated drug, preparation method thereof and use thereof.
BACKGROUND
Pegylated drug has great advantages over the original drug, which can increase water solubility of drug molecules (which is very important for drugs with extremely low solubility such as paclitaxel, camptothecin or platinum); and can prevent or reduce drug agglomeration, immunogenicity and antigenicity. Most small-molecule anticancer drugs can only stay in the blood circulation for a few minutes, while polymer-(anticancer drug) conjugates may stay for tens or hundreds of hours or even longer, which is beneficial from the “enhanced permeability and retention” effect, i.e., the EPR effect, caused by leakage of tumor capillaries. Due to the increased hydrodynamic volume of the polymer-(anticancer drug) conjugates, the renal elimination of the drugs is weakened, the drugs are protected from enzymatic degradation, the half-life of the drugs in plasma is extended, and the bioavailability of the drugs is increased. Moreover, the anticancer drugs can be highly enriched in diseased organs, tissues or cells through the EPR passive targeting or active targeting, thereby greatly reducing the toxic side effects caused by small molecule anticancer drugs spreading all over the body. In addition, the polymer-(anticancer drug) conjugates can limit the cell absorption of drugs to the endocytic pathway, which is conducive to drug delivery to the lysosome, thereby avoiding drug resistance caused by p-glycoprotein pumping out; the polymer-(anticancer drug) conjugates can also stimulate or restore immune function, and this is conducive to killing cancer cells.
The NEKTAR company and the ENZON company in the United States have successfully developed polyethylene glycol conjugated drugs. At present, there are 15 polyethylene glycol conjugated drugs which have been approved by the FDA to enter the market, and in addition, 36 new clinical drugs are in the first-phase, second-phase, third-phase clinical trials or in the NDA phase. However, all the above pegylated drugs are pegylated single drugs.
Chinese patent ZL201510996205.4 discloses that gemcitabine, a chemotherapeutic drug, and AZD7762, a Chk1 inhibitor, are grafted onto a four-arm polyethylene glycol carrier simultaneously. The Chk1 inhibitor has no anticancer effect in itself, but, when combined with gemcitabine, it can enhance the effect of the chemotherapeutic drug. Chinese patents ZL201710761441.7 and ZL201710761572.5 disclose that two anticancer drugs are grafted onto one graft site of polyethylene glycol simultaneously, to thereby realize the inhibition of different cancer cell biological signal channels and targets, and the free combination between different treatment methods.
SUMMARY
The present invention is directed to solving, at least to a certain extent, one of the technical problems in the related art. Therefore, the present invention provides a polyethylene glycol conjugated drug which has excellent tumor inhibition activity. Through the preparation method of the present invention, the polyethylene glycol conjugated drug of the present invention can be prepared efficiently and conveniently.
Polyethylene Glycol Conjugated Drug
In the first aspect of the present invention, the present invention provides a polyethylene glycol conjugated drug of formula (I) or a pharmaceutically acceptable salt thereof.
In the polyethylene glycol conjugated drug of the present invention, multiple identical or different drug molecules are conjugated together by using an amino acid or a polypeptide as a linking chain, and a dicarboxylic acid with an amino group (for example, a natural amino acid with two carboxyl groups) as a linking bridge. The type, ratio and drug loading of the drug can be adjusted. In the formula (I), PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight may be from 2 k to 40 k, such as from 5 k to 10 k or from 10 k to 40 k, such as about 2 k, about 5 k, about 10 k, about 20 k, about 30 k or about 40 k. In certain embodiments, PEG reacts with a carboxyl group on the main chain through a terminal amino group to form an amide bond. Alternatively, PEG reacts with an amino group on the main chain through a terminal carboxyl group to form an amide bond. In certain embodiments, the molecular weight of the PEG comprises the terminal amino group thereof (i.e., the PEG derivative bearing reactive group), and in some embodiments, the molecular weight of the PEG is the molecular weight of polyethylene glycol and X or X′ as a whole, which may be from 2 k to 40 k, such as 2 k to 3 k, 3 k to 5 k, 5 k to 10 k, or 10 k to 40 k, such as about 2 k, about 3 k, about 5 k, about 10 k, about 40 k.
Figure US11793881-20231024-C00002
wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—, —C(═O)—, —NH—C1-6 alkylene-NH—, —C(═O)—C1-6 alkylene-NH—,
Figure US11793881-20231024-C00003
Figure US11793881-20231024-C00004

or PEGm; wherein, PEGm is a single-arm or multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k or 10 k;
A1, A1′ each independently are
Figure US11793881-20231024-C00005
A2 independently is a direct bond or
Figure US11793881-20231024-C00006
L1 independently is a direct bond or —C(═O)—C1-6 alkylene-C(═O)—;
W1, W1′, W2 each independently are Q1,
Figure US11793881-20231024-C00007
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00008
Figure US11793881-20231024-C00009
Q is —N-AC;
Q1 is —N1-AC1;
Q2 is —N2-AC2;
N, N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C00010
(preferably
Figure US11793881-20231024-C00011
AC, AC1, AC2 each independently are drug molecules (for example, drug molecules with anti-tumor activity), preferably PCB, DOX, LPT, SB7, PKA, SN38, PTX or NPB;
n1, n2 each independently are 0, 1, 2, 3, 4, 5 or 6;
Y, Y′ each independently are a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00012
X, X′ each independently are
Figure US11793881-20231024-C00013
PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight independently is 5 k-40 k;
j1 is 1, 2, 3, 4, 5 or 6;
j2, j3 each independently are 0 or 1.
It should be noted that, in some embodiments, PEGm is linked to the residual structure of the compound of the formula (I) through carbonyl.
Alternatively, in the polyethylene glycol conjugated drug of the present invention, multiple identical or different drug molecules are conjugated together by using an amino acid or a polypeptide as a linking chain, and a dicarboxylic acid with an amino group (for example, a natural amino acid with two carboxyl groups) as a linking bridge. The type, ratio and drug loading of the drug can be adjusted. In the formula (I), PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight may be from 2 k to 40 k, such as from 5 k to 10 k or from 10 k to 40 k, such as about 2 k, about 5 k, about 10 k, about 20 k, about 30 k or about 40 k. In certain embodiments, PEG reacts with a carboxyl group on the main chain through a terminal amino group to form an amide bond. Alternatively, PEG reacts with an amino group on the main chain through a terminal carboxyl group to form an amide bond. In certain embodiments, the molecular weight of the PEG comprises the terminal amino group thereof (i.e., the PEG derivative bearing reactive group), and in some embodiments, the molecular weight of the PEG is the molecular weight of polyethylene glycol and X or X′ as a whole, which may be from 2 k to 40 k, such as 2 k to 3 k, 3 k to 5 k, 5 k to 10 k, or 10 k to 40 k, such as about 2 k, about 3 k, about 5 k, about 10 k, about 40 k.
Figure US11793881-20231024-C00014
wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—, —C(═O)—, —NH—C1-6 alkylene-NH—, —C(═O)—C1-6 alkylene-NH—,
Figure US11793881-20231024-C00015
Figure US11793881-20231024-C00016
A1, A1′ each independently are
Figure US11793881-20231024-C00017
A2 independently is a direct bond or
Figure US11793881-20231024-C00018
L1 independently is a direct bond or —C(═O)—C1-6 alkylene-C(═O)—;
W1, W1′, W2 each independently are Q1,
Figure US11793881-20231024-C00019
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00020
Q is —N-AC;
Q1 is —N1-AC1;
Q2 is —N2-AC2;
N, N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C00021
AC, AC1, AC2 each independently are drug molecules (for example, drug molecules with anti-tumor activity), preferably PCB, DOX, LPT, SB7, PKA, SN38 or PTX;
n1, n2 each independently are 0, 1, 2, 3, 4, 5 or 6;
Y, Y′ each independently are a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00022
X, X′ each independently are
Figure US11793881-20231024-C00023
PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight independently is 5 k-40 k;
j1 is 1, 2, 3, 4, 5 or 6;
j2, j3 each independently are 0 or 1.
In some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (II), the formula (III), the formula (IV) or the formula (V):
Figure US11793881-20231024-C00024
In some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (II), wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00025

—NH—C1-6 alkylene-NH—,
Figure US11793881-20231024-C00026
Figure US11793881-20231024-C00027

or PEGm, preferably
Figure US11793881-20231024-C00028
Figure US11793881-20231024-C00029

or PEGm, wherein, PEGm is a single-arm or multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k or 10 k,
A1 independently is
Figure US11793881-20231024-C00030

preferably
Figure US11793881-20231024-C00031
Y independently is a direct bond,
Figure US11793881-20231024-C00032

GLFG, —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00033

preferably a direct bond,
Figure US11793881-20231024-C00034

GLFG,
Figure US11793881-20231024-C00035
X independently is
Figure US11793881-20231024-C00036
W1 independently is
Figure US11793881-20231024-C00037
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00038

preferably
Figure US11793881-20231024-C00039
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N, N1, N2 each independently are G, GFLG,
Figure US11793881-20231024-C00040

(preferably
Figure US11793881-20231024-C00041
AC, AC1, AC2 each independently are SN38, PKA, PCB, LPT, SB7, PTX or NPB, the number-average molecular weight of PEG independently is 5 k-40 k.
Alternatively, in some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (II), wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00042

—NH—C1-6 alkylene-NH—,
Figure US11793881-20231024-C00043

preferably
Figure US11793881-20231024-C00044
A1 independently is
Figure US11793881-20231024-C00045

preferably
Figure US11793881-20231024-C00046
Y independently is a direct bond, GLFG, —C(═O)—C1-6alkylene-C(═O)—,
Figure US11793881-20231024-C00047

preferably a direct bond, GLFG,
Figure US11793881-20231024-C00048
X independently is
Figure US11793881-20231024-C00049
W1 independently is
Figure US11793881-20231024-C00050
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00051

preferably
Figure US11793881-20231024-C00052
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N, N1, N2 each independently are G, GFLG,
Figure US11793881-20231024-C00053
AC, AC1, AC2 each independently are SN38, PKA, PCB, LPT or SB7, the number-average molecular weight of PEG independently is 5 k-40 k.
In some embodiments, wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—, A1 is
Figure US11793881-20231024-C00054

Y is
Figure US11793881-20231024-C00055

X is
Figure US11793881-20231024-C00056

W1 is
Figure US11793881-20231024-C00057

Z4, Z2 and Z1 are
Figure US11793881-20231024-C00058

Z3 and Z0 are
Figure US11793881-20231024-C00059
In some specific embodiments, M is
Figure US11793881-20231024-C00060

A1 is
Figure US11793881-20231024-C00061

Y is
Figure US11793881-20231024-C00062

X is
Figure US11793881-20231024-C00063

W1 is
Figure US11793881-20231024-C00064

Z4, Z2 and Z1 are
Figure US11793881-20231024-C00065

Z3 and Z0 are
Figure US11793881-20231024-C00066

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is PCB, AC2 is PKA.
In some embodiments, M is —NH—C1-6alkylene-NH—, A1 is
Figure US11793881-20231024-C00067

Y is GLFG, X is
Figure US11793881-20231024-C00068

W1 is
Figure US11793881-20231024-C00069

Z2 is
Figure US11793881-20231024-C00070

Z1 is
Figure US11793881-20231024-C00071

Z0 is
Figure US11793881-20231024-C00072
In some specific embodiments, M is
Figure US11793881-20231024-C00073

A1 is
Figure US11793881-20231024-C00074

Y is GLFG, X is
Figure US11793881-20231024-C00075

W1 is
Figure US11793881-20231024-C00076

Z2 is
Figure US11793881-20231024-C00077

Z1 is
Figure US11793881-20231024-C00078

Z0 is
Figure US11793881-20231024-C00079

Q is —N-AC, N is G, AC is SN38.
In some embodiments, M is
Figure US11793881-20231024-C00080

A1 is
Figure US11793881-20231024-C00081

Y is a direct bond or —C(═O)—C1-6alkylene-C(═O)—, X is
Figure US11793881-20231024-C00082

W1 is
Figure US11793881-20231024-C00083

Z1 is
Figure US11793881-20231024-C00084

Z0 is
Figure US11793881-20231024-C00085
In some specific embodiments, M is
Figure US11793881-20231024-C00086

A1 is
Figure US11793881-20231024-C00087

Y is a direct bond, X is
Figure US11793881-20231024-C00088

W1 is
Figure US11793881-20231024-C00089

Z1 is
Figure US11793881-20231024-C00090

Z0 is
Figure US11793881-20231024-C00091

Q is —N-AC, N is GFLG, AC is LPT.
In some specific embodiments, M is
Figure US11793881-20231024-C00092

A1 is
Figure US11793881-20231024-C00093

Y is
Figure US11793881-20231024-C00094

X is
Figure US11793881-20231024-C00095

W1 is
Figure US11793881-20231024-C00096

Z1 is
Figure US11793881-20231024-C00097

Z0 is
Figure US11793881-20231024-C00098

Q is —N-AC, N is GFLG, AC is PCB.
In some embodiments, M is
Figure US11793881-20231024-C00099
A1 is
Figure US11793881-20231024-C00100

Y is a direct bond, X is
Figure US11793881-20231024-C00101

W1 is
Figure US11793881-20231024-C00102

Z2 is
Figure US11793881-20231024-C00103

Z1 is
Figure US11793881-20231024-C00104

Z0 is
Figure US11793881-20231024-C00105
In some specific embodiments, M is
Figure US11793881-20231024-C00106

A1 is
Figure US11793881-20231024-C00107

Y is a direct bond, X is
Figure US11793881-20231024-C00108

W1 is
Figure US11793881-20231024-C00109

Z2 is
Figure US11793881-20231024-C00110

Z1 is
Figure US11793881-20231024-C00111

Z0 is
Figure US11793881-20231024-C00112

Q1 is —N1-AC1, Q2 is —N2-AC2, N1, N2 are GFLG, AC1 is NPB, AC2 is PCB.
In some embodiments, M is PEGm, PEGm is a single-arm polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k,
A1 is
Figure US11793881-20231024-C00113

Y is a direct bond, X is
Figure US11793881-20231024-C00114

W1 is
Figure US11793881-20231024-C00115

Z2 is
Figure US11793881-20231024-C00116

Z1 is
Figure US11793881-20231024-C00117

Z0 is
Figure US11793881-20231024-C00118
In some specific embodiments, M is PEGm, PEGm, is a single-arm polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 5 k, A1 is
Figure US11793881-20231024-C00119

Y is a direct bond, X is
Figure US11793881-20231024-C00120

W1 is
Figure US11793881-20231024-C00121

Z2 is
Figure US11793881-20231024-C00122

Z1 is
Figure US11793881-20231024-C00123

Z0 is
Figure US11793881-20231024-C00124

Q is —N-AC, N is G, AC is SN38.
In some embodiments, M is PEGm, PEGm is a multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 10 k, A1 is
Figure US11793881-20231024-C00125

Y is a direct bond, X is
Figure US11793881-20231024-C00126

W1 is
Figure US11793881-20231024-C00127

Z2 is
Figure US11793881-20231024-C00128

Z1 is
Figure US11793881-20231024-C00129

Z0 is
Figure US11793881-20231024-C00130
In some specific embodiments, M is PEGm, PEGm, is a multi-arm (for example, four-arm, eight-arm, preferably four-arm) polyethylene glycol segment, and its number-average molecular weight is 5 k-40 k, preferably 5 k-10 k or 10 k-40 k, more preferably 10 k, A1 is
Figure US11793881-20231024-C00131

Y is a direct bond, X is
Figure US11793881-20231024-C00132

W1 is
Figure US11793881-20231024-C00133

Z2 is
Figure US11793881-20231024-C00134

Z1 is
Figure US11793881-20231024-C00135

Z0 is
Figure US11793881-20231024-C00136

Q1 is —N1-AC1, Q2 is —N2-AC2, N1, N2 are GFLG, AC1 is LPT, AC2 is PCB.
In some embodiments, M is
Figure US11793881-20231024-C00137

A1 is
Figure US11793881-20231024-C00138

Y is
Figure US11793881-20231024-C00139

X is
Figure US11793881-20231024-C00140

W1 is
Figure US11793881-20231024-C00141

Z3 is
Figure US11793881-20231024-C00142

Z2 is
Figure US11793881-20231024-C00143

Z1 is
Figure US11793881-20231024-C00144

Z0 is
Figure US11793881-20231024-C00145
In some specific embodiments, M is
Figure US11793881-20231024-C00146

A1 is
Figure US11793881-20231024-C00147

Y is
Figure US11793881-20231024-C00148

X is
Figure US11793881-20231024-C00149

W1 is
Figure US11793881-20231024-C00150

Z3 is
Figure US11793881-20231024-C00151

Z2 is
Figure US11793881-20231024-C00152

Z1 is
Figure US11793881-20231024-C00153

Z0 is
Figure US11793881-20231024-C00154

Q1 is —N1-AC1, Q2 is —N2-AC2, N1, N2 are GFLG, AC1 is LPT, AC2 is PCB.
In some embodiments, M is
Figure US11793881-20231024-C00155

A1 is
Figure US11793881-20231024-C00156

Y is
Figure US11793881-20231024-C00157

X is
Figure US11793881-20231024-C00158

W1 is
Figure US11793881-20231024-C00159

Z2 is
Figure US11793881-20231024-C00160

Z1 is
Figure US11793881-20231024-C00161

Z0
Figure US11793881-20231024-C00162
In some specific embodiments, M is
Figure US11793881-20231024-C00163

A1 is
Figure US11793881-20231024-C00164

Y is
Figure US11793881-20231024-C00165

X is
Figure US11793881-20231024-C00166

W1 is
Figure US11793881-20231024-C00167

Z2 is
Figure US11793881-20231024-C00168

Z1 is
Figure US11793881-20231024-C00169

Z0 is
Figure US11793881-20231024-C00170

Q1 is —N1-AC1, Q2 is —N2-AC2, N1, N2 are GFLG, AC1 is LPT, AC2 is PCB.
In some embodiments, M is
Figure US11793881-20231024-C00171

A1 is
Figure US11793881-20231024-C00172

Y is a direct bond, X is
Figure US11793881-20231024-C00173

W1 is
Figure US11793881-20231024-C00174

Z1 is
Figure US11793881-20231024-C00175

Z0 is
Figure US11793881-20231024-C00176
In some specific embodiments, M is
Figure US11793881-20231024-C00177

A1 is
Figure US11793881-20231024-C00178

Y is a direct bond, X is
Figure US11793881-20231024-C00179

W1 is
Figure US11793881-20231024-C00180

Z1 is
Figure US11793881-20231024-C00181

Z0 is
Figure US11793881-20231024-C00182

Q is —N-AC, N is
Figure US11793881-20231024-C00183

AC is PTX.
In some embodiments, M is
Figure US11793881-20231024-C00184

A1 is
Figure US11793881-20231024-C00185

Y is
Figure US11793881-20231024-C00186

X is
Figure US11793881-20231024-C00187

W1 is
Figure US11793881-20231024-C00188

Z2 is
Figure US11793881-20231024-C00189

Z1 is
Figure US11793881-20231024-C00190

Z0 is
Figure US11793881-20231024-C00191
In some specific embodiments, M is
Figure US11793881-20231024-C00192

A1 is
Figure US11793881-20231024-C00193

Y is
Figure US11793881-20231024-C00194

X is
Figure US11793881-20231024-C00195

W1 is
Figure US11793881-20231024-C00196

Z2 is
Figure US11793881-20231024-C00197

Z1 is
Figure US11793881-20231024-C00198

Z0 is
Figure US11793881-20231024-C00199

Q is —N-AC, N is G, AC is SN38.
In some embodiments, wherein:
M is
Figure US11793881-20231024-C00200

—C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00201
A1 is
Figure US11793881-20231024-C00202
Y is a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)— or
Figure US11793881-20231024-C00203

X is
Figure US11793881-20231024-C00204

W1 is
Figure US11793881-20231024-C00205

Z2 is
Figure US11793881-20231024-C00206

Z1 is
Figure US11793881-20231024-C00207

Z0 is
Figure US11793881-20231024-C00208
Alternatively, in some embodiments, wherein:
M is
Figure US11793881-20231024-C00209

—C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C00210

A1 is
Figure US11793881-20231024-C00211

Y is a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)— or
Figure US11793881-20231024-C00212

X is
Figure US11793881-20231024-C00213
Figure US11793881-20231024-C00214

W1 is
Figure US11793881-20231024-C00215

Z2 is
Figure US11793881-20231024-C00216

Z1 is
Figure US11793881-20231024-C00217

Z0 is
Figure US11793881-20231024-C00218
In some specific embodiments, M is
Figure US11793881-20231024-C00219

A1 is
Figure US11793881-20231024-C00220

Y is
Figure US11793881-20231024-C00221

X is
Figure US11793881-20231024-C00222

W1 is
Figure US11793881-20231024-C00223

Z2 is
Figure US11793881-20231024-C00224

Z1 is
Figure US11793881-20231024-C00225

Z0 is
Figure US11793881-20231024-C00226

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00227

A1 is
Figure US11793881-20231024-C00228

Y is
Figure US11793881-20231024-C00229

X is
Figure US11793881-20231024-C00230

W1 is
Figure US11793881-20231024-C00231

Z2 is
Figure US11793881-20231024-C00232

Z1 is
Figure US11793881-20231024-C00233

Z0 is
Figure US11793881-20231024-C00234

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00235

A1 is
Figure US11793881-20231024-C00236

Y is GLFG, X is
Figure US11793881-20231024-C00237

W1 is
Figure US11793881-20231024-C00238

Z2 is
Figure US11793881-20231024-C00239

Z1 is
Figure US11793881-20231024-C00240

Z0 is
Figure US11793881-20231024-C00241

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00242

A1 is
Figure US11793881-20231024-C00243

Y is
Figure US11793881-20231024-C00244

X is
Figure US11793881-20231024-C00245

W1 is
Figure US11793881-20231024-C00246

Z2 is
Figure US11793881-20231024-C00247

Z1 is
Figure US11793881-20231024-C00248

Z0 is
Figure US11793881-20231024-C00249

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00250

A1 is
Figure US11793881-20231024-C00251

Y is GLFG, X is
Figure US11793881-20231024-C00252

W1 is
Figure US11793881-20231024-C00253

Z2 is
Figure US11793881-20231024-C00254

Z1 is
Figure US11793881-20231024-C00255

Z0 is
Figure US11793881-20231024-C00256

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00257

A1 is
Figure US11793881-20231024-C00258

Y is
Figure US11793881-20231024-C00259

X is
Figure US11793881-20231024-C00260

W1 is
Figure US11793881-20231024-C00261

Z2 is
Figure US11793881-20231024-C00262

Z1 is
Figure US11793881-20231024-C00263

Z0 is
Figure US11793881-20231024-C00264

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is LPT.
In some specific embodiments, M is
Figure US11793881-20231024-C00265

A1 is
Figure US11793881-20231024-C00266

Y is a direct bond, X is
Figure US11793881-20231024-C00267

W1 is
Figure US11793881-20231024-C00268

Z2 is
Figure US11793881-20231024-C00269

Z1 is
Figure US11793881-20231024-C00270

Z0 is
Figure US11793881-20231024-C00271

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1, AC2 each independently are PCB, SB7 or LPT.
In some specific embodiments, M is
Figure US11793881-20231024-C00272

A1 is
Figure US11793881-20231024-C00273

Y is
Figure US11793881-20231024-C00274

X is
Figure US11793881-20231024-C00275

W1 is
Figure US11793881-20231024-C00276

Z2 is
Figure US11793881-20231024-C00277

Z1 is
Figure US11793881-20231024-C00278

Z0 is
Figure US11793881-20231024-C00279

Q is —N-AC, N is GFLG, AC is PCB.
In some specific embodiments, M is
Figure US11793881-20231024-C00280

A1 is
Figure US11793881-20231024-C00281

Y is a direct bond, X is
Figure US11793881-20231024-C00282

W1 is
Figure US11793881-20231024-C00283

Z2 is
Figure US11793881-20231024-C00284

Z1 is
Figure US11793881-20231024-C00285

Z0 is
Figure US11793881-20231024-C00286

Q is —N-AC, N is GFLG, AC is NPB.
In some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (III), wherein: M is
Figure US11793881-20231024-C00287

—C(═O)—C1-6 alkylene-NH— or —C(═O)—C1-6 alkylene-C(═O)—, preferably
Figure US11793881-20231024-C00288
A1, A1′ each independently are
Figure US11793881-20231024-C00289

preferably
Figure US11793881-20231024-C00290
Y, Y′ each independently are a direct bond or
Figure US11793881-20231024-C00291
X and X′ are
Figure US11793881-20231024-C00292
W1, W1′ each independently are
Figure US11793881-20231024-C00293

Q1,
Figure US11793881-20231024-C00294
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00295

preferably
Figure US11793881-20231024-C00296
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N, N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C00297
AC, AC1, AC2 each independently are SN38, PKA, PCB, PTX, LPT, SB7 or DOX,
the number-average molecular weight of PEG independently is 5 k-40 k.
Alternatively, in some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (III), wherein:
M is
Figure US11793881-20231024-C00298

—C(═O)—C1-6 alkylene-NH— or —C(═O)—C1-6alkylene-C(═O)—, preferably
Figure US11793881-20231024-C00299
A1, A1 ‘ each independently are
Figure US11793881-20231024-C00300

preferably
Figure US11793881-20231024-C00301
Y, Y’ each independently are a direct bond or
Figure US11793881-20231024-C00302
X and X′ are
Figure US11793881-20231024-C00303
W1, W1′ each independently are Q1,
Figure US11793881-20231024-C00304
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00305

preferably
Figure US11793881-20231024-C00306
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C00307
AC1, AC2 each independently are SN38, PKA, PCB, PTX, LPT, SB7 or DOX,
the number-average molecular weight of PEG independently is 5 k-40 k.
In some embodiments, wherein:
M is
Figure US11793881-20231024-C00308

A1 is
Figure US11793881-20231024-C00309

A1′ is
Figure US11793881-20231024-C00310

Y is a direct bond, Y′ is
Figure US11793881-20231024-C00311

W1 is
Figure US11793881-20231024-C00312

W1′ is
Figure US11793881-20231024-C00313

Z4, Z2 and Z0 are
Figure US11793881-20231024-C00314
Z3 and Z1 are
Figure US11793881-20231024-C00315
In some specific embodiments, M is
Figure US11793881-20231024-C00316

A1 is
Figure US11793881-20231024-C00317

A1′ is
Figure US11793881-20231024-C00318

Y is a direct bond, Y′ is
Figure US11793881-20231024-C00319

W1 is
Figure US11793881-20231024-C00320

W1′ is
Figure US11793881-20231024-C00321

Z4, Z2 and Z0 are
Figure US11793881-20231024-C00322

Z3 and Z1 are
Figure US11793881-20231024-C00323

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 is G, N2 is GFLG, AC1 is SN38, AC2 is PKA.
In some embodiments, M is —C(═O)—C1-6 alkylene-NH—, A1 is
Figure US11793881-20231024-C00324

A1′ is
Figure US11793881-20231024-C00325

Y is a direct bond, Y′ is
Figure US11793881-20231024-C00326

W1 is
Figure US11793881-20231024-C00327

W1′ is Q1, Z2 and Z0 are
Figure US11793881-20231024-C00328

Z1 is
Figure US11793881-20231024-C00329
In some specific embodiments, M is
Figure US11793881-20231024-C00330

A1 is
Figure US11793881-20231024-C00331

A1′ is
Figure US11793881-20231024-C00332

Y is a direct bond, Y′ is
Figure US11793881-20231024-C00333

W1 is
Figure US11793881-20231024-C00334

W1′ is Q1, Z2 is
Figure US11793881-20231024-C00335

Z1 is
Figure US11793881-20231024-C00336

Z0 is
Figure US11793881-20231024-C00337

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 is G or
Figure US11793881-20231024-C00338

N2 is GFLG, AC1 is PTX or DOX, AC2 is PCB or LPT.
In some embodiments, M is —C(═O)—C1-6 alkylene-C(═O)—, A1 and A1′ are
Figure US11793881-20231024-C00339

Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C00340

W1′ is —Z0-(Q1)2, Z3 and Z1 are
Figure US11793881-20231024-C00341

Z2 and Z0 are
Figure US11793881-20231024-C00342
In some specific embodiments, M is
Figure US11793881-20231024-C00343

A1 and A1′ are
Figure US11793881-20231024-C00344

Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C00345

W1′ is —Z0-(Q1)2, Z3 and Z1 are
Figure US11793881-20231024-C00346

Z2 is
Figure US11793881-20231024-C00347

Z0 is
Figure US11793881-20231024-C00348

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is SB7, AC2 is PCB.
In some embodiments, M is —C(═O)—C1-6 alkylene-C(═O)—, A1 and A1′ are
Figure US11793881-20231024-C00349

Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C00350

W1′ is Q1, Z1 and Z0 are
Figure US11793881-20231024-C00351
In some specific embodiments, M is
Figure US11793881-20231024-C00352

A1 and A1′ are
Figure US11793881-20231024-C00353

Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C00354

W1′ is Q1, Z1 and Z0 are
Figure US11793881-20231024-C00355

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is PCB, AC2 is LPT.
In some embodiments, M is —C(═O)—C1-6 alkylene-NH—, A1 is
Figure US11793881-20231024-C00356

A1′ is
Figure US11793881-20231024-C00357

Y and Y′ are a direct bond, W1 and W1′ are
Figure US11793881-20231024-C00358

Z2 is
Figure US11793881-20231024-C00359

Z1 is
Figure US11793881-20231024-C00360

Z0 is
Figure US11793881-20231024-C00361

In some specific embodiments, M is
Figure US11793881-20231024-C00362

A1 is
Figure US11793881-20231024-C00363

A1′ is
Figure US11793881-20231024-C00364

Y and Y′ are a direct bond, W1 and W1′ are
Figure US11793881-20231024-C00365

Z2 is
Figure US11793881-20231024-C00366

Z1 is
Figure US11793881-20231024-C00367

Z0 is
Figure US11793881-20231024-C00368

Q is —N-AC, N is GFLG, AC is SB7.
In some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (IV), wherein:
M is
Figure US11793881-20231024-C00369
A1 is
Figure US11793881-20231024-C00370

preferably
Figure US11793881-20231024-C00371
X is
Figure US11793881-20231024-C00372
W1 independently is
Figure US11793881-20231024-C00373
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00374

preferably
Figure US11793881-20231024-C00375
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N1 and N2 are GFLG,
AC1, AC2 each independently are PCB, SB7, LPT, PKA,
the number-average molecular weight of PEG independently is 5 k-40 k.
In some embodiments, wherein:
M is
Figure US11793881-20231024-C00376

W1 is
Figure US11793881-20231024-C00377

Z2 is
Figure US11793881-20231024-C00378

Z1 is
Figure US11793881-20231024-C00379

Z0 is
Figure US11793881-20231024-C00380
In some specific embodiments, M is
Figure US11793881-20231024-C00381

W1 is
Figure US11793881-20231024-C00382

Z2 is
Figure US11793881-20231024-C00383

Z1 is
Figure US11793881-20231024-C00384

Z0 is
Figure US11793881-20231024-C00385

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is LPT, AC2 is SB7.
In some embodiments, M is
Figure US11793881-20231024-C00386

W1 is
Figure US11793881-20231024-C00387

Z4 and Z1 are
Figure US11793881-20231024-C00388

Z3, Z2 and Z0 are
Figure US11793881-20231024-C00389
In some specific embodiments, M is
Figure US11793881-20231024-C00390

W1 is
Figure US11793881-20231024-C00391

Z4 and Z1 are
Figure US11793881-20231024-C00392

Z3, Z2 and Z0 are
Figure US11793881-20231024-C00393

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is PCB, AC2 is PKA.
In some embodiments, M is
Figure US11793881-20231024-C00394

W1 is
Figure US11793881-20231024-C00395

Z1 is
Figure US11793881-20231024-C00396

Z0 is
Figure US11793881-20231024-C00397
In some specific embodiments, M is
Figure US11793881-20231024-C00398

W1 is
Figure US11793881-20231024-C00399

Z1 is
Figure US11793881-20231024-C00400

Z0 is
Figure US11793881-20231024-C00401

Q is —N-AC, N is GFLG, AC is LPT or PCB.
In some embodiments, the polyethylene glycol conjugated drug has the structure represented by the formula (V), wherein:
L1 is —C(═O)—C1-6 alkylene-C(═O)—, preferably
Figure US11793881-20231024-C00402
A2 is
Figure US11793881-20231024-C00403

preferably
Figure US11793881-20231024-C00404
M is
Figure US11793881-20231024-C00405
A1 is
Figure US11793881-20231024-C00406

preferably
Figure US11793881-20231024-C00407
Y is
Figure US11793881-20231024-C00408
X is
Figure US11793881-20231024-C00409
W1, W2 each independently are
Figure US11793881-20231024-C00410
Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C00411

preferably
Figure US11793881-20231024-C00412
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N1 and N2 are GFLG,
AC1, AC2 each independently are PCB or SB7,
the number-average molecular weight of PEG is 5 k-40 k.
In some embodiments, wherein:
W1 and W2 are
Figure US11793881-20231024-C00413

Z2 is
Figure US11793881-20231024-C00414

Z1 is
Figure US11793881-20231024-C00415

Z0 is
Figure US11793881-20231024-C00416
In some specific embodiments, W1 and W2 are
Figure US11793881-20231024-C00417

Z2 is
Figure US11793881-20231024-C00418

Z1 is
Figure US11793881-20231024-C00419

Z0 is
Figure US11793881-20231024-C00420

Q1 is —N1-AC1, Q2 is —N2-AC2, N1 and N2 are GFLG, AC1 is PCB, AC2 is SB7.
In the second aspect of the present invention, the present invention provides a polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, the polyethylene glycol conjugated drug being selected from:
Figure US11793881-20231024-C00421
Figure US11793881-20231024-C00422
Figure US11793881-20231024-C00423
Figure US11793881-20231024-C00424
Figure US11793881-20231024-C00425
Figure US11793881-20231024-C00426
Figure US11793881-20231024-C00427
Figure US11793881-20231024-C00428
Figure US11793881-20231024-C00429
Figure US11793881-20231024-C00430
Figure US11793881-20231024-C00431
Figure US11793881-20231024-C00432
Figure US11793881-20231024-C00433
Figure US11793881-20231024-C00434
Figure US11793881-20231024-C00435
Figure US11793881-20231024-C00436
Figure US11793881-20231024-C00437
Figure US11793881-20231024-C00438
Figure US11793881-20231024-C00439
Figure US11793881-20231024-C00440
Figure US11793881-20231024-C00441
Figure US11793881-20231024-C00442
Figure US11793881-20231024-C00443
Figure US11793881-20231024-C00444
Figure US11793881-20231024-C00445
Figure US11793881-20231024-C00446
Figure US11793881-20231024-C00447
Figure US11793881-20231024-C00448
Figure US11793881-20231024-C00449
Figure US11793881-20231024-C00450
Figure US11793881-20231024-C00451
Figure US11793881-20231024-C00452
Figure US11793881-20231024-C00453
Figure US11793881-20231024-C00454
Figure US11793881-20231024-C00455
Figure US11793881-20231024-C00456
Figure US11793881-20231024-C00457
Figure US11793881-20231024-C00458
Figure US11793881-20231024-C00459
Figure US11793881-20231024-C00460
Figure US11793881-20231024-C00461
Figure US11793881-20231024-C00462
Figure US11793881-20231024-C00463
Figure US11793881-20231024-C00464
Figure US11793881-20231024-C00465
Figure US11793881-20231024-C00466
Figure US11793881-20231024-C00467
Figure US11793881-20231024-C00468
Figure US11793881-20231024-C00469
Figure US11793881-20231024-C00470
Figure US11793881-20231024-C00471
Figure US11793881-20231024-C00472
Figure US11793881-20231024-C00473
Figure US11793881-20231024-C00474
Figure US11793881-20231024-C00475
Figure US11793881-20231024-C00476
Intermediate and Preparation Method
In the third aspect of the present invention, the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (II) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
Figure US11793881-20231024-C00477
Figure US11793881-20231024-C00478
Figure US11793881-20231024-C00479
Figure US11793881-20231024-C00480
Figure US11793881-20231024-C00481
Figure US11793881-20231024-C00482
Figure US11793881-20231024-C00483
Figure US11793881-20231024-C00484
Figure US11793881-20231024-C00485
Figure US11793881-20231024-C00486
Figure US11793881-20231024-C00487
Figure US11793881-20231024-C00488
Figure US11793881-20231024-C00489
Figure US11793881-20231024-C00490
In the fourth aspect of the present invention, the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (II) or a pharmaceutically acceptable salt thereof, comprising the following steps:
    • (1) preparing the intermediate
Figure US11793881-20231024-C00491
    •  M, A1, W1, Y and j1 being as defined above, wherein:
in the preparation of the intermediate
Figure US11793881-20231024-C00492

when Y is other than a direct bond, —Y—OH has a terminal carboxyl group, when Y is a direct bond,
Figure US11793881-20231024-C00493

has a terminal carboxyl group,
in the preparation of the intermediate
Figure US11793881-20231024-C00494

when Y is other than a direct bond, —Y—H has a terminal amino group, when Y is a direct bond,
Figure US11793881-20231024-C00495

has a terminal amino group;
    • (2) allowing the PEG with amino group or activated amino group and the intermediate
Figure US11793881-20231024-C00496
    •  to carry out amidation reaction, or, allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C00497
    •  to carry out amidation reaction, to obtain the above-mentioned polyethylene glycol conjugated drug.
In the fifth aspect of the present invention, the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (III) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
Figure US11793881-20231024-C00498
Figure US11793881-20231024-C00499
Figure US11793881-20231024-C00500
Figure US11793881-20231024-C00501
Figure US11793881-20231024-C00502
Figure US11793881-20231024-C00503
In the sixth aspect of the present invention, the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (III) or a pharmaceutically acceptable salt thereof, comprising the following steps:
    • (1) preparing the intermediate
Figure US11793881-20231024-C00504
    •  M, A1, A1′, W1, W1′, Y, Y′ and j1 being as defined above, wherein:
when Y or Y′ is other than a direct bond, —Y—H or —Y′—H has a terminal amino group,
when Y or Y′ is a direct bond,
Figure US11793881-20231024-C00505

has a terminal amino group;
    • (2) allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C00506
    •  to carry out amidation reaction, to obtain the above-mentioned polyethylene glycol conjugated drug.
In the seventh aspect of the present invention, the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (IV) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
Figure US11793881-20231024-C00507
In the eighth aspect of the present invention, the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (IV) or a pharmaceutically acceptable salt thereof, comprising the following steps:
    • (1) preparing the intermediate
Figure US11793881-20231024-C00508
    •  M, A1, W1 and j1 being as defined above, wherein,
Figure US11793881-20231024-C00509
    •  has a terminal amino group;
    • (2) allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C00510
    •  to carry out amidation reaction, to obtain the above-mentioned polyethylene glycol conjugated drug.
In the ninth aspect of the present invention, the present invention provides an intermediate for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (V) or a pharmaceutically acceptable salt thereof, the intermediate being selected from:
Figure US11793881-20231024-C00511
In the tenth aspect of the present invention, the present invention provides a method for preparing the above-mentioned polyethylene glycol conjugated drug of the formula (V) or a pharmaceutically acceptable salt thereof, comprising the following steps:
    • (1) preparing the intermediate
Figure US11793881-20231024-C00512
    •  M, A1, A2, W1, W2, L1, Y and j1 being as defined above, wherein, —Y—OH has a terminal carboxyl group;
    • (2) allowing the PEG with amino group or activated amino group and the intermediate
Figure US11793881-20231024-C00513
    •  to carry out amidation reaction, to obtain the above-mentioned polyethylene glycol conjugated drug.
Pharmaceutical Composition and Pharmaceutical Use
In one aspect of the present invention, the present application provides a pharmaceutical composition, comprising a therapeutically and/or prophylactically effective amount of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to the present invention; the composition further comprises one or more pharmaceutically acceptable excipients, such as carriers and/or vehicles. The carriers and/or vehicles include, but are not limited to: ion exchangers, alumina, aluminum stearate, lecithin, serum proteins such as human serum protein, buffer substances such as phosphate, glycerin, sorbic acid, potassium sorbate, a mixture of partial glycerides of saturated plant fatty acids, water, salt or electrolyte, such as protamine sulfate, disodium hydrogen phosphate, potassium hydrogen phosphate, sodium chloride, zinc salt, colloidal silica, magnesium trisilicate, polyvinylpyrrolidone, cellulose material, polyethylene glycol, sodium carboxymethyl cellulose, polyacrylate, beeswax, polyethylene-polyoxypropylene block polymer, and lanolin.
The pharmaceutical composition may be prepared into any pharmaceutically acceptable dosage form. The pharmaceutical composition may also be applied to individuals in need of such treatment in any suitable way of administration, such as oral, parenteral, rectal or pulmonary administration. In the case of oral administration, the pharmaceutical composition may be made into conventional solid preparations, such as tablets, capsules, pills, granules, etc.; it may also be made into oral liquid preparations, such as oral solutions and oral suspensions, and syrup. When the pharmaceutical composition is made into oral preparations, suitable fillers, binders, disintegrants, lubricants, etc. may be added. In the case of parenteral administration, the pharmaceutical composition may be made into injection preparations, including injection solutions, sterile powders for injection, and concentrated solutions for injection. When the pharmaceutical composition is made into injection preparations, they may be produced by a conventional method in the current pharmaceutical field. In the case of preparation of injection preparations, it is not required to add additives, or appropriate additives may be added according to the nature of the drug. In the case of rectal administration, the pharmaceutical composition may be made into suppositories and the like. In the case of pulmonary administration, the pharmaceutical composition may be made into an inhalant or a spray. Preferably, the pharmaceutical composition of the present invention may be made into an injection preparation, such as an injection solution. Alternatively, normal saline is used as the carrier of the injection solutions.
In another aspect, the present application provides use of the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating and/or preventing a disease (such as a cancer). The disease refers to a disease treated by the active ingredient in the polyethylene glycol conjugated drug.
In another aspect, the present application provides the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof for use in treating and/or preventing a disease (such as a cancer). The disease refers to a disease treated by the active ingredient in the polyethylene glycol conjugated drug.
In the present invention, cancer refers to a disease state characterized by cell proliferative, including but not limited to: colon cancer, leukemia, lymphoma, bladder cancer, bone cancer, brain tumor, medulloblastoma, glioma, breast cancer, adenoma/carcinoid, adrenal cortical cancer, pancreatic islet cell cancer, cervical cancer, endometrial cancer, ovarian cancer, colorectal cancer, skin cancer, esophageal cancer, eye cancer, gallbladder cancer, stomach cancer, head and neck cancer, liver cancer, melanoma, Kaposi's sarcoma, kidney cancer, oral cancer, lung cancer, nasopharyngeal cancer, neuroblastoma, ovarian cancer, pancreatic cancer, thyroid cancer, parathyroid penile cancer, prostate cancer, urethral cancer, vaginal cancer, vulvar cancer, anal cancer, sarcoma, etc., including metastasis of the aforementioned cancers.
In another aspect, the present application provides a method for treating and/or preventing a disease (such as a cancer), comprising administering an effective amount of the polyethylene glycol conjugated drug of the present invention or a pharmaceutically acceptable salt thereof to an individual in need thereof. The dosage regimen may be adjusted to provide the optimum desired response. For example, a single amount of drug may be administered, several divided doses may be administered over time, or the dose may be proportionally reduced or increased as indicated by the urgent need for the treatment. It should be noted that the dose value may vary with the type and severity of the condition to be alleviated, and may include single or multiple doses. It should be further understood that for any particular individual, the specific dosage regimen should be adjusted over time according to the individual's needs and the professional judgment of the person administering the composition or supervising the administration of the composition.
In the present invention, “individual” includes a human or a non-human animal. Exemplary human individuals include human individuals suffering from diseases such as those described herein (referred to as patients) or normal individuals. In the present invention, “non-human animals” include all vertebrates, such as non-mammals (such as birds, amphibians, and reptiles) and mammals, such as non-human primates, livestock and/or domesticated animals (such as sheep, dogs, cats, cows, pigs, and etc.).
Explanation or Definition of Terms
In the present invention, the active ingredient suitable for being conjugated with polyethylene glycol may be a drug molecule with at least one amino group, hydroxyl group, carboxyl group or acyl group, for example, a drug molecule having anti-tumor activity with at least one amino group, hydroxyl group, carboxyl group or acyl group, such as MK2, LPT, PCB, SB7, PKA, NPB and the like, which represent the following meanings:
Abbreviation Name CAS number or structural formula
MK2 MK-2206•2HCl 1032350-13-2
LPT Lapatinib 231277-92-2
PCB Palbociclib 571190-30-2
SB7 SB-743921 940929-33-9
PKA A derivative of PKI-587, in said derivative the two terminal methyl groups are removed compared with PKI-587
Figure US11793881-20231024-C00514
NPB Niraparib (MK-4827) 1038915-60-4
Unless otherwise defined below, the meanings of all technical and scientific terms used herein are intended to be the same as those commonly understood by those skilled in the art. The reference to the technology used herein is intended to refer to the technology generally understood in the art, including those technical changes or equivalent technology substitutions that are obvious to those skilled in the art. Although it is believed that the following terms are well understood by those skilled in the art, the following definitions are still set forth to better explain the present invention.
As used herein, “PEG” is an abbreviation for polyethylene glycol, which refers to a homopolymer with a repeating unit of —CH2CH2O—, including single-arm polyethylene glycol, multi-arm polyethylene glycol and their derivatives, such as a derivative with a reactive functional group such as amino or carboxyl group at the terminal. In the present invention, the arms of the multi-arm polyethylene glycol preferably have the same degree of polymerization. When referring to the molecular weight of a multi-arm polyethylene glycol, the molecular weight means the total molecular weight of each arm. In the structural formula of the present invention, the letter “m” or “n” in the subscript of the repeating unit of polyethylene glycol represents the degree of polymerization of polyethylene glycol. When the polyethylene glycol is a multi-arm polyethylene glycol, the letter “m” or “n” represents the degree of polymerization of each arm.
In various parts of this specification, substituents for the disclosed compounds of the present invention are disclosed in terms of group species or ranges. It is specifically pointed out that the present invention includes every independent subcombination of each member of these group species and ranges. For example, the term “C1-C6 alkyl” specifically refers to independently disclosed methyl, ethyl, C3 alkyl, C4 alkyl, C5 alkyl and C6 alkyl.
Unless otherwise indicated, the term “alkyl” refers to a saturated, straight-chain or branched-chain, monovalent hydrocarbon group with 1 to 6 carbon atoms (C1-C6 alkyl group), or 1 to 4 carbon atoms (C1-C4 alkyl group), or 1 to 3 carbon atoms (C1-C3 alkyl group), wherein the alkyl group may be independently and optionally substituted by one or more substituents described herein, including but not limited to deuterium, amino, hydroxyl, cyano, F, Cl, Br, I, mercapto, nitro, oxo (═O) and the like. Examples of the alkyl group include, but not limited to, methyl (Me, —CH3), ethyl (Et, —CH2CH3), n-propyl (n-Pr, —CH2CH2CH3), iso-propyl (i-Pr, —CH(CH3)2), n-butyl (n-Bu, —CH2CH2CH2CH3), iso-butyl (i-Bu, —CH2CH(CH3)2), sec-butyl (s-Bu, —CH(CH3)CH2CH3), tert-butyl (t-Bu, —C(CH3)3), n-pentyl (—CH2CH2CH2CH2CH3), 2-pentyl (—CH(CH3)CH2CH2CH3), 3-pentyl (—CH(CH2CH3)2), 2-methyl-2-butyl (—C(CH3)2CH2CH3), 3-methyl-2-butyl (—CH(CH3)CH(CH3)2), 3-methyl-1-butyl (—CH2CH2CH(CH3)2), 2-methyl-1-butyl (—CH2CH(CH3)CH2CH3), n-hexyl (—CH2CH2CH2CH2CH2CH3), 2-hexyl (—CH(CH3)CH2CH2CH2CH3), 3-hexyl (—CH(CH2CH3)(CH2CH2CH3)), 2-methyl-2-pentyl (—C(CH3)2CH2CH2CH3), 3-methyl-2-pentyl (—CH(CH3)CH(CH3)CH2CH3), 4-methyl-2-pentyl (—CH(CH3)CH2CH(CH3)2), 3-methyl-3-pentyl (—C(CH3)(CH2CH3)2), 2-methyl-3-pentyl (—CH(CH2CH3)CH(CH3)2), 2,3-dimethyl-2-butyl (—C(CH3)2CH(CH3)2), 3,3-dimethyl-2-butyl (—CH(CH3)C(CH3)3), n-heptyl, n-octyl and the like. The term “alkyl” and its prefix “alk”, as used herein, both include straight and branched saturated carbon chains.
The term “alkylene” refers to a saturated divalent hydrocarbon group obtained by removing two hydrogen atoms from a linear or branched saturated alkyl group, such as “C1-C6 alkylene” derived from C1-C6 alkyl, “C1-C4 alkylene” derived from C1-C4 alkyl, “C1-C3 alkylene” derived from C1-C3 alkyl. And the alkylene group may be substituted or unsubstituted, wherein the substituent may be, but not limited to, deuterium, hydroxyl, amino, halogen, cyano, aryl, heteroaryl, alkoxy, alkyl, alkenyl, alkynyl, heterocyclyl, mercapto, nitro or aryloxy. Examples of the alkylene group include, but not limited to, methylene (—CH2—), ethylene (—CH2—CH2—), isopropylidene (—CH2—CH(CH3)—), ethane-1,1-diyl, 2-methoxypropane-1,1-diyl, 2-hydroxypropane-1,1-diyl, 2-methyl-2-hydroxypropane-1,1-diyl and the like. Wherein, the meaning of the alkyl group is as described above.
In addition, it should be noted that, unless it is clearly indicated in other ways, the expressions “each . . . independently are” and “ . . . and . . . each independently are” used throughout this disclosure are interchangeable, and both should be understood in a broad sense. It can mean that the specific options expressed by the same symbol in different groups do not affect each other, or it can mean that the specific options expressed by the same symbol in the same group do not affect each other.
As used herein, a certain variable being “a direct bond” refers to that the linker group does not exist, and at the same time, the substituent on the linker group correspondingly does not exist. For example, regarding —X—Y—Z, if Y is a direct bond, then it is expressed as —X—Z, and at the same time, the substituent on Y correspondingly does not exist.
As used herein, the “pharmaceutically acceptable salt” of the compound of the present invention includes an acid addition salt and base addition salt of the compound, such as hydrochloride, hexafluorophosphate, and meglumine salt.
As used herein, the wavy line “
Figure US11793881-20231024-P00001
” in the structural formula means the position where another group is bonded to the structure represented by the structural formula.
As used herein, the term “effective amount” refers to the amount of a compound that will relieve one or more symptoms of the disease being treated to a certain extent after being administered.
As used herein, the term “treating” means reversing, alleviating, or inhibiting the disease or condition to which such term is applied or the progression of one or more symptoms of such a disease or condition, or preventing such a disease or condition or one or more symptoms of such a disease or condition.
Beneficial Effect
The polyethylene glycol conjugated drug of the present invention has excellent anti-tumor activity. Through the preparation method of the present invention, the polyethylene glycol conjugated drug of the present invention can be prepared efficiently and conveniently.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows the preparation of drugs 44-2 and 27-134;
FIG. 2 shows the measured absorbance values of drugs 44-2 and 27-134;
FIG. 3 shows the inhibitory effect of drug 44-2 on MDA-MB-231 cancer cells;
FIG. 4 shows the inhibitory effect of drug 27-134 on Colo205 cancer cells;
FIG. 5 shows the IC50 calculation results of drugs 44-2 and 27-134;
FIG. 6 , FIG. 7 and FIG. 8 show the tumor growth trend of each group in Example 3;
FIG. 9 , FIG. 10 and FIG. 11 are schematic diagrams of the tumor weight inhibition rate of each group in Example 3;
FIG. 12 shows the photos of euthanized animals of each group in Example 3;
FIG. 13 shows the photos of tumors of each group in Example 3;
FIG. 14 shows the tumor growth trend of each group in Example 4;
FIG. 15 is a schematic diagram of the tumor weight inhibition rate of each group in Example 4.
DETAILED DESCRIPTION
The embodiments of the present invention will be described in detail below in conjunction with examples. However, those skilled in the art will understand that the following examples are only used to illustrate the present invention, not to limit the scope of the present invention. Those without specific conditions among the examples are generally implemented under conventional conditions or under conditions recommended by the manufacturers. The reagents or instruments used without specifying the manufacturers are all conventional products that may be purchased commercially.
The meanings of abbreviations in the examples are as follows:
G Glycine residue L Leucine residue
F Phenylalanine residue Asp Aspartic acid residue
E Glutamate residue Glu Glutamate residue
DMF N,N-dimethylformamide TFA Trifluoroacetic acid
t-Bu Tert-butyl Bn Benzyl
Boc Tert-butoxycarbonyl Fmoc Fluorenyl methoxycarbonyl
HOBT 1-hydroxybenzotriazole Ts p-toluenesulfonyl
HBTU O-benzotriazole-tetramethylurea hexafluorophosphate LPT Lapatinib
DIEA N,N-diiso-propylethylamine SB7 SB-743921
EA Ethyl acetate PCB Palbociclib
TMP
2,4,6-trimethylpyridine NPB Niraparib
GFLG Glycine-phenylalanine-leucine-glycine residue
PyAOP (3H-1,2,3-triazolo[4,5-b]pyridin-3-oxy)tris-1-pyrrolidinylphosphonium hexafluorophosphate
LC NH2—CH2CH2O—CH2CH2O—CH2—COOH or —NH—CH2CH2O—CH2CH2O—CH2—CO—
The source and structure of some raw materials are as follows:
M-NH2-2K•HCl
JenKem, mPEG—CH2CH2—NH2HCl
M-NH2-3K•HCl
JenKem, mPEG—CH2CH2—NH2HCl
M-NH2-5K•HCl
JenKem, mPEG—CH2CH2—NH2HCl
M-SCM-10K
Figure US11793881-20231024-C00515
Example 1 Synthesis of Compound
1. Synthesis of 37-14 (Compound No. 10)
Synthetic route is as follows:
Figure US11793881-20231024-C00516
Figure US11793881-20231024-C00517
Figure US11793881-20231024-C00518
Figure US11793881-20231024-C00519
Figure US11793881-20231024-C00520
Figure US11793881-20231024-C00521
Figure US11793881-20231024-C00522
Figure US11793881-20231024-C00523
Figure US11793881-20231024-C00524
Details are given as follows:
Figure US11793881-20231024-C00525
Boc-Glu-OH (purchased from Ark Pharm, 15.0 g, 60.6673 mmol), HBTU (purchased from Aladdin, 69.0225 g, 182.0022 mmol), HOBT (purchased from Innochem, 24.5921 g, 182.0022 mmol) and H-Glu (OBn)2·TosOH (purchased from Ark Pharm, 63.6473 g, 127.4014 mmol) were added in a 1000 mL round-bottomed flask, and dissolved with DMF (300 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (90.2 mL, 546.0066 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Thereafter, saturated sodium chloride solution (300 mL) was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 25-71: 67.9 g.
Figure US11793881-20231024-C00526
25-71 (52.5355 g, 60.6673 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (TFA, 67.6 mL, 910.0101 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane. The reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium bicarbonate solution (300 mL) was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Thereafter, deionized water (300 mL) was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated and evaporated to dryness. The obtained dry product was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, 150 mL of silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (60%-100% ethyl acetate: 40%-0% petroleum ether and 1%-4% methanol: 99%-96% ethyl acetate) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-73: 44.4 g, yield: 95.56%.
Figure US11793881-20231024-C00527
2-(2-aminoethoxy) ethanol (18.8680 g, 190.2226 mmol) was poured into a 500 mL round-bottomed flask, and diluted with dichloromethane (100 mL), then triethylamine (38.4972 mL, 380.4452 mmol) was added, (Boc) 20 (49.8261 g, 228.2671 mmol) was added slowly with stirring, and the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was evaporated to dryness, then sodium bicarbonate powder was added, the obtained mixture was diluted with dichloromethane, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with 50% ethyl acetate/petroleum ether were carried out, thus obtaining the product 27.3 g, yield 70%.
Figure US11793881-20231024-C00528
16-24 (27.3 g, 132.8144 mmol) was added in a 500 mL flask, nitrogen was introduced for protective purpose, the THF solution of potassium tert-butoxide was added, the mixed solution was placed at 0° C. to react, ethyl bromoacetate (17.6265 mL, 159.3773 mmol) was then added, and the obtained solution was first stirred for 3 hours, and then reacted at room temperature. At the end of the reaction, the reaction solution was first evaporated to dryness, then deionized water and ethyl acetate were added for extraction, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was dried with anhydrous sodium sulfate powder, suction filtering was carried out, and the operations of dry sample loading, column chromatography and gradient elution with 30%-100% ethyl acetate/petroleum ether were carried out, thus obtaining the product 20 g, yield 52%.
Figure US11793881-20231024-C00529
16-36 (17.9 g, 61.4402 mmol) was added in a 250 mL flask, 1,4-dioxane was added, lithium hydroxide (3.2386 g, 135.1685 mmol) was further added with stirring, and 30 min later, deionized water was added until the solution became clear. At the end of the reaction, the reaction solution was extracted three times (100 mL×3) with a mixed solvent of methyl tert-butyl ether and n-hexane (1:1). The aqueous phase was adjusted to pH=1 with concentrated hydrochloric acid, and then extracted three times with ethyl acetate (300 mL×3), the ethyl acetate phases were combined, the dissolution and washing with saturated sodium chloride was carried out three times (100 mL×3), and the obtained solution was concentrated. The operations of dry sample loading, column chromatography and elution with 40%400% ethyl acetate/petroleum ether were carried out, thus obtaining the product 10.1 g, yield 62%.
Figure US11793881-20231024-C00530
Boc-LC-OH (synthesized according to the method of synthesizing 24-36, 15.0236 g, 57.0608 mmol), HBTU (32.4596 g, 85.5912 mmol), HOBT (11.5651 g, 85.5912 mmol) and 25-73 (43.7 g, 57.0608 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (150 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (61.5 mL, 342.3648 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Thereafter, deionized water (300 mL) was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated and evaporated to dryness. The obtained dry product was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, 150 mL of silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (1% ammonia water: 1%-2% methanol: 98%-97% dichloromethane) were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 25-75: 42.1 g, yield: 72.97%.
Figure US11793881-20231024-C00531
25-75 (26.7 g, 26.4064 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (TFA, 19.6 mL, 264.064 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane. Then, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Thereafter, deionized water (300 mL) was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 22-181: 20.3 g, yield: 84.2%.
Figure US11793881-20231024-C00532
Fmoc-L-Lys (Boc)-OH (purchased from Accela, 1.39 g, 2.967 mmol), 22-181 (2.70 g, 2.967 mmol), HBTU (1.69 g, 4.4505 mmol), HOBT (0.6 g, 4.4505 mmol) were added in a 100 mL flask, and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.21 mL, 13.3515 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel and extracted with saturated saline solution (200 mL) and ethyl acetate (250 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, thus obtaining the product 35-3: 4.0 g.
Figure US11793881-20231024-C00533
35-3 (4.04 g, 2.967 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (3.31 mL, 44.505 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated to a small amount. The operation of washing with stirring was carried out with the addition of n-hexane (120 mL) to remove the trifluoroacetic acid, the supernatant was discarded, and n-hexane (120 mL) was added to the lower oily solution. Such operations were repeated three times. Finally, a viscous oily product was obtained. The oily product was dried to give 35-4: 3.74 g.
Figure US11793881-20231024-C00534
Boc-GFLG-OBn (as synthesized in accordance with literature, 6.8282 g, 11.7184 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C00535
35-4 (3.74 g, 32.967 mmol), 25-102 (1.75 g, 3.560 mmol), HBTU (1.69 g, 4.451 mmol), HOBT (0.6 g, 4.451 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (4.4 mL, 26.703 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), evaporated to dryness, and dried in an oven, thus obtaining the product 35-6: 5.1 g.
Figure US11793881-20231024-C00536
35-6 (5.1 g, 2.967 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), morpholine (3.9 mL, 44.505 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated saline solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), and concentrated. Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% of ammonia water and 3%-5% of methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 35-7: 3.4 g, yield 77%.
Figure US11793881-20231024-C00537
35-7 (3.4 g, 2.27 mmol), succinic acid (0.12 g, 1.03 mmol, purchased from InnoChem), HBTU (1.17 g, 3.09 mmol), HOBT (0.42 g, 3.09 mmol) were added in a 500 mL flask, and the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (1.53 mL, 9.27 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated sodium bicarbonate solution (200 mL) and ethyl acetate (250 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), and concentrated. Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography, and elution with a dichloromethane mixed solution containing 1% of ammonia water and 5% of methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 35-11: 3.0 g, yield 96%.
1H-NMR (400 MHz, DMSO-d6) δ 8.59-8.43 (m, 1H), 8.36-8.26 (m, 2H), 8.20-8.14 (m, 1H), 8.01-7.87 (m, 6H), 7.78-7.61 (m, 3H), 7.38-7.11 (m, 55H), 6.93-6.95 (m, 2H), 5.21-4.97 (m, 15H), 4.53-4.52 (m, 1H), 4.42-4.22 (m, 7H), 4.15-4.13 (m, 1H), 3.89-3.87 (m, 3H), 3.76-3.43 (m, 19H), 3.18-3.16 (m, 5H), 2.31-2.98 (m, 7H), 2.84-2.64 (m, 6H), 2.44-2.38 (m, 8H), 2.37-2.28 (m, 8H), 2.21-2.10 (m, 5H), 2.08-1.81 (m, 11H), 1.81-1.68 (m, 3H), 1.51-1.40 (m, 4H), 1.50-1.41 (m, 7H), 1.29-1.16 (m, 18H), 1.28-1.16 (m, 12H), 0.93-0.75 (m, 12H).
Figure US11793881-20231024-C00538
Boc-GFLG-OH (synthesized according to the method of synthesizing 25-102, 13.97 mmol), PCB (5 g, 11.17 mmol), HBTU (6.35 g, 16.76 mmol) and HOBT (2.26 g, 16.76 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (8.31 mL, 50.28 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the filter cake was washed with deionized water (1000 mL), and a yellow solid was separated out by precipitation, and dried, thus obtaining the product 10.3 g.
Figure US11793881-20231024-C00539
30-30 (10.3 g, 11.17 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), then TFA (12.45 mL, 167.55 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated under reduced pressure, and then precipitated three times with n-hexane (50 mL) and methyl tert-butyl ether (400 mL). A solid product was obtained by filtration, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 5% methanol and 1% ammonia water were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 8.6 g, yield 94%.
Figure US11793881-20231024-C00540
Fmoc-Glu-OtBu (3.223 g, 7.5915 mmol, purchased from Ark pharm), 30-33 (synthesized according to the method of synthesizing 30-33) (5.2 g, 6.3263 mmol), HBTU (3.5988 g, 9.4895 mmol), HOBT (1.282 g, 9.4895 mmol) were added in a 500 mL flask, and stirred for 10 minutes. Then DIEA (4.7 mL, 28.4684 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated five times, to obtain a viscous oily product. The oily product was then dried, thus obtaining the product 28-258: 7.78 g.
Figure US11793881-20231024-C00541
28-258 (7.78 g, 6.3263 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (30 mL), TFA (9/396 mL, 126.52 mmol) was added with stirring, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (300 mL) was added to the concentrated reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (80 mL×3), and dried, thus obtaining the product 28-260: 8.1 g.
Figure US11793881-20231024-C00542
Boc-GFLG-OH (synthesized according to the method of synthesizing 25-102, 4.9738 g, 10.0977 mmol), HBTU (4.4186 g, 11.6513 mmol), HOBT (1.5743 g, 11.6513 mmol) and SB-743291 (4.0162 g, 7.7675 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (5.8 mL, 34.9538 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added to the separatory funnel, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Thereafter, deionized water (300 mL) was further added to the organic phase, the obtained solution was shaken, and stood still for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 25-130: 7.7023 g.
Figure US11793881-20231024-C00543
25-130 (7.7023 g, 7.7675 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (5 mL), TFA (8.7 mL, 116.5125 mmol) was added with stirring, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane. Then, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the obtained solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), methyl tert-butyl ether (150 mL) was added to the obtained solution for precipitation to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (80 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-4% methanol: 96%-95% dichloromethane) were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 25-132: 5.4 g, yield: 77.98%.
Figure US11793881-20231024-C00544
28-260 (7.4 g, 6.3263 mmol), 25-132 (5.9218 g, 6.6426 mmol), HBTU (3.5988 g, 9.4895 mmol), HOBT (1.2823 g, 9.4895 mmol) were added in a 500 mL flask, and dissolved with DMF (110 mL), and the mixed solution was stirred to react at 0° C. for 10 minutes. Then DIEA (4.7 mL, 28.4684 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated six times to obtain a viscous oily product. The oily product was dissolved with methanol (10 mL) and dichloromethane (40 mL), methyl tert-butyl ether (450 mL) was added to the obtained solution to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dried, thus obtaining the product 28-264: 12.9 g.
Figure US11793881-20231024-C00545
28-264 (12.9 g, 6.3263 mmol) was added in a 500 mL flask, and dissolved with DMF (50 mL), morpholine (16.5 mL, 189.789 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated five times, to obtain a viscous oily product. The oily product was dissolved with dichloromethane (20 mL) and methanol (80 mL), methyl tert-butyl ether (350 mL) was added to the obtained solution to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (120 mL×2), and dried, thus obtaining the product 28-265: 11.5 g.
Figure US11793881-20231024-C00546
28-265 (11.54 g, 6.3263 mmol), Boc-Gly-OH (1.3299 g, 7.5916 mmol, purchased from Ark pharm), HBTU (3.5988 g, 9.4895 mmol), HOBT (1.2823 g, 9.4895 mmol) were added in a 250 mL flask, and dissolved with DMF (80 mL), and the mixed solution was stirred to react at −5° C. for 10 minutes. Then DIEA (4.7053 mL, 28.4684 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. for 30 minutes, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added for precipitation, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated four times, to obtain a viscous oily product. Then, dichloromethane (70 mL) and methyl tert-butyl ether (350 mL) were added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dried in a vacuum oven, thus obtaining the product 37-1: 12.5 g.
Figure US11793881-20231024-C00547
37-1 (12.537 g, 6.3263 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (30 mL), TFA (14.09 mL, 189.789 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (250 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dissolved with a mixed solvent of methanol (60 mL) and dichloromethane (240 mL), silica gel powder (25 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The the operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 15% ammonia water and 7%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-2: 9.7 g, yield 82%.
Figure US11793881-20231024-C00548
35-11 (0.38 g, 0.124 mmol) and Pd/C (0.0210 g) was added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth, and the diatomaceous earth was washed with DMF (20 mL×3), to obtain a DMF solution containing 35-13.
Figure US11793881-20231024-C00549
37-2 (2.0 g, 1.063 mmol), HBTU (0.56 g, 1.4832 mmol), HOBT (0.2 g, 1.4832 mmol) were added in a DMF (90 mL) solution containing 35-13 (0.364 g, 0.1236 mmol), and then the mixed solution was stirred to react at −5° C. for about 10 minutes. Then DIEA (0.74 mL, 4.4496 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. for 60 minutes, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution, the obtained solution was shaken to be layered, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were further added to the lower liquid, and such operations were repeated six times, to obtain a viscous oily product. Then, dichloromethane (30 mL) and methyl tert-butyl ether (250 mL) were added to the oily product to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dissolved with a mixed solvent of methanol (30 mL)/dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-7% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, thus obtaining the product 35-14: 1.2 g, yield 56%.
Figure US11793881-20231024-C00550
35-14 (1.2 g, 0.0695 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (15 mL), TFA (1.0322 mL, 13.6 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, methyl tert-butyl ether (100 mL) was added to the concentrated solution to separate out a powdery solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water: 6%-7% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 35-16: 0.74 g, yield 67%.
Figure US11793881-20231024-C00551
35-16 (0.3011 g, 0.01754 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), M-SCM-40K (1.5227 g, 0.0369 mmol, purchased from JenKem) was added, and ultrasonic treatment was carried out to dissolve the reactants, the mixed solution reacted in the dark for 7 days at a low speed of stirring at room temperature. At the end of the reaction, n-hexane (120 mL) and methyl tert-butyl ether (40 mL) were added to the reaction solution, the supernatant was discarded, and n-hexane (120 mL) and methyl tert-butyl ether (40 mL) were added to the lower liquid. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (25 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-7% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (5 mL) and dichloromethane (20 mL). Then, methyl tert-butyl ether (80 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried in a vacuum oven, thus obtaining the product 37-14: 0.98 g, yield: 58%.
1H-NMR (600 MHz, DMSO-d6) δ 10.18-10.11 (m, 4H), 9.21-8.97 (m, 4H), 8.24-7.89 (m, 61H), 7.58-7.43 (m, 12H), 7.30-7.08 (m, 99H), 5.91-5.77 (m, 4H), 4.64-4.68 (m, 23H), 4.38-4.14 (m, 57H), 4.07-3.89 (m, 81H), 3.60-3.45 (m, 7482H), 3.24-2.96 (m, 7H), 2.82-2.65 (m, 43H), 2.42-2.40 (m, 12H), 2.35-2.26 (m, 32H), 2.25-2.03 (m, 11H), 1.95-1.67 (m, 26H), 1.63-1.41 (m, 40H), 1.37-1.15 (m, 19H), 1.17-1.05 (m, 17H), 0.90-0.77 (m, 72H), 0.52-0.46 (m, 8H).
2. Synthesis of 10-109 (Compound No. 16)
Synthetic route is as follows:
Figure US11793881-20231024-C00552
Figure US11793881-20231024-C00553
Figure US11793881-20231024-C00554
Figure US11793881-20231024-C00555
Figure US11793881-20231024-C00556
Figure US11793881-20231024-C00557
Figure US11793881-20231024-C00558
Figure US11793881-20231024-C00559
Details are given as follows
Figure US11793881-20231024-C00560
Boc-Glu-(OH) —OBn (purchased from Accela, 10 g, 29.64 mmol), Glu-(OBn)2·TosOH (16.3 g, 32.61 mmol), HBTU (16.9 g, 44.46 mmol) and HOBT (6.1 g, 44.46 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (200 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (22 mL, 133.4 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, saturated sodium bicarbonate solution (200 mL) was added to the reaction solution, and then extraction with ethyl acetate (200 mL×3) was carried out three times, and the obtained organic phases were combined. Saturated sodium chloride solution (200 mL×2) was added to the organic phase, and then extraction with ethyl acetate (100 mL×2) was carried out twice. Finally, the organic phase was dried with anhydrous sodium sulfate, concentrated and evaporated to dryness, thus obtaining the product 31.4 g (weighed).
Figure US11793881-20231024-C00561
23-210 (31.4 g, 29.64 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (100 mL), TFA (33 mL, 444.6 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated and evaporated to dryness under reduced pressure. Saturated sodium bicarbonate solution (200 mL) was added to the reaction solution, and then extraction with ethyl acetate (200 mL×3) was carried out three times, and the obtained organic phases were combined. Saturated sodium chloride solution (200 mL) was added to the organic phase, and then extraction with ethyl acetate (100 mL×2) was carried out twice. Finally, the organic phase was dried with anhydrous sodium sulfate, and then evaporated to dryness for the next reaction.
Figure US11793881-20231024-C00562
29-1 (16.2 g, 29.64 mmol), 10-102 (synthesized according to the method of synthesizing 24-36, 38.5 g, 38.5 mmol), HBTU (16.8 g, 44.4 mmol) and HOBT (6 g, 44.4 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (200 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (22 mL, 133.2 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, saturated sodium bicarbonate solution (200 mL) was added to the reaction solution, and then extraction with ethyl acetate three times (200 mL×3) was carried out three times, and the obtained organic phases were combined. Saturated sodium chloride solution (200 mL×2) was added to the organic phase, and then extraction with ethyl acetate (100 mL×2) was carried out twice. Finally, the organic phase was dried with anhydrous sodium sulfate, concentrated and evaporated to dryness, thus obtaining the product 34.1 g (weighed). The operations of dry sample loading, column chromatography and elution with 45% ethyl acetate were carried out. The elution product was then collected, concentrated, and evaporated to dryness. 11.1 g of pure product was collected and placed in a refrigerator for later use, and 10.7 g of crude product was collected and put into the next deprotection reaction.
Figure US11793881-20231024-C00563
Boc-GFLG-OBn (as synthesized in accordance with literature, 19.0 g, 32.6 mmol), 10% Pd/C catalyst (300 mg) were added in a hydrogenation reactor, and dissolved with DMF (50 mL) where the level of the solvent was above a stirrer. The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation (i.e., pumping the air from the reaction system with a vacuum water pump for about 3 minutes—charging hydrogen—pumping hydrogen—charging hydrogen-pumping hydrogen—charging hydrogen) so that the pressure on the hydrogenation reactor was read as 18 Psi, and then the obtained solution reacted at room temperature overnight. On the second day, after the reaction was found to be completed from the monitoring of the TLC (thin-layer chromatography), workup procedures were performed. The reaction solution was taken out and evenly added dropwise to a suction funnel filled with compacted diatomaceous earth. The reactor was washed with DMF (90 mL) until the reactor did not contain any product, thus obtaining the reaction product.
Figure US11793881-20231024-C00564
30-28 (17.9 mmol), LPT (8 g, 13.77 mmol), HBTU (7.83 g, 20.65 mmol) and HOBT (2.79 g, 20.65 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (10.24 mL, 61.96 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at the low temperature for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, deionized water (1000 mL) was added to wash DMF. A light yellow solid was separated out by precipitation, and dried, thus obtaining the product 14.53 g.
Figure US11793881-20231024-C00565
30-29 (14.53 g, 13.77 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (150 mL), then TFA (15.34 mL, 206.55 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated under reduced pressure, saturated sodium bicarbonate solution (200 mL) was added to neutralize TFA, the product in the aqueous phase was extracted three times with ethyl acetate (150 mL×3), and the obtained organic phases were combined. The organic phase was dried with anhydrous sodium sulfate, suction filtering was carried out, and the filtrate was concentrated, and dried. The operations of dry sample loading, column chromatography and elution with 5% methanol/0.5% ammonia water/dichloromethane were carried out. The elution product was then collected, concentrated, thus obtaining a pure product 13.15 g.
Figure US11793881-20231024-C00566
29-3 (1.95 g, 2.46 mmol) and 10% Pd/C (0.1 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation, so that the pressure on the hydrogenation reactor was read as 0.18 MPa, and then the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), thus obtaining the product 10-85, yield 100%.
Figure US11793881-20231024-C00567
10-85 (1.28 g, 2.46 mmol), GFLG-LPT (synthesized according to the method of synthesizing 14-128, 8.0 g, 8.37 mmol), HBTU (4.20 g, 11.07 mmol), HOBT (1.49 g, 11.07 mmol) were added in a 500 mL flask, and dissolved with DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (5.69 mL, 34.44 mmol) was slowly added dropwise over 3 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-86: 8.2 g, yield 100%.
Figure US11793881-20231024-C00568
10-86 (8.2 g, 2.46 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (8 mL), TFA (2.7 mL, 36.90 mmol), and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was rotary evaporated to obtain a viscous oily product, and methyl tert-butyl ether (60 mL) was then added to the oily product. The powdery solid in the obtained solution was separated out by precipitation, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (40 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 4.5%-6% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 18-87: 5.56 g, yield 70%.
Figure US11793881-20231024-C00569
29-3 (9.9 g, 12.5019 mmol) was partially dissolved with dichloromethane (10 mL), and then TFA (18.5716 mL, 250.0379 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred at room temperature. After TLC detection and color development with phosphomolybdic acid, the reaction was completed. The reaction solution was evaporated to dryness, the dichloromethane was removed, and then the obtained solid was dissolved with ethyl acetate (200 mL). A saturated sodium bicarbonate solution was added until the aqueous phase became alkaline. Then, the organic phase was separated, and the aqueous phase was extracted with ethyl acetate until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was then washed with saturated saline solution three times (100 mL×3), concentrated and evaporated to dryness, thus obtaining the product 8.7 g, extra-quota 0.1 g.
Figure US11793881-20231024-C00570
10-83 (1.6 g, 2.31 mmol), Fmoc-Lys (Boc) —OH (1.14 g, 2.43 mmol), HBTU (1.32 g, 3.47 mmol), HOBT (0.47 g, 3.47 mmol) were added in a 500 mL flask, and dissolved with a proper amount of DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (1.72 mL, 10.39 mmol) was slowly added dropwise over 3 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1%-5% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-92: 2.4 g, yield 92.3%.
Figure US11793881-20231024-C00571
10-92 (0.57 g, 0.506 mmol) and 10% Pd/C (0.1 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation, so that the pressure on the hydrogenation reactor was read as 0.18 MPa, and then the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), thus obtaining the product 10-88: 0.434, yield 100%.
Figure US11793881-20231024-C00572
10-88 (0.434 g, 0.506 mmol), 10-87 (5.56 g, 1.722 mmol), HBTU (0.864 g, 2.277 mmol), HOBT (0.307 g, 2.277 mmol) were added in a 500 mL flask, and dissolved with a proper amount of DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (1.171 mL, 7.084 mmol) was slowly added dropwise over 30 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-89: 5.34 g, yield 100%.
Figure US11793881-20231024-C00573
10-89 (5.34 g, 0.506 mmol) was added in a 250 mL flask, and dissolved with DMF (10 mL), morpholine (0.88 mL, 10.12 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4). Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-7% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-90: 2.65 g, yield 51%.
Figure US11793881-20231024-C00574
30-33 (3.5 g, 4.26 mmol), Fmoc-Lys (Boc) —OH (2.2 g, 4.69 mmol), HBTU (2.42 g, 6.39 mmol), HOBT (0.86 g, 6.39 mmol) were added in a 250 mL flask, and dissolved with a proper amount of DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (3.17 mL, 19.17 mmol) was slowly added dropwise over 30 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 10-71: 5.42 g, yield 100%.
Figure US11793881-20231024-C00575
10-71 (5.42 g, 4.26 mmol) was added in a 250 mL flask, and dissolved with DMF (10 mL), morpholine (7.42 mL, 85.2 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4). The obtained solution was concentrated, and dried in a vacuum oven, thus obtaining the product 10-76: 4.473 g, yield 100%.
Figure US11793881-20231024-C00576
10-76 (4.473 g, 4.26 mmol), succinic anhydride (1.29 g, 12.89 mmol) were added in a 250 mL flask, and dissolved with a proper amount of DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (2.82 mL, 17.04 mmol) was slowly added dropwise over 30 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4). Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-77: 2.98 g, yield 61%.
Figure US11793881-20231024-C00577
10-77 (0.28 g, 0.245 mmol), 10-90 (2.65 g, 0.62 mmol), HBTU (0.139 g, 0.368 mmol), HOBT (0.049 g, 0.368 mmol) were added in a 250 mL flask, and dissolved with a proper amount of DMF (40 mL), and the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (0.18 mL, 1.1 mmol) was slowly added dropwise over 30 minutes. At the end of the addition, the obtained solution continued to react with stirring at −5° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dired in a vacuum oven, thus obtaining the product 10-97: 2.8 g, yield 100%.
Figure US11793881-20231024-C00578
10-97 (2.8 g, 0.245 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (8 mL), and TFA (0.546 mL, 7.35 mmol), and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was rotary evaporated to obtain a viscous oily product, and methyl tert-butyl ether (60 mL) was then added to the oily product. The powdery solid in the obtained solution was separated out by precipitation, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4). Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-10% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 10-98: 1.38 g, yield: 60%
Figure US11793881-20231024-C00579
10-98 (1.29 g, 0.1134 mmol) was added in a 250 mL flask, and dissolved with DMF (10 mL), and M-SCM-20K (0.54 g, 0.054 mmol, purchased from JenKem) was added, the mixed solution reacted in the dark for one week at a low speed of stirring at room temperature. At the end of the reaction, methyl tert-butyl ether (40 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-12% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 10-109: 0.7 g, yield 51%.
1H-NMR (600 MHz, DMSO-d6) δ 7.46-6.89 (m, 225H), 4.21-4.08 (m, 111H), 3.55-3.49 (m, 3882H), 3.08-2.64 (m, 209H), 2.45-2.40 (m, 10H), 2.34-2.28 (m, 28H), 0.88-0.83 (m, 60H).
3. Synthesis of 39-17 (Compound No. 14)
Synthetic route is as follows
Figure US11793881-20231024-C00580
Figure US11793881-20231024-C00581
Figure US11793881-20231024-C00582
Figure US11793881-20231024-C00583
Figure US11793881-20231024-C00584
Details are given as follows:
Figure US11793881-20231024-C00585
Boc-Glu-OH (1.2 g, 4.8 mmol), GFLF-PCB (synthesized according to the method of synthesizing 30-33, 8.2 g, 9.7 mmol), HBTU (5.5 g, 14.4 mmol) and HOBT (1.9 g, 14.4 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (7.1 mL, 43.2 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, a light yellow solid was separated out by precipitation, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 22 g (weighed).
Figure US11793881-20231024-C00586
41-1 (22 g, 11.8 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (26.3 mL, 354 mmol) was added dropwise, and then the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, and precipitated with n-hexane (100 mL) and methyl tert-butyl ether (300 mL), and then suction filtering was carried out. The filter cake was dissolved with dichloromethane (80 mL), methanol (20 mL), silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and gradient elution with 1% ammonia water/3% methanol/dichloromethane-1% ammonia water/5% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, thus obtaining the product 5.9 g, yield 70.2%.
Figure US11793881-20231024-C00587
41-2 (5.9 g, 3.36 mmol), Boc-LC-OH (0.88 g, 3.36 mmol), HBTU (1.9 g, 5.04 mmol) and HOBT (0.68 g, 5.04 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.5 mL, 15.12 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (300 mL) were added to the obtained solution for precipitation to separate out a solid, and suction filtering was carried out. The filter cake was dried in vacuum.
Figure US11793881-20231024-C00588
41-4 (7.9 g, 3.9 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (8.7 mL, 117 mmol) was added dropwise, and then the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, precipitated with n-hexane (100 mL) and methyl tert-butyl ether (300 mL), suction filtering was carried out, and the solid product was separated out, and dried. The operations of dry sample loading, column chromatography and gradient elution with 1% ammonia water: 3% methanol/dichloromethane-1% ammonia water: 5% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, thus obtaining the product.
Figure US11793881-20231024-C00589
Reactants 15-91 (synthesized according to the method of synthesizing 35-3, 0.33 g, 0.1503 mmol) and 10% Pd/C (30 mg) were added in a micro-reactor, and dissolved with DMF (30 mL), H2 (20 psi) was introduced, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed 4 times with DMF to obtain the DMF solution of 24-205 used for the next reaction.
Figure US11793881-20231024-C00590
41-6 (0.84 g, 0.44 mmol), 24-247 (synthesized according to the method of synthesizing 24-205, 0.88 g, 0.091 mmol), HBTU (0.07 g, 0.546 mmol) and HOBT (0.2 g, 0.546 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (0.27 mL, 1.638 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated with n-hexane (100 mL) and methyl tert-butyl ether (300 mL) to separate out a solid, and suction filtering was carried out. The filter cake was dried in vacuum.
Figure US11793881-20231024-C00591
Reactant 41-7 (0.7 g, 0.082 mmol) was dissolved with DMF (30 mL), morpholine (0.214 mL, 2.46 mmol) was added, and then the mixed solution was stirred to react until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product, and suction filtering was carried out. The operations of column chromatography, dry sample loading and gradient elution with 1% ammonia water: 5% methanol/dichloromethane—1% ammonia water: 12% methanol/dichloromethane were carried out, thus obtaining the product 0.5 g.
Figure US11793881-20231024-C00592
Boc-Asp-OH (purchased from damas-beta, 0.18 g, 0.8 mmol), GFLG-SB7 (synthesized according to the method of synthesizing 25-132, 1.5 g, 1.68 mmol), HBTU (0.9 g, 2.4 mmol) and HOBT (0.32 g, 2.4 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (1.19 mL, 7.2 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness. The operations of dry sample loading, column chromatography and gradient elution with 1% ammonia water: 2% methanol/dichloromethane-1% ammonia water: 3% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and evaporated to dryness, obtaining the product used for the next reaction.
Figure US11793881-20231024-C00593
39-1 (1.5 g, 0.8 mmol) was added in a 250 mL round-bottomed flask and dissolved with dichloromethane (20 mL), TFA (1.78 mL, 24 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, and extracted with saturated sodium bicarbonate solution (200 mL), ethyl acetate (100 mL), and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), and evaporated to dryness, thus obtaining the product 1.1 g, yield 73.3%.
Figure US11793881-20231024-C00594
39-5 (1.1 g, 0.58 mmol), Fmoc-Lys (Boc) —OH (0.28 g, 0.609 mmol), HBTU (0.32 g, 0.87 mmol) and HOBT (0.11 g, 0.87 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.43 mL, 2.61 mmol) was slowly added dropwise, and the obtained solution continued to react for 2 hours, and was then moved to room temperature and stirred to react. At the end of the reaction, the reaction solution was extracted with deionized water (200 mL), ethyl acetate (100 mL), and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness, thus obtaining the product 1.3 g.
Figure US11793881-20231024-C00595
39-6 (1.5 g, 0.58 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), morpholine (1.51 mL, 17.4 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was extracted with deionized water (200 mL), ethyl acetate (100 mL), and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness, and the obtained product was used for the next reaction.
Figure US11793881-20231024-C00596
39-8 (0.58 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL). Then, DIEA (0.38 ml, 2.32 mmol) was added, and then the mixed solution was stirred to react at room temperature for 30 minutes. Succinic anhydride (0.17 g, 2.32 mmol) was added, and the obtained solution continued to react. At the end of the reaction, the reaction solution was extracted with deionized water (200 mL), ethyl acetate (100 mL), and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated and evaporated to dryness, and the obtained product was used for the next reaction.
Figure US11793881-20231024-C00597
Reactants 41-9 (0.5 g, 0.06 mmoL), 39-10 (0.134 g, 0.060 mmoL), HBUT (0.034 g, 0.09 mmoL), HOBT (0.012 g, 0.09 mmoL) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.044 mL, 0.27 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading and elution with 1% ammonia water: 4% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out. The elution product was evaporated to dryness, thus obtaining the product 0.5 g, yield 80%.
Figure US11793881-20231024-C00598
39-14 (0.5 g) was dissolved with dichloromethane (5 mL) and TFA (0.106 mL, 1.42 mmol) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, and methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading and gradient elution with 1% ammonia water: 6% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 0.1 g.
1H-NMR (600 MHz, DMSO-d6) δ 10.19-10.15 (m, 7H), 9.11-8.89 (m, 7H), 8.36-8.00 (m, 37H), 7.94-7.85 (m, 13H), 7.54-7.47 (m, 11H), 7.30-7.11 (m, 89H), 6.74-6.63 (m, 2H), 5.87-5.78 (m, 6H), 4.66-3.37 (m, 118H), 3.29-2.53 (m, 123H), 2.45-2.39 (m, 24H), 2.34-2.18 (m, 59H), 2.14-1.42 (m, 107H), 0.94-0.76 (m, 72H).
Figure US11793881-20231024-C00599
Reactant 39-15 (1 g) was dissolved with DMF solution (20 mL), M-SCM-20K (0.4 g) was added, and the obtained solution reacted at a low speed of stirring in the dark. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (50 mL) and n-hexane (100 mL) to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with dichloromethane (50 mL), silica gel powder was added to the obtained solution, and the operations of evaporation, column chromatography, dry sample loading and gradient elution with dichloromethane—1% ammonia water: 6% methanol/dichloromethane were carried out. The elution product was collected, evaporated to dryness, and then dissolved with anhydrous ethanol (10 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, and then n-hexane (50 mL) was added for precipitation. Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 0.15 g.
1H-NMR (600 MHz, DMSO-d6) δ 10.20-10.12 (m, 2H), 9.00-8.90 (m, 2H), 8.16-7.83 (m, 40H), 7.42-7.04 (m, 123H), 4.64-4.13 (m, 129H), 4.03-3.97 (m, 35H), 3.81-3.80 (m, 26H), 3.70-3.66 (m, 149H), 3.51-3.50 (m, 876H), 3.27-2.64 (m, 20H), 2.43-2.24 (m, 54H), 2.17-1.41 (m, 24H), 0.97-0.73 (m, 72H).
4. Synthesis of 43-27 (Compound No. 6)
Synthetic route is as follows
Figure US11793881-20231024-C00600
Figure US11793881-20231024-C00601
Figure US11793881-20231024-C00602
Figure US11793881-20231024-C00603
Figure US11793881-20231024-C00604
Figure US11793881-20231024-C00605
Figure US11793881-20231024-C00606
34-15
Boc-L-Lys (Fmoc)-OH (purchased from Aladdin, 2.78 g, 5.927 mmol), 22-181 (5.4 g, 5.927 mmol), HBTU (3.38 g, 8.891 mmol), HOBT (1.2 g, 8.891 mmol) were added in a 100 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (5.878 mL, 35.565 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (200 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (150 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 34-15: 8.07 g.
Figure US11793881-20231024-C00607
34-15 (8.0 g, 5.927 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (15 mL), trifluoroacetic acid (4.4 mL, 59.271 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, n-hexane (150 mL) was added to layer the obtained solution with shaking, the supernatant was discarded, and n-hexane (150 mL) was added to the lower oily product, and such operations were repeated six times. A viscous oily product was finally obtained, and dried, thus obtaining the product 34-17: 7.5 g.
Figure US11793881-20231024-C00608
34-17 (7.5 g, 5.92 mmol), 34-18 (synthesized according to the method of synthesizing 25-102, 3.5 g, 7.11 mmol), HBTU (3.36 g, 8.88 mmol), HOBT (1.2 g, 8.88 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (8.8 mL, 53.28 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (200 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (150 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 34-19: 10.3 g.
Figure US11793881-20231024-C00609
34-19 (10.3 g, 5.92 mmol) was added in a 500 mL flask, and dissolved with DMF (20 mL), morpholine (7.8 mL, 88.8 mmol) was added, and then the obtained solution reacted at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated saline solution (150 mL) and ethyl acetate (250 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness. The obtained dry product was then dissolved with methanol (30 mL) and dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading and column chromatography and elution with a dichloromethane mixed solution containing 3% methanol were carried out, thus obtaining the product 34-21: 5.37 g, yield 60%.
Figure US11793881-20231024-C00610
34-21 (1.6 g, 1.06 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (30 mL), triethylamine (0.29 mL, 2.12 mmol) was added, and the obtained solution was stirred at 0° C. for 15 minutes, and then phenyl chloroformate (0.13 mL, 1.06 mmol) was added dropwise. At the end of the addition, the obtained solution continued to react at 0° C. with stirring overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with dichloromethane (250 mL) and saturated sodium chloride solution (200 mL), and the organic phase was separated. The aqueous phase was washed with dichloromethane (200 mL×1), and the obtained organic phases were combined. Silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 4% methanol were carried out, thus obtaining the product 43-8: 0.9 g, yield 56%.
Figure US11793881-20231024-C00611
43-8 (0.9 g, 0.55 mmol), 34-21 (0.83 g, 0.55 mmol) were added in a 100 mL flask, and dissolved with DMF (20 mL), triethylamine (0.0771 mL, 0.55 mmol) was added, and the mixed solution was stirred to react at 80° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with ethyl acetate (200 mL) and saturated saline solution (200 mL), and the organic phase was separated. The organic phase was washed with saturated saline solution (150 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-36% methanol were carried out, thus obtaining the product 43-11: 0.95 g, yield 57%.
1H-NMR (400 MHz, DMSO-d6) δ 8.57-8.48 (m, 2H), 8.37-8.24 (m, 2H), 8.21-8.12 (m, 2H), 8.08-7.95 (m, 4H), 7.94-7.80 (m, 4H), 7.76-7.65 (m, 2H), 7.51 (s, 1H), 7.44-7.25 (m, 40H), 7.24-7.10 (m, 11H), 7.01-6.81 (m, 2H), 5.17-5.01 (m, 15H), 4.54 (d, J=4.4 Hz, 2H), 4.41-4.16 (m, 10H), 3.94-3.86 (m, 4H), 3.78-3.68 (d, J=4.4 Hz, 4H), 3.66-3.49 (m, 13H), 3.45 (d, J=6.0 Hz, 2H), 3.42-3.36 (m, 6H), 3.24-3.15 (d, J=5.5 Hz, 4H), 3.08-2.97 (m, 2H), 2.94-2.86 (m, 4H), 2.83-2.71 (m, 3H), 2.46-2.32 (m, 9H), 2.23-2.11 (m, 4H), 1.81-1.68 (m, 4H), 1.68-1.53 (m, 5H), 1.53-1.42 (m, 7H), 1.34 (d, J=5.9 Hz, 18H), 1.31-1.10 (m, 19H), 0.93-0.75 (m, 13H).
Figure US11793881-20231024-C00612
34-23 (synthesized according to the method of synthesizing 43-11, 0.377 g, 0.1236 mmol) and 10% Pd/C (0.0400 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out, and filtered with diatomaceous earth, and the diatomaceous earth was washed with DMF (20 mL×3), as raw material for the next reaction.
Figure US11793881-20231024-C00613
43-15 (0.288 g, 0.1236 mmol), 37-2 (2.0 g, 1.063 mmol), HBTU (0.56 g, 1.4832 mmol), HOBT (0.2 g, 1.4832 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and the mixed solution was stirred to react at −5° C. for 20 minutes. Then DIEA (0.74 mL, 4.4496 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was precipitated three times with n-hexane (120 mL) and methyl tert-butyl ether (30 mL), and a viscous oily product was obtained. Then, methyl tert-butyl ether (250 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (150 mL) and methanol (30 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-6% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 43-21: 1.6 g, yield 75%.
Figure US11793881-20231024-C00614
43-21 (1.6 g, 0.09 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (1 mL, 13.47 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, Methyl tert-butyl ether (150 mL) was added to the concentrated solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) dichloromethane (120 mL), silica gel powder (20 g) was added, the obtained solution was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 43-24: 1.11 g, yield 73%.
Figure US11793881-20231024-C00615
43-24 (0.4 g, 0.023 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), M-SCM-40K (1.983 g, 0.048 mmol) was added, and ultrasonic treatment was carried out to dissolve the reactants, the mixed solution reacted in the dark for 7 days at a low speed of stirring at room temperature. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (50 mL) were added to the reaction solution, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (50 mL) were added to the lower liquid. Such operations were repeated three times, to obtain a viscous oily product. Then, methyl tert-butyl ether (120 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-6% methanol were carried out. The elution product was then collected, concentrated, and evaporated to dryness to obtain a solid. The solid was dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (5 mL) and dichloromethane (20 mL). Then, methyl tert-butyl ether (80 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried in a vacuum oven, thus obtaining the product 43-27: 0.9 g, yield: 38%.
1H-NMR (600 MHz, DMSO-d6) δ 10.16-10.13 (m, 5H), 8.99-8.93 (m, 6H), 8.29-7.95 (m, 84H), 7.92-7.85 (m, 14H), 7.59-7.44 (d, J=3.3 Hz, 70H), 7.33-7.03 (m, 154H), 4.53-4.41 (m, 55H), 3.72-3.41 (m, 7336H), 3.20-3.03 (m, 123H), 2.42-2.38 (m, 25H), 2.36-2.15 (48, 71H), 1.94-1.69 (m, 48H), 1.65-1.39 (m, 71H), 1.36-1.08 (m, 235H), 0.99-0.68 (m, 124H), 0.56-0.39 (m, 16H).
5. Synthesis of 27-134 (Compound No. 18)
Synthetic route is as follows
Figure US11793881-20231024-C00616
Figure US11793881-20231024-C00617
Figure US11793881-20231024-C00618
Figure US11793881-20231024-C00619
Figure US11793881-20231024-C00620
Figure US11793881-20231024-C00621
DMF (10 mL) was added in a flask loaded with 27-119 (synthesized according to the method of synthesizing 35-3, 1 g, 0.7345 mmol), ultrasonic vibration was carried out to completely dissolve the compound, morpholine (0.64 mL, 7.345 mmol) was added, and the mixed solution was stirred to react at room temperature for 2 h. At the end of the reaction, the reaction solution was extracted with saturated sodium bicarbonate solution (100 mL) and ethyl acetate (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with ethyl acetate (200 mL*3), and the obtained organic phases were combined. The organic phase was evaporated to dryness and concentrated to about 50 mL, and then washed with saturated sodium chloride solution (100 mL*3). The obtained organic phases were combined. The organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 27-120 (1.4317 g, 100%)
Figure US11793881-20231024-C00622
Succinic acid (0.039 g, 0.3339 mmol), HBTU (0.3798 g, 1.0017 mmol), HOBT (0.1354 g, 1.0017 mmol) were added in a flask loaded with 27-120 (0.8368 g, 0.7345 mmol), and dissolved with a proper amount of DMF, then the obtained solution was placed at −5° C., and DIEA (0.50 mL, 3.0051 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, an excess amount of a saturated sodium bicarbonate solution was added until the solution became alkaline, the obtained solution was extracted with ethyl acetate (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with ethyl acetate (200 mL*3), and the obtained organic phases were combined. The organic phase was evaporated to dryness and concentrated to about 100 mL. The concentrated solution was taken out, washed with saturated sodium chloride solution (100 mL*3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (50 mL) was added, and the operations of evaporation to dryness, dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 27-121 (0.5811 g, 73.72%)
Figure US11793881-20231024-C00623
27-121 (0.5811 g, 0.2462 mmol) was added in a hydrogenation reactor, Pd/C (0.1 g) and DMF (20 mL) were added, hydrogen was introduced to a pressure of 1.4 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (15 mL×3), and the filtrate was put into a 250 mL round-bottomed flask, obtaining 27-123 as the raw material for the next reaction.
Figure US11793881-20231024-C00624
35-12 (synthesized according to the method of synthesizing 37-2, 1.8 g, 0.9566 mmol), HBTU (0.54 g, 1.4348 mmol), HOBT (0.19 g, 1.4348 mmol) were added in a flask loaded with 27-123 (0.1782 g, 0.1087 mmol), and dissolved with a proper amount of DMF, then the obtained solution was placed at −5° C., and DIEA (0.23 mL, 4.3045 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, a mixed solution (250 mL) of methyl tert-butyl ether:n-hexane=1:5 was added to the reaction solution, the obtained solution was shaken, and stood still, the supernatant was discarded, and the above operations were repeated three times. Then, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a solid, and suction filtering was carried out. The filter cake was then dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (40 mL) was added, the obtained solution was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading. column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 3-5% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 27-128 (0.8 g, 44.69%)
Figure US11793881-20231024-C00625
Dichloromethane was added in a flask loaded with 27-128 (0.8 g, 0.0483 mmol), ultrasonic vibration was carried out to completely dissolve the compound, then TFA (0.107 mL, 1.4503 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the dichloromethane in the reaction solution was evaporated, methyl tert-butyl ether (100 mL) was added, and the obtained solution was shakn to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (40 mL) was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 7-10% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 27-132 (0.5633 g, 71.34%).
1H-NMR (600 MHz, DMSO-d6) δ 10.21-10.17 (m, 4H), 9.15-8.87 (m, 8H), 8.47-7.69 (m, 91H), 7.60-6.88 (m, 202H), 6.78-6.62 (m, 4H), 5.93-5.60 (m, 13H), 5.35-5.29 (m, 1H), 4.57-4.53 (m, 9H), 4.27 (m, 23H), 4.07-3.22 (m, 166H), 3.21-2.85 (m, 40H), 2.85-2.53 (m, 28H), 2.44-2.04 (m, 87H), 2.04-1.95 (m, 7H), 1.83-1.79 (m, 41H), 1.55-1.49 (m, 55H), 1.38-0.99 (m, 92H), 0.86-0.82 (m, 103H), 0.52-0.47 (m, 39H).
Figure US11793881-20231024-C00626
27-132 (0.2633 g, 0.01610 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), M-SCM-20K (0.7955 g, 0.03703 mmol, purchased from JenKem) was added, ultrasonic vibration was carried out to dissolve the compound, and then the mixed solution reacted in the dark for one week at a low speed of stirring at room temperature. At the end of the reaction, methyl tert-butyl ether (200 mL) and n-hexane (70 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (50 mL) was added, the obtained solution was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 7% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 27-134 (0.5876 g, 61.85%).
1H-NMR (600 MHz, DMSO-d5) δ 9.06-9.02 (m, 19H), 8.98-8.92 (m, 11H), 8.28-7.93 (m, 69H), 7.87-7.82 (m, 25H), 7.55-7.49 (m, 32H), 7.44-6.95 (m, 116H), 6.92-6.88 (m, 10H), 6.76-6.63 (m, 26H), 5.40-5.25 (m, 29H), 4.62-4.43 (m, 38H), 4.39-4.07 (m, 64H), 3.72-3.68 (m, 3897H), 3.19-3.10 (m, 20H), 2.91-2.86 (m, 19H), 2.83-2.57 (m, 62H), 2.36-2.06 (m, 66H), 2.05-1.89 (m, 38H), 1.51-1.45 (m, 50H), 1.39-0.97 (m, 242H), 0.95-0.64 (m, 87H).
6. Synthesis of 44-2 (Compound No. 3)
Synthetic route is as follows
Figure US11793881-20231024-C00627
Figure US11793881-20231024-C00628
Figure US11793881-20231024-C00629
Figure US11793881-20231024-C00630
Figure US11793881-20231024-C00631
Figure US11793881-20231024-C00632
Figure US11793881-20231024-C00633
Figure US11793881-20231024-C00634
Figure US11793881-20231024-C00635
Figure US11793881-20231024-C00636
7-ethyl-10-hydroxycamptothecin (also referred to as SN38, 20 g, 50.9684 mmol) and tert-butyl diphenylchlorosilane (purchased from Innochem, TBDPSC1, 79.5 mL, 305.8104 mmol) were added in a 1 L round-bottomed flask, and dissolved with dichloromethane (250 mL) and triethylamine (Et3N, 42.5 mL, 305.8104 mmol), and then the obtained solution was placed in an oil bath at 37° C. and stirred to react overnight. At the end of the reaction, the reaction solution was concentrated and evaporated to dryness under reduced pressure to remove the dichloromethane, the obtained solid was dissolved with dichloromethane (20 mL), the obtained solution was precipitated with n-hexane (200 mL) to separate out a solid product, and filtering was carried out. The filter cake was washed with n-hexane (100 mL), the filtrate was kept in a refrigerator at 2° C.-8° C. for 30 minutes, taken out and filtered, and the filter cake was washed with n-hexane (100 mL). Such operations were repeated five times, to obtain a solid product. The solid product was dried in an oven, thus obtaining the product 25-189: 23.9 g, yield: 74.34%.
Figure US11793881-20231024-C00637
Boc-glycine (Boc-Gly-OH, 7.9647 g, 45.4661 mmol), 25-189 (23.9 g, 37.8884 mmol) and DMAP (0.9258 g, 7.5777 mmol) were added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (100 mL), the mixed solution was stirred at 0° C. for about 30 minutes, then dicyclohexylcarbodiimide (DCC, 15.6350 g, 75.7767 mmol) was added, and the obtained solution was stirred to react at 0° C. for 3 hours. At the end of the reaction, the reaction solution was first filtered to remove the DCC, the filter cake was washed with dichloromethane (60 mL), and the filtrate was collected, evaporated to dryness, and dried, thus obtaining the product 25-199: 29.8549 g.
Figure US11793881-20231024-C00638
25-199 (29.8549 g, 37.8884 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (42.2 mL, 568.326 mmol) was added with stirring, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, the obtained solution was precipitated with n-hexane (150 mL), the supernatant was discarded, and then the lower oily solution was precipitated with n-hexane (150 mL). Such operations were repeated three times to obtain an oily solid. The oily solid was dissolved with dichloromethane (20 mL), silica gel powder (100 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-4% methanol: 99%-96% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-200: 23.4557 g, yield: 90.04%.
Figure US11793881-20231024-C00639
Boc-Gly-OH (purchased from Aladdin, 3.0 g, 17.1252 mmol), HBTU (9.7418 g, 25.6878 mmol), HOBT (3.4709 g, 25.6878 mmol) and H-Glu (OBzl)-OBzl·TosOH (8.5554 g, 17.1252 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (12.7 mL, 77.0634 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 2 hours. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, saturated sodium chloride solution (300 mL) was further added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Next, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. The organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-2% methanol: 99%-98% ethyl acetate) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-211: 6.9213 g, yield: 83.41%.
Figure US11793881-20231024-C00640
25-211 (2.6890 g, 5.5382 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C00641
25-220 (1.6853 g, 5.5382 mmol), HBTU (6.3009 g, 16.6146 mmol), HOBT (2.2450 g, 16.6146 mmol) and 25-200 (8.3810 g, 12.1841 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (8.2 mL, 49.8438 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-222: 9.0 g, yield: 98.85%.
MALDI-TOF MS: [M−H+]1641.76.
Figure US11793881-20231024-C00642
25-222 (9.0 g, 5.4745 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (6.1 mL, 82.1178 mmol) was added with stirring, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, then the reaction solution was transferred to a 2 L separatory funnel, saturated sodium chloride solution (400 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. The organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (70 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (2%-7% methanol: 98%-93% ethyl acetate) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-224: 6.0 g, yield: 70.99%.
MALDI-TOF MS: [M+Na+]1565.64.
Figure US11793881-20231024-C00643
Fmoc-Glu (OtBu)-OH (purchased from Ark Pharm, 4.0646 g, 9.5134 mmol), HBTU (5.4118 g, 14.2701 mmol), HOBT (1.9282 g, 14.2701 mmol) and 25-201 (synthesized according to the method of synthesizing 22-181, 9.1 g, 9.9890 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (7.1 mL, 42.8103 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 2 hours, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-203: 12.5430 g.
Figure US11793881-20231024-C00644
25-203 (12.5430 g, 9.5134 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), trifluoroacetic acid (TFA, 10.6 mL, 142.701 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane. Then, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-5% methanol: 99%-95% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-210: 9.0 g, yield: 74.94%.
MALDI-TOF MS: [M+Na+]1284.24.
Figure US11793881-20231024-C00645
25-210 (9.0 g, 7.1295 mmol), HBTU (3.9376 g, 10.3828 mmol), HOBT (1.4029 g, 10.3828 mmol) and ethylenediamine monohydrate (purchased from TCl, 0.2 mL, 3.4609 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the obtained solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (5.1 mL, 31.1483 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-221: 8.8211 g.
MALDI-TOF MS: [M+Na+]2570.22.
Figure US11793881-20231024-C00646
25-221 (8.8211 g, 3.4609 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), morpholine (4.5 mL, 51.9135 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 25-226: 7.2828 g.
MALDI-TOF MS: [M+Na+]2125.39.
Figure US11793881-20231024-C00647
25-226 (3.2368 g, 1.5382 mmol), HBTU (1.7500 g, 4.6146 mmol), HOBT (0.6235 g, 4.6146 mmol) and 25-207 (synthesized according to the method of synthesizing 25-102) (1.7426 g, 3.5379 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.3 mL, 13.8438 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 2%-6% methanol: 97%-93% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-227: 2.0618 g, yield: 43.9%.
MALDI-TOF MS: [M+Na+]3076.43.
Figure US11793881-20231024-C00648
25-227 (0.6519 g, 0.2135 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (50 mL) until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C00649
The solution of 25-236 (0.4980 g, 0.2135 mmol), HBTU (0.9716 g, 2.5620 mmol), HOBT (0.3462 g, 2.5620 mmol) and 25-224 (2.9 g, 1.8784 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (1.3 mL, 7.6860 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 3 hours. At the end of the reaction, the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (3%-10% methanol: 97%-90% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-238: 1.9233 g, yield: 61.96%.
Figure US11793881-20231024-C00650
25-238 (1.9233 g, 0.1323 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (5 mL), trifluoroacetic acid (TFA, 0.2 mL, 1.9843 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane. Then, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (30 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-5% methanol: 99%-95% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-243: 0.7924 g, yield: 71.01%.
Figure US11793881-20231024-C00651
25-243 (0.4738 g, 0.033 mmol) and M-SCM-40K (purchased from Jenkem Technology, 3.0 g, 0.0727 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (20 mL), and then the mixed solution reacted at room temperature in the dark for one week. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (10 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (300 mL) and methyl tert-butyl ether (50 mL) were added to the lower oily liquid phase for further precipitation. Such operations were repeated three times, to finally obtain a viscous oily product. Then, dichloromethane (5 mL) was added to the viscous oily product, the obtained solution was precipitated with methyl tert-butyl ether (60 mL) to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), to obtain a solid product. The solid product was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (40 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (4%-12% methanol: 96%-88% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-260: 1.6 g, yield: 50.17%.
Figure US11793881-20231024-C00652
25-260 (0.8233 g, 0.0085 mmol) was dissolved with THF (20 mL); TBAF·3H2O (0.0860 g, 0.2726 mmol) was dissolved with THF (10 mL); the THF solution of TBAF was added to the THF solution of 25-260, a certain amount of diluted hydrochloric acid solution (30 mL, 0.05 mol/L) was added, and then the mixed solution was stirred to react at room temperature in the dark overnight. At the end of the reaction, the reaction solution was first evaporated to dryness, anhydrous ethanol (20 mL) was added, the obtained solution was concentrated under reduced pressure and evaporated to dryness. Such operations were repeated three times. The obtained solid was dissolved with DMF (1.0 mL), isopropanol (50 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was further dissolved with DMF (3.0 mL), isopropanol (50 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with isopropanol (30 mL). The solid obtained in the second step was dissolved with dichloromethane (2.0 mL), methyl tert-butyl ether (50 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was then dissolved with dichloromethane (2.0 mL), methyl tert-butyl ether (50 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL), and dried, thus obtaining the product 44-2: 0.5519 g, yield: 69.79%.
1H-NMR (600 MHz, DMSO-d6) δ9.45-9.29 (m, 80H), 9.09-7.93 (m, 103H), 7.65-7.56 (m, 20H), 7.30-7.19 (m, 81H), 6.97-6.95 (s, 40H), 5.46-5.42 (m, 59H), 5.15-5.12 (m, 87H), 4.05-3.54 (m, 6944H), 2.93-2.89 (m, 97H), 2.74-2.66 (m, 39H), 2.34-2.31 (m, 20H), 2.09-2.06 (m, 106H), 1.90-1.72 (m, 104H), 1.48-1.45 (m, 31H), 1.31-1.21 (m, 119H), 0.95-0.84 (m, 96H).
7. Synthesis of 42-52 (Compound No. 1)
Synthetic route is as follows
Figure US11793881-20231024-C00653
Figure US11793881-20231024-C00654
Figure US11793881-20231024-C00655
Figure US11793881-20231024-C00656
Figure US11793881-20231024-C00657
Figure US11793881-20231024-C00658
Figure US11793881-20231024-C00659
Figure US11793881-20231024-C00660
Figure US11793881-20231024-C00661
Figure US11793881-20231024-C00662
Figure US11793881-20231024-C00663
Figure US11793881-20231024-C00664
Figure US11793881-20231024-C00665
Figure US11793881-20231024-C00666
Figure US11793881-20231024-C00667
Figure US11793881-20231024-C00668
Figure US11793881-20231024-C00669
Figure US11793881-20231024-C00670
Figure US11793881-20231024-C00671
Figure US11793881-20231024-C00672
Figure US11793881-20231024-C00673
Figure US11793881-20231024-C00674
Fmoc-Glu-OtBu (purchased from Accela, 3.2226 g, 7.5741 mmol), HBTU (4.3086 g, 11.3612 mmol), HOBT (1.5351 g, 11.3612 mmol) and 44-19 (synthesized according to the method of synthesizing 22-181, 6.9 g, 7.5741 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (7.5 mL, 45.4460 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (80 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (4%-12% methanol: 96%-88% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-20: 6.9 g, yield: 69.10%.
Figure US11793881-20231024-C00675
42-20 (5.0 g, 3.7923 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (4.2 mL, 56.8845 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, the obtained solution was then transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Next, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. The organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 42-25: 4.7872 g.
Figure US11793881-20231024-C00676
1,2-bis (2-aminoethoxy) ethane (purchased from TCl, 50 mL, 340.7327 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (150 mL), triethylamine (94.8928 mL, 681.4654 mmol) was added, and then di-tert-butyl dicarbonate (purchased from Innochem, 74.3751 g, 340.7321 mmol) was slowly added dropwise with stirring at room temperature. At the end of the addition, the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 2%-3% methanol were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 33-143, yield 10%.
Figure US11793881-20231024-C00677
42-25 (4.7872 g, 3.7923 mmol), HBTU (2.1573 g, 5.6885 mmol), HOBT (0.7686 g, 5.6885 mmol) and 33-143 (0.9888 g, 3.9819 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.8 mL, 17.0654 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 42-27: 5.4 g, yield: 95.40%.
Figure US11793881-20231024-C00678
42-27 (5.4 g, 3.6177 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), morpholine (4.7 mL, 54.2635 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (80 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 1%-6% methanol: 98%-93% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-30: 3.0140 g, yield: 65.58%.
Figure US11793881-20231024-C00679
42-30 (3.0140 g, 2.3724 mmol), HBTU (1.2269 g, 3.2352 mmol), HOBT (0.4371 g, 3.2352 mmol) and glutaric acid (0.1425 g, 1.0784 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (1.6 mL, 9.7056 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, saturated sodium chloride solution (200 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, the obtained solid was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 2%-5% methanol: 97%-94% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-34: 2.8437 g, yield: 100%.
1H-NMR (400 MHz, DMSO-d6) δ8.60-8.22 (m, 5H), 8.19-7.63 (m, 11H), 7.55-7.11 (m, 40H), 5.10-5.07 (m, 16H), 3.56-3.47 (m, 20H), 3.19-3.17 (m, 8H), 3.09-3.01 (m, 4H), 2.99-2.65 (m, 16H), 2.43-2.42 (m, 8H), 2.17-2.09 (m, 32H), 1.36-1.34 (m, 18H).
Figure US11793881-20231024-C00680
The solution of 42-14 (synthesized according to the method of synthesizing 25-102, 5.5320 g, 11.2308 mmol), HBTU (5.8080 g, 15.3147 mmol), HOBT (2.0693 g, 15.3147 mmol) and PKA (PKA is a de-terminated dimethyl derivative of clinical novel drug PKI-587, 6.0 g, 10.2098 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (7.6 mL, 45.9441 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dried in a vacuum oven, thus obtaining the product 42-15: 10.8450 g.
Figure US11793881-20231024-C00681
42-15 (10.8450 g, 10.2098 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (5 mL), TFA (11.4 mL, 153.1470 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, methyl tert-butyl ether (150 mL) was then added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 42-18: 9.8230 g, yield: 100%.
Figure US11793881-20231024-C00682
42-20 (1.8683 g, 1.4170 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C00683
The solution of 42-24 (1.3574 g, 1.4170 mmol), HBTU (3.2243 g, 8.5020 mmol), HOBT (1.1488 g, 8.5020 mmol) and 42-18 (8.0 g, 6.2350 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (4.2 mL, 25.5060 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 3 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dried in a vacuum oven, thus obtaining the product 42-26: 6.7086 g.
Figure US11793881-20231024-C00684
42-26 (6.7086 g, 1.4170 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (1.6 mL, 21.2550 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, methyl tert-butyl ether (150 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with 20% methanol/dichloromethane solution (60 mL), silica gel powder (70 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (2%-11% methanol: 98%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-28: 5.4 g, yield: 81.46%.
Figure US11793881-20231024-C00685
42-28 (4.4 g, 0.9405 mmol), HBTU (0.5350 g, 1.4108 mmol), HOBT (0.1906 g, 1.4108 mmol) and 25-254 (synthesized according to the method of synthesizing 30-33) (0.8504 g, 1.0346 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.7 mL, 4.2324 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 3 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with 20% methanol/dichloromethane solution (60 mL), silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (3%-15% methanol: 97%-85% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-32: 3.6 g, yield: 69.82%.
Figure US11793881-20231024-C00686
42-32 (3.6 g, 0.6567 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (30 mL) morpholine (0.9 mL, 9.8505 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with 20% methanol/dichloromethane solution (60 mL), silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 2%-7% methanol: 97%-92% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-36: 3.2 g, yield: 92.64%.
Figure US11793881-20231024-C00687
42-36 (3.2 g, 0.6084 mmol), HBTU (0.3461 g, 0.9126 mmol), HOBT (0.1233 g, 0.9126 mmol) and Boc-LC-OH (synthesized according to the method of synthesizing 24-36, 0.1762 g, 0.6692 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.5 mL, 2.7378 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dried in a vacuum oven, thus obtaining the product 42-40: 3.3473 g.
Figure US11793881-20231024-C00688
42-40 (3.3473 g, 0.6084 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (0.7 mL, 9.1260 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first concentrated under reduced pressure and evaporated to remove the dichloromethane, methyl tert-butyl ether (100 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with 20% methanol/dichloromethane solution (60 mL), silica gel powder (40 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-10% methanol: 96%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-41: 2.1 g, yield: 63.86%.
Figure US11793881-20231024-C00689
42-34 (1.0 g, 0.3792 mmol) and 10% Pd/C (40 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (60 mL) until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C00690
Figure US11793881-20231024-C00691
Figure US11793881-20231024-C00692
Figure US11793881-20231024-C00693
42-41 (2.1 g, 0.3885 mmol), HBTU (0.2007 g, 0.5292 mmol), HOBT (0.0715 g, 0.5292 mmol) and 42-37 solution (0.0845 g, 0.0441 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.3 mL, 1.5876 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded, and such operations were repeated five times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (80 mL) of 20% methanol/dichloromethane, silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 4%-8% methanol: 95%-91% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-43: 1.0 g, yield: 50.38%.
1H-NMR (600 MHz, DMSO-d6) δ 10.31-10.27 (m, 52H), 8.53-7.91 (m, 88H), 7.80-7.71 (m, 28H), 7.62-7.26 (m, 55H), 7.04-6.98 (m, 32H), 5.76 (s, 48H), 5.44-5.22 (m, 80H), 4.78-4.27 (m, 76H), 4.07-4.02 (m, 61H), 3.92-3.20 (m, 2292H), 3.17-3.03 (m, 53H), 2.67-2.59 (m, 118H), 2.33-2.09 (m, 98H), 1.78-1.61 (m, 54H), 1.41-0.70 (m, 127H).
Figure US11793881-20231024-C00694
Figure US11793881-20231024-C00695
Figure US11793881-20231024-C00696
Figure US11793881-20231024-C00697
42-43 (1.0 g, 0.0222 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (5 mL), TFA (0.1 mL, 0.6615 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, methyl tert-butyl ether (150 mL) was added to the obtained solution for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with 20% methanol/dichloromethane solution (50 mL), silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 4%-10% methanol: 95%-89% dichloromethane) were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 42-50: 0.4772 g, yield: 47.97%.
Figure US11793881-20231024-C00698
Figure US11793881-20231024-C00699
Figure US11793881-20231024-C00700
Figure US11793881-20231024-C00701
42-50 (0.4472 g, 0.0106 mmol) and M-SCM-20K (0.5004 g, 0.0233 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (30 mL), and then the mixed solution reacted in the dark at room temperature for 7 days. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation, the supernatant was discarded. Such operations were repeated three times, to obtain a viscous product. Then, the viscous product was dissolved with dichloromethane (5 mL), methyl tert-butyl ether (100 mL) was added for precipitation, to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (80 mL) of 20% methanol/dichloromethane, silica gel powder (40 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (1% ammonia water: 4%-10% methanol: 95%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-52: 0.547 g, yield: 58.96%.
1H-NMR (600 MHz, DMSO-d6) δ 9.36-8.90 (m, 144H), 8.53-7.94 (m, 349H), 7.94-7.48 (m, 250H), 7.32-7.22 (m, 231H), 7.15-7.09 (m, 27H), 7.03-6.96 (m, 16H), 4.54-4.23 (m, 380H), 4.10-3.36 (m, 3418H), 3.19-3.03 (m, 106H), 2.90-2.73 (m, 50H), 2.63-2.59 (m, 380H), 2.41-2.30 (m, 61H), 2.22-2.12 (m, 95H), 1.98-1.49 (m, 288H), 1.40-1.35 (m, 59H), 1.15-1.03 (m, 75H), 0.91-0.85 (m, 240H).
8. Synthesis of 37-200 (Compound No. 2)
Synthetic route is as follows
Figure US11793881-20231024-C00702
Figure US11793881-20231024-C00703
Figure US11793881-20231024-C00704
Figure US11793881-20231024-C00705
Pentatetramine disulfate (4.33 g, 13.20 mmol, purchased from Pharmaron) was added in a 500 mL flask, and dissolved with dichloromethane (30 mL), triethylamine (14.8 mL, 105.6 mmol) was added, and then the mixed solution was stirred to react at 0° C. for 30 minutes. Phenyl chloroformate (9.95 mL, 79.2 mmol) was then slowly added dropwise, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was transferred to a 1 L reparatory funnel, extracted with dichloromethane (200 mL) and deionized water (200 mL), and the organic phase was separated. The aqueous phase was washed with dichloromethane (200 mL×1), and the obtained organic phases were combined, silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 5% methanol were carried out, thus obtaining the product 37-192: 3.3 g, yield 42%.
Figure US11793881-20231024-C00706
35-31 (2.73 g, 2.196 mmol, synthesized according to the method of synthesizing 34-17), tert-butyl succinate (0.459 g, 2.635 mmol, purchased from InnoChem), HBTU (1.249 g, 3.294 mmol), HOBT (0.445 g, 3.294 mmol) were added in a 500 mL flask, and dissolved with DMF (70 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (1.633 mL, 9.882 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (200 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (150 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-45: 3.1 g.
1H-NMR (400 MHz, DMSO-d6) δ 8.52 (d, J=7.3 Hz, 1H), 8.30 (d, J=7.4 Hz, 1H), 7.99-7.93 (m, 4H), 7.88 (d, J=7.3 Hz, 2H), 7.68 (t, J=7.2 Hz, 3H), 7.51 (t, J=7.6 Hz, 1H), 7.43-7.18 (m, 22H), 5.16-5.01 (m, 7H), 4.45-4.07 (m, 7H), 3.70-3.46 (m, 4H), 3.43-3.29 (m, 10H), 3.24-3.12 (m, 4H), 2.46-2.28 (m, 7H), 2.17 (t, J=7.9 Hz, 2H), 1.39-1.24 (m, 9H).
Figure US11793881-20231024-C00707
37-45 (0.5137 g, 0.3624 mmol) and Pd/C (0.010 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out, and filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C00708
47-19 (0.38 g, 0.3624 mmol), 37-2 (3 g, 1.5944 mmol), HBTU (0.8246 g, 2.1744 mmol), HOBT (0.2938 g, 2.1744 mmol) were added in a 250 mL flask, and dissolved with DMF (95 mL), and then the mixed solution was stirred to react at −5° C. for 20 minutes. Then. Then, DIEA (1.078 mL, 6.523 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated three times with n-hexane (120 mL) and methyl tert-butyl ether (30 mL), and a viscous oily product was obtained. Then, methyl tert-butyl ether (250 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (150 mL) and methanol (30 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 4%-8% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 47-21: 2.5 g, yield 83%.
Figure US11793881-20231024-C00709
47-21 (2.5 g, 0.2938 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL), morpholine (7.67 mL, 88.14 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added to the lower oily liquid phase for further precipitation. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (150 mL) was added to the oily product to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×2), and dissolved with dichloromethane (20 mL) and methanol (80 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-10% methanol were carried out, thus obtaining the product 43-123: 1.85 g, yield 77%.
Figure US11793881-20231024-C00710
43-123 (1.85 g, 0.2628 mmol), 37-192 (0.0326 g, 0.0531 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL) triethylamine (0.0336 mL, 0.239 mmol) was added, the obtained solution was stirred to react at 80° C. overnight. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added to the lower oily liquid phase for further precipitation. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (150 mL) was added to the oily product to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×2), and dissolved with dichloromethane (20 mL) and methanol (80 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-7% methanol were carried out, thus obtaining the product 37-195: 0.7 g, yield 40%.
Figure US11793881-20231024-C00711
37-195 (0.7 g, 0.021 mmol) was added in a 100 mL flask, and dissolved with dichloromethane (10 mL), TFA (4.67 mL, 6.29 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dissolved with a mixed solvent of methanol (20 mL) and dichloromethane (80 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-199: 0.697 g, yield 43%.
Figure US11793881-20231024-C00712
37-199 (0.3 g, 0.009 mmol) was added in a 100 mL flask, and dissolved with DMF (40 mL), M-NH2-5K·HCl (0.2772 g, 0.0543 mmol, purchased from JenKem), HBTU (0.21 g, 0.543 mmol), HOBT (0.073 g, 0.543 mmol) were added, and then the mixed solution was stirred to react at −5° C. at a low speed for about 10 min. Then. Then, DIEA (0.7 mL, 4.32 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. for 20 minutes, and was then moved to room temperature and stirred to react in the dark for 7 days at a low speed. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), and dissolved with a mixed solvent of methanol (40 mL) and dichloromethane (160 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 4%-7% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (2 mL) and dichloromethane (30 mL). Then, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried in a vacuum oven, thus obtaining the product 37-200: 0.27 g, yield: 56%.
1H-NMR (600 MHz, DMSO-d6) δ 10.19-10.05 (m, 16H), 9.06-8.84 (m, 15H), 8.32-7.77 (m, 251H), 7.59-7.46 (m, 45H), 7.31-7.05 (m, 313H), 5.92-5.66 (m, 25H), 4.61-4.49 (m, 25H), 4.43-4.29 (m, 14H), 4.26-4.16 (m, 40H), 4.05-3.84 (m, 31H), 3.70-3.61 (m, 113H), 3.58-3.41 (m, 1856H), 3.26-3.24 (m, 28H), 3.20-3.17 (m, 44H), 3.14-3.11 (m, 32H), 3.07-2.87 (m, 99H), 2.81-2.69 (m, 75H), 2.67-2.60 (m, 35H), 2.45-2.37 (m, 87H), 2.36-2.28 (m, 118H), 2.27-2.08 (m, 116H), 1.94-1.69 (m, 145H), 1.62-1.42 (m, 151H), 1.30-1.16 (m, 44H), 0.94-0.75 (m, 247H), 0.53-0.46 (m, 35H).
9. Synthesis of 35-78 (Compound No. 4)
Synthetic route is as follows
Figure US11793881-20231024-C00713
Figure US11793881-20231024-C00714
Figure US11793881-20231024-C00715
Figure US11793881-20231024-C00716
Figure US11793881-20231024-C00717
Figure US11793881-20231024-C00718
Pentaerythritol (5 g, 36.7242 mmol, purchased from Aladdin) was added in a 500 mL flask, the THF solution of potassium tert-butoxide (146.8968 mL, 146.8968 mmol) was added, and then the mixed solution was stirred to react at 0° C. for 20 minutes. Then benzyl bromoacetate (24.5129 mL, 161.5865 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at 0° C. with stirring for 2 hours, and was then moved to room temperature and react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, deionized water (300 mL) and ethyl acetate (300 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (250 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, the obtained solid was dissolved with dichloromethane (300 mL), silica gel powder (55 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 20% ethyl acetate were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 45-57: 12.3 g, yield 46%.
Figure US11793881-20231024-C00719
35-32 (synthesized according to the method of synthesizing 42-25, 9.364 g, 7.418 mmol), Gly-OtBu·HCl (1.243 g, 7.418 mmol, purchased from InnoChem), HBTU (4.219 g, 11.126 mmol), HOBT (1.503 g, 11.126 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (11.034 mL, 66.758 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), evaporated to dryness, and dried in an oven, thus obtaining the product 35-33: 10.2 g.
Figure US11793881-20231024-C00720
35-33 (10.203 g, 7.418 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL), morpholine (9.69 mL, 111.27 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated saline solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, silica gel powder (35 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5% ammonia water and 3% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 35-34: 5.2 g, yield 61%.
Figure US11793881-20231024-C00721
35-34 (5.2 g, 4.509 mmol), succinic anhydride (1.35 g, 13.527 mmol, purchased from InnoChem), were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (4.47 mL, 27.053 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), evaporated to dryness, and dried in an oven, thus obtaining the product 35-35: 4.7 g, yield: 83%.
Figure US11793881-20231024-C00722
35-35 (4.7 g, 3.75 mmol), 35-31 (synthesized according to the method of synthesizing 34-17, 5.203 g, 4.125 mmol), HBTU (2.133 g, 5.625 mmol), HOBT (0.76 g, 5.625 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.789 mL, 16.875 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated sodium chloride solution (270 mL) and ethyl acetate (240 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), and evaporated to dryness, silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 4%-6% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, dried in a vacuum oven, thus obtaining the product 35-36: 6.3 g, yield: 67%.
1H-NMR (400 MHz, DMSO-d6) δ 8.52 (d, J=6.8 Hz, 2H), 8.31 (d, J=6.8 Hz, 3H), 8.20 (s, 1H), 8.08 (s, 1H), 7.96 (m, 2H), 7.86 (m, 3H), 7.78-7.54 (m, 4H), 7.54-7.46 (m, 2H), 7.39-7.26 (m, 42H), 4.26-4.16 (m, 11H), 4.12-3.84 (m, 3H), 3.72-3.47 (m, 15H), 3.25-3.10 (m, 10H), 2.99-2.84 (m, 3H), 2.81-2.67 (m, 2H), 2.45-2.34 (m, 13H), 2.23-2.11 (m, 6H), 1.42-1.34 (m, 9H), 1.29-1.24 (d, J=6.6 Hz, 28H).
Figure US11793881-20231024-C00723
35-36 (0.463 g, 0.185 mmol) and Pd/C (0.030 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out, and filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), thus obtaining a DMF solution containing C7.
Figure US11793881-20231024-C00724
35-48 (0.329 g, 0.185 mmol), 37-2 (synthesized according to the method of synthesizing 37-2, 3.0 g, 1.594 mmol), HBTU (0.842 g, 2.22 mmol), HOBT (0.3 g, 2.22 mmol) were added in a 250 mL flask, and dissolved with DMF (90 mL), and then the mixed solution was stirred to react at −5° C. for 20 minutes. Then DIEA (1.1 mL, 6.66 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated three times with n-hexane (150 mL) and methyl tert-butyl ether (40 mL), to obtain a viscous oily product. Then, methyl tert-butyl ether (250 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (130 mL) and methanol (25 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5% ammonia water and 5%-12% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 35-49: 2.7 g, yield 87%.
Figure US11793881-20231024-C00725
35-49 (2.7 g, 0.1615 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL) piperidine (0.479 mL, 4.8443 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added for precipitation to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (20 mL) were added to the lower oily liquid phase for further precipitation. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (150 mL) was added to the oily product to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×2), and dissolved with dichloromethane (20 mL) and methanol (80 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-7% methanol were carried out, thus obtaining the product 35-73: 1.2 g, yield 45%.
Figure US11793881-20231024-C00726
45-57 (0.118 g, 0.1655 mmol) and Pd/C (0.01 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out, and filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), obtaining a DMF solution containing 35-74.
Figure US11793881-20231024-C00727
35-73 (1.2 g, 0.0727 mmol), 35-74 (0.375 g, 0.0165 mmol), HBTU (0.375 g, 0.99 mmol), HOBT (0.134 g, 0.99 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 20 minutes. Then DIEA (0.492 mL, 2.975 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated three times with n-hexane (150 mL) and methyl tert-butyl ether (40 mL), to obtain a viscous oily product. Then, methyl tert-butyl ether (250 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (130 mL) and methanol (25 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-9% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 35-75: 0.8 g, yield 73%.
Figure US11793881-20231024-C00728
35-75 (0.8 g, 0.012 mmol) was added in a 100 mL flask, and dissolved with dichloromethane (10 mL), TFA (10 mL, 134.65 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (70 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and dissolved with a mixed solvent of methanol (20 mL) and dichloromethane (80 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 4%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 35-77: 0.4 g, yield 51%.
Figure US11793881-20231024-C00729
35-77 (0.4 g, 0.0061 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), M-NH2-20K·HCl (0.379 g, 0.036 mmol, purchased from JenKem), HBTU (0.137 g, 0.36 mmol), HOBT (0.049 g, 0.36 mmol) were added, and then the mixed solution was stirred to react at −5° C. at a low speed for about 10 min. Then DIEA (0.1313 mL, 0.7945 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. for 20 minutes, and was then moved to room temperature and stirred to react in the dark for 7 days at a low speed. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid for precipitation. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), and dissolved with a mixed solvent of methanol (40 mL) and dichloromethane (160 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 4%-7% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, dried in a vacuum oven for 1 hour, and dissolved with anhydrous ethanol (2 mL) and dichloromethane (30 mL). Then, methyl tert-butyl ether (140 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried in a vacuum oven, thus obtaining the product 35-78: 0.46 g, yield: 70%.
1H-NMR (600 MHz, DMSO-d6) δ 10.23-9.98 (m, 34H), 9.12-8.76 (m, 32H), 8.25-8.13 (m, 116H), 8.12-7.95 (m, 240H), 7.84-7.64 (m, 95H), 7.57-7.31 (m, 99H), 7.21-6.91 (m, 630H), 5.88-5.63 (m, 56H), 4.76-4.48 (m, 64H), 4.33-4.26 (m, 154H), 4.05-3.83 (m, 116H), 3.71-3.62 (m, 241H), 3.59-3.41 (m, 3840H), 3.42-3.37 (m, 91H), 3.27-3.21 (m, 393H), 3.19-3.11 (m, 149H), 3.09-3.93 (m, 72H), 2.85-2.73 (m, 102H), 2.52-2.42 (m, 116H), 2.34-2.07 (m, 369H), 1.91-1.84 (m, 120H), 1.78-1.63 (m, 123H), 1.61-1.52 (m, 265H), 1.29-0.92 (m, 89H), 0.85-0.63 (m, 461H), 0.60-0.47 (m, 81H).
10. Synthesis of 33-200 (Compound No. 5)
Synthetic route is as follows
Figure US11793881-20231024-C00730
Figure US11793881-20231024-C00731
Figure US11793881-20231024-C00732
Figure US11793881-20231024-C00733
Figure US11793881-20231024-C00734
Figure US11793881-20231024-C00735
Figure US11793881-20231024-C00736
Figure US11793881-20231024-C00737
24-143 (synthesized according to the method of synthesizing 34-17, 5 g, 3.6723 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), the obtained solution was placed in a low-temperature and constant temperature bath at −5° C. Then, DIEA (2.5390 mL, 18.3615 mmol) was added, and then the mixed solution was stirred to react at room temperature for 30 minutes. Succinic anhydride (1.1025 g, 11.0170 mmol) was added, and, after 1 hour, the obtained solution reacted at room temperature. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, ethyl acetate (200 mL) and deionized water (150 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted two times with ethyl acetate (100 mL×2) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed one time with saturated saline solution (100 mL), concentrated, and evaporated to dryness, thus obtaining the product 5 g, extra-quota 0.1 g, yield 100%.
Figure US11793881-20231024-C00738
Reactants 45-1 (4.9 g, 3.5990 mmol), NH2-Gly-OtBuHCl (purchased from Accela, 0.4721 g, 3.5990 mmol), HBTU (2.0473 g, 5.3985 mmol), HOBT (0.7294 g, 5.3985 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (4 mL, 24.2933 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, ethyl acetate (200 mL) and deionized water (150 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted two times with ethyl acetate (100 mL×2) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed one time with saturated saline solution (100 mL), and concentrated, silica gel powder was added, and the operations of evaporation, column chromatography and elution with 50%-100% ethyl acetate/petroleum ether were carried out, thus obtaining the product 3.5 g, yield 66%.
1H-NMR (400 MHz, DMSO-d6) δ 8.34-8.18 (m, 2H), 8.01-7.85 (m, 4H), 7.72-7.64 (m, 3H), 7.43-7.22 (m, 26H), 5.14-5.03 (m, 8H), 4.41-4.06 (m, 8H), 3.94-3.86 (m, 2H), 3.71-3.66 (m, 2H), 3.58-3.49 (m, 4H), 3.42-3.36 (m, 2H), 3.22-3.13 (m, 3H), 2.98-2.88 (m, 2H), 2.47-1.81 (m, 17H), 1.39-1.37 (m, 9H), 1.28-1.20 (m, 3H).
MALDI-TOF MS: [M+H+]1474.70, [M+Na+]1496.70.
Figure US11793881-20231024-C00739
Reactants 45-6 (0.4702 g, 0.3189 mmol) and 10% Pd/C (50 mg) were added in a micro-reactor, and dissolved with DMF (30 mL), H2 (20 psi) was introduced, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed 3-4 times with DMF to obtain the DMF solution of the product for the next reaction.
Figure US11793881-20231024-C00740
33-162 (synthesized according to the method of synthesizing 37-2, 3 g, 1.5944 mmol), HBTU (0.7256 g, 1.9134 mmol), HOBT (0.2585 g, 1.9134 mmol) were added in a 250 mL flask, and dissolved with a DMF solution of 33-190, and ultrasonic treatment was carried out to completely dissolve the reactants, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (0.9487 mL, 5.7402 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL), n-hexane (150 mL) were added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, the obtained solution was placed in a refrigerator, stood still for 20 minutes, the supernatant was discarded, ethyl acetate (20 mL) was added to the lower liquid, ultrasonic treatment was carried out for 2 minutes, n-hexane (100 mL) was added to the obtained solution, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane (70 mL), silica gel powder was added, and the operations of evaporation, column chromatography and gradient elution with 1% ammonia water: 5% methanol/dichloromethane-1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.9 g, yield 70%.
Figure US11793881-20231024-C00741
33-191 (1.9 g, 0.2218 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), morpholine (0.5796 mL, 6.6540 mmol) was added, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL), n-hexane (100 mL) were added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane (50 mL), silica gel powder was added to the obtained solution, and the operations of evaporation, column chromatography and elution with 1% ammonia water: 7%/dichloromethane-1% ammonia water: 15% methanol/dichloromethane were carried out, thus obtaining the product 1.3 g, yield 72%.
Figure US11793881-20231024-C00742
Dipentaerythritol (purchased from ACROS, 5 g, 19.6634 mmol) was added in a 500 mL flask, nitrogen was introduced for protective purpose, the THF solution of potassium tert-butoxide (141.57 mL, 141.5762 mmol) was added, and the obtained solution was stirred at 0° C. for 1 hour. phenyl bromoacetate (30.4445 g, 141.5762 mmol) was added, and then the obtained solution was stirred to react for 3 hours, and then reacted at room temperature. At the end of the reaction, the reaction solution was first evaporated to dryness, then deionized water and ethyl acetate were added for extraction, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was dried with anhydrous sodium sulfate powder, suction filtering was carried out, and the operations of dry sample loading, column chromatography and gradient elution with 3%-5% ethyl acetate/petroleum ether were carried out, thus obtaining the product 13.9 g, yield 62%.
Figure US11793881-20231024-C00743
Reactants 45-2 (0.2541 g, 0.0223 mmol) and 10% Pd/C (50 mg) were added in a micro-reactor, and dissolved with DMF (30 mL), H2 (20 psi) was introduced, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed 3-4 times with DMF to obtain the DMF solution of the product for the next reaction.
Figure US11793881-20231024-C00744
33-192 (1.3 g, 0.1558 mmol), HBTU (0.0761 g, 0.2007 mmol), HOBT (0.0271 g, 0.2007 mmol) were added in a 250 mL flask, and dissolved with a DMF solution of 45-12, and ultrasonic treatment was carried out to completely dissolve the reactants, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (0.0995 mL, 0.6021 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL), n-hexane (150 mL) were added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, the obtained solution was placed in a refrigerator, stood still for 20 minutes, the supernatant was discarded, ethyl acetate (20 mL) was added to the lower liquid, ultrasonic treatment was carried out for 2 minutes, n-hexane (100 mL) was added to the obtained solution, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane (70 mL), silica gel powder was added to the obtained solution, and the operations of evaporation, column chromatography and gradient elution with 1% ammonia water: 5% methanol/dichloromethane-1% ammonia water: 15% methanol/dichloromethane were carried out, thus obtaining the product 0.8 g, yield 53%.
Figure US11793881-20231024-C00745
33-195 (0.8 g, 0.0158 mmol) was dissolved with dichloromethane (10 mL), TFA (0.03572 mL, 0.4749 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were directly added to the reaction solution, and suction filtering was carried out. The filter cake was dried in vacuum, thus obtaining the product 0.6 g, yield 75%.
Figure US11793881-20231024-C00746
Reactants 33-197 (0.6 g, 0.0119 mmoL), M-NH2HCL-10K (0.1 g, 0.0099 mmoL), HBTU (0.0056 g, 0.0149 mmoL), HOBT (0.0020 g, 0.0149 mmoL) were added in a 250 mL flask, and dissolved with DMF (15 mL) in a condition of ultrasonic, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (0.0073 mL, 0.0446 mmoL) was slowly added dropwise, the obtained solution was stirred for 1 hour, and then reacted at room temperature in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (200 mL) was added to the reaction solution for precipitation, and suction filtering was carried out to obtain a powder product. The powder product was dissolved with a mixed solvent of 20% methanol/dichloromethane, and silica gel powder (3 g) was added to the obtained solution. The operations of evaporation, dry sample loading, column chromatography and gradient elution with 6% methanol/dichloromethane-1% ammonia water: 10% methanol/dichloromethane were carried out. The elution product was then collected and evaporated to dryness, the obtained solid was dissolved with dichloromethane (5 mL) in a condition of ultrasonic, methyl tert-butyl ether (150 mL), n-hexane (50 mL) were added to the obtained solution, and suction filtering was carried out. The filter cake was further dissolved with dichloromethane, methyl tert-butyl ether and n-hexane were added for precipitation, and The process of dissolution and precipitation was repeated three times, thus obtaining the product 0.5 g, yield 71%.
1H-NMR (600 MHz, DMSO-d6) δ 10.17-10.13 (m, 18H), 8.97-8.93 (m, 32H), 8.25-7.88 (m, 412H), 7.59-7.48 (m, 93H), 7.32-7.16 (m, 459H), 5.92-5.67 (m, 58H), 4.40-3.99 (m, 672H), 3.51-3.50 (m, 3560H), 3.29-2.99 (m, 344H), 2.94-2.64 (m, 264H), 2.45-2.05 (m, 133H), 1.93-1.06 (m, 301H), 0.99-0.74 (m, 432H).
11. Synthesis of 40-123 (Compound No. 7)
Synthetic route is as follows
Figure US11793881-20231024-C00747
Figure US11793881-20231024-C00748
Figure US11793881-20231024-C00749
Figure US11793881-20231024-C00750
Figure US11793881-20231024-C00751
Figure US11793881-20231024-C00752
Figure US11793881-20231024-C00753
Figure US11793881-20231024-C00754
Figure US11793881-20231024-C00755
Reactant 42-27 was added in a 250 mL flask, and dissolved with DMF (20 mL), morpholine (7.2 mL, 83.4 mmoL) was added, and then the mixed solution was stirred to react at room temperature for 3 hours. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading and gradient elution with 1% ammonia water: 2% methanol/dichloromethane—1% ammonia water 6% methanol/dichloromethane were carried out, thus obtaining the product 4 g.
Figure US11793881-20231024-C00756
Reactants E4 (4 g, 3.14 mmoL), SA-OtBu ((purchased from Accela, 0.54, 3.14 mmoL), HBUT (1.78 g, 4.71 mmoL), HOBT (0.63 g, 4.71 mmoL) were added in a 250 mL flask, and dissolved with DMF (40 mL), and the obtained solution was stirred at 0° C. for 0.5 hour. Then, DIEA (2.3 mL, 14.13 mmoL) was slowly added dropwise, and then the obtained solution was stirred to react. At the end of the reaction, deionized water (100 mL) and ethyl acetate (100 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness, thus obtaining the product 3.5 g, yield 79%.
1H-NMR (400 MHz, DMSO-d6) δ 8.58-8.43 (m, 1H), 8.35-8.23 (m, 1H), 8.06-7.76 (m, 4H), 7.74-7.65 (m, 1H), 7.37-7.27 (m, 20H), 5.13-5.02 (m, 8H), 4.41-4.13 (m, 4H), 3.95-3.85 (m, 2H), 3.53-3.46 (m, 9H), 3.25-2.99 (m, 8H), 2.89-2.87 (m, 1H), 2.73-2.71 (m, 1H), 2.46-2.30 (m, 9H), 2.21-1.79 (m, 12H), 1.37-1.34 (m, 18H).
MALDI-TOF MS: [M+H+]1426.75, [M+Na+]1448.75.
Figure US11793881-20231024-C00757
Reactants Fmoc-E (OtBu) (OH) (1.39 g, 3.29 mmoL), GFLG-LPT (synthesized according to the method of synthesizing 14-128, 3 g, 3.13 mmoL), HBUT (1.78 g, 4.7 mmoL), HOBT (0.63 g, 4.7 mmoL) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the obtained solution was stirred at −5° C. for 0.5 hour. Then, DIEA (2.34 mL, 14.2 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, deionized water (100 mL) and ethyl acetate (100 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness. Yield 100%.
Figure US11793881-20231024-C00758
33-145 (3.13 mmol) was dissolved with dichloromethane (5 mL) and TFA (6.63 mL, 89.4 mmol) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 2% methanol/dichloromethane—6% methanol/dichloromethane were carried out, thus obtaining the product 2.8 g, yield 70%.
Figure US11793881-20231024-C00759
Reactants 33-147 (2.8 g, 2.14 mmoL), GFLG-SB7 (synthesized according to the method of synthesizing 25-132, 2 g, 2.247 mmoL), HBUT (1.21 g, 3.21 mmoL), HOBT (0.43 g, 3.21 mmoL) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the obtained solution was stirred at −5° C. for 0.5 hour. Then, DIEA (1.59 mL, 9.63 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, deionized water (100 mL) and ethyl acetate (100 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness, thus obtaining the product 4.6 g. Yield 100%.
Figure US11793881-20231024-C00760
Reactant 39-11 (2.14 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), morpholine (5.59 mL, 64.2 mmoL) was added, and the mixed solution was stirred to react at room temperature for 3 hours. At the end of the reaction, deionized water (300 mL) and ethyl acetate (150 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. Yield 100%.
Figure US11793881-20231024-C00761
Reactants 39-12 (2.14 mmoL), Boc-Gly-OH (0.39, 2.247 mmoL), HBUT (1.21 g, 3.21 mmoL), HOBT (0.43 g, 3.21 mmoL) were added in a 250 mL flask, and dissolved with DMF (50 mL), and the obtained solution was stirred at −5° C. for 0.5 hour. Then, DIEA (1.59 mL, 9.63 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, deionized water (300 mL) and ethyl acetate (150 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness, yield 100%.
Figure US11793881-20231024-C00762
39-13 (2.14 mmol) was dissolved with dichloromethane (5 mL) and TFA (4.7 mL, 64.2 mmol), in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 3% methanol/dichloromethane—1% ammonia water: 6% methanol/dichloromethane were carried out, thus obtaining the product 3 g, yield 69%.
Figure US11793881-20231024-C00763
Reactant 45-9 (0.22 g, 0.1551 mmoL) was added in a hydrogenation reactor, DMF was added dropwise along the inner wall to dissolve the reactant, 10% Pd/C (0.05 g) was added, hydrogen was introduced, and the obtained solution was stirred to react overnight. At the end of the reaction, the reaction solution was filtered by suction through a sand core funnel filled with compacted diatomaceous earth to remove the Pd/C, and then the diatomaceous earth was washed 3-4 times with DMF (40 ml), thus obtaining a product solution for the next reaction.
Figure US11793881-20231024-C00764
Reactants 39-20 (1.5 g, 0.7445 mmoL), 45-29 (0.10551 mmoL), HBUT (0.3529 g, 0.9306 mmoL), HOBT (0.1257 g, 0.9306 mmoL) were added in a 250 mL flask, and dissolved with DMF (50 mL), and the obtained solution was stirred at −5° C. for 0.5 hour. Then, DIEA (0.4614 mL, 2.7918 mmoL) was slowly added dropwise, and, after 1 hour, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 4% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out. The elution product was evaporated to dryness, thus obtaining the product 1.4 g, yield 40%.
Figure US11793881-20231024-C00765
45-35 (1.4 g) was dissolved with dichloromethane (5 mL) and TFA (0.5741 mL, 7.73 mmol) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 5% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.2 g, yield 80%.
Figure US11793881-20231024-C00766
Reactants 35-74 (2 g, 5.4 mmol), succinyl alcohol (5.5082 g, 47.86 mmol), DMAP (0.2922 g, 2.392) were added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), and the obtained solution was stirred at −5° C., and DCC (9.8750 g, 47.86 mmol) was quickly added in batches. The obtained solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was filtered, and the filtrate was evaporated to dryness. The operations of column chromatography, dry sample loading and gradient elution with 10% ethyl acetate/petroleum ether-ethyl acetate were carried out, thus obtaining the product 3 g, yield 81%.
Figure US11793881-20231024-C00767
Reactant 45-35 (1.2 g, 0.101 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), the obtained solution was placed in a low-temperature and constant temperature bath (−5° C.) and stirred for 30 minutes, and DIEA (0.1 mL) was added dropwise. Then, 45-65 (0.015 g, 0.021 mmoL) was added. After dissolution, the obtained solution reacted at room temperature in the dark at a low speed of stirring. At the end of the reaction, methyl tert-butyl ether (150 mL) was added in a conical flask, the reaction solution was poured into the conical flask, then n-hexane (200 mL) was added, to separate out a product, and suction filtering was carried out. The operations of column chromatography (column height: 5 cm) and gradient elution with 7% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 0.7 g.
1H-NMR (600 MHz, DMSO-d6)δ 10.14-10.12 (m, 12H), 9.02-9.00 (m, 4H), 8.95-8.94 (m, 14H), 8.18-8.16 (m, 41H), 8.13-8.05 (m, 90H), 7.86-7.83 (m, 30H), 7.55-7.47 (m, 41H), 7.26-7.17 (m, 274H), 7.11-7.08 (m, 65H), 7.02-7.00 (m, 44H), 6.73-6.64 (m, 6H), 4.39-4.13 (m, 71H), 4.03-3.45 (m, 268H), 3.22-2.66 (m, 207H), 2.41-2.38 (m 59H), 2.31-2.28 (m, 99H), 2.26-1.97 (m, 127H), 1.88-1.47 (m, 281H), 0.97-0.73 (m, 288H).
Figure US11793881-20231024-C00768
M-NH2·HCL −10K (0.0528 g, 0.05 mmoL), 40-121 (0.37 g, 0.012 mmoL), HOBT (0.009 g, 0.072 mmoL), HBTU (0.027 g, 0.072 mmoL) were added in a 250 mL flask, and dissolved with DMF solution (20 mL), the obtained solution was placed in a low-temperature and constant temperature bath, after 30 minutes. Then, DIEA (0.035 mL, 0.216 mmol) was added dropwise, after 1 hour, the obtained solution was moved to room temperature and stirred to react in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (50 mL) and n-hexane (150 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The filter cake was dissolved with 20% methanol: 80% dichloromethane (50 mL). The operations of dry sample loading, column chromatography (column height: 5 cm) and gradient elution with 1% ammonia water: 5-10% methanol/dichloromethane were carried out. The elution product was evaporated to dryness, and dissolved with anhydrous ethanol (5 mL) and dichloromethane (2 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, n-hexane (100 mL) was added, and suction filtering was carried out. The process of dissolution and precipitation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 0.45 g.
1H-NMR (600 MHz, DMSO-d6) δ 10.12-10.10 (m, 16H), 8.93-8.91 (m, 16H), 8.19-8.06 (m, 172H), 7.84-7.67 (m, 65H), 7.21-7.11 (m, 354H), 4.54-3.89 (m, 134H), 3.48-3.46 (m, 3578H), 3.21-3.11 (m, 175H), 2.89-2.87 (m, 28H), 2.79-2.66 (m, 80H), 2.43-2.07 (m, 353H), 1.93-1.43 (m, 340H), 0.96-0.74 (m, 288H).
12. Synthesis of 41-40 (Compound No. 13) Synthetic route is as follows
Figure US11793881-20231024-C00769
Figure US11793881-20231024-C00770
Figure US11793881-20231024-C00771
Figure US11793881-20231024-C00772
Figure US11793881-20231024-C00773
Figure US11793881-20231024-C00774
Figure US11793881-20231024-C00775
Reactants Fmoc-Glu-OH (purchased from Aladdin, 0.7719 g, 2.0899 mmol), 31-155 (synthesized according to the method of synthesizing 27-120, 5 g, 4.3887 mmol), HBUT (2.3777 g, 6.2697 mmol), HOBT (0.8472 g, 6.2697 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and the obtained solution was stirred at −5° C. for 30 minutes. Then, DIEA (3.1208 mL, 18.8091 mmol) was slowly added dropwise, the obtained solution reacted at the low temperature for 2 hours, and then reacted at room temperature. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (150 mL×2), concentrated, and evaporated to dryness, thus obtaining the product 5.5 g, yield 100%.
Figure US11793881-20231024-C00776
Reactant 39-27 (5.4 g, 2.0899 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and then the mixed solution was stirred at room temperature. Then morpholine (4.5544 mL, 52.2475 mmol) was added dropwise. At the end of the addition, the obtained solution reacted at room temperature for 2 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (150 mL×2), concentrated to 100 mL, and silica gel powder (15 g) was added. The operations of evaporation, column chromatography and gradient elution with 1% ammonia water: 0.5% methanol/dichloromethane-1% ammonia water: 2% methanol/dichloromethane were carried out, thus obtaining the product 3.9848 g, yield 73%.
Figure US11793881-20231024-C00777
Reactant 31-155 (synthesized according to the method of synthesizing 27-120, 1 g, 0.87 mmol) was dissolved with DMF (20 mL), and the obtained solution was stirred at 0° C., and DIEA (0.58 mL, 3.51 mmol) was added dropwise. After 30 minutes, succinic anhydride (0.26 g, 2.16 mmol) was added. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (100 mL) and ethyl acetate (100 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was evaporated to dryness, yield 100%.
Figure US11793881-20231024-C00778
Reactants 39-29 (2.0 g, 0.87 mmol), 41-26 (0.4721 g, 0.87 mmol), HBTU (0.49 g, 1.30 mmol), HOBT (0.17 g, 1.30 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the obtained solution was stirred at −5° C. for 30 minutes. Then, DIEA (0.64 mL, 3.91 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, ethyl acetate (200 mL) and deionized water (150 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted two times with ethyl acetate (100 mL×2), and the obtained organic phases were combined. The organic phase was washed one time with saturated saline solution (100 mL), and concentrated, silica gel powder was added, and the operations of evaporation, column chromatography, and elution with 50%-100% ethyl acetate/petroleum ether were carried out, thus obtaining the product 1.8 g, yield 60%.
1H-NMR (400 MHz, DMSO-d6) δ8.57-8.47 (m, 3H), 8.35-7.88 (m, 10H), 7.75-7.65 (m, 3H), 7.39-7.27 (m, 60H), 6.76-6.61 (m, 3H), 5.15-5.02 (m, 24H), 4.42-4.29 (m, 9H), 3.93-3.87 (m, 5H), 3.61-3.47 (m, 13H), 3.42-3.36 (m, 7H), 2.90-2.80 (m, 6H), 2.47-2.39 (m, 12H), 2.23-1.68 (m, 31H), 1.38-1.14 (m, 55H).
Figure US11793881-20231024-C00779
Reactants 41-27 (0.41 g, 0.113 mmol) and 10% Pd/C (0.166 g) were dissolved with DMF (30 mL), and added in a hydrogenation reactor, the device was set ready, hydrogen was introduced to a pressure of 18 Ps, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed four times with DMF (25 mLx4), thus obtaining the product solution.
Figure US11793881-20231024-C00780
Reactants 39-20 (3.0 g, 1.48 mmol), 41-33 (0.2858 g, 0.113 mmol), HBTU (0.77 g, 2.034 mmol), HOBT (0.27 g, 2.034 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the obtained solution was stirred at −5° C. for 30 minutes. Then, DIEA (1.0 mL, 6.102 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 2% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.64 g, yield 55%.
Figure US11793881-20231024-C00781
41-34 (1.64 g, 0.06215 mmol) was dissolved with dichloromethane (5 mL) and TFA (0.41 mL, 5.5935 mmol) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 5% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.13 g, yield 70%.
Figure US11793881-20231024-C00782
Reactants 41-35 (1.1 g, 0.04350 mmol) and M-SCM-10K (1.43 g, 0.14355 mmol) were dissolved with DMF solution (20 mL), and the obtained solution reacted at a low speed of stirring in the dark. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (50 mL) and n-hexane (100 mL), and suction filtering was carried out. The operations of column chromatography, dry sample loading and gradient elution with dichloromethane—1% ammonia water: 8% methanol/dichloromethane were carried out. The elution product was then evaporated to dryness, and dissolved with anhydrous ethanol (10 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, and then n-hexane (50 mL) was added for precipitation. Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 1 g. Yield 41%.
1H-NMR (600 MHz, DMSO-d6) δ8.58-8.53 (m, 5H), 8.13-7.92 (m, 111H), 7.72-7.65 (m, 34H), 7.58-7.46 (m, 51H), 7.41-7.33 (m, 88H), 7.30-7.16 (m, 241H), 5.29-5.23 (m, 12H), 5.16-5.08 (s, 19H), 4.15-4.12 (m, 48H), 4.05-3.97 (m, 75H), 3.51-3.50 (m, 3285H), 3.25-3.23 (m, 173H), 3.16-2.98 (m, 242H), 2.93-2.85 (m, 54H), 2.76-2.72 (m, 50H), 2.68-2.65 (m, 55H), 2.36-2.27 (m, 74H), 0.94-0.75 (m, 216H).
13. Synthesis of 39-55 (Compound No. 12)
Synthetic route is as follows
Figure US11793881-20231024-C00783
Figure US11793881-20231024-C00784
Figure US11793881-20231024-C00785
Figure US11793881-20231024-C00786
Figure US11793881-20231024-C00787
Figure US11793881-20231024-C00788
Figure US11793881-20231024-C00789
33-22 (synthesized according to the method of synthesizing 22-181, 0.5 g, 0.54 mmol) was added in a 100 mL round-bottomed flask, and dissolved with dichloromethane (10 mL) in a condition of ultrasonic. Phenyl chloroformate (0.3 mL, 2.19 mmol) was added, and the obtained solution was stirred to react at 0° C. for 30 minutes. Then phenyl chloroformate (0.13 mL, 1.09 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature for 2 hours. At the end of the reaction, deionized water (200 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (150 mL×2), and evaporated to dryness, thus obtaining the product 0.5 g.
Figure US11793881-20231024-C00790
39-29 (1.4 g, 0.59 mmol), 39-31 (0.5 g, 0.54 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL). Then, DIEA (0.1 mL) was added, and then the mixed solution was stirred to react at 80° C. until the reaction ended. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (100 mL) and ethyl acetate (150 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (100 mL×2), and concentrated to 50 mL, silica gel powder (6 g) was added, and the operations of evaporation, column chromatography and gradient elution with 2% methanol/dichloromethane-3% methanol/dichloromethane were carried out, thus obtaining the product 1.3 g, yield 65.38%.
1H-NMR (400 MHz, DMSO-d6) δ8.57-8.47 (m, 3H), 8.40-8.06 (m, 6H), 8.01-7.65 (m, 4H), 7.38-7.28 (s, 60H), 7.22-7.11 (m, 1H), 5.14-5.03 (m, 24H), 4.42-4.31 (m, 8H), 3.94-3.86 (m, 5H), 3.60-3.48 (m, 13H), 2.88-2.81 (m, 4H), 2.47-2.37 (m, 11H), 2.22-2.13 (m, 6H), 2.10-1.72 (m, 23H), 1.37-1.31 (m, 29H), 1.26-1.21 (m, 18H), 0.88-0.82 (m, 2H).
Figure US11793881-20231024-C00791
39-30 (0.16 g, 0.048 mmol) and 10% Pd/C (70 mg) were dissolved with DMF (30 mL), and added in a hydrogenation reactor, the device was set ready, hydrogen was introduced to a pressure of 18 Ps, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was filtered by suction with diatomaceous earth as a filter cake to remove the Pd/C, and then the diatomaceous earth was washed four times with DMF (25 mL×4), thus obtaining the product solution.
Figure US11793881-20231024-C00792
39-20 (1.25 g, 0.625 mmol), 39-51 (0.048 mmol), HBTU (0.32 g, 0.864 mmol), HOBT (0.11 g, 0.864 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and ultrasonic treatment was carried out to completely dissolve the reactants, and the obtained solution was stirred at −5° C. for 30 minutes. Then, DIEA (0.42 mL, 2.59 mmol) was slowly added dropwise, and the obtained solution was stirred at the low temperature for 2 hours, and then reacted at room temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (250 mL) was added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, the supernatant was discarded, ethyl acetate (20 mL) was added to the lower liquid, ultrasonic treatment was carried out for 3 minutes, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were added to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane (20 mL), silica gel powder (10 g) was added, the operations of evaporation, column chromatography and gradient elution with 1% ammonia water: 6% methanol/dichloromethane-1% ammonia water: 15% methanol/dichloromethane were carried out, thus obtaining the product 0.6 g.
Figure US11793881-20231024-C00793
39-52 (0.6 g) was dissolved with dichloromethane (15 mL) and TFA (0.2267 mL, 3.0521 mmol), and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, ethyl acetate (20 mL) was added, ultrasonic treatment was carried out for 2 minutes, methyl tert-butyl ether (150 mL) and n-hexane (70 mL) were added, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane in a condition of ultrasonic, silica gel powder (6 g) was added, and the operations of evaporation with a rotary evaporator, column chromatography and gradient elution with 1% ammonia water: 6% methanol/dichloromethane-1% ammonia water: 15% methanol/dichloromethane were carried out, thus obtaining the product 0.3 g.
Figure US11793881-20231024-C00794
39-53 (0.6 g) was dissolved with DMF (20 mL), M-SCM-20K (0.9378 g) was added, ultrasonic treatment was carried out to dissolve the reactants, and then the obtained solution reacted in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (150 mL), n-hexane (70 mL) were added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane, silica gel powder (10 g) was added, and the operations of evaporation, column chromatography and gradient elution with dichloromethane-1% ammonia water: 15% methanol/dichloromethane were carried out. The elution product was collected, evaporated to dryness, and then dissolved with anhydrous ethanol (3 mL), and the obtained solution was treated by ultrasonic to obtain homogeneous phase. Then, methyl tert-butyl ether (150 mL), n-hexane (50 mL) were added, and suction filtering was carried out. The filter cake was further dissolved with anhydrous ethanol (3 mL), methyl tert-butyl ether and n-hexane were added for precipitation. The process of dissolution and precipitation was repeated three times. Suction filtering was carried out, and the filter cake was dried, thus obtaining the product 0.8 g.
1H-NMR (600 MHz, DMSO-d6) δ9.93-9.81 (m, 7H), 9.09-9.01 (m, 14H), 8.79-7.94 (m, 163H), 7.87-6.50 (m, 404H), 5.79-5.70 (m, 5H), 5.29-5.23 (m, 18H), 4.81-4.00 (m, 138H), 3.51-3.50 (m, 2227H), 3.25-2.64 (m, 177H), 2.36-1.91 (m, 101H), 1.55-1.32 (m, 293H), 0.88-0.72 (m, 216H).
14. Synthesis of 29-235 (Compound No. 15)
Figure US11793881-20231024-C00795
Figure US11793881-20231024-C00796
Figure US11793881-20231024-C00797
Figure US11793881-20231024-C00798
Figure US11793881-20231024-C00799
Figure US11793881-20231024-C00800
Figure US11793881-20231024-C00801
Figure US11793881-20231024-C00802
Figure US11793881-20231024-C00803
Figure US11793881-20231024-C00804
Figure US11793881-20231024-C00805
Figure US11793881-20231024-C00806
Figure US11793881-20231024-C00807
Figure US11793881-20231024-C00808
Figure US11793881-20231024-C00809
Figure US11793881-20231024-C00810
Figure US11793881-20231024-C00811
Figure US11793881-20231024-C00812
Figure US11793881-20231024-C00813
Boc-Lys (Boc)-OH (purchased from Arm Pharm, 0.3769 g, 1.0879 mmol), 26-232 (synthesized according to the method of synthesizing 22-181, 0.989 mmol), HBTU (0.5627 g, 1.4835 mmol), HOBT (0.2005 g, 1.4835 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (0.7356 mL, 4.4505 mmol) was slowly added dropwise over 3 minutes. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L reparatory funnel, pure water (120 mL) and ethyl acetate (80 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (80 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated sodium chloride solution (80 mL×3), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining a crude product 26-250: yield 100%.
Figure US11793881-20231024-C00814
26-250 (0.989 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (10 mL), TFA (2.2182 mL, 29.87 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. The residue was dissolved with ethyl acetate (50 mL), an excess amount of solid sodium bicarbonate was added to the obtained solution for neutralization until there was no bubble, and filtering was carried out. Silica gel powder (15 g) was added to the filtrate, and the obtained solution was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-6% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 26-255: 0.8 g, yield 81%.
Figure US11793881-20231024-C00815
26-255 (0.8 g, 0.7698 mmol), 41-26 (2.0990 g, 1.6936 mmol), HBTU (0.8761 g, 2.3095 mmol), HOBT (0.3121 g, 2.3095 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (1.1458 mL, 6.9285 mmol) was slowly added dropwise over 3 minutes. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, pure water (120 mL) and ethyl acetate (80 mL) were added for extraction, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated sodium chloride solution (80 mL×3), concentrated and evaporated to dryness. The obtained solid was dissolved with methanol/dichloromethane (1:4) solution (200 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-5% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 26-258: 1.6884 g, yield 63%.
Figure US11793881-20231024-C00816
29-147 (synthesized according to the method of synthesizing 42-20, 1.7952 g, 1.3616 mmol) and 10% Pd/C (0.03 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation, so that the pressure on the hydrogenation reactor was read as 0.18 MPa, and then the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), thus obtaining the product 29-152, yield 100%.
Figure US11793881-20231024-C00817
29-152 (1.3616 mmol), 42-18 (6.0 g, 6.2632 mmol), HBTU (3.0990 g, 8.1696 mmol), HOBT (1.1040 g, 8.1696 mmol) were added in a 500 mL flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (4.0532 mL, 24.5088 mmol) was slowly added dropwise over 7 minutes, and the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4). Silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 29-153: 3.6 g, yield 47%.
Figure US11793881-20231024-C00818
29-153 (3.6 g, 1.3493 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (10 mL), then TFA (1.5031 mL, 20.2401 mmol) was added, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. Then, methyl tert-butyl ether (40 mL) was added to separate out a powdery solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 29-157, yield 100%.
Figure US11793881-20231024-C00819
29-157 (1.3493 mmol), GFLG-PCB (synthesized according to the method of synthesizing 30-33, 1.220 g, 1.4842 mmol), HBTU (0.7676 g, 2.0240 mmol), HOBT (0.2735 g, 2.0240 mmol) were added in a 250 mL flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (1.0 mL, 6.0719 mmol) was slowly added dropwise over 3 minutes. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product 29-162: yield 100%.
Figure US11793881-20231024-C00820
29-162 (1.3493 mmol) was added in a 250 mL flask, and dissolved with DMF (15 mL), morpholine (1.2 mL, 13.493 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-9% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 29-164: 4.1 g, yield 59%.
Figure US11793881-20231024-C00821
29-164 (4.1 g, 0.7795 mmol), Boc-Gly-OH (0.1502 g, 8574 mmol), HBTU (0.4434 g, 1.1692 mmol), HOBT (0.1578 g, 0.1.1692 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.5797 mL, 3.5076 mmol) was slowly added dropwise, and the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and the washed filter cakes were collected, and dried in a vacuum oven, thus obtaining the product, yield 100%.
Figure US11793881-20231024-C00822
29-167 (0.7795 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (5 mL), TFA (0.8683 mL, 11.6921 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. Then, methyl tert-butyl ether (250 mL) was added to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dissolved with methanol (60 mL)/dichloromethane (240 mL) solution, silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product: 3.2 g, yield 76%.
Figure US11793881-20231024-C00823
Reactants 26-258 (0.2545 g, 0.073 mmol), 10% Pd/C (40 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), then hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C00824
Figure US11793881-20231024-C00825
Figure US11793881-20231024-C00826
Reactants 29-194 (3.2 g, 0.9211 mmol), 29-196 (0.073 mmol), HBTU (0.5 g, 1.3159 mmol), HOBT (0.1778 g, 1.3159 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the obtained solution was stirred at −5° C. for 30 minutes. Then, DIEA (0.6525 mL, 3.9477 mmol) was slowly added dropwise, and the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution, the obtained solution was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of thy sample loading, column chromatography and elution with 1% ammonia water: 3% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 2.2 g, yield 67%.
1H-NMR (600 MHz, DMSO-d6) δ 10.17-10.13 (m, 10H), 9.10-8.84 (m, 88H), 8.35-7.43 (m, 676H), 7.37-6.69 (m, 420H), 5.87-5.73 (m, 12H), 4.60-4.09 (m, 217H), 3.96-3.43 (m, 1173H), 3.21-2.65 (m, 524H), 2.30-1.66 (m, 440H), 1.59-1.08 (m, 541H), 0.92-0.75 (m, 360H).
Figure US11793881-20231024-C00827
Figure US11793881-20231024-C00828
Figure US11793881-20231024-C00829
29-197 (2.2 g) was dissolved with dichloromethane (10 mL) and TFA (4 mL) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. Methyl tert-butyl ether (100 mL) was added to separate out a solid, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 4% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.4 g, yield 52%.
1H-NMR (600 MHz, DMSO-d6)δ 10.13-10.07 (m, 10H), 9.37-9.29 (m, 63H), 9.09-8.84 (m, 51H), 8.55-8.49 (m, 20H), 8.03-7.38 m, 560H), 7.12-7.06 (m, 376H), 6.74-6.64 (m, 13H), 5.36-5.28 (m, 12H), 4.57-4.19 (m, 153H), 3.85-3.60 (m, 803H), 3.16-3.01 (m, 317H), 2.30-2.10 (m, 150H), 1.91-1.72 (m, 143H), 1.54-1.44 (m, 127H), 1.34-1.15 (m, 940H), 0.93-0.76 (m, 360H).
Figure US11793881-20231024-C00830
Figure US11793881-20231024-C00831
Figure US11793881-20231024-C00832
Reactants 29-201 (1.0 g) and M-SCM-20K (1.2163 g, 0.0589 mmol) were dissolved with DMF solution (20 mL), and the obtained solution reacted at a low speed of stirring in the dark for one week. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution, the obtained solution was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of column chromatography, dry sample loading and gradient elution with 1% ammonia water: 3% methanol/dichloromethane—1% ammonia water: 8% methanol/dichloromethane were carried out. The elution product was then evaporated to dryness, and dissolved with anhydrous ethanol (10 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, and then n-hexane (50 mL) was added for precipitation. Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 1.3 g. Yield 61%.
1H-NMR (600 MHz, DMSO-d6) δ 10.05-9.88 (m, 10H), 9.41-9.30 (m, 62H), 9.11-8.89 (m, 50H), 8.58-8.51 (m, 20H), 8.11-7.40 m, 562H), 7.15-7.08 (m, 378H), 6.78-6.66 (m, 13H), 5.38-5.31 (m, 15H), 4.58-4.21 (m, 151H), 3.95-3.65 (m, 796H), 3.52-3.43 (m, 370614), 3.19-3.07 (m, 321H), 2.32-2.13 (m, 148H), 1.93-1.76 (m, 146H), 1.58-1.46 (m, 125H), 1.36-1.16 (m, 935H), 0.98-0.74 (m, 366H).
15. Synthesis of 37-108 (Compound No. 17)
Synthetic route is as follows
Figure US11793881-20231024-C00833
Figure US11793881-20231024-C00834
Figure US11793881-20231024-C00835
Figure US11793881-20231024-C00836
Figure US11793881-20231024-C00837
Figure US11793881-20231024-C00838
Figure US11793881-20231024-C00839
Figure US11793881-20231024-C00840
Figure US11793881-20231024-C00841
Figure US11793881-20231024-C00842
Figure US11793881-20231024-C00843
Erythritol (purchased from Aladdin, 2.5 g, 20.4717 mmol) was added in a 500 mL flask, and dissolved with THF (130 mL), and then the obtained solution reacted at 0° C. Under the protection of nitrogen gas, the THF solution of potassium tert-butoxide (1 mol/L) (98.2642 mL, 98.2642 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring for 5 hours. Then benzyl bromoacetate (14.5937 mL, 92.1225 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (200 mL) and ethyl acetate (250 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness. The obtained dry product was dissolved with dichloromethane, silica gel powder (50 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 1.5%-5% ethyl acetate were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-39: 4.8 g, yield 33%.
Figure US11793881-20231024-C00844
37-39 (1.03 g, 1.441 mmol) and 10% Pd/C (0.040 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), then hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C00845
37-49 (0.14 g, 0.3013 mmol), 37-66 (synthesized according to the method of synthesizing 35-4, 1.9 g, 1.506 mmol), HBTU (1.537 g, 4.0528 mmol), HOBT (0.5473 g, 4.0528 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (2.01 mL, 12.1585 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), evaporated to dryness, and dried in an oven, thus obtaining the product 37-67: 1.61 g.
Figure US11793881-20231024-C00846
37-67 (1.6053 g, 0.3013 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL), morpholine (2.6245 mL, 30.125 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated saline solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5% ammonia water and 5%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 37-68: 0.59 g, yield 45%.
Figure US11793881-20231024-C00847
33-143 (3.7248 g, 15.0 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (30 mL), triethylamine (2.598 mL, 18.4912 mmol) was added, and then the obtained solution was stirred to react at 0° C. for 30 minutes. Phenyl chloroformate (1.39 mL, 11.0947 mmol) was slowly added dropwise, and then the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with dichloromethane (200 mL) and deionized water (200 mL), and the organic phase was separated. The aqueous phase was washed with dichloromethane (200 mL×1), and the obtained organic phases were combined, silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 3% methanol were carried out, thus obtaining the product 37-79: 2.34 g, yield 69%.
Figure US11793881-20231024-C00848
37-68 (0.59 g, 0.1329 mmol), 37-79 (0.2938 g, 0.7975 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and then the mixed solution was stirred to react at 80° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with ethyl acetate (200 mL) and saturated saline solution (200 mL), and the organic phase was separated. The organic phase was washed with saturated saline solution (150 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 6%-8% methanol were carried out, thus obtaining the product 37-81: 0.27 g, yield 39%.
1H-NMR (400 MHz, DMSO-d6) δ 8.32-8.14 (m, 20H), 7.41-7.38 (m, 80H), 7.26-7.10 (m, 4H), 6.21-5.93 (m, 8H), 5.34-5.20 (m, 32H), 4.51-4.45 (m, 16H), 3.96-3.81 (m, 24H), 3.63-3.04 (m, 32H), 2.21-2.05 (m, 64H), 1.84-1.55 (m, 16H), 1.48-1.33 (m, 36H), 1.25 (m, 9H).
Figure US11793881-20231024-C00849
37-81 (0.27 g, 0.0488 mmol) and 10% Pd/C (0.070 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C00850
Figure US11793881-20231024-C00851
37-89 (0.1998 g, 0.0488 mmol), 37-38 (synthesized according to the method of synthesizing 39-20, 1.769 g, 0.87796 mmol), HBTU (0.4442 g, 1.1712 mmol), HOBT (0.1583 g, 1.1712 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.58 mL, 3.5136 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (250 mL) and methyl tert-butyl ether (40 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (250 mL) and methyl tert-butyl ether (40 mL) were added to the lower oily liquid phase for further precipitation, and such operations were repeated four times, to obtain a viscous oily product. Methyl tert-butyl ether (150 mL) was added to the oily product to separate out a solid, and then filtering was carried out, silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 8%-10% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 37-91: 1.2 g, yield: 68%.
Figure US11793881-20231024-C00852
Figure US11793881-20231024-C00853
37-91 (1.2 g, 0.0488 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (20 mL), trifluoroacetic acid (0.7248 mL, 9.76 mmol), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), and dissolved with a mixed solvent of methanol (20 mL) dichloromethane (80 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 8%-12% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 37-101: 0.69 g, yield 40%.
Figure US11793881-20231024-C00854
Figure US11793881-20231024-C00855
37-101 (0.3 g, 0.0084 mmol) was added in a 250 mL flask, and dissolved with DMF (35 mL), M-SCM-10K (0.5348 g, 0.0505 mmol, purchased from JenKem) was added, and ultrasonic treatment was carried out to dissolve the reactants, and then the mixed solution reacted in the dark for 7 days at a low speed of stirring at room temperature. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (130 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid. Such operations were repeated three times, to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-9% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven for 1 hour. The obtained dry product was dissolved with anhydrous ethanol (7 mL) and dichloromethane (20 mL), then methyl tert-butyl ether (100 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried in a vacuum oven, thus obtaining the product 37-108: 0.3 g, yield: 52%.
1H-NMR (600 MHz, DMSO-d6) δ8.49-8.22 (m, 49H), 8.12-8.03 (m, 212H), 7.91-7.66 (m, 48H), 7.36-7.01 (m, 388H), 6.97-6.85 (m, 16H), 6.70-6.01 (m, 40H), 5.34-5.16 (m, 64H), 4.92-4.26 (m, 144H), 4.09-4.03 (m, 152H), 3.76-3.54 (m, 86H), 3.51-3.41 (m, 3722H), 3.44-3.19 (m, 160H), 2.93-2.72 (m, 48H), 2.46-2.05 (m, 192H), 1.84-1.55 (m, 144H), 1.25-0.91 (m, 297H).
16. Synthesis of 29-226 (Compound No. 8)
Synthetic route is as follows
Figure US11793881-20231024-C00856
Figure US11793881-20231024-C00857
Figure US11793881-20231024-C00858
Figure US11793881-20231024-C00859
Figure US11793881-20231024-C00860
Figure US11793881-20231024-C00861
Figure US11793881-20231024-C00862
Figure US11793881-20231024-C00863
Figure US11793881-20231024-C00864
Figure US11793881-20231024-C00865
Figure US11793881-20231024-C00866
Figure US11793881-20231024-C00867
Fmoc-Glu-OtBu (4 g, 9.401 mmol, purchased from InnoChem), H-Gly-OtBu·HCl (1.7 g, 10.3415 mmol, purchased from InnoChem), HBTU (5.3 g, 14.1021 mmol) and HOBT (1.9 g, 14.1021 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (70 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (7.0 mL, 42.3061 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with pure water (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was then extracted with saturated sodium chloride solution (150 mL×3), concentrated, evaporated to dryness, and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00868
29-168 (9.401 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (10 mL), and TFA (7.0 mL, 94.01 mmol), and then the mixed solution wag stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was subjected to rotary evaporation to obtain an oily product, the oily product was then transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (100 mL) was added to adjust the pH to alkaline, ethyl acetate (80 mL) was then added for extraction, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was then extracted with saturated sodium chloride solution (100 mL×3), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining a crude product, yield 100%.
Figure US11793881-20231024-C00869
29-171 (9.401 mmol), H-Glu-(OtBu)2 (2.6789 g, 10.3415 mmol), HBTU (5.3 g, 14.1021 mmol) and HOBT (1.9 g, 14.1021 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (70 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (7.0 mL, 42.3061 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with pure water (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (150 mL×3), concentrated, evaporated to dryness, and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00870
29-173 (9.401 mmol) was added in a 250 mL flask, and dissolved with DMF (10 mL), morpholine (8.2 mL, 94.01 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with pure water (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (150 mL×3), and concentrated, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 4%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 3.7 g, yield 74%.
Figure US11793881-20231024-C00871
Fmoc-Gly-OH (2.2 g, 7.5985 mmol, purchased from InnoChem), 29-184 (3.7 g, 6.9078 mmol), HBTU (3.9 g, 10.3616 mmol), HOBT (1.400 g, 10.3616 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (70 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (5.1 mL, 31.0849 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with pure water (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (150 mL×3), and concentrated, silica gel powder (25 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-7% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 4.5 g, yield 77%.
Figure US11793881-20231024-C00872
29-185 (0.9281 g, 1.0354 mmol) and 10% Pd/C catalyst (30 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), the hydrogenation reactor was then sealed, hydrogen was introduced so that the pressure on the hydrogenation reactor was read as 18 psi, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a suction funnel filled with compacted diatomaceous earth. The reaction device and diatomaceous earth were washed with DMF (30 mL×3), and the filtrate was collected, thus obtaining the reaction product.
Figure US11793881-20231024-C00873
Boc-Glu-(OH)2 (0.39 g, 1.5738 mmol, purchased from InnoChem), 34-17 (4.5 g, 3.3051 mmol), HBTU (1.8 g, 4.7216 mmol) and HOBT (0.6380 g, 4.7216 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (2.3 mL, 14.1647 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with pure water (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (150 mL×3), concentrated, evaporated to dryness, and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00874
K-7 (1.5738 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (10 mL), TFA (1.7531 mL, 15.738 mmol), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. The oily product was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (100 mL) was added to adjust the pH to alkaline, ethyl acetate (80 mL) was then added for extraction, and the organic phase was separated, The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (100 mL×3), and concentrated, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 3.2 g, yield 77%.
Figure US11793881-20231024-C00875
K-8 (3.0 g, 1.1389 mmol), 29-209 (1.0354 mmol), HBTU (0.5891 g, 1.5531 mmol) and HOBT (0.2099 g, 1.5531 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (0.7701 mL, 4.6595 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 2.7 g, yield 79%.
Figure US11793881-20231024-C00876
24-36 (4 g, 15.1924 mmol), H-Glu-(OBn)2 (6.9 g, 13.8112 mmol, purchased from InnoChem), HBTU (7.8567 g, 20.7169 mmol), HOBT (2.8 g, 20.7169 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (70 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (10.2723 mL, 62.1506 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated sodium bicarbonate solution (100 mL) and ethyl acetate (80 mL), and the organic phase was separated. The aqueous phase was extracted with ethyl acetate (80 mL×2), and the obtained organic phases were combined. The organic phase was extracted with saturated sodium chloride solution (150 mL×3), and concentrated, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1%-3% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 8.7 g, yield 62%.
Figure US11793881-20231024-C00877
K-10 (2.7 g, 4.7469 mmol) and 10% Pd/C catalyst (30 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), the hydrogenation reactor was then sealed, hydrogen was introduced so that the pressure on the hydrogenation reactor was read as 18 psi, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a suction funnel filled with compacted diatomaceous earth. The reaction device and diatomaceous earth were washed with DMF (30 mL×3), and the filtrate was collected, thus obtaining the reaction product.
Figure US11793881-20231024-C00878
K-11 (2.1484 mmol), G-SN38-TBDPS (synthesized according to the method of synthesizing 25-200, 3.0 g, 4.3614 mmol), HBTU (2.4443 g, 6.4453 mmol) and HOBT (0.8710 g, 6.4453 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (3.1959 mL, 19.3360 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, methyl tert-butyl ether (80 mL) was added to the reaction solution, the reaction flask was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00879
K-12 (2.1484 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (5 mL), and TFA (2.3932 mL, 32.226 mmol), and then the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product, methyl tert-butyl ether (60 mL) was added to the oily product to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 2.7 g, yield 72%.
Figure US11793881-20231024-C00880
K-11 (2.5985 mmol), 42-18 (6.0 g, 6.2363 mmol), HBTU (2.9563 g, 7.7953 mmol) and HOBT (1.0534 g, 7.7953 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (3.8653 mL, 23.360 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, methyl tert-butyl ether (80 mL) was added to the reaction solution, the reaction flask was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00881
K-14 (2.5985 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (5 mL), and TFA (2.8946 mL, 38.9775 mmol), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product, methyl tert-butyl ether (60 mL) was added to the oily product to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-8% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 3.3 g, yield 61%.
Figure US11793881-20231024-C00882
29-210 (0.6579 g, 0.1972 mmol) and 10% Pd/C catalyst (30 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), the hydrogenation reactor was then sealed, hydrogen was introduced so that the pressure on the hydrogenation reactor was read as 18 psi, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a suction funnel filled with compacted diatomaceous earth. The reaction device and diatomaceous earth were washed with DMF (30 mL×3), and the filtrate was collected, thus obtaining the reaction product.
Figure US11793881-20231024-C00883
K-15 (3.3 g, 1.6566 mmol), 29-212 (0.5391 g, 0.1972 mmol), HBTU (0.8975 g, 2.3667 mmol) and HOBT (0.3198 g, 2.3667 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (1.1735 mL, 7.1 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at 0° C. overnight. At the end of the reaction, methyl tert-butyl ether (80 mL) was added to the reaction solution, the reaction flask was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00884
29-213 (0.1972 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (5 mL), and TFA (0.22 mL, 2.958 mmol), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product, methyl tert-butyl ether (60 mL) was added to the oily product to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-9% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 2.7 g, yield 69%.
Figure US11793881-20231024-C00885
29-214 (2.7 g, 0.1405 mmol), K-13 (0.5117 g, 0.2951 mmol), HBTU (0.1599 g, 0.4215 mmol), HOBT (0.057 g, 0.4215 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF, and then the mixed solution was stirred at 0° C. for 30 minutes. DIEA (0.2090 g, 1.2645 mmol) was then added, and the obtained solution continued to react at 0° C. with stirring overnight. At the end of the reaction, methyl tert-butyl ether (80 mL) was added, the reaction flask was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00886
29-216 (0.1405 mmol) was added in a 250 mL flask, and dissolved with DMF (8 mL), morpholine (0.3378 mL, 3.8778 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. Methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL) were then added, the obtained solution was shaken, and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, dissolved with methanol/dichloromethane (1:4) solution (10 mL), and the obtained solution was precipitated with methyl tert-butyl ether. Such operations were repeated three times, thus obtaining a crude product.
Figure US11793881-20231024-C00887
M-SCM-5K (0.8773 g, 0.1667 mmol, purchased from JenKem) was added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL). Then, DIEA (0.3443 mL, 2.0833 mmol) was added, the obtained solution was stirred at 0° C. for 10 minutes, then the DMF (20 mL) solution of 29-220 (1.0 g, 0.0416 mmol) was slowly added dropwise with a drop funnel over about 2 hours. At the end of the addition, the obtained solution was stirred at 0° C. for 15 minutes, and then moved to room temperature and stirred to react in the dark for one week at a low speed. At the end of the reaction, methyl tert-butyl ether (80 mL) was added to the reaction solution, the reaction flask was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (30 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 4%-15% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product 1.6 g, yield 58%.
1H-NMR (600 MHz, DMSO-d6) δ 9.27-9.02 (m, 62H), 8.36-7.95 (m, 171H), 7.77-7.51 (m, 115H), 7.34-7.12 (m, 157H), 6.69-6.65 (m, 13H), 4.57-4.50 (m, 34H), 4.31-4.17 (m, 71H), 3.91-3.80 (m, 207H), 3.55-3.45 (m, 1430H), 3.26-3.20 (m, 12H), 3.12-3.05 (m, 71H), 2.93-2.88 (m, 12H), 2.81-2.65 (m, 50H), 2.25-2.19 (m, 61H), 1.89-1.19 (m, 298H), 0.85-0.79 (m, 96H).
Figure US11793881-20231024-C00888
29-221 in a 250 mL flask was dissolved first with THF (10 mL), and then with diluted hydrochloric acid (10 mL, 0.05 mol/L), TBAF (67 mg, 0.256 mmol) was added, and then the obtained solution was stirred to react at room temperature for 3 hours. At the end of the reaction, the reaction solution was first evaporated to obtain an oily product, then anhydrous ethanol was added to the oily product to remove water, and the obtained solution was evaporated to dryness. Such operations were repeated three times, and a solid product was obtained. The solid product was dissolved with DMF (20 mL), and then precipitated with isopropanol (30 mL). Such operations were repeated three times. The obtained solid product was dissolved with dichloromethane and a small amount of anhydrous ethanol, and then precipitated with methyl tert-butyl ether. Such operations were repeated three times. The precipitate was dried, thus obtaining the product 1.1 g, yield 72%
1H-NMR (600 MHz, DMSO-d6) δ 9.06-9.00 (m, 40H), 8.29-8.22 (m, 50H), 8.15-7.95 (m, 96H), 7.73-7.47 (m, 121H), 7.29-7.08 (m, 170H), 4.59-4.11 (m, 99H), 3.95-3.73 (m, 240H), 3.53-3.48 (m, 1434.3H), 3.24-3.00 (m, 110H), 2.92-2.87 (m, 9H), 2.80-5.65 (m, 45H), 2.14-2.08 (m, 45H), 1.91-1.28 (m, 244H), 0.85-0.81 (m, 96H)
17. Synthesis of 27-253 (Compound No. 9)
Synthetic route is as follows
Figure US11793881-20231024-C00889
Figure US11793881-20231024-C00890
Figure US11793881-20231024-C00891
Figure US11793881-20231024-C00892
Figure US11793881-20231024-C00893
Figure US11793881-20231024-C00894
Figure US11793881-20231024-C00895
Figure US11793881-20231024-C00896
Figure US11793881-20231024-C00897
Figure US11793881-20231024-C00898
Figure US11793881-20231024-C00899
Figure US11793881-20231024-C00900
Figure US11793881-20231024-C00901
Figure US11793881-20231024-C00902
Figure US11793881-20231024-C00903
Figure US11793881-20231024-C00904
Figure US11793881-20231024-C00905
29-168 (3.33 g, 5.8079 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (20 mL), ultrasonic treatment was carried out to completely dissolve the compound, morpholine (5.06 mL, 58.079 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, the reaction solution was extracted with saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, and dried, thus obtaining the product 4.2 g, overweight.
Figure US11793881-20231024-C00906
27-181 (2.03 g, 5.8079 mmol), Fmoc-Gly-OH (1.72 g, 5.8079 mmol, purchased from InnoChem), HBTU (3.3 g, 8.7119 mmol) and HOBT (1.13 g, 8.7119 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (4.32 mL, 26.1356 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, silica gel powder (60 ml) was added, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (2%-3% methanol: 97%-98% dichloromethane) were carried out. The elution product was then collected, concentrated under reduced pressure, and dried, thus obtaining the product 2.68 g, yield: 73.42%.
Figure US11793881-20231024-C00907
27-184 (2.68 g, 4.9669 mmol) and 10% Pd/C catalyst (100 mg) were added in a hydrogenation reactor, and dissolved with DMF (50 mL), the hydrogenation reactor was then sealed, hydrogen was introduced to a pressure of 18 psi, and then the mixed solution was stirred to react at room temperature overnight. After the reaction was found to be completed from the monitoring of the TLC, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (30 mL×3), thus obtaining a reaction product solution.
Figure US11793881-20231024-C00908
27-201 (1.57 g, 2.9123 mmol), 34-17 (3.34 g, 2.6475 mmol), HBTU (1.50 g, 3.9713 mmol) and HOBT (0.54 g, 3.9713 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (1.97 mL, 11.9138 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, silica gel powder (60 ml) was added, and the operations of evaporation, dry sample loading, column chromatography and elution with an elutent (3% methanol: 97% dichloromethane) were carried out. The elution product was then collected, concentrated under reduced pressure, and dried, thus obtaining the product 3.58 g, yield: 75.84%.
Figure US11793881-20231024-C00909
27-202 (3.58 g, 1.9456 mmol) and 10% Pd/C catalyst (100 mg) were added in a hydrogenation reactor, and dissolved with DMF (50 mL), the hydrogenation reactor was then sealed, hydrogen was introduced to a pressure of 18 psi, and then the mixed solution was stirred to react at room temperature overnight. After the reaction was found to be completed from the monitoring of the TLC, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (30 mL×3), thus obtaining a reaction product solution.
Figure US11793881-20231024-C00910
K-11 (0.65 g, 1.6590 mmol), 30-33 (3 g, 3.6498 mmol), HBTU (0.94 g, 2.4885 mmol) and HOBT (0.34 g, 2.4885 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (1.23 mL, 7.4655 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dried, thus obtaining the product 5.9 g, overweight.
Figure US11793881-20231024-C00911
M-6 (3.32 g, 1.6590 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), TFA (2.35 mL, 16.590 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, the reaction solution was concentrated under reduced pressure, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the obtained solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 7% methanol/1% ammonia water/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 2.5 g, yield 79.36%.
Figure US11793881-20231024-C00912
M-7 (2.5 g, 1.3244 mmol), 27-204 (0.43 g, 0.3010 mmol), HBTU (0.69 g, 1.806 mmol) and HOBT (0.24 g, 1.806 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.90 mL, 5.418 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dried, thus obtaining the product 4.5 g, overweight.
Figure US11793881-20231024-C00913
27-212 (2.69 g, 0.3010 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), TFA (0.22 mL, 3.010 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, the reaction solution was concentrated under reduced pressure, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the obtained solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 8% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.9 g, yield 71.76%.
1H-NMR (600 MHz, DMSO-d6) δ10.17-10.13 (m, 8H), 8.99-8.91 (m, 8H), 8.34-8.14 (m, 16H), 8.14-7.94 (m, 24H), 7.88-7.67 (m, 30H), 7.45-7.05 (m, 49H), 5.83-5.77 (m, 10H), 5.35-5.28 (m, 5H), 4.56-3.98 (m, 51H), 3.74-3.49 (m, 60H), 3.15-2.99 (m, 48H), 2.81-2.66 (m, 19H), 2.41-2.03 (m, 68H), 1.89-1.85 (m, 50H), 1.57-1.51 (m, 43H), 1.34-1.23 (m, 18H), 0.98-0.77 (m, 72H).
Figure US11793881-20231024-C00914
Paclitaxel (also referred to as PTX, 0.5 g, 0.5855 mmol), TBDMS-Cl (purchased from Innochem, 0.53 g, 3.5310 mmol), imidazole (0.2 g, 2.9425 mmol) were added in a 500 mL round-bottomed flask, and dissolved with anhydrous DMF (20 mL), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was diluted with dichloromethane (200 mL), washed in turn with saturated NH4Cl (50 mL), deionized water (50 mL), and saturated sodium chloride solution (100 mL), and the obtained organic phase was dried with anhydrous sodium sulfate. The operations of dry sample loading, column chromatography and elution with petroleum ether:ethyl acetate=1:1 were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 0.35 g, yield 62.5%, wherein hydroxy in position 2′ of paclitaxel was protected by TBDMS.
Figure US11793881-20231024-C00915
Fmoc-Gly-OH (0.44 g, 1.4476 mmol), EDCI (0.28 g, 1.4476 mmol), DMAP (0.02 g, 0.1810 mmol) were added in a 500 mL round-bottomed flask, and dissolved with anhydrous dichloromethane (50 mL) and anhydrous DMF (25 mL), and then the mixed solution was stirred to react at room temperature for 15 min. Then 27-214 (0.35 g, 0.3619 mmol) was added, and the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was diluted with dichloromethane (200 mL), washed in turn with saturated NH4Cl (100 mL), deionized water (50 mL), and saturated sodium chloride solution (100 mL), and the obtained organic phase was dried with anhydrous sodium sulfate. The operations of dry sample loading, column chromatography and elution with 3% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 0.31 g, yield 68.89%, wherein the esterification occurred at hydroxy in position 7.
1H-NMR (400 MHz, DMSO-d6) δ 8.83 (m, 1H), 7.99 (m, 2H), 7.92-7.81 (m, 4H), 7.76-7.59 (m, 6H), 7.57-7.27 (m, 12H), 7.21 (m, 1H), 5.99 (s, 1H), 5.86 (m, 1H), 5.56-5.40 (m, 3H), 5.01 (m, 1H), 4.80 (s, 2H), 4.26 (s, 3H), 3.66 (m, 3H), 2.45 (s, 3H), 1.99 (s, 6H), 1.65 (s, 5H), 1.55 (s, 3H), 1.00 (m, 6H), 0.80 (s, 9H), 0.05 (m, 6H).
Figure US11793881-20231024-C00916
27-235 (0.31 g, 0.2487 mmol) was added in a 500 mL round-bottomed flask, piperidine (0.25 ml, 2.487 mmol) and DMF (5 mL) were added, and then the mixed solution was stirred to react at room temperature for 2 h. At the end of the reaction, the reaction solution was concentrated under reduced pressure to remove the piperidine, thus obtaining the DMF solution of the reaction product.
Figure US11793881-20231024-C00917
27-234 (1.9 g, 0.2135 mmol), 27-239 (0.2487 mmol), HBTU (0.12 g, 0.3203 mmol) and HOBT (0.04 g, 0.3203 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.17 mL, 0.9608 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with a small amount of a mixed solvent of methanol and dichloromethane, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were then added to the obtained solution for precipitation, and suction filtering was carried out. The process of dissolution and precipitation was repeated three times, thus obtaining the product 1.6 g, yield 75.82%.
Figure US11793881-20231024-C00918
27-240 (1.6 g, 0.1615 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), ultrasonic treatment was carried out to completely dissolve the compound, morpholine (0.14 mL, 1.615 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 7% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.2 g, yield 78.43%.
Figure US11793881-20231024-C00919
27-243 (1.2 g, 0.1268 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL),
Figure US11793881-20231024-P00002
λM-SCM-5K (1.45 g, 0.2790 mmol, purchased from JenKem), ultrasonic vibration was carried out to dissolve the compound, the mixed solution reacted in the dark for one week at a low of speed stirring at room temperature. At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 9% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.9 g, yield 75.70%.
1H-NMR (600 MHz, DMSO-d6) δ10.16-10.12 (m, 8H), 9.02-8.98 (m, 11H), 8.08-7.98 (m, 55H), 7.72-7.64 (m, 14H), 7.56-7.09 (m, 49H), 7.05-6.98 (m, 2H), 6.69-6.65 (m, 3H), 5.80-5.37 (m, 21H), 5.14-4.75 (m, 20H), 4.56-4.30 (m, 35H), 4.03-4.38 (m, 45H), 3.51 (s, 1120H), 3.44-3.04 (m, 65H), 2.77-2.68 (m, 13H), 2.41-2.04 (m, 55H), 2.02-1.69 (m, 39H), 1.68-1.26 (m, 66H), 1.18-1.12 (m, 5H), 1.06-0.69 (m, 45H), 0.09-0.06 (m, 3H).
Figure US11793881-20231024-C00920
27-247 (1.9 g, 0.0958 mmol), TBAF (0.06 g, 0.1916 mmol) were added in a 500 mL round-bottomed flask, and dissolved with THF (20 mL), and then the mixed solution was stirred to react at room temperature for 1.5 h. At the end of the reaction, the reaction solution was concentrated under reduced pressure to obtain a solid product, the solid product was dissolved with DMF (5 mL), isopropanol was added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by filtering. The obtained solid product was dissolved with dichloromethane (10 mL), and the obtained solution was precipitated with methyl tert-butyl ether. Such operations were repeated three times. The obtained solid product was dried, thus obtaining the product 0.75 g, yield 62.5%.
1H-NMR (400 MHz, DMSO-d6) δ 10.16-10.10 (m, 8H), 9.02-8.97 (m, 11H), 8.55-7.81 (m, 58H), 7.70-7.62 (m, 9H), 7.21-6.99 (m, 53H), 6.71-6.66 (m, 5H), 5.88-5.84 (m, 10H), 5.37-4.96 (m, 10H), 4.59-4.28 (m, 27H), 4.14-3.81 (m, 32H), 3.57-3.48 (s, 1101H), 3.19-3.15 (m, 61H), 2.81-2.76 (m, 7H), 2.44-2.27 (s, 68H), 1.82-1.43 (m, 89H), 1.36-1.32 (m, 36H), 0.90-0.79 (m, 40H).
18. Synthesis of 49-5(Compound No. 11)
Synthetic route is as follows
Figure US11793881-20231024-C00921
Figure US11793881-20231024-C00922
Figure US11793881-20231024-C00923
Figure US11793881-20231024-C00924
Figure US11793881-20231024-C00925
Figure US11793881-20231024-C00926
Figure US11793881-20231024-C00927
Figure US11793881-20231024-C00928
Figure US11793881-20231024-C00929
Figure US11793881-20231024-C00930
27-202 (3 g, 1.6826 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), TFA (1.25 mL, 16.826 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, the reaction solution was concentrated under reduced pressure, saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL) were added to the obtained solution for extraction, and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, and dried, thus obtaining the product 4.3 g, overweight.
Figure US11793881-20231024-C00931
27-216 (2.90 g, 1.6826 mmol), Gly-OtBu (0.24 g, 1.8509 mmol, purchased from InnoChem), HBTU (0.96 g, 2.5239 mmol) and HOBT (0.34 g, 2.5239 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (1.25 mL, 7.5717 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, and dried in vacuum, thus obtaining the product 6.6 g, overweight.
Figure US11793881-20231024-C00932
27-218 (2 g, 1.0867 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), TFA (0.81 mL, 10.867 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, the reaction solution was concentrated under reduced pressure, saturated sodium chloride solution (200 mL) and ethyl acetate (200 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, and dried, thus obtaining the product 4.3 g, overweight.
Figure US11793881-20231024-C00933
27-221 (1.94 g, 1.0867 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (20 mL) by ultrasonic, Boc-NHNH2 (0.16 g, 1.1954 mmol), DCC (0.67 g, 3.2601 mmol) and DMAP (0.026 g, 0.2173 mmol) were added to the flask, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, saturated saline solution (200 mL) and ethyl acetate (200 mL) were added to the reaction solution for extraction, and the organic phase was separated. The aqueous phase was then extracted with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was concentrated under reduced pressure, and the operations of dry sample loading, column chromatography and elution with 3% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.62 g, yield 78.64%.
Figure US11793881-20231024-C00934
27-224 (1.62 g, 0.8535 mmol), and 10% Pd/C catalyst (100 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), the hydrogenation reactor was then sealed, hydrogen was introduced to a pressure of 18 psi, and then the mixed solution was stirred to react at room temperature overnight. After the reaction was found to be completed from the monitoring of the TLC, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF (30 mL×3), thus obtaining a reaction product solution.
Figure US11793881-20231024-C00935
K-11 (0.69 g, 1.4272 mmol), 14-128 (3 g, 3.1398 mmol), HBTU (1.62 g, 4.2816 mmol) and HOBT (0.58 g, 4.2816 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (2.12 mL, 12.8448 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dried, thus obtaining the product 5.1 g, weighed.
Figure US11793881-20231024-C00936
27-205 (3.03 g, 1.4272 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), TFA (1.06 mL, 14.272 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, the reaction solution was concentrated under reduced pressure, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the obtained solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 8% methanol/1% ammonia water/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 2 g, yield 69.20%.
Figure US11793881-20231024-C00937
27-259 (0.35 g, 0.2248 mmol), 27-231 (2 g, 0.9891 mmol), HBTU (0.51 g, 1.3488 mmol) and HOBT (0.18 g, 1.3488 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.67 mL, 4.0464 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted at −5° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (50 mL) and methyl tert-butyl ether (400 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. The obtained solid product was dissolved with dichloromethane and methanol, and the operations of dry sample loading, column chromatography and elution with 6% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.3 g, yield 60.46%.
Figure US11793881-20231024-C00938
27-260 (1.3 g, 0.1361 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), ultrasonic treatment was carried out to completely dissolve the compound, morpholine (0.12 mL, 1.361 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 6% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 0.91 g, yield 73.39%.
Figure US11793881-20231024-C00939
49-265 (0.91 g, 0.0999 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), M-SCM-5K (1.14 g, 0.2198 mmol, purchased from JenKem) was added, ultrasonic vibration was carried out to dissolve the compound, and then the mixed solution reacted in the dark for one week at a low speed of stirring at room temperature. At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 9% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 1.23 g, yield 63.07%.
1H-NMR (600 MHz, DMSO-d6) δ9.85-9.79 (m, 6H), 8.77-8.71 (m, 7H), 8.55-7.91 (m, 63H), 7.89-7.63 (m, 23H), 7.47-6.98 (m, 93H), 6.69-6.54 (s, 7H), 5.27-5.21 (m, 14H), 4.72-4.57 (m, 20H), 4.41-4.12 (m, 32H), 3.85-3.79 (m, 43H), 3.55-3.48 (m, 1115H), 3.27-3.12 (m, 19H), 3.09-2.95 (m, 32H), 2.90-2.60 (m, 32H), 2.14-1.70 (m, 31H), 1.54-1.14 (m, 95H), 0.86-0.79 (m, 51H).
Figure US11793881-20231024-C00940
49-1 (1.23 g, 0.0632 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (0.094 mL, 1.264 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 9% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried, thus obtaining the product 0.98 g, yield 80.33%.
Figure US11793881-20231024-C00941
49-3 (0.98 g, 0.0506 mmol) was added in a 500 mL dried round-bottomed flask, and dissolved with anhydrous methanol (10 mL), TFA (0.018 mL, 0.253 mmol) and adriamycin (also referred to as DOX, 0.028 g, 0.0506 mmol) were added, and then the mixed solution was stirred to react at room temperature overnight, At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by suction filtering, and dissolved with dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with 9% methanol/dichloromethane were carried out. The elution product was then collected, concentrated, and dried. The obtained dry product was dissolved with anhydrous alcohol (5 mL) and dichloromethane (1 mL), and the obtained solution was precipitated with methyl tert-butyl ether (40 mL). Such operations were repeated three times. Filtering was carried out, and the filter cake was dried, thus obtaining the product 0.65 g, yield 65%, wherein the formation of hydrazone bond occurred at carbonyl in position 13 of adriamycin.
1H-NMR (600 MHz, DMSO-d6) δ 10.28 (s, 5H), 8.98-8.94 (m, 8H), 8.58-8.51 (m, 8H), 8.34-7.92 (m, 79H), 7.49-7.45 (m, 10H), 7.46-7.10 (m, 82H), 6.68 (s, 5H), 6.54 (s, 3H), 5.26 (s, 20H), 4.80-4.71 (m, 16H), 4.56 (s, 10H), 4.41-4.06 (m, 42H), 3.95-3.74 (m, 45H), 3.52-3.50 m, 1289H), 3.11-2.97 (m, 57H), 2.78-2.74 (m, 26H), 2.11 (s, 26H), 1.60-1.52 (m, 40H), 1.00-0.61 (m, 72H).
19. Synthesis of 39-42 (Compound No. 19)
Synthetic route is as follows
Figure US11793881-20231024-C00942
Figure US11793881-20231024-C00943
Figure US11793881-20231024-C00944
Figure US11793881-20231024-C00945
GFLG-LPT (1.0 g, 1.04 mmol, synthesized according to the method of synthesizing 14-128), 39-51 (0.08 mmol), HBTU (0.54 g, 1.44 mmol), HOBT (0.19 g, 1.44 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and ultrasonic treatment was carried out to completely dissolve the reactants, and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.71 mL, 4.32 mmol) was slowly added dropwise, and the obtained solution was stirred at the low temperature for 2 hours, and then reacted at room temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (250 mL) was added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, the supernatant was discarded, ethyl acetate (20 mL) was added to the lower liquid, ultrasonic treatment was carried out for 3 minutes, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were added to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane (20 mL), silica gel powder (10 g) was added, and the operations of evaporation, column chromatography and gradient elution with 3% methanol/dichloromethane-10% methanol/dichloromethane were carried out, thus obtaining the product 0.2 g.
Figure US11793881-20231024-C00946
39-40 (0.2 g) was dissolved with dichloromethane (15 mL), and TFA (0.033 mL, 0.444 mmol), and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, ethyl acetate (20 mL) was added, ultrasonic treatment was carried out for 2 minutes, and then methyl tert-butyl ether (150 mL) and n-hexane (70 mL) were added for precipitation to separate out a solid. Suction filtering was carried out, and the filter cake was dried in vacuum, thus obtaining the product 0.2 g.
Figure US11793881-20231024-C00947
39-41 (0.6 g) was dissolved with DMF (20 mL) and M-SCM-5K (0.9378 g) was added, and ultrasonic treatment was carried out to dissolve the reactants, and then the obtained solution reacted in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (150 mL), n-hexane (70 mL) were added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane, silica gel powder (10 g) was added, the operations of evaporation, column chromatography and gradient elution with 1% ammonia water: 4% methanol dichloromethane-1% ammonia water: 8% methanol/dichloromethane were carried out. The elution product was collected, evaporated to dryness, and dissolved with anhydrous ethanol (3 mL), and the obtained solution was then treated by ultrasonic to obtain homogeneous phase. Then, methyl tert-butyl ether (150 mL), n-hexane (50 mL) were added to the obtained solution, and suction filtering was carried out. The filter cake was further dissolved with anhydrous ethanol (3 mL), and precipited with methyl tert-butyl ether and n-hexane. The process of dissolution and precipitation was repeated three times. Suction filtering was carried out, and the filter cake was dried, thus obtaining the product 0.15 g.
1H-NMR (400 MHz, DMSO-d6) δ10.06-9.84 (m, 3H), 8.84-8.36 (m, 4H), 8.29-7.65 (m, 85H), 7.57-6.79 (m, 187H), 6.73-6.51 (m, 15H), 4.83-4.07 (m, 86H), 3.50-3.49 (m, 512H), 3.08-2.99 (m, 81H), 1.70-1.17 (m, 125H), 0.90-0.80 (m, 72H).
20. Synthesis of 41-32 (Compound No. 20)
Synthetic route is as follows
Figure US11793881-20231024-C00948
Figure US11793881-20231024-C00949
Figure US11793881-20231024-C00950
Figure US11793881-20231024-C00951
Reactants GFLG-LPT (1.0 g, 1.48 mmol, synthesized according to the method of synthesizing 14-128), 41-33 (0.077 mmol), HBTU (0.35 g, 0.924 mmol), HOBT (0.1 g, 0.924 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.45 mL, 2.772 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation to obtain a powder product. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 2% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 0.6 g.
Figure US11793881-20231024-C00952
41-29 (0.6 g) was dissolved with dichloromethane (5 mL) and TFA (0.17 mL, 2.31 mmol) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was concentrated, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the obtained solution for precipitation to obtain a powder. The powder was dried in vacuum, thus obtaining the product 0.6 g.
Figure US11793881-20231024-C00953
Reactants 41-31 (0.6 g, 0.044 mmol) and M-SCM-5K (1.6 g, 0.30 mmol) were dissolved with DMF solution (20 mL), and then the mixed solution reacted at a low speed of stirring in the dark. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (50 mL) and n-hexane (100 mL), and suction filtering was carried out. The operations of column chromatography, dry sample loading and gradient elution with dichloromethane—1% ammonia water: 8% methanol/dichloromethane were carried out. The elution product was then evaporated to dryness, and dissolved with anhydrous ethanol (10 mL), the obtained solution was treated by ultrasonic to obtain homogeneous phase, and then n-hexane (50 mL) was added for precipitation. Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 0.4 g.
1H-NMR (600 MHz, DMSO-d6) δ 9.91-9.83 (m, 8H), 8.80-8.72 (m, 10H), 8.58-8.50 (m, 10H), 8.27-7.96 (m, 82H), 7.63-7.49 (m, 128H), 7.24-7.14 (m, 51H), 6.71-6.50 (m, 7H), 5.29-5.21 (m, 22H), 4.52-4.40 (m, 82H), 4.04-3.98 (m, 54H), 3.51-3.50 (m, 600H), 3.17-3.14 (m, 83H), 3.03-2.97 (m, 122H), 2.88-2.86 (m, 15H), 0.91-0.70 (m, 72H).
21. Synthesis of 33-207 (Compound No. 21)
Synthetic route is as follows
Figure US11793881-20231024-C00954
Figure US11793881-20231024-C00955
Figure US11793881-20231024-C00956
Figure US11793881-20231024-C00957
Figure US11793881-20231024-C00958
Figure US11793881-20231024-C00959
GFLG-PCB (synthesized according to the method of synthesizing 30-33, 2 g, 2.43 mmol), HBTU (1.15 g, 3.03 mmol), HOBT (0.41 g, 3.03 mmol) were added in a 250 mL flask, and dissolved with a DMF solution of 33-190, and ultrasonic treatment was carried out to completely dissolve the reactants, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (1.5 mL, 9.108 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature until the reaction ended. At the end of the reaction, methyl tert-butyl ether (100 mL), n-hexane (150 mL) were added to the reaction solution, ultrasonic treatment was carried out for 5 minutes, the obtained solution was placed in a refrigerator, and stood still for 20 minutes, the supernatant was discarded, ethyl acetate (20 mL) was added to the lower liquid, ultrasonic treatment was carried out for 2 minutes, n-hexane (100 mL) was added, and suction filtering was carried out. The filter cake was dried in vacuum, thus obtaining the product 1.4 g.
Figure US11793881-20231024-C00960
33-194 (1.4 g, 0.32 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (70 mL), morpholine (0.84 mL, 9.6 mmol) was added, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL), n-hexane (100 mL) were added to the reaction solution, and ultrasonic treatment was carried out for 5 minutes to separate out a solid. Suction filtering was carried out, and the filter cake was dried in vacuum, thus obtaining the product 1.3 g.
Figure US11793881-20231024-C00961
33-196 (1.3 g, 0.316 mmol), HBTU (0.153 g, 0.406 mmol), HOBT (0.0541 g, 0.406 mmol) were added in a 250 mL flask, and dissolved with a DMF solution of 45-12 (19 mL, 0.0452 mmol), DMSO (80 mL) was added, and ultrasonic treatment was carried out to completely dissolve the reactants, and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.2 mL, 1.22 mmol) was slowly added dropwise, and, after 1 hour, the obtained solution reacted with stirring at room temperature. At the end of the reaction, deionized water (100 mL) was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was dried in vacuum, thus obtaining the product 1.3 g.
Figure US11793881-20231024-C00962
33-199 (1.3 g, 0.316 mmol) was dissolved with dichloromethane (10 mL), TFA (0.7 mL, 9.48 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were directly added to the reaction solution, and suction filtering was carried out. The filter cake was dried in vacuum, thus obtaining the product 1.2 g.
Figure US11793881-20231024-C00963
Reactants 33-199 (1.20 g, 0.048 mmoL), M-NH2HCL-5K (2.0 g, 0.38 mmoL), HBTU (0.21 g, 0.576 mmoL), HOBT (0.077 g, 0.576 mmoL) were added in a 250 mL flask, and dissolved with DMF (75 mL) in a condition of ultrasonic, and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (0.0073 mL, 0.0446 mmoL) was slowly added dropwise, and the obtained solution was stirred for 1 hour, and then reacted at room temperature in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (200 mL) was added to the reaction solution for precipitation, and suction filtering was carried out to obtain a powder product. The powder product was dissolved with a mixed solvent of 20% methanol/dichloromethane, and silica gel (6 g) was added. The operations of evaporation, dry sample loading, column chromatography and gradient elution with 6% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out. The elution product was then collected and evaporated to dryness, the obtained solid was dissolved with dichloromethane (5 mL) in a condition of ultrasonic, methyl tert-butyl ether (150 mL) and n-hexane (50 mL) were added, and suction filtering was carried out. The filter cake was then dissolved with dichloromethane, and the obtained solution was precipitated with methyl tert-butyl ether and n-hexane. The process of dissolution and precipitation was repeated three times, thus obtaining the product 0.5 g.
1H-NMR (400 MHz, DMSO-d6) δ10.58-10.39 (m, 14H), 9.05-8.89 (m, 13H), 8.23-7.66 (m, 169H), 7.26-6.91 (m, 165H), 3.51-3.50 (m, 1957H), 3.26-3.22 (m, 148H), 2.97-2.83 (m, 232H), 2.34-2.28 (m, 86H), 1.94-1.45 (m, 282H), 0.94-0.75 (m, 144H).
22. Synthesis of 29-160 (Compound No. 22)
Synthetic route is as follows
Figure US11793881-20231024-C00964
Figure US11793881-20231024-C00965
Figure US11793881-20231024-C00966
Figure US11793881-20231024-C00967
Reactants 30-33 (3.5 g, 4.2581 mmol), 29-149 (synthesized according to the method of synthesizing W3, 0.3275 mmol), HBTU (2.2359 g, 5.8958 mmol), HOBT (0.7967 g, 5.8958 mmol) were added in a 250 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (2.9 mL, 17.6873 mmol) was slowly added dropwise, the obtained solution was stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution, the obtained solution was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was collected, and dried, thus obtaining a crude product.
Figure US11793881-20231024-C00968
29-150 (0.3275 mmol) was dissolved with dichloromethane (10 mL) and TFA (0.3648 mL) in a condition of ultrasonic, and then the mixed solution was stirred to react. At the end of the reaction, the reaction solution was evaporated to dryness to obtain an oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of column chromatography, dry sample loading, and elution with 1% ammonia water: 4% methanol/dichloromethane—1% ammonia water: 10% methanol/dichloromethane were carried out, thus obtaining the product 1.0 g, yield 30%.
Figure US11793881-20231024-C00969
Reactants 29-154 (0.4 g) and M-SCM-10K (0.75 g, 0.07 mmol) were dissolved with DMF solution (20 mL), and then the obtained solution reacted at a low speed of stirring in the dark for one week. At the end of the reaction, methyl tert-butyl ether (100 mL) was added to the reaction solution, the obtained solution was placed in a refrigerator and taken out after 30 minutes, a solid was separated out, and suction filtering was carried out. The filter cake was collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of column chromatography, dry sample loading and gradient elution with 1% ammonia water: 3% methanol/dichloromethane—1% ammonia water: 8% methanol/dichloromethane were carried out. The elution product was evaporated to dryness, and dissolved with anhydrous ethanol (8 mL) and a small amount of dichloromethane, and the obtained solution was precipitated with methyl tert-butyl ether (50 mL). Such precipitation operation was repeated three times. The precipitate was dried in vacuum, thus obtaining the product 0.6 g. Yield 55%.
1H-NMR (600 MHz, DMSO-d6) δ 10.18-10.09 (m, 8H), 9.12-8.90 (m, 17H), 8.25-7.82 (m, 72H), 7.503-7.44 (m, 13H), 7.19-7.15 (m, 41H), 7.05-6.97 (m, 11H), 6.90-6.81 (m, 7H), 6.69-6.64 (m, 5H), 5.36-5.26 (m, 9H), 4.59-4.32 (m, 27H), 4.05-3.84 (m, 31H), 3.52-3.48 (m, 1925H), 2.32-2.85 (m, 28H), 2.76-2.69 (m, 39H), 2.43-2.38 (m, 23H), 2.33-2.22 (m, 50H), 1.99-1.74 (m, 85H), 1.60-1.45 (m, 59H), 1.37-1.32 (m, 48H), 1.25-1.18 (m, 40H), 0.89-0.78 (m, 72H).
23. Synthesis of 35-98 (Compound No. 23)
Figure US11793881-20231024-C00970
Figure US11793881-20231024-C00971
Figure US11793881-20231024-C00972
Figure US11793881-20231024-C00973
Figure US11793881-20231024-C00974
Figure US11793881-20231024-C00975
Diglycolamine (25.84 mL, 260.59 mmol, purchased from TCI) was added in a 1 L flask, and dissolved with dichloromethane (50 mL), triethylamine (72.64 mL, 521.18 mmol) was added, and then the obtained solution was stirred at 0° C. for 1 hour. Tert-butyl dicarbonate was dissolved with dichloromethane, and slowly added dropwise to the flask. At the end of the addition, the obtained solution continued to react at 0° C. with stirring overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, silica gel powder (50 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 50%-60% ethyl acetate were carried out, thus obtaining the product 37-88: 53.4861 g.
Figure US11793881-20231024-C00976
37-88 (53.4861 g, 260.59 mmol) was added in a 1 L flask, stirred to react at 0° C. for 30 minutes, and the THF solution of potassium tert-butoxide (286.64 mL, 1 mol/L, 286.64 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred for 1 hour. Then ethyl bromoacetate (28.82 mL, 260.59 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at 0° C. for 30 minutes, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was concentrated and evaporated to dryness. The obtained dry product was then dissolved with methanol (30 mL) and dichloromethane (120 mL), silica gel powder (100 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 20% ethyl acetate were carried out, thus obtaining the product 37-148: 52.1 g, yield 68.6%.
Figure US11793881-20231024-C00977
37-148 (52.1 g, 178.8 mmol) was added in a 1 L flask, and dissolved with 1,4-dioxane (100 mL), lithium hydroxide (9.4 g, 393.4 mmol) was added, and then the mixed solution was stirred to react at room temperature for 30 minutes, pure water (200 mL) was then added, and the obtained solution continued to react with stirring for 2 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with n-hexane (125 mL) and methyl tert-butyl ether (125 mL). The aqueous phase was adjusted to pH=2 with concentrated hydrochloric acid, and then extracted with ethyl acetate (200 mL×2), and the obtained organic phases were combined. Silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 50%-60% ethyl acetate were carried out, thus obtaining the product 37-151:45.1 g, yield: 96%.
Figure US11793881-20231024-C00978
Boc-Glu-OH (20.0 g, 80.89 mmol, purchased from Ark Pharm), HBTU (92.02 g, 242.66 mmol), HOBT (32.8 g, 242.66 mmol) and H-Glu (OBn)2·TsOH (84.861 g, 161.8 mmol, purchased from Ark Pharm) were added in a 1000 mL flask, and dissolved with DMF (200 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (120.32 mL, 728 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with saturated sodium bicarbonate solution (600 mL) and ethyl acetate (300 mL), the aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness, thus obtaining the product 35-82: 70 g.
Figure US11793881-20231024-C00979
35-82 (70 g, 80.89 mmol) was added in a 1000 mL round-bottomed flask, and dissolved with dichloromethane (50 mL), trifluoroacetic acid (300 mL, 4044.5 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, ethyl acetate (300 mL) and saturated sodium bicarbonate solution (300 mL) were added, a lot of bubbles were generated, a sodium bicarbonate solid was further added till a pH of greater than 7, and then the extraction was carried out. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was evaporated to dryness, thus obtaining 35-84: 62 g.
Figure US11793881-20231024-C00980
37-151 (19.36 g, 73.5364 mmol), HBTU (41.83 g, 110.3045 mmol), HOBT (14.91 g, 110.3045 mmol) and 35-84 (61.95 g, 80.89 mmol) were added in a 1000 mL round-bottomed flask, and dissolved with DMF (200 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (54.69 mL, 330.9136 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was first transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (500 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was concentrated to a small amount, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 50%-70% ethyl acetate were carried out, thus obtaining the product 35-85: 51 g, yield: 69%.
Figure US11793881-20231024-C00981
35-85 (23.4 g, 23.14 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (30 mL), trifluoroacetic acid (85.93 mL, 1157.13 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, ethyl acetate (300 mL) and saturated sodium bicarbonate solution (300 mL) were added, a lot of bubbles were generated, a sodium bicarbonate solid was further added till a pH of greater than 7, and then the extraction was carried out. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was evaporated to dryness, thus obtaining 35-86: 18.2 g, yield: 86%.
Figure US11793881-20231024-C00982
35-86 (18.2 g, 19.98 mmol), HBTU (11.36 g, 29.97 mmol), HOBT (4.05 g, 29.97 mmol) and Boc-Lys (Fmoc) —OH (8.5 g, 18.16 mmol, purchased from Accela) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (14.86 mL, 89.90 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was first transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was concentrated to a small amount, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 80%-100% ethyl acetate were carried out, thus obtaining the product 35-88: 19.6 g, yield: 79%.
Figure US11793881-20231024-C00983
35-88 (7.0 g, 5.1413 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (20 mL), trifluoroacetic acid (5.7270 mL, 77.1191 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (150 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness, thus obtaining the product 35-89: 6.4853 g.
Figure US11793881-20231024-C00984
35-89 (4.2 g, 3.33 mmol), HBTU (1.72 g, 4.54 mmol), HOBT (0.61 g, 4.54 mmol) and mono-tert-butyl succinate (0.53 g, 3.03 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and then the mixed solution was stirred to react at 0° C. for 30 minutes. Then DIEA (2.25 mL, 13.62 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L reparatory funnel, deionized water (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was concentrated to a small amount, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 3% methanol were carried out, thus obtaining the product 35-90: 4.3 g.
1H-NMR (600 MHz, DMSO-d6) δ 8.62-8.53 (m, 1H), 8.40-8.24 (d, J=7.4 Hz, 1H), 7.95-7.81 (m, 1H), 7.88-7.82 (d, J=7.5 Hz, 3H), 7.77-7.64 (m, 3H), 7.51-7.43 (m, 2H), 7.38-7.29 (m, 22H), 7.24-7.12 (t, J=5.6 Hz, 1H), 5.15-5.01 (m, 9H), 4.46-4.15 (m, 8H), 3.92-3.82 (m, 2H), 3.64-3.50 (m, 4H), 3.38-3.27 (m, 2H), 3.20-3.13 (d, J=5.0 Hz, 2H), 3.01-2.89 (m, 3H), 2.48-2.32 (m, 10H), 2.18-2.10 (t, J=8.0 Hz, 2H), 2.05-1.71 (m, 7H), 1.56-1.46 (d, J=5.9 Hz, 1H), 1.40-1.37 (m, 2H), 1.36-1.21 (m, 10H).
Figure US11793881-20231024-C00985
35-90 (0.622 g, 0.4390 mmol) and Pd/C (0.0300 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C00986
Boc-Leu-OH·H2O (40 g, 160.44 mmol, purchased from InnoChem), Gly-OBn·TsOH (56.837 g, 168.462 mmol, purchased from Ark pharm), HBTU (66.93 g, 176.48 mmol), HOBT (23.85 g, 176.48 mmol) were added in a 1000 mL flask, and dissolved with DMF (250 mL), and then the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (145.85 mL, 882.4356 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (250 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness. The operations of dry sample loading, column chromatography and elution with a petroleum ether mixed solution containing 30%-40% EA were carried out, thus obtaining the product 37-53: 60.7 g.
Figure US11793881-20231024-C00987
37-53 (60.7 g, 160.44 mmol) was added in a 1000 mL flask, and dissolved with dichloromethane (40 mL), TFA (95 mL, 1283.52.9 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (350 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (1500 mL×2), and the obtained organic phases were combined. The organic phase was concentrated and evaporated to dryness, thus obtaining the product 37-54: 45 g.
Figure US11793881-20231024-C00988
37-54 (45 g, 160.44 mmol), Boc-Phe-OH (40.438 g, 152.42 mmol, purchased from aladdin), HBTU (66.93 g, 1276.48 mmol), HOBT (23.85 g, 176.48 mmol) were added in a 1000 mL flask, and dissolved with DMF (250 mL), and the mixed solution was stirred to react at −5° C. for 20 minutes. Then DIEA (119.85 mL, 722 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (350 mL) and ethyl acetate (300 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (250 mL×2), concentrated and evaporated to dryness, thus obtaining the product 37-56: 84 g.
Figure US11793881-20231024-C00989
37-56 (84 g, 160.44 mmol) was added in a 1000 mL flask, and dissolved with dichloromethane (40 mL), TFA (95 mL, 1283.52.9 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was transferred to a 2 L conical flask, saturated sodium bicarbonate solution (350 mL) was added, a lot of bubbles were generated, a sodium bicarbonate solid was slowly added till a pH of greater than 7, to separate out a solid, and filtering was carried out. The filter cake was washed with pure water (100 mL×2), and dried, thus obtaining the product 37-59: 68 g.
Figure US11793881-20231024-C00990
37-59 (68.27 g, 152.42 mmol), Boc-Gly-OH (25.37 g, 144.799 mmol, purchased from aladdin), HBTU (63.58 g, 167.66 mmol), HOBT (63.58 g, 167.66 mmol) were added in a 1000 mL flask, and dissolved with DMF (250 mL), and then the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (113.3 mL, 685.89 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (300 mL) and ethyl acetate (350 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (250 mL×2), and stood still at room temperature for 1.5 hours, to separate out a solid, and filtering was carried out. The filter cake was washed with ethyl acetate:petroleum ether (3:7) (150 mL×5), thus obtaining the product 37-62: 72.8 g.
Figure US11793881-20231024-C00991
37-62 (30 g, 51.4871 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (20 mL), trifluoroacetic acid (30.6 mL, 411.9 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated, saturated sodium bicarbonate solution (200 mL) was added, a lot of bubbles were generated, then a sodium bicarbonate solid was slowly added till a pH of greater than 7, to separate out a solid, and filtering was carried out. The filter cake was washed with deionized water (150 mL×4), and dried, thus obtaining the product 37-149: 24.85 g.
Figure US11793881-20231024-C00992
Boc-Glu-OH (5.7864 g, 23.4032 mmol, purchased from Ark pharm), 37-149 (24.85 g, 51.4871 mmol), HBTU (26.626 g, 70.2096 mmol), HOBT (9.4874 g, 70.2096 mmol) were added in a 500 mL flask, and dissolved with DMF (150 mL), and then the mixed solution was stirred to react at −5° C. for about 10 minutes. Then DIEA (34.8 mL, 210.628 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (200 mL) and ethyl acetate (300 mL) were added, and the obtained solution was shaken for extraction. The aqueous phase was washed with ethyl acetate (150 mL×1), and the obtained organic phases were combined. The organic phase was concentrated and evaporated to dryness. The dry product was dissolved with methanol (20 mL) and dichloromethane (100 mL), silica gel powder (50 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 4%-8% methanol were carried out. The elution product was then collected, and dried in a vacuum oven, thus obtaining the product 37-152: 19.2 g, yield: 69.8%.
Figure US11793881-20231024-C00993
37-152 (19.2 g, 16.3215 mmol) was added in a 1000 mL flask, and dissolved with dichloromethane (30 mL), trifluoroacetic acid (9.6966 mL, 130.5722 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, methyl tert-butyl ether (200 mL) was added to the concentrated solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dried, thus obtaining the product 37-154: 17.5 g.
Figure US11793881-20231024-C00994
Boc-Gly-OH (3.4310 g, 19.5858 mmol, purchased from Ark Pharm), 37-154 (17.5 g, 16.3215 mmol), HBTU (9.2847 g, 24.4823 mmol), HOBT (3.3083 g, 24.4823 mmol) were added in a 1000 mL flask, and dissolved with DMF (150 mL), and then the mixed solution was stirred to react at −5° C. for about 10 minutes. Then DIEA (12.14 mL, 73.4468 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was further stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, ethyl acetate (200 mL), methyl tert-butyl ether (200 mL), n-hexane (300 mL) were added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dried, thus obtaining the product 37-156: 19.2 g.
Figure US11793881-20231024-C00995
37-156 (10.499 g, 8.5125 mmol) and 10% Pd/C (0.10 g) were added in a hydrogenation reactor, and dissolved with DMF (50 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the obtained DMF solutions were combined, as raw material for the next reaction.
Figure US11793881-20231024-C00996
37-158 (8.965 g, 0.4390 mmol), Palbociclib (8 g, 17.8763 mmol, also referred to as PCB), HBTU (9.6848 g, 25.5375 mmol), HOBT (3.4509 g, 25.5375 mmol) were added in a 500 mL flask, and dissolved with DMF (130 mL), and then the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (12.6626 mL, 76.6125 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (100 mL) were added to the reaction solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (100 mL×3), and dried, thus obtaining the product 37-159: 16.3 g.
Figure US11793881-20231024-C00997
37-159 (16.3 g, 8.5125 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (30 mL), trifluoroacetic acid (18.964 mL, 255.375 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (250 mL) was added to the reaction solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (240 mL) and methanol (60 mL), silica gel powder (50 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-7% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 37-161: 11.2 g, yield 73%.
Figure US11793881-20231024-C00998
35-93 (0.464 g, 0.4390 mmol), 37-161 (3.5 g, 1.9315 mmol), HBTU (0.9988 g, 2.6338 mmol), HOBT (0.3559 g, 2.6338 mmol) were added in a 250 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (1.306 mL, 7.9015 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 40 minutes, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated two times with n-hexane (100 mL) and methyl tert-butyl ether (60 mL), to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried, thus obtaining the product 35-94: 3.614 g.
Figure US11793881-20231024-C00999
35-94 (3.614 g, 0.4390 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), morpholine (1.7 mL, 19.7507 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, methyl tert-butyl ether (150 mL) was added to the reaction product to separate out a solid, and then filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with dichloromethane (200 mL) and methanol (50 mL), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-9% methanol were carried out. The elution product was then collected, concentrated and dried, thus obtaining the product 35-95: 0.7 g, yield 20%.
Figure US11793881-20231024-C01000
45-57 (0.0412 g, 0.0565 mmol) and 10% Pd/C (0.10 g) were added in a hydrogenation reactor, and dissolved with DMF (50 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C01001
37-172 (0.007 g, 0.0199 mmol), 35-95 (0.7 g, 0.0874 mmol), HBTU (0.45 g, 1.192 mmol), HOBT (0.16 g, 1.192 mmol) were added in a 250 mL flask, and dissolved with DMF (35 mL), and then the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (0.59 mL, 3.575 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred at −5° C. for 20 minutes, and then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated one time with n-hexane (150 mL) and methyl tert-butyl ether (60 mL), to obtain a viscous oily product. Methyl tert-butyl ether (100 mL) was added to the oily product to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried, thus obtaining the product 35-96: 0.6434 g.
Figure US11793881-20231024-C01002
35-96 (0.6436 g, 0.0199 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (25 mL), trifluoroacetic acid (2.073 mL, 27.92 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, methyl tert-butyl ether (150 mL) was added to the concentrated solution to separate out a solid, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (10 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 5%-8% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, thus obtaining the product 35-97: 0.23 g, yield 36%.
Figure US11793881-20231024-C01003
35-97 (0.23 g, 0.0072 mmol) was added in a 250 mL flask, and dissolved with DMF (10 mL), M-NH2·HCl-10K (0.452 g, 0.043 mmol, purchased from JenKem), HBTU (0.163 g, 0.43 mmol), HOBT (0.058 g, 0.43 mmol) were added, and then the mixed solution was stirred at −5° C. for about 15 minutes at a low speed. Then DIEA (0.1226 mL, 0.7415 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. for 20 minutes, and was then moved to room temperature and stirred to react in the dark for 7 days at a low speed. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (40 mL) were added to the reaction solution, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (40 mL) were added to the lower liquid. Such operations were repeated two times, and a viscous oily product was obtained. Methyl tert-butyl ether (100 mL) was added to obtain a viscous product. The viscous product was dissolved with a mixed solvent of methanol (30 mL) and dichloromethane (120 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 8%-11% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, dried in a vacuum oven, and dissolved with anhydrous ethanol (10 mL) and dichloromethane (15 mL). Then, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dried in a vacuum oven, thus obtaining the product 35-98: 0.3 g, yield 57%.
1H-NMR (600 MHz, DMSO-d6) δ 9.24-9.10 (m, 5H), 8.53-8.13 (m, 134H), 7.96-7.82 (m, 85H), 7.86-7.64 (m, 68H), 7.59-7.42 (m, 68H), 7.41-7.34 (m, 71H), 7.30-7.21 (m, 69H), 7.17-7.04 (m, 28H), 6.99-6.73 (m, 5H), 6.68-6.53 (m, 5H), 4.45-4.23 (m, 8H), 4.14-4.01 (m, 21H), 3.79-3.54 (m, 304H), 3.51-3.42 (m, 3763H), 3.14-3.03 (m, 205H), 2.98-2.73 (m, 298H), 2.79-2.70 (m, 270H), 2.62-2.51 (m, 17H), 2.40-2.35 (m, 26H), 2.31-2.24 (m, 22H), 2.12-1.90 (m, 21H), 1.84-1.62 (m, 17H), 1.44-1.29 (m, 221H), 1.25-1.16 (m, 173H).
24. Synthesis of 44-172 (Compound No. 24)
Figure US11793881-20231024-C01004
Figure US11793881-20231024-C01005
Figure US11793881-20231024-C01006
Figure US11793881-20231024-C01007
Figure US11793881-20231024-C01008
Figure US11793881-20231024-C01009
Figure US11793881-20231024-C01010
Figure US11793881-20231024-C01011
Figure US11793881-20231024-C01012
Figure US11793881-20231024-C01013
Boc-Gly-OH (3.0 g, 17.1252 mmol, purchased from Ark Pharm), HBTU (9.7418 g, 25.6878 mmol), HOBT (3.4709 g, 25.6878 mmol) and H-Glu (OBzl)-OBzl·TosOH (8.5554 g, 17.1252 mmol, purchased from Ark Pharm) were added in a 500 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (12.7 mL, 77.0634 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react for 2 hours. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. And, saturated sodium chloride solution (300 mL) was further added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated and evaporated to dryness. The obtained solid product was dissolved with a mixed solvent (50 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-2% methanol: 99%-98% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 25-241: 6.9213 g, yield: 83.41%.
Figure US11793881-20231024-C01014
25-241 (2.0 g, 4.1276 mmol) and 10% Pd/C (100 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 2.0 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C01015
Boc-GFLG-OBn (9.9 g, 17 mmol, synthesized according to the method of synthesizing 37-62) and 10% Pd/C (0.025 g) were added in a hydrogenation reactor, and dissolved with DMF (40 mL), hydrogen was introduced to a pressure of 2.1 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed three times with DMF (20 mL×3), and the filtrate was put into a 500 mL round-bottomed flask, as raw material for the next reaction.
Figure US11793881-20231024-C01016
The DMF solution of 43-116 (8.4534 g, 17.1618 mmol), Niraparib (4.5821 g, 14.3015 mmol, also referred to as NPB), HBTU (8.1356 g, 21.4523 mmol) and HOBT (2.8986 g, 21.4523 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (10.6 mL, 64.3568 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride aqueous solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, ethyl acetate (200 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. The obtained organic phases were combined, saturated sodium chloride aqueous solution (300 mL) was then added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated and evaporated to dryness, and then dried in an oven, thus obtaining the product 42-89: 11.3695 g.
Figure US11793881-20231024-C01017
42-89 (11.3695 g, 14.3015 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (30 mL), TFA (15.9 mL, 214.5225 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (65 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (0%-2% methanol: 100%-98% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-90: 8.6 g, yield: 86.6%.
Figure US11793881-20231024-C01018
The solution of 42-105 (1.2560 g, 4.1276 mmol), 42-90 (6.3095 g, 9.0807 mmol), HBTU (4.6961 g, 12.3828 mmol) and HOBT (1.6732 g, 12.3828 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (6.1 mL, 37.1484 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 42-107: 6.8432 g.
Figure US11793881-20231024-C01019
42-107 (6.4832 g, 4.1276 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (15 mL), TFA (4.6 mL, 61.9140 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), and dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (70 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (0.5% ammonia water: 2%-10% methanol: 97.5%-89.5% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-110: 2.9609 g, yield: 46.05%.
Figure US11793881-20231024-C01020
Fmoc-Lys (Boc)-OH (3.6002 g, 7.6839 mmol, purchased from Accela), 35-86 (9.1 g, 9.9890 mmol), HBTU (4.3710 g, 11.5258 mmol) and HOBT (1.5574 g, 11.5258 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (7.6 mL, 46.4032 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride aqueous solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride aqueous solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 44-148: 10.4619 g.
Figure US11793881-20231024-C01021
44-156 (10.4619 g, 7.6839 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), morpholine (10.0 mL, 115.2583 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated five times, and a viscous solid was obtained. The viscous solid was dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-5% methanol: 99%-95% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-157: 8.7542 g, yield: 100%.
Figure US11793881-20231024-C01022
Glycerin (5 g, 54.295 mmol, purchased from Innochem) was added in a 500 mL flask, nitrogen was introduced for protective purpose, the THF solution of potassium tert-butoxide (211 mL, 211.7505 mmol) was added, the obtained solution was stirred at 0° C. for 3 hours, benzyl bromoacetate (30.964 g, 195.46 mmol) was added, and the obtained solution was stirred for 2 hours, and then reacted at room temperature. At the end of the reaction, the reaction solution was first evaporated to dryness, then deionized water and ethyl acetate were added for extraction, and the organic phase was separated. The aqueous phase was extracted with ethyl acetate until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was dried with anhydrous sodium sulfate powder, suction filtering was carried out, and the filtrate was subjected to dry sample loading, column chromatography and gradient elution with 1%-2% ethyl acetate/petroleum ether, thus obtaining the product 9 g, yield 31%.
Figure US11793881-20231024-C01023
45-91 (0.5 g, 0.9318 mmol) and 10% Pd/C (0.0200 g) were added in a reactor, and dissolved with DMF (30 mL). The air in the reactor was then pumped out to reach a vacuum state by a water pump, hydrogen was introduced to a pressure of 0.16 MPa, hydrogen was then discharged, the reactor was pumped to reach a vacuum state by the water pump, and hydrogen was then introduced again. Such operations were repeated three times. Finally. hydrogen was introduced again, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), and the DMF solutions were combined as the raw material for the next step.
Figure US11793881-20231024-C01024
36-186 solution (0.5021 g, 1.8862 mmol), 44-157 (8.5957 g, 7.5448 mmol), HBTU (3.2190 g, 8.4879 mmol) and HOBT (1.1469 g, 8.4879 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (4.2 mL, 25.4637 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Ethyl acetate (200 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, and evaporated to dryness. The obtained solid product was dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (2%-8% methanol: 98%-92% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-161: 3.2551 g, yield: 47.54%.
1H-NMR (600 MHz, DMSO-d6) δ 8.33-8.02 (m, 18H), 7.50-7.17 (m, 60H), 5.36-4.94 (m, 24H), 4.55-4.50 (m, 12H), 3.95-3.87 (m, 6H), 3.67-3.47 (m, 25H), 3.39-3.16 (m, 16H), 2.47-2.38 (m, 24H), 2.25-1.94 (m, 12H), 1.94-1.79 (m, 6H), 1.57-1.46 (m, 6H), 1.38 (s, 27H), 1.26-1.23 (m, 6H).
Figure US11793881-20231024-C01025
44-161 (1.0 g, 0.2755 mmol, home-made) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 1.6 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C01026
Figure US11793881-20231024-C01027
The solution of 44-166 (0.3181 g, 0.1248 mmol), 42-110 (2.8 g, 1.7974 mmol), HBTU (0.8519 g, 2.2464 mmol) and HOBT (0.3035 g, 2.2464 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (1.1 mL, 6.7392 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 44-167: 2.4242 g.
Figure US11793881-20231024-C01028
Figure US11793881-20231024-C01029
44-167 (1.7663 g, 0.0840 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (1.0 mL, 12.6010 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-10% methanol: 96%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-168: 0.9538 g, yield: 54.79%.
1H-NMR (600 MHz, DMSO-d6) δ 8.61-8.57 (m, 20H), 8.46-7.80 (m, 196H), 7.77-7.44 (m, 53H), 7.44-7.04 (m, 166H), 5.33-5.31 (m, 3H), 4.67-4.18 (m, 77H), 4.11-3.92 (m, 46H), 3.86-3.84 (m, 40H), 3.79-3.57 (m, 44H), 3.19-3.04 (m, 45H), 2.94-2.89 (m, 52H), 2.88-2.71 (m, 102H), 2.17-1.90 (m, 60H), 1.61-1.51 (m, 96H), 1.28-1.21 (m, 178H), 0.96-0.78 (m, 144H).
Figure US11793881-20231024-C01030
Figure US11793881-20231024-C01031
44-168 (0.8105 g, 0.0420 mmol) and M-SCM-10K (2.0019 g, 0.1890 mmol, purchased from JenKem) were added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.7 mL, 4.2 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 10 minutes, and then reacted at room temperature for one week. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (20 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated five times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), and precipitated with methyl tert-butyl ether (60 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The filter cake was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 2%-10% methanol: 97%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-172: 0.6468 g, yield: 29.53%.
1H-NMR (600 MHz, DMSO-d6) δ 8.61-8.57 (m, 20H), 8.46-7.80 (m, 196H), 7.77-7.44 (m, 53H), 7.44-7.04 (m, 166H), 5.33-5.31 (m, 3H), 4.67-4.18 (m, 77H), 4.11-3.92 (m, 46H), 3.86-3.84 (m, 40H), 3.79-3.57 (m, 44H), 3.58-3.44 (m, 2853H), 3.24-3.04 (m, 45H), 2.94-2.89 (m, 52H), 2.88-2.71 (m, 102H), 2.17-1.90 (m, 60H), 1.61-1.51 (m, 96H), 1.28-1.21 (m, 178H), 0.94-0.77 (m, 144H).
25. Synthesis of 41-126 (Compound No. 25)
Figure US11793881-20231024-C01032
Figure US11793881-20231024-C01033
Figure US11793881-20231024-C01034
Figure US11793881-20231024-C01035
Figure US11793881-20231024-C01036
Figure US11793881-20231024-C01037
Figure US11793881-20231024-C01038
Figure US11793881-20231024-C01039
Figure US11793881-20231024-C01040
N-Boc-L-glutamic acid 5-benzyl ester (10 g, 29.6 mmoL, purchased from Aladdin), H-Glu (Obzl)-Obzl·TsOH (16.2 g, 32.6 mmol, purchased from Ark Pharm), HOBT (6 g, 44.4 mmoL), HBTU (16.8 g, 44.4 mmoL) were added in a 250 mL flask, and dissolved with DMF (80 mL), and ultrasonic treatment was carried out to completely dissolve the reactants, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (22 mL, 133.4 mmoL) was slowly added dropwise, and the obtained solution reacted under this condition until the reaction ended. At the end of the reaction, deionized water (100 mL) was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (100 mL×2), concentrated and evaporated to dryness. The operations of dry sample loading, column chromatography and elution with 30% ethyl acetate/petroleum ether were carried out. The elution product was then collected, concentrated, and evaporated to dryness, thus obtaining the product.
Figure US11793881-20231024-C01041
39-81 (29.6 mmol) was dissolved with dichloromethane (5 mL), TFA (22 mL, 296 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, saturated sodium bicarbonate solution (300 mL) was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (100 mL), concentrated and evaporated to dryness.
Figure US11793881-20231024-C01042
Fmoc-L-Lys(Boc)-OH (5.1430 g, 10.9767 mmol, purchased from Accela), 39-83 (6 g, 10.9767 mmol), HBTU (6.2442 g, 16.4651 mmol), HOBT (1.8257 g, 16.4651 mmol) were added in a 250 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. DIEA (8.2 mL, 19.3954 mmol) was slowly added dropwise, and then the obtained solution reacted at −5° C. overnight. At the end of the reaction, the reaction solution was extracted with pure water and ethyl acetate, and the organic phase was concentrated, thus obtaining the product 4.6 g.
Figure US11793881-20231024-C01043
Reactant 41-115 (4.6 g, 4.6132 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL), morpholine (8 mL, 92.2639 mmoL) was added, and then the mixed solution was stirred to react at room temperature for 3 hours. At the end of the reaction, saturated saline solution (150 mL) and ethyl acetate (200 mL) were added to the reaction solution, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness, thus obtaining the product 4 g.
Figure US11793881-20231024-C01044
41-116 (4 g, 5.1620 mmol), 39-114 (1.8 g, 5.1620 mmol), HBTU (2.9364 g, 7.7429 mmol), HOBT (1.0462 g, 7.7429 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. DIEA (8.45 mL, 50.9319 mmol) was slowly added dropwise, and then the obtained solution reacted at −5° C. overnight. At the end of the reaction, the reaction solution was precipitated with petroleum ether, the lower liquid was collected, pure water was then added, and suction filtering was carried out. The above operations were repeated three times. The obtained solid was collected, and dried, thus obtaining the product 5 g, yield 87%.
Figure US11793881-20231024-C01045
Reactant 41-117 (5 g, 5.6303 mmol) was added in a 250 mL flask, and dissolved with DMF (30 mL), morpholine (9 mL, 103.24 mmoL) was added, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was precipitated with petroleum ether, the lower liquid was collected, pure water was then added, and suction filtering was carried out. The obtained solid was collected, and dried, thus obtaining the product 2.6 g, yield 58%.
Figure US11793881-20231024-C01046
41-118 (2.6 g, 2.9353 mmol), HBTU (1.4312 g, 3.7740 mmol), HOBT (0.5099 g, 3.7740 mmol) were added in a 250 mL flask, and dissolved with the DMF solution of 45-121 (that is, 36-186, 0.8387 mmol), and then the mixed solution was stirred at −5° C. for about 30 minutes. DIEA (2.1 mL, 12.852 mmol) was slowly added dropwise, and then the obtained solution reacted at −5° C. overnight. At the end of the reaction, saturated saline solution (150 mL) and ethyl acetate (200 mL) were added to the reaction solution, and the organic phase was separated. The aqueous phase was extracted three times with ethyl acetate (50 mL×3) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was washed two times with saturated saline solution (50 mL×2), and evaporated to dryness. The operations of dry sample loading, column chromatography and elution with 1%-7% methanol/dichloromethane were carried out, thus obtaining the product 0.5 g, yield 55.6%.
Figure US11793881-20231024-C01047
41-119 (0.1 g, 0.0348 mmol) and 10% Pd/C (150 mg) were added in a hydrogenation reactor, and dissolved with stirring with DMF (35 mL) that was added slowly, hydrogen was introduced to a pressure of 300 psi, and then the mixed solution was stirred to react at room temperature overnight. Next day, the reaction solution was filtered by suction through a sand core funnel filled with diatomaceous earth to remove the Pd/C, thus obtaining the DMF solution of the product, directly used for next reaction.
Figure US11793881-20231024-C01048
Fmoc-Glu-OH (1.6433 g, 4.4485 mmol, purchased from Aladdin), GFLG-NPB (synthesized according to the method of synthesizing 42-90, 6.8 g, 9.7867 mmol), HBTU (5.0615 g, 13.3455 mmol), HOBT (1.8032 g, 13.3455 mmol) were added in a 250 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of −5° C. for 30 minutes. Then DIEA (6.6 mL, 40.0365 mmol) was slowly added dropwise, and the obtained solution continued to react under this condition for 3 hours. At the end of the reaction, methyl tert-butyl ether (30 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 500 mL round-bottomed flask, and evaporated to dryness, thus obtaining the product 10.2 g, yield 100%.
Figure US11793881-20231024-C01049
41-93 (7.6 g, 4.4485 mmol) was dissolved with DMF (40 mL), morpholine (7.8 mL, 88.97 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, ethyl acetate (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 500 mL round-bottomed flask, silica gel powder was added, and the operations of evaporation, column chromatography and elution with 3% methanol/dichloromethane were carried out, thus obtaining the product 4.4 g, yield 65.7%.
Figure US11793881-20231024-C01050
37-62 (14.95 g, 25.654 mmol and 10% Pd/C (0.300 g) were added in a reactor, and dissolved with DMF (40 mL). The air in the reactor was then pumped out to reach a vacuum state by a water pump, hydrogen was introduced to a pressure of 0.16 MPa, hydrogen was then discharged, the reactor was pumped to reach a vacuum state by the water pump, and hydrogen was then introduced again. Such operations were repeated three times. Finally, hydrogen was introduced again, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), and the DMF solutions were combined as the raw material for the next step.
Figure US11793881-20231024-C01051
36-81 (5.3 g, 10.7255 mmol), Palbociclib (4 g, 8.9380 mmol, also referred to as PCB), HBTU (5 g, 13.4069 mmol), HOBT (1.8 g, 13.4069 mmol) were added in a 500 mL flask, and stirred at −5° C. for about 20 minutes. Then DIEA (6.6 mL, 40.2208 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (50 mL) were then added to the lower oily product. Such operations were repeated three times, to obtain an oily product. Methyl tert-butyl ether (200 mL) was added to the oily product to separate out a solid, and then suction filtering was carried out. The filter cake was dried, thus obtaining 36-84: 15.9 g.
Figure US11793881-20231024-C01052
36-84 (15.9 g, 8.938 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (10 mL), and TFA (6.6 mL, 89.38 mmol), and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to 10 mL, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a powder product, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent (200 mL) of 20% methanol: 80% dichloromethane solution, silica gel power (60 ml) was added, and the obtained mixture was then evaporated to dryness to obtain a powder solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5% ammonia water: 2%-5% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 36-98: 8.5 g, yield: 91.4%.
Figure US11793881-20231024-C01053
Fmoc-Glu (OtBu)-OH (3.3522 g, 7.7879 mmol, purchased from Ark Pharm), 36-98 (6.8 g, 8.2728 mmol), HBTU (4.7061 g, 12.4092 mmol), HOBT (1.6767 g, 12.4092 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of −5° C. for 0.5 hour. DIEA (6.2 mL, 37.2276 mmol) was then slowly added dropwise, and the obtained solution continued to react under this condition for 3 hours. At the end of the reaction, methyl tert-butyl ether (30 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 500 mL round-bottomed flask, and dissolved with 20% methanol/dichloromethane, silica gel powder was added, and the operations of evaporation, column chromatography, and elution with 2% methanol/dichloromethane were carried out, thus obtaining the product 8.9 g, yield 100%.
Figure US11793881-20231024-C01054
41-92 (8.9 g, 7.2447 mmol) was added in a reaction flask, and dissolved with dichloromethane (20 mL), and TFA (8 mL, 108.6709 mmol), and then the mixed solution was stirred to react at room temperature for 3 hours. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, methyl tert-butyl ether (30 mL) and n-hexane (200 mL) were added for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 500 mL round-bottomed flask, and evaporated to dryness, thus obtaining the product 8.5 g, yield 100%.
Figure US11793881-20231024-C01055
41-95 (4.4 g, 2.9319 mmol), 41-97 (3.6121 g, 3.0785 mmol), HBTU (1.6679 g, 4.3979 mmol), HOBT (0.5492 g, 4.3979 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (2.2 mL, 13.1936 mmol) was slowly added dropwise, and the obtained solution continued to react under this condition for 3 hours. At the end of the reaction, methyl tert-butyl ether (30 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 2 L round-bottomed flask, and evaporated to dryness, thus obtaining the product 7.7873 g.
Figure US11793881-20231024-C01056
41-98 (6.2 g, 2.3343) was dissolved with DMF (20 mL), morpholine (6 mL, 70.0298 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, methyl tert-butyl ether (100 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid powder was transferred to a 500 mL round-bottomed flask, and evaporated to dryness, thus obtaining the product 5.68 g.
Figure US11793881-20231024-C01057
41-103 (5.5 g, 2.2598 mmol), Boc-Gly-OH (0.4157 g, 2.3728 mmol, purchased from Aladdin), HBTU (1.2855 g, 3.3897 mmol), HOBT (0.4580 g, 3.3897 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of −5° C. for 30 minutes. Then DIEA (1.7 mL, 10.1692 mmol) was slowly added dropwise, and the obtained solution continued to react under this condition for 3 hours. At the end of the reaction, ethyl acetate (30 mL) and n-hexane (200 mL) were added to the reaction solution for precipitation, and suction filtering was carried out many times. The obtained solid powder was transferred to a 2 L round-bottomed flask, and evaporated to dryness, for the next reaction.
Figure US11793881-20231024-C01058
41-104 (5.8 g, 2.2598 mmol), and dichloromethane (20 mL) were added in a flask, TFA (5 mL, 67.2110 mL) was slowly added dropwise, and then the obtained solution was stirred to react at room temperature for 3 hours. At the end of the reaction, the dichloromethane was removed with a rotary evaporator, the obtained solution was precipitated with ethyl acetate (30 mL) and n-hexane (200 mL), and suction filtering was carried out many times. The obtained solid powder was transferred to a 500 mL round-bottomed flask, and evaporated to dryness, thus obtaining the product 5.5 g, yield 98%.
Figure US11793881-20231024-C01059
Figure US11793881-20231024-C01060
41-105 (0.8660 g, 0.3476 mmol), HBTU (0.1975 g, 0.5215 mmol), HOBT (0.0705 g, 0.5215 mmol) were added in a 250 mL flask, and dissolved with DMF solution of 41-120 (0.0348 mmol), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (2 mL, 12.1005 mmol) was slowly added dropwise, and the obtained solution reacted at −5° C. overnight. At the end of the reaction, pure water was added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 0.84 g, yield 100%.
Figure US11793881-20231024-C01061
Figure US11793881-20231024-C01062
41-122 (0.84 g, 0.0348 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (30 mL) in a condition of ultrasonic, TFA (0.3 mL, 0.2326 mmol) was added, and then the obtained solution was stirred at room temperature overnight. Next day, the reaction solution was first evaporated to remove the dichloromethane, methyl tert-butyl ether was then added for precipitation, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 0.8 g, yield 100%.
Figure US11793881-20231024-C01063
Figure US11793881-20231024-C01064
41-125 (0.8 g, 0.0348 mmol) was dissolved with DMF (20 mL) and M-SCM-10K (1.1058 g, 0.1044 mmol, purchased from JenKem) was added, and ultrasonic treatment was carried out to dissolve the reactants, and then the obtained solution reacted in the dark at a low speed of stirring. At the end of the reaction, methyl tert-butyl ether (150 mL), n-hexane (70 mL) were added to the reaction solution to separate out a solid, and suction filtering was carried out. The filter cake was dissolved with 20% methanol/dichloromethane, silica gel powder (3 g) was added, the operations of evaporation, column chromatography and gradient elution with 1% ammonia water+5%-10% methanol/dichloromethane were carried out, thus obtaining the product 0.35 g, yield 19.4%.
1H-NMR (600 MHz, DMSO-d6) δ 10.13-10.12 (m, 7H), 9.29-9.27 (m, 16H), 8.95-8.92 (m, 7H), 8.57-8.56 (m, 17H), 8.18-8.16 (m, 37H), 8.14-7.95 (m, 137H), 7.89-7.87 (m, 50H), 7.59-7.54 (m, 43H), 7.35-7.25 (m, 176H), 5.83-5.81 (m, 7H), 5.16-5.08 (m, 6H), 4.57-4.35 (m, 58H), 4.13-4.10 (m, 25H), 4.08-4.06 (m, 49H), 3.84-3.82 (m, 26H), 3.72-3.65 (m, 128H), 3.51-3.49 (m, 2888H), 3.24-3.19 (m, 30H), 3.13-3.10 (m, 44H), 3.06-3.02 (m, 40H), 2.91-2.90 (m, 14H), 2.78-2.74 (m, 35H), 2.65-2.60 (m, 26H), 2.41-2.30 (m, 47H), 2.21-1.96 (m, 84H), 1.83-1.75 (m, 91H), 1.64-1.39 (m, 156H), 1.20-1.16 (m, 24H), 0.90-0.85 (m, 162H).
26. Synthesis of 49-136 (Compound No. 26)
Figure US11793881-20231024-C01065
Figure US11793881-20231024-C01066
Figure US11793881-20231024-C01067
Figure US11793881-20231024-C01068
Figure US11793881-20231024-C01069
Fmoc-Lys (Boc) —OH (3 g, 6.4029 mmol, purchased from Accela), HBTU (3.64 g, 9.6044 mmol), HOBT (1.30 g, 9.6044 mmol) were added in a flask loaded with H-Glu (OBn)2 (3.36 g, 6.7230 mmol, purchased from Ark Pharm), and dissolved with a proper amount of DMF, and then, at −5° C., DIEA (4.76 mL, 28.8131 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dried in a vacuum oven, thus obtaining the product (6.96 g, extra-quota).
Figure US11793881-20231024-C01070
49-96 (2 g, 2.5710 mmol) and 10% Pd/C (0.05 g) were added in a hydrogenation reactor, and dissolved with DMF (20 mL), hydrogen was introduced to a pressure of 300 Psi, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (15 mL×3) three times, and the filtrate was put into a 250 mL round-bottomed flask, thus obtaining the product as the raw material for the next reaction.
Figure US11793881-20231024-C01071
39-84 (8 g, 10.4459 mmol), HBTU (5.94 g, 15.6689 mmol), HOBT (2.12 g, 15.6689 mmol) were added in a flask loaded with 49-17 (3.69 g, 10.4459 mmol), and dissolved with a proper amount of DMF, and then, at −5° C., DIEA (7.77 mL, 47.0066 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, the obtained solid was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (100 mL) was added, and then the obtained mixture was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with 100% dichloromethane were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (9.6 g, 83.48%)
Figure US11793881-20231024-C01072
DMF was added in a flask loaded with 49-101 (9.6 g, 8.7193 mmol), ultrasonic vibration was carried out to completely dissolve the compound, morpholine (7.59 mL, 87.193 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 h. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, the obtained solid was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4) solution, silica gel powder (100 mL) was added, and then the obtained mixture was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 3%-5% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (5.3 g, 69.19%)
Figure US11793881-20231024-C01073
49-104 (4.74 g, 5.3991 mmol), HBTU (2.92 g, 7.7130 mmol), HOBT (1.04 g, 7.7130 mmol) were added in a flask loaded with 49-118 (1.53 g, 2.5710 mmol), and dissolved with a proper amount of DMF, and then, at −5° C., DIEA (4.76 mL, 28.8131 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dried in a vacuum oven, thus obtaining the product (8.65 g, extra-quota)
Figure US11793881-20231024-C01074
DMF was added in a flask loaded with 49-119 (5.96 g, 2.5710 mmol), ultrasonic vibration was carried out to completely dissolve the compound, morpholine (5.19 mL, 25.710 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 h. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dried in a vacuum oven, thus obtaining the product (7.6 g, extra-quota)
Figure US11793881-20231024-C01075
Boc-Gly-OH (0.49 g, 2.8281 mmol, purchased from Aladdin), HBTU (1.46 g, 3.8565 mmol), HOBT (0.52 g, 3.8565 mmol) was added in a flask loaded with 49-123 (5.39 g, 2.5710 mmol), and dissolved with a proper amount of DMF, and then, at −5° C., DIEA (4.76 mL, 28.8131 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, the obtained solid was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (100 mL) was added, and then the obtained mixture was evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 2%-5% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (3.2 g, 55.27%)
Figure US11793881-20231024-C01076
49-124 (1 g, 0.4437 mmol) and 10% Pd/C (0.05 g) were added in a hydrogenation reactor, and dissolved with DMF (20 mL), hydrogen was introduced to a pressure of 300 Psi, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (15 mL×3) three times, and the filtrate was put into a 250 mL round-bottomed flask, thus obtaining the product, as the raw material for the next reaction.
Figure US11793881-20231024-C01077
47-98 (2.56 g, 3.7271 mmol), HBTU (2.02 g, 5.3244 mmol), HOBT (0.72 g, 5.3244 mmol) were added in a flask loaded with 49-125 (0.68 g, 0.4437 mmol), and dissolved with a proper amount of DMF, and then, at −5° C., DIEA (2.64 mL, 15.9732 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was extracted with saturated NaCl solution (200 mL) and EA (200 mL), and stood still to be layered, and the organic phase was separated. The aqueous phase was then washed with EA (200 mL×3), and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dried in a vacuum oven, thus obtaining the product (4.3 g, extra-quota)
Figure US11793881-20231024-C01078
Dichloromethane was added in a flask loaded with 49-128 (3.06 g, 0.4437 mmol), ultrasonic vibration was carried out to completely dissolve the compound, TFA (2.27 mL, 4.437 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane and a majority of the TFA, then methyl tert-butyl ether (200 mL) was added to the obtained solution for precipitation, the supernatant was discarded. Such operations were repeated three times. Suction filtering was carried out, and a solid product was obtained. The obtained solid product was dissolved with a mixed solvent of dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 3-6% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (1.3 g, 43.92%). 1H NMR (400 MHz, DMSO-d6) δ 10.39 (s, 4H), 8.05-7.98 (m, 24H), 7.81-7.36 (m, 99H), 7.10-7.04 (m, 6H), 5.39-5.24 (m, 14H), 3.16-2.65 (m, 122H), 1.37-1.16 (m, 62H), 1.05-0.80 (m, 72H).
Figure US11793881-20231024-C01079
49-134 (1.3 g, 0.1943 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), and M-SCM-5K (2.27 g, 0.4274 mmol, purchased from JenKem), ultrasonic vibration was carried out to dissolve the compound, and then, at −5° C., DIEA (0.90 mL, 5.4401 mmol) was slowly added dropwise. At the end of the addition, the obtained solution reacted for half an hour, and was then moved to room temperature and stirred to react in the dark for one week at a low speed. At the end of the reaction, n-hexane (25 mL) and methyl tert-butyl ether (200 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and then n-hexane and methyl tert-butyl ether were added to the obtained solution for precipitation. Such operations were repeated three times. Suction filtering was carried out, and a solid product was obtained. The obtained solid product was dissolved with a mixed solvent of dichloromethane and methanol. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 6-10% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (2.1 g, 63.25%).
Figure US11793881-20231024-C01080
49-135 (2.1 g, 0.1229 mmol), TBAF (0.51 g, 1.9671 mmol), THF (20 mL) and diluted HCl (20 mL) were added in a 500 mL round-bottomed flask, and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated under reduced pressure to obtain a solid product, the solid product was dissolved with DMF (5 mL), and isopropanol was added to the obtained solution for precipitation. Such operations were repeated three times. A solid product was obtained by filtering. The obtained solid product was dissolved with dichloromethane (10 mL), and methyl tert-butyl ether was added to the obtained solution for precipitation. Such operations were repeated three times to obtain a solid product. The solid product was dried, thus obtaining the product (1.2 g, 64.17%).
1H NMR (600 MHz, DMSO-d6) δ8.10-7.91 (m, 21H), 7.81-7.24 (m, 25H), 7.06-6.95 (m, 8H), 5.36-5.10 (m, 22H), 3.55-3.46 (m, 1056H), 3.18-2.36 (m, 133H), 1.37-1.16 (m, 62H).
27. Synthesis of 40-176 (Compound No. 27)
Figure US11793881-20231024-C01081
Figure US11793881-20231024-C01082
Figure US11793881-20231024-C01083
Figure US11793881-20231024-C01084
36-81 (8.45 g, 17.1618 mmol), Lapatinib (8.3 g, 14.3015 mmol, also referred to as LPT), HBTU (8.1 g, 21.4522 mmol), HOBT (2.9 g, 21.4522 mmol) were added in a 500 mL flask, and stirred at −5° C. for about 20 minutes. Then DIEA (10.6 mL, 64.3567 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated NaHCO3 solution (200 mL) and ethyl acetate (200 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated sodium chloride solution (100 ml×2), and evaporated to dryness, thus obtaining 36-143: 14 g, yield: 92.8%.
Figure US11793881-20231024-C01085
36-143 (14 g, 14.3015 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (20 mL), TFA (10.6 mL, 143.015 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to 10 mL, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a powder product, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent (200 mL) of 20% methanol: 80% dichloromethane, silica gel power (60 ml) was added, and the obtained mixture was then evaporated to dryness to obtain a powder solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water: 5%-10% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 36-145: 6.2 g, yield 92.1%.
Figure US11793881-20231024-C01086
Fmoc-L-Lys(Boc)-OH (0.18 g, 0.3855 mmol, purchased from Accela), 44-208 (2 g, 0.3855 mmol, Compound No. 29), HBTU (0.2193 g, 0.5783 mmol), HOBT (0.0781 g, 0.5783 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. DIEA (0.2878 mL, 1.7348 mmol) was slowly added dropwise, and then the obtained solution reacted at −5° C. overnight. At the end of the reaction, methyl tert-butyl ether and n-hexane were added to the reaction solution for precipitation, and suction filtering was carried out. The obtained solid was dissolved with 10% methanol/dichloromethane, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and gradient elution with 1% ammonia water+4%-8% methanol/dichloromethane were carried out, thus obtaining the product 1.8 g, yield 82.9%.
Figure US11793881-20231024-C01087
40-164 (1.8 g, 0.3193 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (30 mL), morpholine (0.5563 mL, 6.3852 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the reactants, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were added to the reaction solution to separate out a solid product, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 1.7293 g, yield 100%.
Figure US11793881-20231024-C01088
Fmoc-Gly-OH (0.0949 g, 0.3193 mmol, purchased from Accela), 40-165 (1.7 g, 0.3193 mmol), HBTU (0.1817 g, 0.4790 mmol), HOBT (0.0647 g, 0.4790 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then DIEA (0.2384 mL, 1.4369 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were added to the reaction solution to separate out a solid product, and suction filtering was carried out. The filter cake was dried, thus obtaining the product 1.8 g, yield, 100%.
Figure US11793881-20231024-C01089
40-167 (1.8 g, 0.3193 mmol) was added in a 250 mL round-bottomed flask, and dissolved with DMF (30 mL), morpholine (0.5563 mL, 6.3852 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, methyl tert-butyl ether (150 mL) and n-hexane (100 mL) were added to the reaction solution to separate out a solid product, and suction filtering was carried out. The obtained solid was dissolved with 10% methanol/dichloromethane, silica gel powder was added, and the operations of evaporation, dry sample loading, column chromatography and gradient elution with 1% ammonia water+4%-8% methanol/dichloromethane were carried out, thus obtaining the product 1.5 g, yield 85.85%.
Figure US11793881-20231024-C01090
40-169 (1.5 g, 0.2741 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), DIEA (0.1895 mL, 1.1420 mmol), and 4ARM-SCM-10K (0.6222 g, 0.0571 mmol) was added, and ultrasonic treatment was carried out to dissolve the reactants, and then the obtained solution reacted in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (200 mL) was added to the reaction solution to separate out a solid product, and suction filtering was carried out. The solid product was dissolved with 10% methanol/dichloromethane, silica gel powder (5 g) was added, and the operations of evaporation, column chromatography and gradient elution with 5%-15% methanol/dichloromethane were carried out, thus obtaining the product 1.2 g, yield 66.67%.
Figure US11793881-20231024-C01091
40-171 (1.2 g, 0.0371 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (15 mL), TFA (0.1379 mL, 1.8562 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, methyl tert-butyl ether (150 mL) was added, ultrasonic treatment was carried out for 2 minutes to separate out a solid product, and suction filtering was carried out. The solid product was dissolved with a mixed solvent of 20% methanol/dichloromethane, silica gel powder was added, and then the obtained mixture was evaporated to dryness with a rotary evaporator. The operations of dry sample loading, column chromatography and gradient elution with 1% ammonia water+5%-15% methanol/dichloromethane were carried out, thus obtaining the product 0.8 g, yield 80.21%.
1H-NMR (600 MHz, DMSO-d6) δ 10.15-9.90 (m, 14H), 9.05-9.03 (m, 1H), 8.94-8.93 (m, 2H), 8.76-8.71 (m, 12H), 8.61-8.55 (m, 11H), 8.25-7.58 (m, 155H), 7.52-7.41 (m, 16H), 7.36-6.99 (m, 198H), 6.71-6.63 (m, 10H), 6.57-6.50 (m, 4H), 5.29-5.22 (m, 26H), 4.80-4.52 (m, 39H), 4.42-4.10 (m, 58H), 4.06-3.89 (m, 14H), 3.86-3.74 (m, 31H), 3.70-3.56 (m, 65H), 3.54-3.42 (m, 907H), 3.22-2.98 (m, 81H), 2.91-2.60 (m, 37H), 2.43-2.09 (m, 68H), 1.93-1.44 (m, 124H), 1.39-1.14 (m, 144H), 0.90-0.75 (m, 120H).
Figure US11793881-20231024-C01092
40-175 (0.8 g, 0.0282 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL), DIEA (0.0932 mL, 0.5640 mmol), and M-SCM-5K (0.6206 g, 0.1186 mmol) was added, and ultrasonic treatment was carried out to dissolve the reactants, and then the obtained solution reacted in the dark at a low speed. At the end of the reaction, methyl tert-butyl ether (150 mL) was added to the reaction solution to separate out a solid product, and suction filtering was carried out. The filter cake was dissolved with 10% methanol/dichloromethane, silica gel powder was added to the obtained solution, and the operations of evaporation, column chromatography and gradient elution with 5%-15% methanol/dichloromethane were carried out, thus obtaining the product 0.9 g, yield 69.23%.
1H-NMR (600 MHz, DMSO-d6) δ 9.88-9.81 (m, 9H), 8.94-8.55 (m, 17H), 8.21-7.98 (m, 61H), 7.87-7.71 (m, 21H), 7.47-7.45 (m, 12H), 7.23-7.14 (m, 292H), 6.67-6.53 (m, 11H), 5.26-5.23 (m, 19H), 4.75-4.57 (m, 17H), 4.35-4.19 (m, 35H), 3.51-3.33 (m, 2730H), 3.06-3.01 (m, 111H), 2.62-2.60 (m, 62H), 2.40-2.37 (m, 68H), 2.18-1.76 (m, 221H), 1.60-1.48 (m, 91H), 1.24-1.16 (m, 57H), 0.88-0.78 (m, 120H).
28. Synthesis of 46-51 (Compound No. 28)
Figure US11793881-20231024-C01093
Figure US11793881-20231024-C01094
Figure US11793881-20231024-C01095
Figure US11793881-20231024-C01096
Figure US11793881-20231024-C01097
Figure US11793881-20231024-C01098
Figure US11793881-20231024-C01099
Figure US11793881-20231024-C01100
Figure US11793881-20231024-C01101
Figure US11793881-20231024-C01102
Figure US11793881-20231024-C01103
Figure US11793881-20231024-C01104
Figure US11793881-20231024-C01105
Figure US11793881-20231024-C01106
H-Glu (oBz1)-oBz1 (15 g, 30.02 mmol), Boc-Gly-OH (5.25 g, 30.02 mmol), HBTU (6.08 g, 45.03 mmol), HOBT (17.07 g, 45.03 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (22.33 mL, 135.11 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, pure water (200 mL) and ethyl acetate (200 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated sodium chloride solution (100 ml*2), and concentrated, and the operations of dry sample loading, column chromatography and gradient elution with 20%-50% ethyl acetate/petroleum ether were carried out, thus obtaining the product 10 g, yield 69%
Figure US11793881-20231024-C01107
39-227 (2 g, 4.28 mmol) and 10% Pd/C (0.075 g) were added in a reactor, and dissolved with DMF (40 mL), hydrogen was introduced to a pressure of 0.16 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), and the DMF solutions were combined as the raw material for the next step.
Figure US11793881-20231024-C01108
14-128 (6 g, 6.27 mmol), HBTU (3.2 g, 8.55 mmol), HOBT (1.15 g, 8.55 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (4.2 mL, 25.65 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (100 mL×3) was added for precipitation, the lower oily product was dissolved with a small amount of dichloromethane, and methyl tert-butyl ether was added to the obtained solution to separate out a solid product. The solid product was dried, thus obtaining the product 8 g, extra-quota.
Figure US11793881-20231024-C01109
33-233 (8 g, 9.4 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (20 mL), TFA (13 mL, 188 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to 10 mL, methyl tert-butyl ether (200 mL) was added to the obtained solution to separate out a powder product, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×3), and dissolved with a mixed solvent (200 mL) of 20% methanol: 80% dichloromethane, silica gel powder (100 mL) was added, and then the obtained mixture was evaporated to dryness to obtain a powder solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5%-1% ammonia water: 4%-7% methanol were carried out. The elution product was then collected, concentrated and evaporated to dryness, thus obtaining the product 6 g.
Figure US11793881-20231024-C01110
35-85 (5.4828 g, 5.4225 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (6.0 mL, 81.3375 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, the obtained solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, deionized water (400 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 44-180: 4.7556 g, yield: 96.27%.
Figure US11793881-20231024-C01111
44-180 (4.7556 g, 5.2202 mmol), Boc-L-Lys (Fmoc)-011 (2.2235 g, 4.7456 mmol), HBTU (2.6996 g, 7.1185 mmol) and HOBT (0.9618 g, 7.1185 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (4.7 mL, 46.1032 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 4 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (400 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 44-181: 6.4613 g.
Figure US11793881-20231024-C01112
44-181 (6.4613 g, 4.7456 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (5.3 mL, 71.184 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, the obtained solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 44-182: 5.9861 g.
Figure US11793881-20231024-C01113
44-182 (5.9861 g, 4.7456 mmol), mono-tert-butyl succinate (0.9920 g, 4.7456 mmol), HBTU (2.6996 g, 7.1185 mmol) and HOBT (0.9618 g, 7.1185 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for 30 minutes. Then DIEA (4.7 mL, 46.1032 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 4 hours. At the end of the reaction, the reaction solution was transferred to a 1 L reparatory funnel, saturated sodium chloride solution (400 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, and evaporated to dryness. The obtained dry product was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (60 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1%-2% methanol: 99%-98% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-183: 4.6123 g, yield: 69.45%.
Figure US11793881-20231024-C01114
44-183 (1.9313 g, 1.3624 mmol) and 10% Pd/C (80 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 2.0 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C01115
The solution of 46-36 (0.4349 g, 0.4114 mmol), 46-35 (4.1058 g, 1.9748 mmol, synthesized according to the method of synthesizing 33-235), HBTU (0.9361 g, 2.4684 mmol) and HOBT (0.3335 g, 2.4684 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (1.2 mL, 7.4054 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 46-39: 3.8267 g.
Figure US11793881-20231024-C01116
46-39 (3.8267 g, 0.4114 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (4.6 mL, 61.71 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), thus obtaining the product 46-41: 2.794 g, yield: 73.46%.
Figure US11793881-20231024-C01117
46-41 (2.794 g, 0.3022 mmol), 36-98 (0.3726 g, 0.0.4533 mmol), HBTU (0.1719 g, 0.4533 mmol) and HOBT (0.0613 g, 0.4533 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.3 mL, 1.8132 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 46-42: 3.0369 g.
Figure US11793881-20231024-C01118
46-42 (3.0369 g, 0.3022 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (10 mL), morpholine (0.5 mL, 5.4395 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), thus obtaining the product 46-44: 0.4886 g, yield: 16.5%.
Figure US11793881-20231024-C01119
Boc-L-Lys (Fmoc)-OH (9.0 g, 19.2086 mmol), glycine benzyl ester hydrochloride (4.2608 g, 21.1295 mmol), HBTU (10.9270 g, 28.8129 mmol) and HOBT (3.8932 g, 28.8129 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (14.3 mL, 86.4387 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride aqueous solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and the aqueous phase was separated. Ethyl acetate (100 mL) was then added to the aqueous phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. The obtained organic phases were combined, saturated sodium chloride aqueous solution (300 mL) was then added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and the aqueous phase was separated. Finally, the organic phase was concentrated, evaporated to dryness, and dried in an oven, thus obtaining the product 42-92: 11.8271 g.
Figure US11793881-20231024-C01120
42-92 (11.8271 g, 19.2086 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (40 mL), TFA (21.4 mL, 288.129 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (60 mL), and finally dried in an oven, thus obtaining the product 42-93: 9.9040 g.
Figure US11793881-20231024-C01121
42-93 (9.9040 g, 19.2086 mmol), mono-tert-butyl succinate (3.6805 g, 21.1295 mmol), HBTU (10.9270 g, 28.8129 mmol) and HOBT (3.8932 g, 28.8129 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (14.2 mL, 86.4387 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride aqueous solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Ethyl acetate (200 mL) was then added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, aqueous sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 42-128: 12.9040 g.
Figure US11793881-20231024-C01122
42-128 (12.9040 g, 19.2086 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (20 mL), morpholine (25.1 mL, 288.1290 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Ethyl acetate (200 mL) was then added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, deionized water (400 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 42-133: 8.6350 g.
Figure US11793881-20231024-C01123
The solution of 42-133 (7.5191 g, 16.7263 mmol), 44-149 (that is, 36-186, 2.4930 g, 4.6462 mmol), HBTU (7.9291 g, 20.9079 mmol) and HOBT (2.8251 g, 20.9079 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (10.4 mL, 62.7237 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium bicarbonate solution (400 mL) and ethyl acetate (300 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Ethyl acetate (200 mL) was then added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, and the concentrated product was dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (40 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (2%-8% methanol: 98%-92% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 42-134: 4.8 g, yield: 66.19%.
1H NMR (400 MHz, DMSO-d6) δ 8.38-8.35 (m, 3H), 8.11-8.01 (m, 3H), 7.56 (t, J=5.2 Hz, 3H), 7.44-7.27 (m, 15H), 5.12 (s, 6H), 4.36-4.17 (m, 3H), 3.97-3.80 (m, 6H), 3.33 (s, 11H), 3.06 (m, 6H), 2.45-2.31 (m, 12H), 1.69-1.46 (m, 12H), 1.36 (m, 27H), 1.32-1.26 (m, 6H).
Figure US11793881-20231024-C01124
42-134 (0.5 g, 0.3204 mmol) and 10% Pd/C (50 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 2.0 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C01125
Figure US11793881-20231024-C01126
Figure US11793881-20231024-C01127
The solution of 46-46 (0.0194 g, 0.0151 mmol), 46-44 (0.4886 g, 0.0497 mmol), HBTU (0.0257 g, 0.0678 mmol) and HOBT (0.0092 g, 0.0678 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (100 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.1 mL, 1.057 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and then moved to room temperature and stirred to react overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 46-47: 0.4628 g.
Figure US11793881-20231024-C01128
Figure US11793881-20231024-C01129
Figure US11793881-20231024-C01130
46-47 (0.4628 g, 0.0151 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (10 mL), TFA (5 mL, 2.265 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), and dissolved with a mixed solvent (80 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 6%-10% methanol: 93%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 46-49: 0.2613 g, yield: 56.64%.
Figure US11793881-20231024-C01131
Figure US11793881-20231024-C01132
Figure US11793881-20231024-C01133
46-49 (0.2613 g, 0.0085 mmol), M-NH2·HCl-10K (0.3253 g, 0.0308 mmol), HBTU (0.0146 g, 0.0385 mmol) and HOBT (0.0052 g, 0.0385 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (20 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.1 mL, 1.9422 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and then moved to room temperature and stirred to react in the dark at a low speed for one week. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated five times, to obtain a powdery solid, and a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (100 mL), and dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 5%-15% methanol: 94%-84% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 46-51: 0.2251 g, yield: 42.66%.
1H NMR (600 MHz, DMSO-d6) δ 8.97-8.53 (m, 41H), 8.32-7.90 (m, 183H), 7.90-7.60 (m, 57H), 7.54-7.45 (m, 27H), 7.38-6.99 (m, 254H), 6.67-6.53 (m, 21H), 5.26-5.24 (m, 42H), 4.87-4.03 (m, 168H), 3.87-3.40 (m, 2876H), 3.24-3.11 (m, 110H), 3.10-2.93 (m, 142H), 2.92-2.70 (m, 108H), 2.69-2.61 (m, 20H), 2.43-2.00 (m, 104H), 1.86-1.47 (m, 162H), 1.23-1.11 (m, 61H), 0.99-0.66 (m, 162H).
29. Synthesis of 44-234 (Compound No. 29)
Figure US11793881-20231024-C01134
Figure US11793881-20231024-C01135
Figure US11793881-20231024-C01136
Figure US11793881-20231024-C01137
Figure US11793881-20231024-C01138
Figure US11793881-20231024-C01139
Figure US11793881-20231024-C01140
Figure US11793881-20231024-C01141
Figure US11793881-20231024-C01142
Figure US11793881-20231024-C01143
35-84 (8.99 g, 11.7386 mmol), Boc-L-Lys (Fmoc)-OH (5.0 g, 10.6714 mmol), HBTU (6.0706 g, 16.0072 mmol) and HOBT (2.1629 g, 16.0072 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (10.6 mL, 64.0287 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, evaporated to dryness, and dried, thus obtaining the product 36-200: 12.9804 g.
Figure US11793881-20231024-C01144
36-200 (11.9 g, 9.7832 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (10.9 mL, 146.748 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), thus obtaining the product 44-207: 8.351 g, yield: 76.47%.
Figure US11793881-20231024-C01145
Mono-tert-butyl succinate (1.5638 g, 8.9775 mmol), 44-207 (8.351 g, 7.4812 mmol), HBTU (4.2558 g, 11.2218 mmol) and HOBT (1.5163 g, 11.2218 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (9.9 mL, 59.8499 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 3 hours. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, saturated sodium chloride solution (300 mL) and ethyl acetate (200 mL) were added, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then ethyl acetate (100 mL) was added to the aqueous phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, the obtained organic phases were combined, saturated sodium chloride solution (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Then, deionized water (300 mL) was added to the organic phase, the obtained solution was shaken for extraction, and then the organic phase was separated from the aqueous phase. Finally, the organic phase was concentrated, and evaporated to dryness. The obtained dry product was dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (2%-8% methanol: 98%-92% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-208: 2.5268 g, yield: 35.85%.
Figure US11793881-20231024-C01146
44-208 (2.5268 g, 1.9858 mmol) and 10% Pd/C (60 mg) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was sealed, hydrogen was introduced to a pressure of 2.2 MPa in the reactor, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was taken out and evenly added dropwise to a sand core funnel filled with compacted diatomaceous earth, and then suction filtering was carried out. The diatomaceous earth was washed with DMF until it did not contain any product, thus obtaining a reaction product solution.
Figure US11793881-20231024-C01147
The solution of 44-212 (1.0846 g, 1.1893 mmol), 36-145 (5.0 g, 5.2329 mmol), HBTU (2.7062 g, 7.1358 mmol) and HOBT (0.9642 g, 7.1358 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (3.5 mL, 21.4074 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 3 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 44-213: 5.5443 g.
Figure US11793881-20231024-C01148
44-213 (5.5443 g, 1.1893 mmol) was added in a 500 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (1.3 mL, 17.8395 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), thus obtaining the product 44-215: 5.0 g, yield: 91.28%.
Figure US11793881-20231024-C01149
44-215 (5.0 g, 1.0856 mmol), 36-98 (1.16 g, 1.4113 mmol), HBTU (0.6176 g, 1.6284 mmol) and HOBT (0.22 g, 1.6284 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (80 mL), and then the mixed solution was stirred at −5° C. for bout 30 minutes. Then DIEA (1.1 mL, 6.5136 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred to react for 3 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 44-218: 5.8728 g.
Figure US11793881-20231024-C01150
44-218 (5.8728 g, 1.0856 mmol) was added in a 500 mL round-bottomed flask, and dissolved with DMF (20 mL), morpholine (1.9 mL, 21.7120 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated five times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (60 mL) was added, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-15% methanol: 96%-84% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-219: 0.8841 g, yield: 15.7%.
Figure US11793881-20231024-C01151
Figure US11793881-20231024-C01152
The solution of 46-46 (0.0611 g, 0.0473 mmol), 44-219 ((0.8841 g, 0.1704 mmol), HBTU (0.0808 g, 0.2130 mmol) and HOBT (0.0288 g, 0.2130 mmol) were added in a 500 mL round-bottomed flask, and dissolved with DMF (30 mL), and then the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.1 mL, 0.6628 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and then moved to room temperature and stirred in the dark overnight. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dried in an oven, thus obtaining the product 44-221: 0.7946 g.
Figure US11793881-20231024-C01153
Figure US11793881-20231024-C01154
44-221 (0.7946 g, 0.0473 mmol) was added in a 250 mL round-bottomed flask, and dissolved with dichloromethane (20 mL), TFA (0.5 mL, 7.095 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was first concentrated under reduced pressure to remove the dichloromethane, and then precipitated with methyl tert-butyl ether (150 mL) to obtain a powdery solid, and filtering was carried out. The solid product was washed with methyl tert-butyl ether (100 mL), and dissolved with a mixed solvent (60 mL) of 20% methanol/dichloromethane, silica gel powder (30 ml) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-10% methanol: 96%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-232: 0.2239 g, yield: 28.46%.
Figure US11793881-20231024-C01155
Figure US11793881-20231024-C01156
44-232 (0.2239 g, 0.0135 mmol), M-NH2·HCl-10K (0.5547 g, 0.0525 mmol), HBTU (0.0230 g, 0.0606 mmol) and HOBT (0.0082 g, 0.0606 mmol) were added in a 250 mL round-bottomed flask, and dissolved with DMF (80 mL), and the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (0.1 mL, 0.5385 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 1 hour, and then moved to room temperature and stirred in the dark for one week. At the end of the reaction, n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were added to the reaction solution for precipitation, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (30 mL) were then added to the lower oily solution for precipitation. Such operations were repeated three times, to obtain an oily solid. The oily solid was dissolved with dichloromethane (10 mL), the obtained solution was precipitated with methyl tert-butyl ether (150 mL) to separate out a powdery solid, and then a solid product was obtained by filtering. The solid product was washed with methyl tert-butyl ether (60 mL), and dissolved with a mixed solvent (100 mL) of 20% methanol/dichloromethane, silica gel powder (50 mL) was added to the obtained solution, and the operations of evaporation, dry sample loading, column chromatography, and elution with an elutent (1% ammonia water: 3%-10% methanol: 96%-89% dichloromethane) were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried, thus obtaining the product 44-234: 0.2549 g, yield: 39.2%.
1H-NMR (600 MHz, DMSO-d6) δ 8.95-8.51 (m, 17H), 8.26-7.92 (m, 115H), 7.53-7.46 (m, 16H), 7.35-7.25 (m, 38H), 7.19-7.17 (m, 84H), 4.84-4.07 (m, 110H), 4.05-3.98 (m, 13H), 3.53-3.51 (m, 2874H), 3.25-2.94 (m, 117H), 2.89-2.85 (m, 73H), 2.77-2.73 (m, 47H), 2.69-2.61 (m, 16H), 2.41-2.29 (m, 52H), 2.23-1.75 (m, 71H), 1.59-1.48 (m, 77H), 1.34-1.23 (m, 30H), 0.85-0.83 (m, 60H)
30. Synthesis of 35-167 (Compound No. 32)
Figure US11793881-20231024-C01157
Figure US11793881-20231024-C01158
Figure US11793881-20231024-C01159
Figure US11793881-20231024-C01160
Figure US11793881-20231024-C01161
Figure US11793881-20231024-C01162
Figure US11793881-20231024-C01163
Figure US11793881-20231024-C01164
Figure US11793881-20231024-C01165
Fmoc-Gl-OH (3.57 g, 9.66 mmol), HBTU (10.99 g, 28.9 mmol), HOBT (3.91 g, 28.9 mmol) and H-Glu-(OtBu)-OtBu·HCl (6.57 g, 20.28 mmol) were added in a 500 mL flask, and dissolved with DMF (150 mL), and the mixed solution was stirred at 0° C. for about 30 minutes. Then DIEA (8.78 mL, 53.11 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (250 mL) were added for extraction, the aqueous phase was washed with ethyl acetate (200 mL), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL), concentrated and evaporated to dryness, thus obtaining the product 35-124: 8.2 g.
Figure US11793881-20231024-C01166
35-124 (8.2 g, 9.62 mmol) was added in a 500 mL flask, and dissolved with dichloromethane (30 mL), trifluoroacetic acid (21.4 mL, 288.6 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, methyl tert-butyl ether (200 mL) was added to the reaction solution to separate out a solid, and filtering was carried out. The filter cake was washed with methyl tert-butyl ether (50 mL×2), and dried, thus obtaining the product 35-125: 6 g.
Figure US11793881-20231024-C01167
Fmoc-Gly-OH (9 g, 30.27 mmol), HBTU (16 g, 42.19 mmol), HOBT (6 g, 44.4 mmol) and H-Glu-(OtBu)-OtBu·HCl (8 g, 27.05 mmol) were added in a 500 mL flask, and dissolved with DMF (80 mL), and the mixed solution was stirred at 0° C. for about 30 minutes. Then DIEA (25 mL, 148.5 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (300 mL) were added for extraction, the aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness, thus obtaining the product 35-121: 14 g, yield: 87.5%.
Figure US11793881-20231024-C01168
35-121 (14 g, 26 mmol) was added in a 250 mL flask, and dissolved with DMF (200 mL), morpholine (14 mL, 260 mmol) was added, and the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (200 mL) and ethyl acetate (200 mL), and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, thus obtaining the product 35-122: 68.2 g.
Figure US11793881-20231024-C01169
35-122 (8.1 g, 25.6 mmol), HBTU (12.1 g, 31.98 mmol), HOBT (4.3 g, 31.98 mmol) and 35-125 (3.35 g, 5.33 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and the mixed solution was stirred at 0° C. for about 20 minutes. Then DIEA (15.9 mL, 95.94 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with deionized water (250 mL) and ethyl acetate (300 mL), the aqueous phase was washed with ethyl acetate (150 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness. The obtained dry product was dissolved with methanol (20 mL) and dichloromethane (80 mL), silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 5%-8% methanol were carried out, thus obtaining the product 35-126: 9.7 g.
Figure US11793881-20231024-C01170
35-126 (9.7 g, 5.33 mmol) was added in a 250 mL flask, and dissolved with DMF (150 mL), morpholine (4.6 mL, 53.3 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, n-hexane (200 mL) and methyl tert-butyl ether (50 mL) were added to the reaction solution, the obtained solution was shaken to be layered, the supernatant was discarded, and n-hexane (200 mL) and methyl tert-butyl ether (50 mL) were then added to the lower oily solution. Such operations were repeated 4 times, to finally obtain an oily product. The oily product was dried, thus obtaining 35-128: 6.36 g, yield: 75%.
Figure US11793881-20231024-C01171
Fmoc-Gl-OtBu (5 g, 11.8 mmol), HBTU (6.7 g, 17.7 mmol), HOBT (2.4 g, 17.7 mmol) and H-Gly-OBn·HCl (2.5 g, 12.37 mmol) were added in a 500 mL flask, and dissolved with DMF (80 mL), and the mixed solution was stirred at 0° C. for about 30 minutes. Then DIEA (11 mL, 64.9 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (200 mL) and ethyl acetate (300 mL) were added for extraction, the aqueous phase was washed with ethyl acetate (200 mL×2), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness, thus obtaining the product 35-111: 5.7 g.
Figure US11793881-20231024-C01172
35-111 (6.7 g, 11.8 mmol) was added in a 250 mL flask, and dissolved with DMF (45 mL), morpholine (8.22 mL, 94.4 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, deionized water (150 mL) and ethyl acetate (250 mL) were added for extraction, and the organic phase was separated. The aqueous phase was washed with ethyl acetate (200 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness, thus obtaining the product 35-112: 3.2 g, yield 78%.
Figure US11793881-20231024-C01173
35-112 (3.2 g, 9.1 mmol), HBTU (5.2 g, 13.65 mmol), HOBT (1.8 g, 13.65 mmol) and Fmoc-Gly-OH (3.2 g, 10.92 mmol) were added in a 250 mL flask, and dissolved with DMF (30 mL), and the mixed solution was stirred at 0° C. for about 20 minutes. Then DIEA (7 mL, 42.39 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with deionized water (250 mL) and ethyl acetate (300 mL), the aqueous phase was washed with ethyl acetate (150 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness. The obtained dry product was dissolved with methanol (20 mL) and dichloromethane (80 mL), silica gel powder (30 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with an ethyl acetate mixed solution containing 30%-70% petroleum ether were carried out, thus obtaining the product 35-113: 5.7 g.
Figure US11793881-20231024-C01174
35-113 (5.7 g, 9.1 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (30 mL), trifluoroacetic acid (20.4 mL, 273 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, n-hexane (150 mL) and methyl tert-butyl ether (40 mL) were added to layer the obtained solution, the supernatant was discarded, and n-hexane (150 mL) and methyl tert-butyl ether (40 mL) were added to the lower liquid, to obtain a viscous oily product. The oily product was dried, thus obtaining the product 35-114: 3.59 g, yield 68%.
Figure US11793881-20231024-C01175
35-128 (10.2 g, 6.4 mmol), HBTU (1.36 g, 3.59 mmol), HOBT (0.49 g, 3.59 mmol) and 35-114 (3 g, 5.3 mmol) were added in a 250 mL flask, and dissolved with DMF (40 mL), and the mixed solution was stirred at 0° C. for about 20 minutes. Then DIEA (5 mL, 29.15 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with deionized water (250 mL) and ethyl acetate (300 mL), the aqueous phase was washed with ethyl acetate (150 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×1), concentrated and evaporated to dryness. The obtained dry product was dissolved with methanol (20 mL) and dichloromethane (80 mL), silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 4%-8% methanol were carried out, thus obtaining the product 35-142: 4 g, yield 81%.
Figure US11793881-20231024-C01176
35-142 (9.2 g, 1.86 mmol) and 10% Pd/C (0.050 g) were added in a hydrogenation reactor, and dissolved with DMF (40 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C01177
Boc-Lys (Fmoc) —OH (4.7 g, 10 mmol), HBTU (5.7 g, 15 mmol), HOBT (2.0 g, 15 mmol) and H-Gly-OBn·HCl (2.2 g, 11 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and the mixed solution was stirred at −5° C. for about 30 minutes. Then DIEA (9.1 mL, 55 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at −5° C. for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was transferred to a 1 L separatory funnel, and extracted with saturated sodium chloride solution (200 mL) and ethyl acetate (250 mL), the aqueous phase was washed with ethyl acetate (200 mL×1), and the obtained organic phases were combined. The organic phase was washed with saturated saline solution (200 mL×2), concentrated and evaporated to dryness, thus obtaining the product 35-115: 6.5 g.
Figure US11793881-20231024-C01178
35-115 (7.9 g, 12.81 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (20 mL), trifluoroacetic acid (7.4 mL, 100 mmol) was added with stirring, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, and precipitated two times with n-hexane (150 mL) and methyl tert-butyl ether (40 mL), to obtain a viscous oily product. The oily product was dried, thus obtaining the product 35-116: 5.2 g.
Figure US11793881-20231024-C01179
35-144 (8.9 g, 4.3 mmol), HBTU (2.45 g, 6.45 mmol), HOBT (0.9 g, 6.45 mmol) and 35-116 (2.7 g, 4.3 mmol) were added in a 250 mL flask, and dissolved with DMF (200 mL), and the mixed solution was stirred at 0° C. for about 20 minutes. Then DIEA (3.9 mL, 23.65 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, n-hexane (200 mL) and methyl tert-butyl ether (40 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (200 mL) and methyl tert-butyl ether (40 mL) were added to the lower oily solution. Such operations were repeated three times, to obtain a viscous oily product. The oily product was dried, thus obtaining the product 35-146: 11 g.
Figure US11793881-20231024-C01180
35-146 (11 g, 4.3 mmol) and 10% Pd/C (0.050 g) were added in a hydrogenation reactor, and dissolved with DMF (40 mL), hydrogen was introduced to a pressure of 1.8 MPa, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The diatomaceous earth was then washed with DMF (20 mL×3), and the DMF solutions were combined as raw material for the next reaction.
Figure US11793881-20231024-C01181
35-148 (6.8 g, 2.75 mmol), HBTU (1.4 g, 3.75 mmol), HOBT (0.51 g, 3.75 mmol) and 35-128 (4 g, 2.5 mmol) were added in a 250 mL flask, and dissolved with DMF (150 mL), and the mixed solution was stirred at 0° C. for about 20 minutes. Then DIEA (1.86 mL, 11.25 mmol) was slowly added dropwise. At the end of the addition, the obtained solution continued to react with stirring at 0° C. overnight. At the end of the reaction, n-hexane (200 mL) and methyl tert-butyl ether (40 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (200 mL) and methyl tert-butyl ether (40 mL) were added to the lower oily solution. Such operations were repeated three times, to obtain a viscous oily product. The oily product was dissolved with dichloromethane and methanol, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 0.5% ammonia water and 4%-10% methanol were carried out. The elution product was then collected, and dried, thus obtaining the product 35-155: 1.2 g, yield: 12%. 1H-NMR (600 MHz, DMSO-d6) δ8.13-8.05 (m, 22H), 7.85-7.55 (m, 8H), 7.38-7.28 (m, 8H), 4.71-4.33 (m, 7H), 4.31-4.09 (m, 14H), 3.85-3.42 (m, 12H), 3.18-2.35 (m, 4H), 2.31-2.29 (m, 32H), 2.07-1.91 (m, 26H), 1.89-1.55 (m, 6H), 1.45-1.38 (m, 144H), 1.25-1.11 (m, 21-1).
Figure US11793881-20231024-C01182
35-155 (1.2 g, 0.3 mmol) was added in a 250 mL flask, and dissolved with DMF (25 mL), morpholine (4 mL, 43.68 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower oily solution. Such operations were repeated three times, to obtain a viscous oily product. The oily product was dried, thus obtaining the product 35-157: 1.02 g.
Figure US11793881-20231024-C01183
35-157 (1.02 g, 0.3 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (30 mL) and trifluoroacetic acid (10 mL, 134 mmol), and the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was concentrated to a small amount, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to layer the obtained solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower liquid, to obtain a viscous oily product. The oily product was dried, thus obtaining the product 35-159: 0.8 g.
Figure US11793881-20231024-C01184
35-159 (0.1 g, 0.0367 mmol) was added in a 250 mL flask, and dissolved with DMF (20 mL). Then, DIEA (0.6 mL, 3.63 mmol) was added, the obtained solution was stirred for 30 minutes, M-SCM-10K (0.85 g, 0.081 mmol, purchased from JenKem) was added, and then the mixed solution was moved to room temperature and stirred to react in the dark for 7 days at a low speed. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower oily solution. Such operations were repeated three times, to obtain an oily product. The oily product was dissolved with methanol (30 mL) and dichloromethane (120 mL) solution, silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 6%-10% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product 35-161: 0.87 g, yield: 58%.
Figure US11793881-20231024-C01185
35-161 (0.5 g, 0.02 mmol), 35-99 (0.45 g, 0.5 mmol, synthesized according to the method of synthesizing 25-132), HBTU (0.15 g, 0.05 mmol), HOBT (0.06 g, 0.05 mmol) were added in a 250 mL flask, and dissolved with DMF (35 mL), and the mixed solution was stirred at −5° C. for 20 minutes. Then DIEA (0.22 mL, 1.4 mmol) was slowly added dropwise. At the end of the addition, the obtained solution was stirred to react at −5° C. for 30 minutes, and then moved to room temperature and stirred to react in the dark for 6 days at a low speed. At the end of the reaction, n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to layer the reaction solution, the supernatant was discarded, and n-hexane (100 mL) and methyl tert-butyl ether (30 mL) were added to the lower oily solution. Such operations were repeated three times, to obtain a viscous oily product. The oily product was dissolved with methanol (30 mL) and dichloromethane (120 mL) solution, silica gel powder (15 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with a dichloromethane mixed solution containing 1% ammonia water and 7%-10% methanol were carried out. The elution product was then collected, concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining the product. 35-167: 0.24 g, yield: 50%. 1H-NMR (600 MHz, DMSO-d6) δ 9.04-9.03 (m, 2H), 8.37-8.34 (m, 29H), 8.18-8.02 (m, 42H), 8.01-7.80 (m, 48H), 7.61-7.59 (m, 38H), 7.39-7.36 (m, 25H), 7.27-6.95 (m, 190H), 6.69-6.66 (m, 4H), 4.67-4.49 (m, 13H), 4.38-4.23 (m, 16H), 4.19-4.12 (m, 10H), 3.90-3.87 (m, 11H), 3.79-3.75 (m, 9H), 3.70-3.68 (m, 16H), 3.61-3.58 (m, 20H), 3.51-3.49 (m, 1941H), 3.14-3.03 (m, 68H), 2.68-2.59 (m, 73H), 2.35-2.34 (m, 39H), 1.61-1.54 (m, 16H), 1.48 (m, 34H), 1.34-1.32 (m, 31H), 1.23-1.21 (m, 186H), 0.95-0.81 (m, 139H), 0.52-0.05 (m, 28H).
31. Synthesis of 41-137 (Compound No. 30)
Figure US11793881-20231024-C01186
Figure US11793881-20231024-C01187
Figure US11793881-20231024-C01188
Figure US11793881-20231024-C01189
Figure US11793881-20231024-C01190
6-Amino caproic acid (4.61 g, 35.1407 mmol) was added in a 1 L flask, a mixed solution (150 mL) of THF:H2O=1:1 was added to completely dissolve the compound, and the obtained solution was stirred at 0° C. A sodium carbonate solid (7.45 g, 70.2814 mmol) was then added, ultrasonic treatment was carried out to dissolve the compound, and the obtained solution was stirred to react at 0° C. for 30 minutes. Fmoc-Cl (10 g, 38.6548 mmol) was dissolved in 30 mL THF, and then slowly added dropwise to the reaction solution. At the end of the addition, the obtained solution was moved to room temperature and stirred to react. At the end of the reaction, 50 g citric acid was dissolved in 450 mL deionized water, and added to the reaction solution, to adjust the pH to 3. Then, the obtained solution was transferred to a 1 L separatory funnel, and extracted with EA (300 mL×3). The organic phase was collected, concentrated and evaporated to dryness. The obtained solid product was dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (50 mL) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and elution with 2% methanol/dichloromethane solution were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (7.7 g, 86.51%).
Figure US11793881-20231024-C01191
Paclitaxel (10 g, 11.71 mmol, also referred to as PTX, purchased from Beisheng, Chongqing), imidazole (3.986 g, 58.5 mmol, purchased from InnoChem) were added in a 500 mL flask, and dissolved with DMF (100 mL), tert-butyl dimethyl chlorosilane (10.59 g, 70.26 mmol, purchased from InnoChem) was added under the protection of nitrogen, and then the mixed solution was stirred to react at room temperature. At the end of the reaction, the reaction solution was extracted with saturated ammonium chloride solution and dichloromethane. The organic phase was concentrated and evaporated to dryness, thus obtaining the product 11.3 g, yield 100%.
Figure US11793881-20231024-C01192
49-17 (4.2 g, 11.9297 mmol), 45-158 (11 g, 11.3616 mmol), DMAP (0.2776 g, 2.2723 mmol) were added in a 500 mL flask, and dissolved with dichloromethane (50 mL), DCC (11.7212 mL, 56.808 mmol) was added in batches under the condition of stirring at −5° C., and then the mixed solution reacted at −5° C. overnight. At the end of the reaction, the reaction solution was extracted with saturated sodium chloride solution and ethyl acetate, and the organic phase was separated. The aqueous phase was extracted one time with ethyl acetate, and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution, silica gel powder was added to the organic phase, and the operations of evaporation, sample loading, column chromatography and gradient elution with 20%-25% ethyl acetate/petroleum ether were carried out, thus obtaining the product 8 g, yield 54.05%.
Figure US11793881-20231024-C01193
45-161 (7.5 g, 5.7535 mmol) was added in a 500 mL flask, and dissolved with DMF, morpholine (10.024 mL, 115.0695 mmol) was added, and then the mixed solution was stirred to react at room temperature for 2 hours. At the end of the reaction, the reaction solution was extracted with saturated sodium chloride solution and ethyl acetate, and the organic phase was separated. The aqueous phase was extracted one time with ethyl acetate, and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution, silica gel powder was added to the organic phase, and the operations of evaporation, sample loading, column chromatography and gradient elution with 20%-25% ethyl acetate/petroleum ether were carried out, thus obtaining the product 4.5 g, yield 72.58%.
Figure US11793881-20231024-C01194
Fmoc-E (OH)2 (2 g, 5.34142 mmol, purchased from Aladdin), E(OtBu)2 (3.3632 g, 11.3698 mmol, purchased from Innochem), HBTU (6.1598 g, 16.2426 mmol), HOBT (2.1947 g, 16.2426 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (8 mL, 48.7277 mmol) was slowly added dropwise, and the obtained solution continued to react with stirring under this condition for 3 hours. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with ethyl acetate (150 mL) and deionized water (300 mL), and the organic phase was separated. The aqueous phase was extracted many times with ethyl acetate (300 mL) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was concentrated, silica gel powder was added, and the operations of evaporation, column chromatography, and elution with 4% methanol/dichloromethane were carried out, thus obtaining the product 5 g, extra-quota 0.4 g.
Figure US11793881-20231024-C01195
41-123 (5 g, 5.8684 mmol) was dissolved with DMF, morpholine (10.2 mL, 117.638 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was precipitated with petroleum ether, the supernatant was discarded, pure water was added to the lower liquid, and suction filtering was carried out. The solids were collected and combined, and dissolved with DMF, pure water was added, and suction filtering was carried out. The filter cake was dried to obtain the product 3.3 g, yield 89%.
Figure US11793881-20231024-C01196
Fmoc-Lys(Boc)-OH (2.455 g, 5.2399 mmol, purchased from Aladdin), 41-124 (3.3 g, 5.2399 mmol), HBTU (2.9528 g, 7.8760 mmol), HOBT (1.0520 g, 7.8760 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (3.9 mL, 23.5797 mmol) was slowly added dropwise, and the obtained solution continued to react with stirring under this condition for 3 hours. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with ethyl acetate (150 mL) and deionized water (300 mL), and the organic phase was separated. The aqueous phase was extracted many times with ethyl acetate (300 mL) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was concentrated, silica gel powder was added, and the operations of evaporation, column chromatography, and elution with 50% ethyl acetate/petroleum ether were carried out, thus obtaining the product 3.4 g, yield 77%.
Figure US11793881-20231024-C01197
45-91 (0.6183 g, 1.1523 mmol) was added in a hydrogenation reactor; and dissolved with DMF (30 mL), 10% Pd/C (100 mg) was added, DMF (30 mL) was added to dissolve the reactant. H2 (300 psi) was introduced, and the obtained solution was stirred overnight, thus obtaining the product for the next reaction.
Figure US11793881-20231024-C01198
41-127 (3.4 g, 4.0764 mmol) was dissolved with DMF, morpholine (7.1 mL, 81.5280 mmol) was added, and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, the reaction solution was transferred to a 2 L reparatory funnel, and extracted with ethyl acetate (150 mL) and deionized water (300 mL), and the organic phase was separated. The aqueous phase was extracted many times with ethyl acetate (300 mL) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was dried, thus obtaining the product 3.49 g.
Figure US11793881-20231024-C01199
41-130 (3.5 g, 4.0764 mmol), 41-128 (1.523 mmol), HBTU (1.9664 g, 5.1852 mmol), HOBT (0.7006 g, 5.1852 mmol) were added in a 250 mL flask, and dissolved with DMF (20 mL), and the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (2.6 mL, 15.5556 mmol) was slowly added dropwise, and the obtained solution continued to react with stirring under this condition for 3 hours. At the end of the reaction, the reaction solution was transferred to a 2 L separatory funnel, and extracted with ethyl acetate (150 mL) and deionized water (300 mL), and the organic phase was separated. The aqueous phase was extracted many times with ethyl acetate (300 mL) until there was no product in the aqueous phase, and the obtained organic phases were combined. The organic phase was evaporated to dryness, and dried, thus obtaining the product (3.5 g, extra-quota 0.3 g), for the next reaction.
Figure US11793881-20231024-C01200
41-131 (3.2 g, 1.1523 mmol) was added in a flask, and dissolved with dichloromethane (20 mL), TFA (20 mL, 276.552 mmol) was added, and then the obtained solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was first evaporated to remove a part of the TFA, and then precipitated with EA (200 mL) and n-hexane (200 mL), and suction filtering was carried out. The obtained solid powder was transferred to a 2 L round-bottomed flask, and evaporated to dryness, thus obtaining the product 2 g.
Figure US11793881-20231024-C01201
41-132 (0.28 g, 0.1545), M-SCM-5K (3.279 g, 0.6178 mmol, purchased from JenKem) were added in a 250 mL flask, and dissolved with DMF (30 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (1 mL, 6.0172 mmol) was slowly added dropwise, and the obtained solution was stirred to react at room temperature in the dark for one week. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (200 mL) and n-hexane (50 mL), and suction filtering was carried out, to obtain a powder product 1 g, yield 38.46%.
Figure US11793881-20231024-C01202
41-133 (0.1064 g, 0.0062 mmol), 45-163 (0.1 g, 0.0925 mmol), HBTU (0.0421 g, 0.1109 mmol), HOBT (0.0150 g, 0.1109 mmol) were added in a 100 mL flask, and dissolved with DMF (20 mL), and then the obtained solution was stirred to react under low-temperature and constant temperature condition of 0° C. for 30 minutes. Then DIEA (0.5 mL, 0.3329 mmol) was slowly added dropwise, and the obtained solution continued to react with stirring under this condition overnight. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (200 mL) and n-hexane (50 mL), and filtered by suction to obtain a powder product. The obtained powder product was dissolved to obtain a solution. The obtained solution was concentrated, silica gel powder was added, and the operations of evaporation, column chromatography, and elution with 4% methanol/dichloromethane were carried out, thus obtaining the product 0.1 g, yield 55.56%.
Figure US11793881-20231024-C01203
41-134 (0.7 g, 0.0234 mmol), TBAF (1.4684 g, 5.6160 mmol) were added in a 100 mL flask, and dissolved with THF (20 mL), and then the mixed solution was stirred to react at room temperature for 3 hours. At the end of the reaction, the reaction solution was precipitated with methyl tert-butyl ether (200 mL) and n-hexane (50 mL), and filtered by suction to obtain a powder product. The operations of dry sample loading, column chromatography and elution with 4% methanol/dichloromethane were carried out, thus obtaining the product 0.35 g, yield 50%.
1H-NMR (600 MHz, DMSO-d6) δ 8.55-8.54 (m, 8H), 7.96-7.94 (m, 3H), 7.82-7.80 (m, 7H), 7.57-7.39 (m, 21H), 7.29-7.24 (m, 18H), 7.22-7.21 (m, 28H), 6.97-6.90 (m, 48H), 6.78-6.61 (m, 86H), 5.77-5.76 (m, 9H), 5.37-5.32 (m, 3H), 5.09-5.04 (m, 5H), 4.52-4.42 (m, 3H), 4.35-4.23 (m, 9H), 3.51-3.49 (m, 1414H), 3.32-3.31 (m, 41H), 3.06-3.01 (m, 77H), 2.74-2.71 (m, 26H), 2.61-2.59 (m, 14H), 2.05-1.96 (m, 55H), 1.74-1.67 (m, 44H), 1.46-1.39 (m, 76H), 1.24-1.21 (m, 91H), 1.16-1.14 (m, 22H), 1.05-1.01 (m, 112H), 0.87-0.79 (m, 28H).
32. Synthesis of 49-166 (Compound No. 31)
Figure US11793881-20231024-C01204
Figure US11793881-20231024-C01205
Figure US11793881-20231024-C01206
Figure US11793881-20231024-C01207
Figure US11793881-20231024-C01208
Figure US11793881-20231024-C01209
Figure US11793881-20231024-C01210
Figure US11793881-20231024-C01211
Figure US11793881-20231024-C01212
Figure US11793881-20231024-C01213
Figure US11793881-20231024-C01214
Boc-Glu-OH (5.0 g, 20.22 mmol, purchased from Aladdin), H-Glu (OBzl)-OBzl·TsOH (21.2 g, 42.46 mmol, purchased from Ark Pharm), HOBT (8 g, 60.66 mmol), HBTU (23 g, 60.66 mmol) were added in a 250 mL flask, and dissolved with DMF (80 mL), and ultrasonic treatment was carried out to completely dissolve the reactants, and then the obtained solution was stirred at −5° C. for 30 minutes. Then DIEA (30 mL, 181 mmol) was slowly added dropwise, and the obtained solution reacted at the low temperature under the reaction ended. At the end of the reaction, deionized water (100 mL) was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (100 mL), concentrated and evaporated to dryness. The operations of dry sample loading, column chromatography and gradient elution with 40% ethyl acetate/petroleum ether-50% ethyl acetate/petroleum ether were carried out. The elution product was then collected, concentrated, and evaporated to dryness.
Figure US11793881-20231024-C01215
39-80 (19.2 mmol) was dissolved with dichloromethane (5 mL), TFA (14 mL, 192 mmol) was added, and ultrasonic treatment was carried out to completely dissolve the compound. A ground glass stopper was used, and the mixed solution was stirred to react at room temperature. At the end of the reaction, saturated sodium bicarbonate solution (300 mL) was added to the reaction solution, the obtained solution was extracted three times with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (100 mL), concentrated and evaporated to dryness.
Figure US11793881-20231024-C01216
7-Ethyl-10-hydroxycamptothecin (15.00 g, 38.23 mmol, also referred to as SN38) was added in a 1000 mL round-bottomed flask, and dissolved with dichloromethane (150 mL), tert-butyl diphenylchlorosilane (59.64 ml, 229.36 mmol, purchased from Accela), triethylamine (31.88 ml, 229.36 mmol) were added, and then the obtained solution was placed in an oil bath at 37° C. and stirred to react overnight. At the end of the reaction, the reaction solution was evaporated to obtain a viscous solution, the viscous solution was precipitated with n-hexane (150 ml) to obtain a solid product, and suction filtering was carried out. The filter cake was dried, thus obtaining the product (23.15 g, 96%).
Figure US11793881-20231024-C01217
47-96 (23.15 g, 36.70 mmol), Boc-Gly-OH (8.71 g, 49.70 mmol, purchased from Aladdin), DMAP (0.94 g, 7.65 mmol) were added in a 1000 mL round-bottomed flask, and dissolved with dichloromethane (150 mL), and then the mixed solution was stirred at 0° C. for 30 minutes. Then, DCC (39.41 g, 191.15 mmol) was added in three batches, with an interval of 30 minutes each batch. At the end of the addition, the obtained solution reacted at 0° C. for 2 hours, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was precipitated with n-hexane (200 mL) and petroleum ether (50 mL). Such operations were repeated three times, and filtering was carried out to obtain a solid product. The solid product was dried in a vacuum oven, thus obtaining the product (27.53 g, 94%).
Figure US11793881-20231024-C01218
47-97 (27.53 g, 34.50 mmol) was added in a 1000 mL round-bottomed flask, and dissolved with dichloromethane (50 mL) and trifluoroacetic acid (28.40 ml, 382.30 mmol), and then the mixed solution reacted at room temperature. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed with saturated sodium chloride solution (200 mL×2), and concentrated, silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery product. The operations of column chromatography and gradient elution (with 1%-3% CH3OH, the rest of CH2Cl2) were carried out. The elution product was then collected, and concentrated, thus obtaining the product (16.98 g, 72%).
Figure US11793881-20231024-C01219
Fmoc-Lys (Boc) —OH (5.0 g, 10.6714 mmol, purchased from Aladdin), H-Gly-OBn (3.7802 g, 11.2050 mmol, purchased from Innochem), HBTU (6.0705 g, 16.0072 mmol), HOBT (2.1630 g, 16.0072 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the obtained solution was stirred to react at 0° C. for 30 minutes. Then DIEA (7.9371 mL, 48.0215 mmol) was slowly added dropwise, the obtained solution continued to react at 0° C. with stirring overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining a crude product.
Figure US11793881-20231024-C01220
29-242 (6.57 g, 10.6714 mmol) was added in a 500 mL flask, and dissolved with a proper amount of dichloromethane, TFA (7.9248 mL, 106.714 mmol) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was evaporated to obtain an oily solution, a saturated sodium bicarbonate solution was added to adjust pH until the solution became alkaline, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining a crude product.
Figure US11793881-20231024-C01221
Boc-Lys (Boc) —OH (4.2805 g, 11.7385 mmol, purchased from Ark Pharm), 29-243 (5.50 g, 10.6714 mmol), HBTU (6.0705 g, 16.0072 mmol), HOBT (2.1630 g, 16.0072 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at 0° C. for 30 min. Then DIEA (7.9371 mL, 48.0215 mmol) was slowly added dropwise, the obtained solution continued to react at 0° C. overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), concentrated, evaporated to dryness, and dried in a vacuum oven, thus obtaining a crude product.
Figure US11793881-20231024-C01222
Morpholine (9.24 mL, 106.714 mmol) was added in a 500 ml flask loaded with 29-245 (9.0 g, 10.6714 mmol), and dissolved with DMF (10 mL), and then the mixed solution was stirred to react at room temperature for 1 hour. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), and concentrated, silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery product. The operations of column chromatography and gradient elution (with 1% ammonia water, 4%-5% methanol, the rest of dichloromethane) were carried out. The elution product was then collected, concentrated, thus obtaining the product 29-246: 3.7 g. Yield 56%.
Figure US11793881-20231024-C01223
Erythritol (4.5 g, 36.849 mmol) was added in a 500 mL two-neck flask, and dissolved with THF (60 mL) in a condition of ultrasonic, and then the obtained solution was stirred at 0° C. After introducing nitrogen for protective purpose, potassium tert-butoxide (200 mL, 184.245 mmol) was added, and the obtained solution was stirred at 0° C. for 2 hours. Then, benzyl bromoacetate (29.187 mL, 184.245 mmol) was added, and the obtained solution was stirred for 3 hours and then reacted at room temperature. At the end of the reaction, the reaction solution was extracted with pure water and ethyl acetate, and the organic phase was concentrated. The operations of dry sample loading, column chromatography and gradient elution with 1%-2% ethyl acetate/petroleum ether were carried out, thus obtaining the product 5 g, yield 20%.
Figure US11793881-20231024-C01224
21-221 (0.64 g, 0.9793 mmol) and 10% Pd/C (100 mg) were added in a hydrogenation reactor, DMF (30 mL) was slowly added to dissolve the reactant with stirring, hydrogen was introduced to a pressure of 300 psi, and then the mixed solution was stirred to react at room temperature overnight. Next day, the reaction solution was filtered by suction through a sand core funnel filled with diatomaceous earth to remove the Pd/C, thus obtaining the DMF solution of the product, directly used for next reaction.
Figure US11793881-20231024-C01225
38-120 (0.39 g, 1.0966 mmol), 29-246 (3.0 g, 4.8249 mmol), HBTU (2.4951 g, 6.5795 mmol), HOBT (0.8891 g, 6.5795 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (3.2624 mL, 19.7384 mmol) was slowly added dropwise, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), and concentrated, silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery product. The operations of column chromatography and gradient elution (with 50%-80% ethyl acetate, the rest of petroleum ether) were carried out. The elution product was then collected, concentrated, thus obtaining the product (1.6 g, 53%).
Figure US11793881-20231024-C01226
29-248 (0.52 g, 0.1878 mmol) and 10% Pd/C (0.0, 5 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation so that the pressure on the hydrogenation reactor was read as 0.18 MPa, and then the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), thus obtaining the DMF solution of the product, as the raw material for the next reaction.
Figure US11793881-20231024-C01227
49-79 (0.45 g, 0.1878 mmol), M-NH2HCl-5K (4.91 g, 0.9389 mmol, purchased from JenKem), HBTU (0.43 g, 1.1237 mmol), HOBT (0.15 g, 1.1267 mmol) were added in a 500 mL flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (0.56 mL, 3.3780 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. with stirring for 1 hour, and then reacted at room temperature in the dark for 3 days at a low speed of stirring. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. The obtained solution was then shaken with methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL), and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the reaction solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1% ammonia water and 3%-7% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (3.2 g, 73.73%).
Figure US11793881-20231024-C01228
49-80 (3.2 g, 0.1383 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (5 mL) and TFA (0.82 mL, 11.0640 mmol), and then the mixed solution was stirred to react at room temperature in the dark overnight at a low speed. At the end of the reaction, the reaction solution was rotary evaporated to obtain an oily solution, and methyl tert-butyl ether (60 mL) was then added to the oily solution. A powdery solid was separated out of the obtained solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-12% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (1.74 g, 56.35%).
Figure US11793881-20231024-C01229
39-84 (5.16 g, 6.7433 mmol), mono-tert-butyl succinate (1.40 g, 8.0920 mmol, purchased from Accela), HBTU (3.84 g, 10.1149 mmol), HOBT (1.36 g, 10.1149 mmol) were added in a 500 mL flask, and dissolved with DMF (50 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (10.03 mL, 60.6897 mmol) was slowly added dropwise, the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, deionized water (200 mL) was added to the reaction solution, the obtained solution was extracted with ethyl acetate (100 mL×3), and the obtained organic phases were combined. The organic phase was washed two times with saturated sodium chloride solution (200 mL), and concentrated, silica gel powder was added, and the obtained mixture was then evaporated to dryness to obtain a powdery product. The operations of column chromatography and gradient elution (with 50%-90% ethyl acetate, the rest of petroleum ether) were carried out. The elution product was then collected, concentrated, thus obtaining the product (5.66 g, 90.99%).
Figure US11793881-20231024-C01230
49-157 (2.8 g, 3.0367 mmol) and 10% Pd/C (0.08 g) were added in a hydrogenation reactor, and dissolved with DMF (30 mL). The hydrogenation reactor was then sealed to perform the “three pumping and three charging” operation so that the pressure on the hydrogenation reactor was read as 0.18 MPa, and then the obtained solution reacted at room temperature overnight. At the end of the reaction, the reaction solution was filtered with diatomaceous earth. The filter cake was washed with DMF (20 mL×3), thus obtaining the DMF solution of the product as raw material for the next reaction.
Figure US11793881-20231024-C01231
49-158 (1.71 g, 3.0367 mmol), 47-98 (8.77 g, 12.7541 mmol), HBTU (6.90 g, 18.2202 mmol), HOBT (2.46 g, 18.2202 mmol) were added in a 500 mL flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for about 30 minutes. Then DIEA (13 mL, 78.9542 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. with stirring for 1 hour, and was then moved to room temperature and stirred to react overnight. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. The obtained solution was then shaken with methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL), and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the obtained solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (60 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography, and gradient elution with a dichloromethane mixed solution containing 3%-7% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (11.3 g, extra-quota).
Figure US11793881-20231024-C01232
49-159 (9.84 g, 3.0367 mmol) was added in a 250 mL flask, and dissolved with dichloromethane (8 mL), TFA (8 mL) was added, and then the mixed solution was stirred to react at room temperature overnight. At the end of the reaction, the reaction solution was rotary evaporated to obtain an oily solution, and methyl tert-butyl ether (60 mL) was then added to the oily solution. A powdery solid was separated out of the obtained solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (60 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 1%-4% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (2.7 g, 27.92%).
Figure US11793881-20231024-C01233
49-153 (1.19 g, 0.0535 mmol), 49-161 (1.5 g, 0.4710 mmol), HBTU (0.24 g, 0.6422 mmol), HOBT (0.08 g, 0.6422 mmol) were added in a 500 mL flask, and dissolved with DMF (60 mL), and then the mixed solution was stirred to react at −5° C. for 30 minutes. Then DIEA (0.60 mL, 3.6395 mmol) was slowly added dropwise, and the obtained solution continued to react at −5° C. with stirring for 1 hour, and then reacted at room temperature in the dark overnight at a low speed of stirring. At the end of the reaction, the reaction solution was shaken with n-hexane (100 mL), and the supernatant was discarded. The above operations were repeated three times. The obtained solution was then shaken with methyl tert-butyl ether (80 mL) and a small amount of n-hexane (10 mL), and the supernatant was discarded. The above operations were repeated three times. A powdery solid was separated out of the obtained solution, and suction filtering was carried out. The filter cake was washed with methyl tert-butyl ether (40 mL×3), the washed filter cakes were collected, and dissolved with a mixed solvent (100 mL) of methanol/dichloromethane (1:4), silica gel powder (20 g) was added, and the obtained mixture was then evaporated to dryness to obtain a powdery solid. The operations of dry sample loading, column chromatography and gradient elution with a dichloromethane mixed solution containing 3%-15% methanol were carried out. The elution product was then collected, concentrated, and dried in a vacuum oven, thus obtaining the product (0.95 g, 37.25%).
Figure US11793881-20231024-C01234
Figure US11793881-20231024-C01235
49-162 (0.95 g, 0.0199 mmol) was added in a 500 ml flask, and dissolved with THF (10 ml) and diluted hydrochloric acid (10 ml, 0.05 mmol/L) by ultrasonic, TBAF (0.5 g, 1.9133 mmol) was added, and then the mixed solution was stirred to react at room temperature in the dark for 3 hours. At the end of the reaction, the reaction solution was evaporated to dryness. The obtained dry product was dissolved with DMF (5 ml), and the obtained solution was precipitated with isopropanol. Such operations were repeated three times. The precipitate was dissolved with anhydrous ethanol and a small amount of dichloromethane, and the obtained solution was precipitated with methyl tert-butyl ether. Such operations were repeated three times. The obtained solid was then collected, and dried in a vacuum oven, thus obtaining the product (0.75 g, 93.75%).
1H NMR (600 MHz, DMSO-d6) δ 8.36-8.18 (m, 32H), 8.12-7.89 (m, 56H), 7.81-7.76 (m, 16H), 7.35 (s, 100H), 7.05-6.96 (m, 27H), 5.95-5.18 (m, 124H), 4.25-3.81 (m, 156H), 3.53-3.49 (m, 3706H), 3.12-2.78 (m, 123H), 2.08 (s, 109H), 1.47-1.20 (m, 211H), 0.99-0.78 (m, 136H).
Example 2 Activity Assay
27-134 (Compound No. 18), 44-2 (Compound No. 3) were taken as examples below, while the test method for other compounds was the same, and the inhibitory effect on cancer cells was also significant.
I. Experimental Materials:
    • 1. Customer samples: Colo205, MDA-MB-231 cancer cell, 2 drugs (27-134, 44-2)
    • 2. Experimental equipment and reagent: PerkinElmer multifunctional microplate reader, CCK8 cell proliferation and cytotoxicity detection kit
II. Experimental Method
Drug formulation: the drugs were formulated into 0.1 g/ml with physiological saline, corresponding to a molar concentration of 7.4537 mM for each drug.
    • 1. Cells were cultivated and digested by trypsin. The cells were blown into a single cell suspension with the corresponding medium. The suspension was inoculated into a 96-well plate with 100 μl per well, the cell density being about 10-15%. Cultivation continued in an incubator at 37° C. and 5% CO2 for 6 hours until the cells are attached to the wall, yet to be treated.
    • 2. According to the requirement of drug concentration, drug-containing culture media with different concentrations were prepared by a multiple dilution method. Two groups of different gradient combinations of the same drug were screened on one plate, as shown in FIG. 1 .
    • 3. Drug gradient: 100 μl of the fresh culture media (the total volume was 200 μl, the drug concentration was shown in FIG. 1 ) containing the corresponding drugs prepared in the step 2 were respectively added, and cultivation continued for 48 hours.
    • 4. After 48 hours of drug treatment, the original medium was discarded.
    • 5. 100 μl of a medium (containing 10% CCK8) was added to each well and cultivation continued in the cell incubator for 2 hours.
    • 6. The absorbance was measured at 450 nm, with the results shown in FIG. 2 .
III. Analysis of the Experimental Results:
    • 1. The cell inhibition rate at each drug concentration was calculated from the readings as follows:
96% 86% 76% 69% 64% 41% 15% 6% −1% 0%
20 6.67 2.22 0.74 0.25 0.08 0.027 0.009 0.003 0
83% 75% 73% 67% 34% 13% 6% 9% 5% 0%
5 1.67 0.56 0.19 0.06 0.021 0.007 0.002 0.001 0
100% 92% 82% 78% 58% 26% 21% 12% 5% 0%
60 20.00 6.67 2.22 0.74 0.25 0.082 0.027 0.009 0
92% 81% 79% 45% 19% 12% 5% 4% 0% 0%
10 3.33 1.11 0.37 0.12 0.041 0.014 0.005 0.002 0
2. Plot:
The inhibitory effect of drug 44-2 on MDA-MB-231 cancer cells, as shown in FIG. 3 .
The inhibitory effect of drug 27-134 on Colo205 cancer cells, as shown in FIG. 4 .
3. Calculation of IC50 for individual drug
The results are shown in FIG. 5 .
Example 3 In Vivo Anti-Tumor Efficacy Pre-Test of Multiple Test Samples on NPG Mouse Subcutaneous Transplantation Tumor Models of Human Breast Cancer BT474 Cells
I. Experimental Materials:
Preparation Methods:
Test sample diluent: a proper amount of PEG300 and absolute alcohol was taken, and sodium chloride injection was added to make that the content of PEG300 and absolute alcohol was 20% (v/v).
Test samples: 41-32, 41-40 and 39-55 were respectively taken in a proper volume, and a proper amount of each of the test sample diluent was added, to respectively prepare solutions with the concentrations of 8.3 mg/mL, 4.6 mg/mL and 5.5 mg/mL.
SB7·HCL: a proper amount of SB7·HCL (conversion factor: 93.4%) was taken, a certain volume of ethanol (5%, V/V) was added for dissolving, and, after complete dissolution, a proper amount of sodium chloride injection was added, to prepare a solution with a concentration of 0.5 mg/mL.
LPT: a proper amount of LPT was taken, and a certain volume of 0.5% CMC-Na solution was added, followed by uniform stirring on a magnetic stirrer to prepare a solution with a concentration of 0.56 mg/mL.
Negative control: the test sample diluent was directly used.
Preservation and treatment of the prepared solutions: the prepared test samples and control sample were preserved at 2-8 V or in an ice box before administration, and the residual test samples and control sample after administration were treated as medical waste.
Human breast cancer cell BT474: it was from the Cell Resource Center of Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences, cultured under the conditions of RPMI1640+10% FBS, 37° C., 5% CO2.
Animal species & strain: NPG mice
Animal level: SPF level
Animal source: Beijing Vitalstar Biotechnology Co., Ltd.
Animal age at tumor inoculation: about 4-5 weeks.
Animal weight at tumor inoculation: about 15-18 g. The weights of animals of the same sex were between 80-120% of the average weight.
Animal sex and number: female, 60 mice, 36 modeling animals were screened for final experiments, and the remaining animals were either transferred to veterinarian or euthanasia.
Animals were reared in an independent ventilation system (IVC), at most 6 animals of the same group in each cage, and an SPF level animal house was provided, with the environmental conditions controlled as follows: room temperature 20-26° C., 40-70% of relative humidity and illumination with 12 hour light dark alternation.
Feed: qualified mouse feed (manufacturer: Beijing Keao Xieli Feed Co., Ltd.) was provided each day. The animals ate freely and drunk water freely.
2. Experimental Method:
BT474 cells were revived, and cell passage amplification was carried out. When amplified to a sufficient number, the cells in the logarithmic growth phase were collected for cell inoculation. An estrogen sustained-release tablet (17 beta-ESTRADIOL, product No.: SE-121, Innovative Research of America) was embedded under the skin at the neck back of NPG mice before cell inoculation. A BT474 cell suspension with the concentration of 7.5×107/mL and a Matrigel Basement membrane Matrix (BD Co.) were mixed according to the volume ratio of 1:1 to obtain a cell suspension with the concentration of 3.75×107/mL. 0.2 mL of the cell suspension was inoculated into the right mammary fat pad of the mice. The tumor growth was observed after inoculation, and 36 tumorigenic animals with the tumor volume of 66.83-324.35 mm3 were finally screened and used for the test.
The tumorigenic animals were randomly divided into 6 groups according to the tumor volume and the body weight, including: group 1 (negative control group, test sample diluent), group 2 (LPT, 20 mg/kg), group 3 (SB7+LPT, 5+5.6 mg/kg), group 4 (41-32, i.e., Compound No. 20, 83 mg/kg), group 5 (41-40, i.e., Compound No. 13, 46 mg/kg) and group 6 (39-55, i.e., Compound No. 12, 55 mg/kg), 6 animals in each group, with the administration volume of 10 mL/kg. The negative control, SB7, 41-32, 41-40 and 39-55 were intravenously injected; LPT was intragastrically administered. The groups 2 and 4 were administered one time every 3 days (the administration was stopped once at D19 due to insufficient drug dosage), while the rest groups were administered one time/week, for a duration of 4 weeks, at D29 the animals were euthanized. During the experiment, the general clinical symptoms of the animals were observed 2 times every day, and the body weight and tumor diameter were measured two times every week. The tumor was stripped after euthanization, and the tumor weight was weighed. The tumor volume, relative tumor volume RTV, relative tumor proliferation rate T/C % and tumor weight inhibition rate IRTW % were calculated. The relative tumor proliferation rate T/C %≤40% of the administration group and the RTV of that group being significantly different compared with the RTV of the negative control group (P≤0.05) were considered to be effective, and the IRTW≥60% was taken as an effectiveness auxiliary reference indicator.
A. Measurement of Tumor Diameter:
Test animal: all animals
Test time: the day of grouping (i.e., D1, the day of first administration), 2 times per week after first administration, and before euthanasia, the long and short diameters of tumor were measured using a slide caliper and recorded, and the tumor volume was calculated.
The tumor volume was calculated according to the following formula:
V=½×long diameter×short diameter2
B. Evaluation of Therapeutic Efficacy Based on the Tumor Volume
The relative tumor volume (RTV) and the relative tumor proliferation rate T/C % were calculated according to the following formula:
RTV=V t /V 0
Vt: tumor volume obtained by measuring tumor every day
V0: initial tumor volume (before administration)
T/C %=average RTV of the administration group/average RTV of the control group×100%
If T/C % was ≤40%, and the RTV of the administration group was different in statistics compared with the RTV of the control group (P<0.05), tumor growth inhibition effect was achieved; on the other hand, if TIC % was >40%, tumor growth was not inhibited.
C. Evaluation of Therapeutic Efficacy Based on the Tumor Weight
After the experiment, tumor nodules were stripped and weighed, and the differences in tumor weight among the groups were compared to further calculate the tumor inhibition rate IRTW. IRTW>60% was taken as an effective reference indicator. The calculation was conducted according to the following formula:
IR TW(%)=(W Control group −W Administration group)/W Control group×100%
3. Experimental Results:
Throughout the experiment, 1 animal in the group 2 died at D19; 2 animals in the group 3 died at D15 and D25, respectively, of which 1 animal was observed after dissection to have white sand-like particles filled in the bladder, the cause of death being considered to be related to the inoculation of estrogen tablet; the cause of death of other 2 animals was presumed to be related to the toxicity of the control. The weights of the animals in the groups 1-6 all gradually increased, and no significant difference (P>0.05) was observed among the groups.
In the negative control group (the group 1), the tumor gradually increased throughout the experiment, by the end of the experiment (D29), the group 1 had an average tumor volume of 1938.55±511.20 mm3 and an average RTV of 14.98±8.63; the average tumor volumes of the groups 2-6 were 1313.80±241.46 mm3, 1463.75±1088.95 mm3, 1232.77±652.36 mm3, 1616.52±985.05 mm3, 346.96±203.35 mm3 respectively, and the average RTVs thereof were 8.13±2.92, 8.80±3.57, 8.27±3.92, 11.61±8.28, 2.26±1.32 respectively, and the tumor volumes of the group 6 during D15-D29 were significantly lower than that of the group 1 (P≤0.05); the RTV of the group 6 at D12 was significantly lower than that of the group 1 (P≤0.05), and no significant difference in tumor volume and RTV was observed among other groups (P>0.05).
The tumor growth trend of each group is shown in FIG. 6 , FIG. 7 and FIG. 8 .
By the end of the experiment (D29), the T/C % values of the groups 2-6 were 54.27%, 58.74%, 55.21%, 77.54% and 15.07%, respectively, and the IRTW % values thereof were 45.73%, 41.26%, 44.79%, 22.46% and 84.93%, respectively, and the T/C % of the group 6 was reduced to less than 40% during D12-D29.
At the end of the experiment, the tumors of the animals were weighed after euthanasia. The average tumor weights of the groups 1-6 were 1.807±0.350 g, 1.226±0.370 g, 1.185±0.934 g, 0.899±0.428 g, 1.287±0.746 g, 0.266±0.167 g, respectively, the tumor weight of the group 6 being significantly lower than that of the group 1 (P≤0.05). The IRTW % of the groups 2-6 were 32.15%, 34.42%, 50.25%, 28.78%, 85.28%, respectively.
The schematic diagrams of the tumor weight inhibition rate of each group are shown in FIG. 9 , FIG. 10 and FIG. 11 . FIG. 12 shows the photos of euthanized animals of each group. FIG. 13 shows the photos of tumors of each group.
Conclusion: under the experimental conditions, the administration groups all had tumor growth inhibition effects of different degrees on NPG mouse subcutaneous transplantation tumor models of human breast cancer BT474 cells. The test sample 39-55, which was administered by tail vein injection at a dose of 55 mg/kg, had an obvious inhibition effect on the tumor growth of the NPG mouse subcutaneous transplantation tumor models of human breast cancer BT474 cells, and the effect was superior to that of the combination of SB7 which was administered by tail vein injection at a dose of 5 mg/kg and LPT which was intragastrically administered at a dose of 5.6 mg/kg. LPT which was intragastrically administered at a dose of 20 mg/kg, 41-32 which was administered by intravenous injection at a dose of 83 mg/kg and 41-40 which was administered by intravenous injection at a dose of 46 mg/kg had certain inhibition effects on NPG mouse subcutaneous transplantation tumor models of human breast cancer BT474 cells.
Example 4 In Vivo Anti-Tumor Efficacy Pre-Test of Test Samples on BALB/c Nude Mouse Subcutaneous Transplantation Tumor Models of Human Colon Cancer COLO-205 Cells
1. Experimental Materials
Test Sample
Name: 39-17 (i.e., Compound No. 14); concentration: 10 mg/mL.
Vehicle/Negative Control
Name: sodium chloride injection; lot No.: 4B19091206; specification: 100 mL: 0.9 g; character: colorless and clear liquid; preservation condition: preserved in a sealed container; manufacturer: Shandong Qidu Pharmaceutical Co., Ltd.
Preparation of the test sample and the control:
Preparation Methods:
Test sample: directly used, without dilution.
SB7·HCL: a proper amount of SB7·HCL (conversion factor: 93.4%) was taken, a certain volume of ethanol (5%, V/V) was added for dissolving, and, after complete dissolution, a proper amount of sodium chloride injection was added, to prepare a solution with a concentration of 0.3 mg/mL.
PCB: a proper amount of PCB was taken, and a certain volume of 0.5% CMC-Na solution was added, followed by uniform stirring on a magnetic stirrer to prepare a solution with a concentration of 1.04 mg/mL.
Negative control: sodium chloride injection was directly used.
Preservation and treatment of the prepared solutions: the prepared test samples and control sample were preserved at 2-8° C. or in an ice box before administration, and the residual test samples and control sample after administration were treated as medical waste.
Human colon cancer COLO-205 cell: it was from the Cell Resource Center of Institute of Basic Medicine of Chinese Academy of Medical Sciences, cultured under the conditions of RPMI1640+10% FBS, 37° C., 5% CO2.
Animal species & strain: BALB/c nude mice
Animal level: SPF level
Animal source: Beijing Charles River Laboratory Animal Technology Co., Ltd.
Animal age at tumor inoculation: about 4-5 weeks.
Animal weight at tumor inoculation: about 15-18 g. The weights of animals of the same sex were between 80-120% of the average weight.
Animal sex and number: male, 25 mice, 18 modeling animals were screened for final experiments, and the remaining animals were either further reared or euthanized.
Animals were reared in an independent ventilation system (IVC), at most 6 animals of the same group in each cage, and an SPF level animal house was provided, with the environmental conditions controlled as follows: room temperature 20-26° C., 40-70% of relative humidity and illumination with 12 hour light dark alternation.
Feed: qualified mouse feed (manufacturer: Beijing Keao Xieli Feed Co., Ltd.) was provided each day. The animals ate freely and drunk water freely.
2. Experimental Method:
COLO-205 cells were revived, and cell passage amplification was carried out. When amplified to a sufficient number, the cells in the logarithmic growth phase were collected for cell inoculation. According to the actual cell number, the cells were adjusted to have a concentration of 5×107/mL, and inoculated subcutaneously in the right armpit of 25 mice at 0.2 mL per mouse. The tumor growth after inoculation was observed. When the tumor volume was about 100-300 mm3, the animals were screened according to the size of the tumor volume, excluding those that had too large tumor volume and those that were non-tumorigenic, and finally 18 tumorigenic animals were screened for test.
The 18 tumorigenic animals were randomly divided into 3 groups, including: group 1 (negative control group, sodium chloride injection), group 2 (SB7+PCB, 3+10.4 mg/kg), and group 3 (39-17, 153 mg/kg), 6 animals in each group, with the administration volume of 10 mL/kg for the negative control, SB7, PCB, and 15.3 mL/kg for 39-17. The negative control, SB7 and 39-17 were intravenously injected, and PCB was intragastrically administered, one time/week, for a duration of 3 weeks, at D22 the animals were euthanized. During the experiment, the general clinical symptoms of the animals were observed 2 times every day, and the body weight and tumor diameter were measured two times every week. The tumor was stripped after euthanization, and the tumor weight was weighed. The tumor volume, relative tumor volume RTV, relative tumor proliferation rate T/C % and tumor weight inhibition rate IRTW % were calculated. The relative tumor proliferation rate T/C %≤40% of the administration group and the RTV of that group being significantly different compared with the RTV of the negative control group (P≤0.05) were considered to be effective, and the IRTW≥60% was taken as an effectiveness reference indicator.
A. Measurement of Tumor Diameter:
Test animal: all animals
Test time: the day of grouping (i.e., D1, the day of first administration), 2 times per week after first administration, and before euthanasia, the long and short diameters of tumor were measured using a slide caliper and recorded, and the tumor volume was calculated.
The tumor volume was calculated according to the following formula:
V=½×long diameter×short diameter2
B. Evaluation of Therapeutic Efficacy Based on the Tumor Volume
The relative tumor volume (RTV) and the relative tumor proliferation rate T/C % were calculated according to the following formula:
RTV=V t /V 0
Vt: tumor volume obtained by measuring tumor every day
V0: initial tumor volume (before administration)
T/C %=average RTV of the administration group/average RTV of the control group×100
If T/C % was ≤40%, and the RTV of the administration group was different in statistics compared with the RTV of the control group (P<0.05), tumor growth inhibition effect was achieved; on the other hand, if T/C % was >40%, tumor growth was not inhibited.
C. Evaluation of Therapeutic Efficacy Based on the Tumor Weight
After the experiment, tumor nodules were stripped and weighed, and the differences in tumor weight among the groups were compared to further calculate the tumor inhibition rate IRTW. IRTW>60% was taken as an effective reference indicator. The calculation was conducted according to the following formula:
IR TW(%)=(W Control group −W Administration group)/W Control group×100
3. Experimental Results:
Throughout the experiment, 1 animal in the group 3 died at D8, and the weight of the animal after death was 14.5 g, the weight loss of the animal before death being greater, which was presumed to be related to the toxicity of 39-17; 2 animals in the group 1 died at D19 and D20 respectively, wherein tumor ulceration was observed for 1 animal before death, which was presumed to be related to the larger tumor load. The weight of the animal in the group 1 gradually decreased, the weight of the animal in the group 2 slightly increased and then decreased, and the weight of the animal in the group 3 gradually increased. The weight of the animal in the group 3 was obviously higher than that in the group 1 (P≤0.05) during D8-D22, and was significantly higher than that in the group 2 (P≤0.05) during D12-D22.
In the negative control group (group 1), the tumor gradually increased throughout the experiment, by the end of the experiment (D22), the group 1 had an average tumor volume of 1900.58±489.19 mm3 and an average RTV of 16.03±6.43; the average tumor volumes of the groups 2-3 were 774.06±228.43 mm3, 33.83±37.01 mm3 respectively, and the average RTVs thereof were 6.38±1.81, 0.24±0.21 respectively, the tumor volumes of the group 2 during D5-D22 were significantly lower than that of the group 1 (P≤0.05), and the tumor volumes of the group 3 during D5-D22 were significantly lower than those of the groups 1 and 2 (P≤0.05); the RTVs of the group 2 during D5-D19 were significantly lower than that of the group 1 (P≤0.05), and the tumor volumes of the group 3 during D5-D22 were significantly lower than those of the groups 1 and 2 (P≤0.05).
The tumor growth trend of each group is shown in FIG. 14 .
By the end of the experiment (D22), the T/C % values of the groups 2-3 were 59.68%, 1.88%, respectively, and the IRTW % values thereof were 40.32%, 98.12%, respectively. The T/C % of the group 3 was reduced to less than 40% during D5-D22, and was significantly lower than that of the group 1 (P≤0.05).
At the end of the experiment, the tumors of the animals were weighed after euthanasia. The average tumor weights of the groups 1-3 were 1.551±0.290 g, 0.607±0.173 g, 0.036±0.036 g, respectively, the tumor weights of the groups 2-3 being significantly lower than that of the group 1 (P≤0.05). The IRTW % of the groups 2-3 were 60.86%, 97.68%, respectively.
The schematic diagram of the tumor weight inhibition rate of each group is shown in FIG. 15 .
Conclusion: under the experimental conditions, the test sample 39-17, which was administered by tail vein injection at a dose of 153 mg/kg, had an obvious inhibition effect on the tumor growth of the subcutaneous transplantation tumor models of human colon cancer COLO-205 cells, and the combination of SB7 which was administered by tail vein injection at a dose of 3 mg/kg and PCB which was intragastrically administered at a dose of 10.4 mg/kg also had an obvious inhibition effect on the tumor growth of the tumor models. The effect of 39-17 was obviously superior to that of the combination of PCB and SB7.
Although the specific embodiments of the disclosure have been described in detail, those skilled in the art will understand that various modifications and changes can be made to the details according to all the teachings that have been disclosed, and these changes are within the protection scope of the disclosure. The full scope of the disclosure is given by the appended claims and any equivalents thereof.

Claims (22)

The invention claimed is:
1. A polyethylene glycol conjugated drug of formula (I) or a pharmaceutically acceptable salt thereof,
Figure US11793881-20231024-C01236
wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—, —C(═O)—, —NH—C1-6alkylene-NH—, —C(═O)—C1-6 alkylene-NH—,
Figure US11793881-20231024-C01237
Figure US11793881-20231024-C01238
 or PEGm; wherein, PEGm is a single-arm or multi-arm polyethylene glycol segment, and its number-average molecular weight is 5k-40k;
A1, A1′ each independently are
Figure US11793881-20231024-C01239
A2 independently is a direct bond or
Figure US11793881-20231024-C01240
L1 independently is a direct bond or —C(═O)—C1-6 alkylene-C(═O)—;
W1, W1′, W2 each independently are Q1,
Figure US11793881-20231024-C01241
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C01242
Figure US11793881-20231024-C01243
Q is —N-AC;
Q1 is —N1-AC1;
Q2 is —N2-AC2;
N, N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C01244
AC, AC1, AC2 each independently are drug molecules;
n1, n2 each independently are 0, 1, 2, 3, 4, 5 or 6;
Y, Y′ each independently are a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C01245
X, X′ each independently are
Figure US11793881-20231024-C01246
PEG is a single-arm polyethylene glycol segment, and its number-average molecular weight independently is 5k-40k;
j1 is 1, 2, 3, 4, 5 or 6;
j2, j3 each independently are 0 or 1.
2. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1, the polyethylene glycol conjugated drug having the structure represented by the formula (II),
Figure US11793881-20231024-C01247
wherein:
M is —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C01248
—NH—C1-6alkylene-NH—,
Figure US11793881-20231024-C01249
Figure US11793881-20231024-C01250
 or PEGm, wherein, PEGm is a single-arm or multi-arm polyethylene glycol segment, and its number-average molecular weight is 5k-40k,
A1 independently is
Figure US11793881-20231024-C01251
Y independently is a direct bond,
Figure US11793881-20231024-C01252
 GLFG, —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C01253
X independently is
Figure US11793881-20231024-C01254
W1 independently is
Figure US11793881-20231024-C01255
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C01256
Figure US11793881-20231024-C01257
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N, N1, N2 each independently are G, GFLG,
Figure US11793881-20231024-C01258
AC, AC1, AC2 each independently are SN38, PKA, PCB, LPT, SB7, PTX or NPB, the number-average molecular weight of PEG independently is 5k-40k.
3. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 2, wherein:
M is —C(═O)—C1-6alkylene-C(═O)—, A1 is
Figure US11793881-20231024-C01259
 Y is
Figure US11793881-20231024-C01260
 X is
Figure US11793881-20231024-C01261
 W1 is
Figure US11793881-20231024-C01262
 Z4, Z2 and Z1 are
Figure US11793881-20231024-C01263
 Z3 and Z0 are
Figure US11793881-20231024-C01264
-or, M is —NH—C1-6 alkylene-NH—, A1 is
Figure US11793881-20231024-C01265
 Y is GLFG, X is
Figure US11793881-20231024-C01266
 W1 is
Figure US11793881-20231024-C01267
 Z2 is
Figure US11793881-20231024-C01268
 Z1 is
Figure US11793881-20231024-C01269
 Z0 is
Figure US11793881-20231024-C01270
or, M is
Figure US11793881-20231024-C01271
 A1 is
Figure US11793881-20231024-C01272
 Y is a direct bond or —C(═O)—C1-6 alkylene-C(═O)—, X is
Figure US11793881-20231024-C01273
 W1 is
Figure US11793881-20231024-C01274
 Z1 is
Figure US11793881-20231024-C01275
 Z0 is
Figure US11793881-20231024-C01276
or, M is
Figure US11793881-20231024-C01277
 A1 is
Figure US11793881-20231024-C01278
 Y is a direct bond, X is
Figure US11793881-20231024-C01279
 W1 is
Figure US11793881-20231024-C01280
 Z2 is
Figure US11793881-20231024-C01281
 Z1 is
Figure US11793881-20231024-C01282
 Z0 is
Figure US11793881-20231024-C01283
or, M is PEGm, PEGm is a single-arm polyethylene glycol segment, and its number-average molecular weight is 5k-40k,
 A1 is
Figure US11793881-20231024-C01284
 Y is a direct bond, X is
Figure US11793881-20231024-C01285
 W1 is
Figure US11793881-20231024-C01286
 Z2 is
Figure US11793881-20231024-C01287
 Z1 is
Figure US11793881-20231024-C01288
 Z0 is
Figure US11793881-20231024-C01289
or, M is PEGm, PEGm is a multi-arm polyethylene glycol segment, and its number-average molecular weight is 5k-40k,
 A1 is
Figure US11793881-20231024-C01290
 Y is a direct bond, X is
Figure US11793881-20231024-C01291
 W1 is
Figure US11793881-20231024-C01292
 Z2 is
Figure US11793881-20231024-C01293
 Z1 is
Figure US11793881-20231024-C01294
 Z0 is
Figure US11793881-20231024-C01295
or, M is
Figure US11793881-20231024-C01296
 A1 is
Figure US11793881-20231024-C01297
 Y is
Figure US11793881-20231024-C01298
 X is
Figure US11793881-20231024-C01299
 W1 is
Figure US11793881-20231024-C01300
 Z3 is
Figure US11793881-20231024-C01301
 Z2 is
Figure US11793881-20231024-C01302
 Z1 is
Figure US11793881-20231024-C01303
 Z0 is
Figure US11793881-20231024-C01304
-or, M is
Figure US11793881-20231024-C01305
 A1 is
Figure US11793881-20231024-C01306
 Y is
Figure US11793881-20231024-C01307
 X is
Figure US11793881-20231024-C01308
 W1 is
Figure US11793881-20231024-C01309
 Z2 is
Figure US11793881-20231024-C01310
 Z1 is
Figure US11793881-20231024-C01311
 Z0 is
Figure US11793881-20231024-C01312
or, M is
Figure US11793881-20231024-C01313
 A1 is
Figure US11793881-20231024-C01314
 Y is a direct bond, X is
Figure US11793881-20231024-C01315
 W1 is
Figure US11793881-20231024-C01316
 Z1 is
Figure US11793881-20231024-C01317
 Z0 is
Figure US11793881-20231024-C01318
or, M is
Figure US11793881-20231024-C01319
 A1 is
Figure US11793881-20231024-C01320
 Y is
Figure US11793881-20231024-C01321
 X is
Figure US11793881-20231024-C01322
 W1 is
Figure US11793881-20231024-C01323
 Z2 is
Figure US11793881-20231024-C01324
 Z1 is
Figure US11793881-20231024-C01325
 Z0 is
Figure US11793881-20231024-C01326
4. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 2, wherein:
M is
Figure US11793881-20231024-C01327
 —C(═O)—C1-6 alkylene-C(═O)—,
Figure US11793881-20231024-C01328
 A1 is
Figure US11793881-20231024-C01329
 Y is a direct bond, GLFG, —C(═O)—C1-6 alkylene-C(═O)— or
Figure US11793881-20231024-C01330
 X is
Figure US11793881-20231024-C01331
 W1 is
Figure US11793881-20231024-C01332
 Z2 is
Figure US11793881-20231024-C01333
 Z1 is
Figure US11793881-20231024-C01334
 Z0 is
Figure US11793881-20231024-C01335
5. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1, the polyethylene glycol conjugated drug having the structure represented by the formula (III),
Figure US11793881-20231024-C01336
wherein:
M is
Figure US11793881-20231024-C01337
 —C(═O)—C1-6 alkylene-NH— or —C(═O)—C1-6 alkylene-C(═O)—,
A1, A1′ each independently are
Figure US11793881-20231024-C01338
Y, Y′ each independently are a direct bond or
Figure US11793881-20231024-C01339
X and X′ are
Figure US11793881-20231024-C01340
W1, W1′ each independently are
Figure US11793881-20231024-C01341
 Q1,
Figure US11793881-20231024-C01342
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C01343
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N, N1, N2 each independently are GFLG, G,
Figure US11793881-20231024-C01344
AC, AC1, AC2 each independently are SN38, PKA, PCB, PTX, LPT, SB7 or DOX, the number-average molecular weight of PEG independently is 5k-40k.
6. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 5, wherein:
M is
Figure US11793881-20231024-C01345
 A1 is
Figure US11793881-20231024-C01346
 A1′ is
Figure US11793881-20231024-C01347
 Y is a direct bond, Y′ is
Figure US11793881-20231024-C01348
 W1 is
Figure US11793881-20231024-C01349
 W1′ is
Figure US11793881-20231024-C01350
 Z4, Z2 and Z0 are
Figure US11793881-20231024-C01351
 Z3 and Z1 are
Figure US11793881-20231024-C01352
or, M is —C(═O)—C1-6alkylene-NH—, A1 is
Figure US11793881-20231024-C01353
 A1′ is
Figure US11793881-20231024-C01354
 Y is a direct bond, Y′ is
Figure US11793881-20231024-C01355
 W1 is
Figure US11793881-20231024-C01356
 W1′ is Q1, Z2 and Z0 are
Figure US11793881-20231024-C01357
 Z1 is
Figure US11793881-20231024-C01358
or, M is —C(═O)—C1-6 alkylene-C(═O)—, A1 and A1′ are
Figure US11793881-20231024-C01359
 Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C01360
 W1′ is —Z0-(Q1)2, Z3 and Z1 are
Figure US11793881-20231024-C01361
 Z2 and Z0 are
Figure US11793881-20231024-C01362
or, M is —C(═O)—C1-6 alkylene-C(═O)—, A1 and A1′ are
Figure US11793881-20231024-C01363
 Y and Y′ are a direct bond, W1 is
Figure US11793881-20231024-C01364
W1′ is Q1, Z1 and Z0 are
Figure US11793881-20231024-C01365
or, M is —C(═O)—C1-6alkylene-NH—, A1 is
Figure US11793881-20231024-C01366
 A1′ is
Figure US11793881-20231024-C01367
 Y and Y′ are a direct bond, W1 and W1′ are
Figure US11793881-20231024-C01368
 Z2 is
Figure US11793881-20231024-C01369
 Z1 is
Figure US11793881-20231024-C01370
 Z0 is
Figure US11793881-20231024-C01371
7. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1, the polyethylene glycol conjugated drug having the structure represented by the formula (IV),
Figure US11793881-20231024-C01372
wherein:
M is
Figure US11793881-20231024-C01373
A1 is preferably
Figure US11793881-20231024-C01374
X is
Figure US11793881-20231024-C01375
W1 independently is
Figure US11793881-20231024-C01376
Z4, Z3, Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C01377
Q is —N-AC,
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N1 and N2 are GFLG,
AC1, AC2 each independently are PCB, SB7, LPT, PKA, the number-average molecular weight of PEG independently is 5k-40k.
8. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 7, wherein:
M is
Figure US11793881-20231024-C01378
 W1 is
Figure US11793881-20231024-C01379
Z2 is
Figure US11793881-20231024-C01380
 Z1 is
Figure US11793881-20231024-C01381
 Z0 is
Figure US11793881-20231024-C01382
or, M is
Figure US11793881-20231024-C01383
 W1 is
Figure US11793881-20231024-C01384
 Z4 and Z1 are
Figure US11793881-20231024-C01385
 Z3, Z2 and Z0 are
Figure US11793881-20231024-C01386
or, M is
Figure US11793881-20231024-C01387
 W1 is
Figure US11793881-20231024-C01388
 Z1 is
Figure US11793881-20231024-C01389
 Z0 is
Figure US11793881-20231024-C01390
9. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1, the polyethylene glycol conjugated drug having the structure represented by the formula (V),
Figure US11793881-20231024-C01391
wherein:
L1 is —C(═O)—C1-6 alkylene-C(═O),
A2 is
Figure US11793881-20231024-C01392
M is
Figure US11793881-20231024-C01393
A1 is
Figure US11793881-20231024-C01394
Y is
Figure US11793881-20231024-C01395
X is
Figure US11793881-20231024-C01396
W1, W2 each independently are
Figure US11793881-20231024-C01397
Z2, Z1, Z0 each independently are
Figure US11793881-20231024-C01398
Q1 is —N1-AC1,
Q2 is —N2-AC2,
N1 and N2 are GFLG,
AC1, AC2 each independently are PCB or SB7,
the number-average molecular weight of PEG is 5k-40k.
10. The polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 9, wherein:
W1 and W2 are
Figure US11793881-20231024-C01399
 Z2 is
Figure US11793881-20231024-C01400
 Z1 is
Figure US11793881-20231024-C01401
 Z0 is
Figure US11793881-20231024-C01402
11. A polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof, wherein the polyethylene glycol conjugated drug is selected from:
Figure US11793881-20231024-C01403
Figure US11793881-20231024-C01404
Figure US11793881-20231024-C01405
Figure US11793881-20231024-C01406
Figure US11793881-20231024-C01407
Figure US11793881-20231024-C01408
Figure US11793881-20231024-C01409
Figure US11793881-20231024-C01410
Figure US11793881-20231024-C01411
Figure US11793881-20231024-C01412
Figure US11793881-20231024-C01413
Figure US11793881-20231024-C01414
Figure US11793881-20231024-C01415
Figure US11793881-20231024-C01416
Figure US11793881-20231024-C01417
Figure US11793881-20231024-C01418
Figure US11793881-20231024-C01419
Figure US11793881-20231024-C01420
Figure US11793881-20231024-C01421
Figure US11793881-20231024-C01422
Figure US11793881-20231024-C01423
Figure US11793881-20231024-C01424
Figure US11793881-20231024-C01425
Figure US11793881-20231024-C01426
Figure US11793881-20231024-C01427
Figure US11793881-20231024-C01428
Figure US11793881-20231024-C01429
Figure US11793881-20231024-C01430
Figure US11793881-20231024-C01431
Figure US11793881-20231024-C01432
Figure US11793881-20231024-C01433
Figure US11793881-20231024-C01434
Figure US11793881-20231024-C01435
Figure US11793881-20231024-C01436
Figure US11793881-20231024-C01437
Figure US11793881-20231024-C01438
Figure US11793881-20231024-C01439
Figure US11793881-20231024-C01440
Figure US11793881-20231024-C01441
Figure US11793881-20231024-C01442
Figure US11793881-20231024-C01443
Figure US11793881-20231024-C01444
Figure US11793881-20231024-C01445
Figure US11793881-20231024-C01446
Figure US11793881-20231024-C01447
Figure US11793881-20231024-C01448
Figure US11793881-20231024-C01449
Figure US11793881-20231024-C01450
Figure US11793881-20231024-C01451
Figure US11793881-20231024-C01452
Figure US11793881-20231024-C01453
Figure US11793881-20231024-C01454
Figure US11793881-20231024-C01455
Figure US11793881-20231024-C01456
Figure US11793881-20231024-C01457
Figure US11793881-20231024-C01458
12. An intermediate for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 2, wherein the intermediate is selected from:
Figure US11793881-20231024-C01459
Figure US11793881-20231024-C01460
Figure US11793881-20231024-C01461
Figure US11793881-20231024-C01462
Figure US11793881-20231024-C01463
Figure US11793881-20231024-C01464
Figure US11793881-20231024-C01465
Figure US11793881-20231024-C01466
Figure US11793881-20231024-C01467
Figure US11793881-20231024-C01468
Figure US11793881-20231024-C01469
Figure US11793881-20231024-C01470
Figure US11793881-20231024-C01471
Figure US11793881-20231024-C01472
Figure US11793881-20231024-C01473
Figure US11793881-20231024-C01474
Figure US11793881-20231024-C01475
Figure US11793881-20231024-C01476
Figure US11793881-20231024-C01477
13. A method for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 2, comprising the following steps:
(1) preparing the intermediate
Figure US11793881-20231024-C01478
 M, A1, W1, Y and j1 being as defined in claim 2, wherein:
in the preparation of the intermediate
Figure US11793881-20231024-C01479
 when Y is other than a direct bond, —Y—OH has a terminal carboxyl group, when Y is a direct bond,
Figure US11793881-20231024-C01480
 has a terminal carboxyl group,
in the preparation of the intermediate
Figure US11793881-20231024-C01481
 when Y is other than a direct bond, —Y—H has a terminal amino group, when Y is a direct bond,
Figure US11793881-20231024-C01482
 has a terminal amino group;
(2) allowing the PEG with amino group or activated amino group and the intermediate
Figure US11793881-20231024-C01483
 to carry out amidation reaction, or, allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C01484
 to carry out amidation reaction, to obtain the polyethylene glycol conjugated drug as defined in claim 2.
14. An intermediate for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 5, wherein the intermediate is selected from:
Figure US11793881-20231024-C01485
Figure US11793881-20231024-C01486
Figure US11793881-20231024-C01487
Figure US11793881-20231024-C01488
Figure US11793881-20231024-C01489
Figure US11793881-20231024-C01490
Figure US11793881-20231024-C01491
Figure US11793881-20231024-C01492
Figure US11793881-20231024-C01493
15. A method for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 5, comprising the following steps:
(1) preparing the intermediate
Figure US11793881-20231024-C01494
 M, A1, A1′, W1, W1′, Y, Y′ and j1 being as defined in claim 5, wherein:
when Y or Y′ is other than a direct bond, —Y—H or —Y′—H has a terminal amino group,
when Y or Y′ is a direct bond,
Figure US11793881-20231024-C01495
 has a terminal amino group;
(2) allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C01496
 to carry out amidation reaction, to obtain the polyethylene glycol conjugated drug as defined in claim 5.
16. An intermediate for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 7, wherein the intermediate is selected from:
Figure US11793881-20231024-C01497
17. A method for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 7, comprising the following steps:
(1) preparing the intermediate
Figure US11793881-20231024-C01498
 M, A1, W1 and j1 being as defined in claim 7, wherein,
Figure US11793881-20231024-C01499
 has a terminal amino group;
(2) allowing the PEG with carboxyl group or activated carboxyl group and the intermediate
Figure US11793881-20231024-C01500
 to carry out amidation reaction, to obtain the polyethylene glycol conjugated drug as defined in claim 7.
18. An intermediate for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 9, wherein the intermediate is selected from:
Figure US11793881-20231024-C01501
19. A method for preparing the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 9, comprising the following steps:
(1) preparing the intermediate
Figure US11793881-20231024-C01502
 M, A1, A2, W1, W2, L1, Y and j1 being as defined in claim 9, wherein, —Y—OH has a terminal carboxyl group;
(2) allowing the PEG with amino group or activated amino group and the intermediate
Figure US11793881-20231024-C01503
 to carry out amidation reaction, to obtain the polyethylene glycol conjugated drug as defined in claim 9.
20. A pharmaceutical composition, comprising a therapeutically effective amount of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1; the composition further comprises one or more pharmaceutically acceptable excipients.
21. A method for treating a cancer, comprising administering an effective amount of the polyethylene glycol conjugated drug or a pharmaceutically acceptable salt thereof according to claim 1 to an individual in need thereof, wherein the cancer refers to a cancer treated by the active ingredient in the polyethylene glycol conjugated drug.
22. The method according to claim 21, wherein the cancer is selected from colon cancer, leukemia, lymphoma, bladder cancer, bone cancer, brain tumor, medulloblastoma, glioma, breast cancer, adenoma/carcinoid, adrenal cortical cancer, pancreatic islet cell cancer, cervical cancer, endometrial cancer, ovarian cancer, colorectal cancer, skin cancer, esophageal cancer, eye cancer, gallbladder cancer, stomach cancer, head and neck cancer, liver cancer, melanoma, Kaposi's sarcoma, kidney cancer, oral cancer, lung cancer, nasopharyngeal cancer, neuroblastoma, ovarian cancer, pancreatic cancer, thyroid cancer, parathyroid penile cancer, prostate cancer, urethral cancer, vaginal cancer, vulvar cancer, anal cancer, and sarcoma, as well as metastasis of these cancers.
US17/779,649 2019-11-28 2020-11-18 Polyethylene glycol conjugate medicament, preparation method therefor and use thereof Active US11793881B2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CN201911190064 2019-11-28
CN201911190064.1 2019-11-28
CN201911190064 2019-11-28
CN202010738638 2020-07-28
CN202010738638.0 2020-07-28
CN202010738638 2020-07-28
CN202010737415 2020-07-28
CN202010737415 2020-07-28
CN202010737415.2 2020-07-28
PCT/CN2020/129705 WO2021104120A1 (en) 2019-11-28 2020-11-18 Polyethylene glycol conjugate medicament, preparation method therfor and use thereof

Publications (2)

Publication Number Publication Date
US20230088403A1 US20230088403A1 (en) 2023-03-23
US11793881B2 true US11793881B2 (en) 2023-10-24

Family

ID=75996355

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/779,649 Active US11793881B2 (en) 2019-11-28 2020-11-18 Polyethylene glycol conjugate medicament, preparation method therefor and use thereof

Country Status (10)

Country Link
US (1) US11793881B2 (en)
EP (1) EP4066861A4 (en)
JP (1) JP2022554026A (en)
KR (1) KR102542715B1 (en)
CN (1) CN112851928B (en)
AU (1) AU2020389657A1 (en)
BR (1) BR112022010360A2 (en)
CA (1) CA3159842A1 (en)
MX (1) MX2022006519A (en)
WO (1) WO2021104120A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3189933A1 (en) * 2020-07-28 2022-02-03 Chongqing Upgra Biotechnology Co., Ltd. Polyethylene glycol conjugate drug, and preparation method therefor and use thereof
WO2022022354A1 (en) * 2020-07-28 2022-02-03 重庆阿普格雷生物科技有限公司 Polyethylene glycol conjugate drug synergist, preparation method therefor, and use thereof
WO2022242488A1 (en) * 2021-05-18 2022-11-24 重庆阿普格雷生物科技有限公司 Polyethylene glycol-drug conjugate and use thereof
CN116354976A (en) * 2021-12-27 2023-06-30 上海复旦张江生物医药股份有限公司 Process for purifying camptothecin derivatives

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104105508A (en) 2011-12-21 2014-10-15 加利福尼亚大学董事会 Telodendrimers with enhanced drug delivery
WO2015027054A2 (en) 2013-08-21 2015-02-26 The Research Foundation For The State University Of New York Telodendrimers and nanocarriers and methods of using same
CN104987504A (en) 2015-04-23 2015-10-21 南京明臻医药科技有限公司 Pegylated lapatinib, injection and preparation method thereof
CN105601903A (en) 2015-12-25 2016-05-25 大连理工大学 High polymer compound with anticancer activity, and preparing method and application thereof
WO2017210963A1 (en) 2016-06-07 2017-12-14 北京键凯科技有限公司 Peg linker and ligand drug conjugate
CN107670050A (en) 2017-08-30 2018-02-09 重庆阿普格雷生物科技有限公司 Anticancer intermediate and polyethylene glycol conjugation cancer therapy drug based on PKI 587, and its preparation method and application
CN107670048A (en) 2017-08-30 2018-02-09 重庆阿普格雷生物科技有限公司 Intermediate medicine and polyethylene glycol conjugation Synergistic anti-cancer medicine with Synergistic anti-cancer activity, and its preparation method and application
US20220105189A1 (en) 2019-02-03 2022-04-07 Chongqing Upgra Biotechnology Co., Ltd. Polyethylene glycol conjugated drug and its preparation method and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
US20050158273A1 (en) * 1997-09-25 2005-07-21 Harris J. M. Soluble, degradable polyethylene glycol) derivatives for controllable release of bound molecules into solution
CN104877127B (en) * 2015-06-23 2017-11-10 厦门赛诺邦格生物科技股份有限公司 A kind of eight arms polyethyleneglycol derivative, preparation method and its bio-related substance of modification
CN104758946B (en) * 2015-04-07 2017-09-29 中国科学院过程工程研究所 A kind of antibody coupling medicine and its preparation method and application
CN112843242B (en) * 2019-11-28 2024-03-01 重庆阿普格雷生物科技有限公司 Polyethylene glycol coupling drug, preparation method and application thereof
CN112915210A (en) * 2019-12-06 2021-06-08 重庆阿普格雷生物科技有限公司 Polyethylene glycol coupled drug, preparation method and application thereof

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104105508A (en) 2011-12-21 2014-10-15 加利福尼亚大学董事会 Telodendrimers with enhanced drug delivery
US20140363371A1 (en) 2011-12-21 2014-12-11 The Regents Of The University Of California Telodendrimers with enhanced drug delivery
WO2015027054A2 (en) 2013-08-21 2015-02-26 The Research Foundation For The State University Of New York Telodendrimers and nanocarriers and methods of using same
CN104987504A (en) 2015-04-23 2015-10-21 南京明臻医药科技有限公司 Pegylated lapatinib, injection and preparation method thereof
CN105601903A (en) 2015-12-25 2016-05-25 大连理工大学 High polymer compound with anticancer activity, and preparing method and application thereof
WO2017210963A1 (en) 2016-06-07 2017-12-14 北京键凯科技有限公司 Peg linker and ligand drug conjugate
US20190117790A1 (en) 2016-06-07 2019-04-25 Jenkem Technology Co., Ltd. (Beijing) Peg linker and ligand drug conjugate
CN107670050A (en) 2017-08-30 2018-02-09 重庆阿普格雷生物科技有限公司 Anticancer intermediate and polyethylene glycol conjugation cancer therapy drug based on PKI 587, and its preparation method and application
CN107670048A (en) 2017-08-30 2018-02-09 重庆阿普格雷生物科技有限公司 Intermediate medicine and polyethylene glycol conjugation Synergistic anti-cancer medicine with Synergistic anti-cancer activity, and its preparation method and application
US20200261588A1 (en) 2017-08-30 2020-08-20 Chongqing Upgra Biological Sci. & Tech., Ltd. Intermediate drug with synergistic anticancer activity and polyethylene glycol-coupled synergistic anticancer drug, and preparation method therefor and use thereof
US20220105189A1 (en) 2019-02-03 2022-04-07 Chongqing Upgra Biotechnology Co., Ltd. Polyethylene glycol conjugated drug and its preparation method and use
JP2022523752A (en) 2019-02-03 2022-04-26 チョンチン、アップグラ、バイオテクノロジー、カンパニー、リミテッド Polyethylene glycol conjugate and its manufacturing method and use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
International Search Report, International Application No. PCT/CN2020/129705, dated Feb. 20, 2021 (8 pages).
Office Action and English Translation, Japanese Patent Application No. 2022-531503, dated Nov. 2023 (10 pages). 2022.
Written Opinion, International Application No. PCT/CN2020/129705, dated Feb. 20, 2021 (5 pages).

Also Published As

Publication number Publication date
BR112022010360A2 (en) 2022-08-16
US20230088403A1 (en) 2023-03-23
WO2021104120A1 (en) 2021-06-03
EP4066861A1 (en) 2022-10-05
KR20220102659A (en) 2022-07-20
CN112851928B (en) 2023-04-25
MX2022006519A (en) 2022-08-19
CA3159842A1 (en) 2021-06-03
CN112851928A (en) 2021-05-28
JP2022554026A (en) 2022-12-27
AU2020389657A1 (en) 2022-06-23
KR102542715B1 (en) 2023-06-14
EP4066861A4 (en) 2023-12-27

Similar Documents

Publication Publication Date Title
US11793881B2 (en) Polyethylene glycol conjugate medicament, preparation method therefor and use thereof
CN104530417B (en) A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof
JP7362749B2 (en) Polyethylene glycol conjugate and its manufacturing method and use
JP2020531591A (en) Intermediate agents with synergistic anticancer activity and polyethylene glycol-conjugated synergistic anticancer agents, their production methods and their use
WO2021103342A1 (en) Polyethylene glycol conjugated drug, and preparation method therefor and use thereof
TW202342492A (en) Thiostrepton-inspired compounds for treatment of cancer and preparation thereof
US20230073036A1 (en) Polyethylene glycol conjugate drug, preparation method therefor and application thereof
US20240115713A1 (en) Polyethylene glycol conjugate drug, and preparation method therefor and use thereof
RU2805370C1 (en) Medicine, representing a conjugate with polyethylene glycol, method for its preparation and its application
EP4190360A1 (en) Polyethylene glycol conjugate drug synergist, preparation method therefor, and use thereof
WO2017086392A1 (en) Composition comprising novel glutamic acid derivative and block copolymer, and use thereof
CN110418653B (en) Pectin-adriamycin conjugate and preparation method and application thereof
CN110152013B (en) Pectin-adriamycin conjugate and preparation method and application thereof
US11952461B2 (en) Siloxy polyethylene glycol and derivatives thereof
TW202325273A (en) Fap-targeted neutron capture agents, and uses and formulations related thereto

Legal Events

Date Code Title Description
AS Assignment

Owner name: CHONGQING UPGRA BIOTECHNOLOGY CO., LTD., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LI, GAOQUAN;LI, DAJUN;ZHANG, QIAN;AND OTHERS;REEL/FRAME:060176/0628

Effective date: 20211025

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE